Notifications
2015_11_01 Data Snapshot

Table 1.  Get Full Table

Barcode UUID Date Type Category Notes
TCGA-01-0628-11A-01D e9ae38f1-072d-4250-93bf-7bbde6026909 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0628-11A-01R b7896d87-fe4d-4d88-882d-5fdb3527437f 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0628-11A-01T deae44b5-a44c-4077-ac64-76864e3a143f 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0630-11A-01D 401bb80b-60ee-42d3-9cf2-56ce0cbc1677 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0630-11A-01R 9d3c14d1-32a9-4d2f-9383-a579b715447c 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0630-11A-01T da577e9c-5e5d-426c-8bf7-7fcdf8486608 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0631-11A-01D 2e948a4f-81c8-4a11-80bf-87a9e5f84954 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0631-11A-01R 369e4cc2-8a5f-42c5-b3ed-6aaba24aa29c 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0631-11A-01T 059b29f2-3e15-4693-b5d4-bdb68050f2c1 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0633-11A-01D efd59047-5ecd-4cb3-80a3-e53a4b572e48 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0633-11A-01R 51f633f2-4bac-4981-8620-5887ca32a343 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0633-11A-01T 94510fa9-a877-4a50-b104-dd7c9d497438 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0636-11A-01D f7b26c0f-4c1d-4a4b-9b28-4f8c889b4683 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0636-11A-01R f54cfac8-93b0-469d-a012-122aeccc78f8 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0636-11A-01T 083fa5da-8733-4a55-a599-207213e02325 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0637-11A-01D d7124cca-9bad-4cb2-8f04-f64582fb7ffd 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0637-11A-01D-0508-04 8a482094-bda5-454f-b06f-841f89a57d39 08/23/2013 OV Barcode incorrect Incorrect Plate Number, should be 0357
TCGA-01-0637-11A-01R 5e01180c-7334-43b4-9245-4d3d9d0836c1 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0637-11A-01T f6310914-cb41-4d13-b0c2-84aa54072389 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0639-11A-01D 83fedd48-da85-4880-9ee2-246a9e2f3a70 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0639-11A-01R 5bd7b70f-8d22-4a0e-a42c-611360c4e259 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0639-11A-01T 7496860f-bf92-48f3-8eeb-57f3e9db752a 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0642-11A-02D 1d8afdb0-6c1d-458d-93b9-870b0675fd8c 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0642-11A-02R 00462f80-e951-42d8-b26b-39e81f3f1aa3 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-01-0642-11A-02T 499f98ea-f749-4018-9881-bba7b043165d 03/14/2011 OV Item is noncanonical Fallopian Normals
TCGA-02-0001 30a1fe5e-5b12-472c-aa86-c2db8167ab23 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0007 fb75eb9d-05be-4e6b-a515-f39efb15e66c 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0010 45a58ede-e7a4-424d-851e-e6a4062e46e4 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0021 d85fa9be-f7fb-407b-af46-31f495b210d6 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0023 c45e9e8b-35ab-4477-acdc-b18be0b3497d 07/27/2011 GBM Neoadjuvant therapy Subject positive for neoadjuvant therapy.
TCGA-02-0024 0553e60e-3510-417d-af8a-75947ebe8ab6 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0028 7ef0564e-d95d-4df5-969b-b204c207daea 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0043 de0cb811-bae0-407e-b8b3-97d1512bfa80 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0055 da5f6940-e8ee-4fd1-a8da-4cd68e02e59c 07/27/2011 GBM Neoadjuvant therapy Subject positive for neoadjuvant therapy.
TCGA-02-0057 7ee03602-bfec-413d-a05b-609cf60c6481 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0058 9734478b-05a2-4b5c-b8aa-9e6b0b0db02d 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma. Current TCGA tissue is reported as treated tissue.
TCGA-02-0080 5da36fd2-0cea-41b8-90dc-b94c3c28cbd9 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0083 b72fab50-aed2-48e7-b6ad-2a5bc7157cfd 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0087-01A 4b2fd094-364e-49d9-9d8d-39b67fb03587 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0087-01A-01-BS1 21dabc6b-5f9d-476c-9d23-14702263b368 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0087-01A-01-TS1 dcfb7654-4ec3-4130-b1b3-c3caffd43850 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0087-01A-01D 55a00ea5-1e54-4c5b-8a37-fb1402213d0b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0087-01A-01R fb412b52-9f70-44fa-b1e5-d2c8ca8ec43c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0087-01A-01T b533682f-39ea-4156-b67c-9c767d52e18c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0089 dfaae397-52c3-4d29-b665-971969e23432 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0099 883dc176-925a-44f7-9ec8-e0cce33c2a54 06/28/2011 GBM Neoadjuvant therapy Radiation treatment start date prior to date of procurement.
TCGA-02-0102 f3e57166-c428-4a44-9396-679e3a2b16a2 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0106-01A 1ba0cc6b-0902-407e-bab9-55068aac0d1f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0106-01A-01-BS1 ac55c894-dcc6-4caf-81a1-3700cfffcb44 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0106-01A-01D 7231a1e8-c43c-4673-a49b-6ef1d3464679 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0106-01A-01R 720269e3-5a8d-4021-8cd0-985946078505 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0106-01A-01T 26414f90-6c59-4455-bac5-6b1f4b055ad4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0107 372a4cc6-8fc9-4157-9cdc-fe020b176249 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0111-01A d2ce91f1-9e0e-4dc9-a153-34c9335136fa 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0111-01A-01-BS1 c9c99afb-327f-491e-b824-7bf761b8d242 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0111-01A-01-TS1 89374f94-22f0-4c3d-a890-ee6082c14bd5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0111-01A-01D 3b4ceb98-f8bb-4c4b-a0cb-3147ac7c3b88 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0111-01A-01R d4ad9fef-4c7f-4808-9e9a-48b9b5cbb506 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0111-01A-01T 3934a790-6f16-42b2-ba04-7c25c3dcc5e5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0113 b363b624-a5b0-46e4-b671-8813cc12eaf4 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0114 658c8e31-2c60-40f0-ab25-d0d0168647db 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0116 e117fe84-f003-40a4-96b5-8e26d0513151 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-02-0250-01B de15eca3-09df-42e1-a64f-3636eac9dc91 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-01-BS1 e7315aa9-6cb4-4699-b6af-16032378641c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02-BS2 050e875f-1086-47c9-8475-e3710f5c880d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02D d3256ce3-8c6f-426b-a1b9-58f40d376715 03/14/2011 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02D d3256ce3-8c6f-426b-a1b9-58f40d376715 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02R de085437-2eeb-480b-b469-1c521584cb99 03/14/2011 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02R de085437-2eeb-480b-b469-1c521584cb99 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02T d544d141-34b5-4ff6-af80-bbb4e1e592a4 03/14/2011 GBM Item is noncanonical No Matching Normal
TCGA-02-0250-01B-02T d544d141-34b5-4ff6-af80-bbb4e1e592a4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0258-01A c759563a-5c79-4a20-a8df-7d4b73265f89 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0258-01A-01-BS1 20723954-089c-4c85-a447-e0020f50d476 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0258-01A-01-TS1 5167145e-a13f-4602-ad98-09e645d47e28 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0258-01A-01D 58b0292b-1daf-4f5f-87ff-91811c1e356e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0258-01A-01R af3aea19-83e2-4261-8af3-f648e3340acf 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0258-01A-01T 0de5bda5-0c4e-4a70-b4e6-ca59d1f4b419 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0260-01A 3cb49f40-ce08-4af5-87da-6bb4268aaefc 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0260-01A-02-BS2 39ec2ae6-b1db-472e-aa73-f788409b3a7f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0260-01A-03-BS3 a9f5306a-1e02-4936-9fba-77834bd4fb9f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0260-01A-03D 14ac57cf-5292-478b-8baf-94fb2b97a8f4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0260-01A-03R cce77c94-3628-4526-bfb8-e9347e107943 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0260-01A-03T a24eaa6b-1ebb-4b4e-8fa0-34ac3239a571 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0266-01A e67add7d-df58-4e3d-aa61-d80c8756540a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0266-01A-01-BS1 ae25afee-b03f-41e9-87dc-370340d98f26 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0266-01A-01-TS1 52ab3195-de07-4f97-a27a-2e9d2cba4453 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0266-01A-01D 3f2a026e-3b52-42fc-811a-8f35d2faadf7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0266-01A-01R 4c2b0b29-4d64-499c-972d-af5dd7d06d93 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0266-01A-01T 030a236f-31b6-447c-84f5-e1febc7230b4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0269-01B 71e4f1fd-bab5-4b24-9a99-eae0cc91b5b1 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0269-01B-01-BS1 9eac90f9-6e5c-4af8-b49a-b8fc3348a894 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0269-01B-01-TS1 4c1a3d9e-b9ee-4860-9e71-a5c0ded031e4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0269-01B-01D 21fcb45d-9cef-4127-8428-2b0cd5f8d564 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0269-01B-01R 0c71ad00-a1a0-4f86-8d9a-a757b4ff4032 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0269-01B-01T f1f8ed87-1aa8-47bb-8d5b-e7f28e5f53b3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0271-01A 55f69b4a-4222-4cb9-83f6-0b583f7d2310 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0271-01A-01-BS1 cba09e5d-db4d-43df-9721-2512944f0fb3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0271-01A-01-TS1 4196b769-baee-4e87-adc0-6d1fedf47ebc 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0271-01A-01D 8996b945-713f-443c-94f0-bc141b5b0043 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0271-01A-01R 7889a33b-a075-4cd2-a46e-dad8c0042c91 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0271-01A-01T 5a67c5e0-eda7-4530-88f1-67738eddeba3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0281-01A f6f8ef39-906e-43bc-93ff-21f5c37d64c8 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0281-01A-01-BS1 eba2e2d8-2548-4735-9cb8-cc139fd572b1 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0281-01A-01-TS1 a8ad1fd9-c6a4-444a-a78e-79cb040e1b61 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0281-01A-01D 1c8d7f35-dcaf-4473-b104-6d93d3a067c9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0281-01A-01R 984b7893-7234-4c05-b5a1-ebafa042ec95 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0281-01A-01T 1468840e-3f8e-4544-b57f-e8ea4a33ccaf 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0285-01A 775452a9-7af8-4f91-a21e-194ccac93813 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0285-01A-01-BS1 417d0ce0-f451-4a3f-ada2-fee5f95f7c41 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0285-01A-01-TS1 b7e3cc80-8abe-4f85-95d0-7332eaed92fd 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0285-01A-01D b13033c0-7105-40cb-9569-1caa2cef5c08 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0285-01A-01R 320014e0-032b-4f04-91de-4b6419c54a44 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0285-01A-01T 1b1b2037-8665-44ca-95a3-6010a193412e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0289-01A 681395f8-8da0-40aa-ab40-3139a166819f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0289-01A-01-BS1 173de243-c092-4915-b039-5f1ba7264786 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0289-01A-01-TS1 9f31d52a-5a7d-4e81-9798-6a386dcafe29 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0289-01A-01D 880b619b-fc9f-49cf-9081-896cf6fcf526 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0289-01A-01R 57f72fdb-23dc-4700-82b9-c71e0093ba75 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0289-01A-01T 088b2650-003c-4b74-bcff-0d04929c8bef 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0290-01A ca87988a-9aa3-4b60-b557-c4b91cb07b2c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0290-01A-01-BS1 dbc6978d-2dcb-4439-8b76-040786253026 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0290-01A-01-TS1 06c77b0e-e21e-4d10-ae5d-e71d8fae1ddb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0290-01A-01D 5526a060-cd00-499d-a530-5dec74152d2a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0290-01A-01R 78764a99-b43e-4603-8bd9-901a2284470b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0290-01A-01T 38aca152-de6a-4285-b408-d69cddfb8a65 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0317-01A da2df347-d387-4db1-a98c-f65a2799b58f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0317-01A-01-BS1 ac6c0002-97d3-4ec9-84a0-aa59a55a5ad7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0317-01A-01-TS1 6b6be5f1-8e00-4836-990c-256685c2b28b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0317-01A-01D e34728d1-a112-4dca-b395-e8a332bfef80 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0317-01A-01R 839a53cb-2589-408c-91ea-876515b4a28a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0317-01A-01T ebcc337c-ddb4-40e7-b891-54e09aa9cd7a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0321-01A 6e7783f4-634c-4673-ac90-91597041e5b9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0321-01A-01-BS1 c8aacb16-a44d-457f-95ac-40f9cd146a2f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0321-01A-01-TS1 21c1b187-d6ef-419e-9a5a-798a6920102b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0321-01A-01D 345ebc4a-fe1a-49c8-9f26-84490de6be51 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0321-01A-01R 7432a869-aa98-4bbc-9d94-8bfd00d0d33e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0321-01A-01T d8b88607-8806-4c6d-bd5e-afae8107a631 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0324-01A 215e9dd4-acf8-41c7-98ca-0a655d3713a3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0324-01A-01-BS1 f7119931-9d3d-4166-b701-0b2ab0ccc096 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0324-01A-01-TS1 5e197c18-99d7-4a08-a583-459584302a94 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0324-01A-01D 7ddb39b3-1b1d-41a4-9cd7-cdac5ec4ed61 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0324-01A-01R 03763f57-7daa-42ca-ab8f-faf4b706f80d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0324-01A-01T c5ac11f5-b657-4408-98cc-200dae3c8e20 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0325-01A 8b24ff72-ca7d-482d-bddb-27f504a17006 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0325-01A-01-BS1 150a26b6-a600-4e2a-932d-28bcdfa636f9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0325-01A-01-TS1 2285fee9-7052-4e72-ad36-d254bbec13a2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0325-01A-01D b1d81550-a0c5-4ef5-95c6-27cb77ba06cf 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0325-01A-01R f0f5af02-96fd-48c7-8e8d-1dd8e6518d73 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0325-01A-01T 36121f0a-1dff-4220-82c5-64b77cd03311 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0326-01A 23d261c2-a661-412e-90e0-acae10122cd7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0326-01A-01-BS1 e183ea80-7a91-4851-bc2f-aa6dd57ddc2e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0326-01A-01-TS1 078acdb5-24fe-498c-9929-c14966c87f1e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0326-01A-01D 137d095d-d9fa-4f54-a59c-c6d2df4a2242 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0326-01A-01R 245f53f1-c51b-4c4c-bb2c-4912cac718fa 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0326-01A-01T a75c40fa-a6ee-41d6-8573-112df5a638ac 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A 107c0827-9987-4291-a5c6-df0b33f71597 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01-BS1 e57275da-90fc-4be4-bab2-9ef0a5e1b1bb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01-TS1 ce2b33ab-8a13-401d-baa1-b88cd09e6752 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01D 0bded383-ccbc-43f3-b469-cc3fd195f99f 03/14/2011 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01D 0bded383-ccbc-43f3-b469-cc3fd195f99f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01R 637f812f-eded-4bd1-9855-b6e8eb30f119 03/14/2011 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01R 637f812f-eded-4bd1-9855-b6e8eb30f119 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01T 0a1a35d9-b828-46f0-a870-b2d84e313a70 03/14/2011 GBM Item is noncanonical No Matching Normal
TCGA-02-0329-01A-01T 0a1a35d9-b828-46f0-a870-b2d84e313a70 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0330-01A 8965bbd9-36a3-4a13-9885-38e56b28a649 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0330-01A-01-BS1 46c1ee66-a238-4486-9893-422075c35489 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0330-01A-01-TS1 c2a615c6-73db-4e22-b7c6-785941908f82 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0330-01A-01D 13cb7d8c-62d8-4132-abbc-2e0b14f8e046 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0330-01A-01R 610f3ae1-47f6-4975-b801-c06fae735e4e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0330-01A-01T 6108a5c2-1139-4be3-999a-b1e61549ad3c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0332-01A 4ffa6fa8-99cc-41a3-b84a-a14574d4e6db 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0332-01A-01-BS1 60ce892d-5701-4650-8120-ead9cf3d90ec 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0332-01A-01-TS1 8c0e3c26-40b5-41fc-ab46-a62f812a561e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0332-01A-01D bfea5c85-bae4-431b-b2be-a39160cdc37f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0332-01A-01R ddad703b-f4b1-41f7-a95e-101fcfb667ef 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0332-01A-01T 60acb56d-f18f-4de4-ab80-203a68102dc3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0333-01A d4e1fa0f-069d-4b5e-ac8c-3b855fda85fe 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0333-01A-01-BS1 8efff1ff-6b49-4cd6-ac15-f6e535977ac4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0333-01A-02-BS2 ca2506d8-429b-43fe-b87d-4dfb8999adca 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0333-01A-02D d3fcedea-2c26-40c8-994d-dacc625cd9c8 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0333-01A-02R b314600b-4168-40d5-b406-7c00667983ec 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0333-01A-02T 37e65eab-be13-4d04-8c5b-28d4d6686e19 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0336-01A fde4e14f-1a9e-4a2d-8e92-506b4fac0839 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0336-01A-01-BS1 1149abc7-38fd-4d10-b1e9-7caa8011a3c7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0336-01A-01-TS1 221bced4-99ea-492e-93ec-fa3316eb5250 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0336-01A-01D 695dcdcf-08e0-4f11-a4e2-a62585a05f4a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0337-01A 023a5d07-0e00-466e-8d92-19758d50226b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0337-01A-01-BS1 02cfc076-c847-46f7-96bf-0fee6ea08a51 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0337-01A-01-TS1 02da2b6f-46e3-4732-a374-595fe0b0a43e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0337-01A-01D 14c97c81-699c-4c4e-a95a-aad81d09fb48 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0337-01A-01R 20630b3d-88d4-4de0-8671-ffbf4596752c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0337-01A-01T 619c8e95-b5ea-46bd-97c1-0808bc276fd2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0338-01A 218769d8-5818-4ad4-8a38-50e7991e2b2e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0338-01A-01-BS1 be0f11dd-efcc-45b2-be4b-45c0aa717279 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0338-01A-01-TS1 43174f16-205a-4511-9c01-3c6038f1325f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0338-01A-01D 56b6c236-f2eb-44a5-8620-d01feb23432e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0338-01A-01R 00992266-6974-44f5-bea1-1e36c971345a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0338-01A-01T 532ab7d1-9dec-442a-8981-d1b25f8b3703 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0339-01A 30448f7a-f27c-4e28-971b-9928c23d7f49 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0339-01A-01-BS1 c0246ad0-dd46-4339-ae72-82f61cba8794 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0339-01A-01-TS1 56d50762-23ee-4e95-98f6-af824cbc450b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0339-01A-01D 5ef16f4b-088c-4830-9cc0-90aa304c81f9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0339-01A-01R 793c36d7-fcf9-411e-9b22-ca4bf2b33247 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0339-01A-01T 873e2622-ba53-4219-8af1-cf10d3811e16 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0422-01A 36d86af4-2773-4e58-83e0-14ad7b80c179 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0422-01A-01-BS1 82a876cf-7878-4016-a6ef-b737ec16ad19 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0422-01A-01-TS1 3fc10cd8-3eec-4256-b722-e12d697b56e6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0422-01A-01D b61a4f4d-fa91-415a-b907-94cf45c44567 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0422-01A-01R 9a27aa87-1b56-4ff7-be79-c1f7602143d4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0422-01A-01T 30d3bad0-02e1-4164-a328-4c8e506e3411 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0430-01A dd7e99bb-233f-46b1-a640-dd97762990b6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0430-01A-01-BS1 e7d0b71f-c363-44d4-9d3f-0255553f749d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0430-01A-01-TS1 ec4b0525-396e-4955-ba54-8b5a9a09cf1b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0430-01A-01D 2c262bf4-f80b-4ea1-9bac-ae7b77824178 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0430-01A-01R 6b79eef4-dac5-4868-8d56-c80ead552aa5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0430-01A-01T a4875dd0-d3d6-43ad-bb65-52e50091c74e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0432-01A d65cdb49-6b19-4c5a-8903-58a6bc91a769 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0432-01A-01-BS1 7c98bffe-0fef-4386-96f0-032264bd6be3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0432-01A-02-BS2 2bbf7216-3d94-4fd3-a1ee-10dca29fe486 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0432-01A-02D 20f82cb2-cce6-48df-8bad-b4ffe7d17965 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0432-01A-02R 6e67efa5-f2b3-4715-9358-3230ba7c85e6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0432-01A-02T 2f3e15b5-398b-4c4a-b491-6770a9aceb1d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0439-01A 33614e32-e752-4ca0-ab50-63bace8b1002 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0439-01A-01-BS1 30cdf57d-164c-4541-8ce0-ed3b4bdf3d7e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0439-01A-01-TS1 a9411241-e113-46af-9bbc-3406486c7174 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0439-01A-01D 7db2a119-4d1b-467a-8a13-d00b697b0523 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0439-01A-01R 671b8204-6048-43ce-8b16-fe95161f00eb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0439-01A-01T f8e3b8e8-7f14-45df-82b8-00a95f2e927b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0440-01A bc95f7bc-dfdf-4d18-80bc-7f63c2e49160 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0440-01A-01-BS1 0533791d-c86b-429f-b5e5-0c1add17c51d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0440-01A-01-TS1 c66e12ca-92ad-4550-9293-0a299060f0ff 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0440-01A-01D f76a9ee8-27f8-4141-908e-d2170c8802a7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0440-01A-01R da0872bd-ffec-4df2-b856-61d19909f5d5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0440-01A-01T e4dde96b-ccd9-49a5-85bb-be3af52ce703 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0446-01A 0335ca76-6205-4314-8183-5df174e6a330 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0446-01A-01-BS1 dd03674e-ad0c-489a-877f-afde8f7bb031 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0446-01A-01-TS1 758c4560-f2ad-4a03-9863-7e45d3b2ef10 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0446-01A-01D ed19f468-0bee-4c7b-a92c-ed1c1c34227b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0446-01A-01R 9d8e614b-a8f5-4f8e-aa90-cc2ae5d8a0ff 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0446-01A-01T de879024-2711-480e-a0ac-2cee7ed8af71 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0451-01A 243162ca-8b38-443e-a108-b20109f7864b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0451-01A-01-BS1 581c6349-442a-494e-b869-b576beeeb0df 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0451-01A-01-TS1 32c1fc60-a1be-4180-aef0-a35e0f42b53f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0451-01A-01D 97a56fa4-1799-4a5e-a322-4603cc8c488c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0451-01A-01R d61b8bc4-622f-4ed7-b7cb-97d10246fb8c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0451-01A-01T d485c6ff-8639-475b-afe4-36c2c83dfb03 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0456-01A 6ee961cc-3afd-4564-a652-69a76f2996fe 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0456-01A-01-BS1 9bbb1662-df19-4c1b-9808-0a90b560b0b6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0456-01A-01-TS1 ef21296c-f831-4449-8a16-933f0090a558 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0456-01A-01D 06cf8452-0a10-4439-a374-e6dda8593a2f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0456-01A-01R 12304a8a-3694-46dc-917c-d1a3e435f0e7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-0456-01A-01T 15eb5137-acf9-49e4-aa9e-c3d2d82a7b9c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-02-2470 e948d951-9299-4dec-9772-60b4ac3569cb 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-04-1331-01A-01T-0436-07 350a7c91-7762-4724-8eaa-eadc315ce879 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1332-01A-01T-0436-07 66034479-db77-4c63-97e0-78286ac4f13a 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1332-10A-01W-0488-09 fb4f221e-04bf-4b66-bb89-c6622db4bb08 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1332-10A-01W-0489-09
TCGA-04-1335-01A-01T-0436-07 eeac4627-9cf3-4ea5-84b4-995bc70ce396 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1335-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1335-11A-01W-0488-09 0ee466a7-6282-433a-b150-aa2b086e9947 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1335-11A-01W-0489-09
TCGA-04-1336-01A-01T-0436-07 6ff09f20-4b84-4552-9a0c-82736ebcc182 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1336-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1336-11A-01W-0488-09 0469461d-d3a2-4df5-8209-c1e0c20b0f39 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1336-11A-01W-0489-09
TCGA-04-1337-01A-01T-0436-07 cebd3fdd-b1ad-4383-99e6-546c2768295e 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1337-11A-01W-0488-09 1e91af92-473e-4fd4-84f8-b5f8dfa87d6c 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1337-11A-01W-0489-09
TCGA-04-1338-01A-01T-0436-07 bda360d1-270e-4387-8d20-d0402a2a3d72 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1338-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1338-11A-01W-0488-09 05f030ca-8eab-47d4-9092-1678bc64e6c1 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1338-11A-01W-0489-09
TCGA-04-1341-01A-01T-0436-07 0934d173-6208-41e5-bac2-69be8bd13979 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1341-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1341-10A-01W-0488-09 463af5ef-b30c-4fe4-a565-fe2583e0ab2f 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1341-10A-01W-0489-09
TCGA-04-1342-01A-01T-0436-07 7774449c-d6ed-45ca-854f-fdf674c51c61 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1342-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1342-11A-01W-0488-09 bff63e7a-f4ad-4cbe-a88a-c46688e120f9 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1342-11A-01W-0489-09
TCGA-04-1343-01A-01T-0436-07 f0e454de-73ae-4317-a285-9a47fbc1fa40 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1343-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1343-10A-01W-0488-09 16190739-5c6d-4362-9a54-3dd730b42f7a 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1343-10A-01W-0489-09
TCGA-04-1346-01A-01T-0436-07 2cc43b78-5c23-446a-a514-6d965843720f 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1346-11A-01W-0488-09 6487b7f9-b014-4007-957c-0db2eb7d5e31 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1346-11A-01W-0489-09
TCGA-04-1347-01A-01T-0436-07 bd29b74e-bef4-477a-a7f9-a8d075055559 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-04-1347-11A-01W-0488-09 9a004a0c-a2cd-4ba1-8d11-bea410d8463c 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-04-1347-11A-01W-0489-09
TCGA-04-1348-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1349-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1356-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1357-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1360-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1361-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1362-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1369-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1370-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1514-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1516-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1517-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1519-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1525-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1542-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1638-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1644-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1646-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1648-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1649-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1651-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-04-1654-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-05-4244-01A-21-2190-20 59881fe3-70f4-4fa0-9355-f50250872752 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4245 03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2 09/02/2010 LUAD Qualification metrics changed [intgen.org]: Changes to qualification metrics / Indivumed Prior Malignancy Subset
TCGA-05-4245 03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2 10/31/2012 LUAD Prior malignancy Prior malignancy colon cancer treated with systemic chemotherapy.
TCGA-05-4245 03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2 11/10/2012 LUAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy colon cancer treated with systemic chemotherapy.
TCGA-05-4249-01A-21-2190-20 5b46a235-49a6-43ea-91b6-82a384702477 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4250-01A-21-2190-20 3f069d62-c371-4f30-bdb4-c58093bbb1d7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4382 3434b91a-c05f-460f-a078-7b1bb6e7085d 10/31/2012 LUAD Prior malignancy Prior maligancy cancer of the penis. No systemic chemotherapy or radiation.
TCGA-05-4384 9a50e7e4-831d-489f-87d2-979e987561cc 10/31/2012 LUAD Prior malignancy Prior malignancy rectal cancer. Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-05-4384-01A-21-2190-20 5e735c28-5f2b-47ec-98fb-2f57cc8a5d6a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4396 9f81c602-8afa-4588-b0b6-6e5a1a128d5a 10/31/2012 LUAD Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-05-4396-01A-22-2190-20 b7cb4257-cc52-4219-8e7b-0a6e881532af 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4397-01A-21-2190-20 e2c7eef9-5765-4ee9-92dd-a632be207eba 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4398-01A-21-2190-20 33467565-286d-4be1-a430-d1a74a5752f0 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4402 722d6818-f1cb-49f4-b68a-fd0a31304681 10/31/2012 LUAD Prior malignancy Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-05-4402-01A-21-2190-20 4e5d6d6d-af25-4b7c-bb75-357b90e36434 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4405 f587c9ab-2949-4410-80d6-a050865d48aa 10/31/2012 LUAD Prior malignancy Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-05-4405-01A-22-2190-20 86533c79-3f76-4293-ac1e-cbe3482a1765 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4410 d28e465c-e553-4c53-8bb7-3d8199b9a8a5 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-05-4410-01A-22-2190-20 b5ff5d37-3c6b-4fdb-9d52-668269d77d4c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4417-01A-23-2190-20 9d52cd8c-4ff7-44fb-8abc-441150545c46 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4418 d2c1e896-6886-4122-bb48-5fbcd3f641f4 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-05-4418-01A-21-2190-20 51411ac1-143c-428b-8a13-22ececc4d2f0 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4420-01A-21-2190-20 17a82652-9990-4947-998e-ac10b35923d2 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4422-01A-21-2190-20 6fd0d313-a9a6-46e2-b37f-d2bc537bed19 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4426-01A-21-2190-20 c737047d-6c28-4463-84b6-dd585bb960fc 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4427 78a24c56-576c-4245-bb42-6603b3d19897 10/31/2012 LUAD Prior malignancy Prior malignancy malignant melanoma of the skin. No systemic chemotherapy or radiation.
TCGA-05-4427-01A-22-2190-20 8d0744f3-398b-485e-a564-092cc3d1a268 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4430-01A-11-2190-20 c4a810c3-91fc-4010-a669-cb616238d295 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-4434 d94fe32f-bedd-4f4c-9feb-fcb60d40f4bb 10/31/2012 LUAD Prior malignancy Prior malignancy breast cancer. No systemic chemotherapy or radiation.
TCGA-05-4434-01A-21-2190-20 a1067628-2a22-4bbf-8978-7ae9b7953e39 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-5420 8b119d1c-6d21-4bbd-8a00-12da7b97d6c4 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer treated with hormone therapy. Prior malignancy secondary malignancy of unknown location treated with radiation in unknown field.
TCGA-05-5420 8b119d1c-6d21-4bbd-8a00-12da7b97d6c4 11/10/2012 LUAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with hormone therapy. Prior malignancy secondary malignancy of unknown location treated with radiation in unknown field.
TCGA-05-5420-01A-21-2190-20 24209db7-f1fb-41fd-9f5e-de3f6480a606 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-5423-01A-21-2190-20 4c1ed504-6b5d-49d4-bc1d-5844ae2e7f8b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-5425-01A-11-2190-20 591cdbcf-f93b-4ae6-b1ad-7cc69a11862b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-5429-01A-21-2190-20 88f95b94-582d-4db9-82d1-f6253c6c9837 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-05-5715-01A-41-2191-20 4f36ddf4-4d4a-4733-9809-d4fd53d8457a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-06-0119 2cb9975f-2d1e-4c74-867f-8b151c22b246 07/30/2010 GBM Item in special subset [schaefc]: NECROSIS_STUDY
TCGA-06-0119-01A-08D 558557e0-392a-45ce-a2c6-52ac8dbea8c7 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0119-01A-08D 558557e0-392a-45ce-a2c6-52ac8dbea8c7 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0119-01A-08R 9dc6a695-9cc3-4e4c-b89b-79e52ea2657f 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0119-01A-08R 9dc6a695-9cc3-4e4c-b89b-79e52ea2657f 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0119-01A-08T f7c0f6a2-2c13-4621-ac3e-9848ce00702a 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0119-01A-08T f7c0f6a2-2c13-4621-ac3e-9848ce00702a 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0119-10A-01D 38d4497c-a4b7-4858-a42a-cc613b43ebfc 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0119-10A-01D 38d4497c-a4b7-4858-a42a-cc613b43ebfc 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0121 0ff91707-190e-4e2d-a3a0-42e3207225e9 07/30/2010 GBM Item in special subset [schaefc]: NECROSIS_STUDY
TCGA-06-0121-01A-04D e458cdc4-923a-4edd-97d6-f3afefb487ec 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0121-01A-04D e458cdc4-923a-4edd-97d6-f3afefb487ec 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0121-01A-04R 1ef96ea9-6672-498b-a076-ccc05fe12ae1 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0121-01A-04R 1ef96ea9-6672-498b-a076-ccc05fe12ae1 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0121-01A-04T 4c941a51-cb95-40fe-b674-6fa2a81ac81b 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0121-01A-04T 4c941a51-cb95-40fe-b674-6fa2a81ac81b 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0121-10A-01D f65fe926-6652-45a1-be5c-bb3363d1db1f 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0121-10A-01D f65fe926-6652-45a1-be5c-bb3363d1db1f 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0125-02A-11D 74e53350-e588-4f8a-816e-67984adca9b5 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0125-02A-11R ff843d81-7920-4737-a182-63eb98e6aa7d 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0125-02A-31-2189-20 90b8929e-a919-460e-b3d6-48eb33bcad0a 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-06-0131 d75996d6-9f02-4478-a4a1-dfa7ab41de77 09/02/2010 GBM Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-06-0137 d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775 07/30/2010 GBM Item in special subset [schaefc]: NECROSIS_STUDY
TCGA-06-0137 d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775 09/02/2010 GBM Qualified in error [intgen.org]: Qualified in Error - Decommissioned
TCGA-06-0137-01A-01D 2668dd90-3e2e-42a8-98ed-7c2d82cfd56d 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0137-01A-01R 47dd7f46-877d-4f6e-935f-758a09684d5b 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0137-01A-01T e8ffac42-9569-484f-9e1c-1608929ed73d 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0137-01A-02D 132cd8b9-75b7-485f-b58f-6e782a38ba48 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0137-01A-02R 3db36939-8a0d-4909-93a3-78eb7f9086cf 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0137-01A-02T 5e58ae78-5f2e-4467-8f76-a2b958a860df 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0137-01B-02D ab6b6bf7-40b4-47f9-a004-ad74e38beb3a 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0137-01B-02R 4ab122f4-a986-4007-bc54-c67ffa4457d9 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0137-01B-02T 1e32c54a-1a1a-461d-823a-8fe58e4805d0 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0137-10A-01D f0e4a38b-697d-43ce-aa40-31f7a828ec8e 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0137-10A-01D f0e4a38b-697d-43ce-aa40-31f7a828ec8e 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0138-01A-01D 9fa9ea2a-0038-4a1f-9dd6-979f972a26f0 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0138-01A-01R b5edea7b-17f0-4004-bf27-ddee227f86bd 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0138-01A-01T 87196b6b-2e00-4a7c-bf89-3aa7de98cda8 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0139-01B-05D a8b24891-cc1c-4d3f-856e-5eee57c6ea69 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0139-01B-05R 26816bb8-c2d4-4d0e-a8c4-9c6808ca87d6 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0139-01B-05T 403cede0-cf43-4d6f-aa2c-42a7c24d1ebc 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0139-10A-01D 018966a4-712b-4921-a7e7-02e390f43288 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0140 0164acd3-34db-4d35-b96c-936daad0ff22 07/30/2010 GBM Item in special subset [schaefc]: NECROSIS_STUDY
TCGA-06-0140-01A-01D b05e1f5d-e731-4204-b544-9a6cfa93f325 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0140-01A-01D b05e1f5d-e731-4204-b544-9a6cfa93f325 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0140-01A-01R a5e5bd60-02ce-41fa-b973-2eb537e85a6e 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0140-01A-01R a5e5bd60-02ce-41fa-b973-2eb537e85a6e 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0140-01A-01T 0ccdb67c-5745-4d17-9ac0-07ba8eb386df 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0140-01A-01T 0ccdb67c-5745-4d17-9ac0-07ba8eb386df 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0140-10A-01D 5a9ce7ea-8415-4a14-a150-65cc0397e580 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0140-10A-01D 5a9ce7ea-8415-4a14-a150-65cc0397e580 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0142-01A-01D f764aafc-631e-49f7-806d-5507bc4d49a1 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0142-01A-01R f3106b84-1b71-4546-9f36-be0a3aa5fd4e 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0142-01A-01T b5534734-e68f-4c15-9a02-d7f058c696eb 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0142-10A-01D 08050169-fdfb-4bf7-9da5-0fe4204a785c 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0145-01A-02D 722257d1-2c1a-431d-8415-e5483907a662 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-02R d7c4e45a-98c4-4fca-8db3-7f4a52aa4f95 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-02T 7f5e9fef-78f2-48de-b78b-492ef05b1fa9 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-03D bfa7fba3-f31c-437d-b880-e3143cdfd308 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-03R 454d11ab-1c39-4d2e-8235-b986bef7938d 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-03T ddc34ca8-1a3f-459c-ad90-04ffd3b6eb00 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-04D 2c81dac0-c673-49c5-ac17-37cefc869321 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-04R fb42860d-6540-408a-9011-545096a1c58d 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-04T 310c3b55-e5e7-4839-9a42-3d020e51d57a 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-05D 620a33c7-5201-485d-8240-5e2b59f3e5cf 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-05R 90236dea-6e6c-4d2a-9b09-d200f0bec94a 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-05T 8607a2dd-73bb-44c8-a034-6027b5f29201 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-06D ab9cc7c1-150f-4389-9f09-ca5b17727082 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-06R 2fac2b3f-0f2e-4abf-aaa9-58b129cc3feb 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-01A-06T 041dee76-fccd-4000-a0cd-6e134b045608 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0145-10A-01D 0550bba3-e5c2-4de6-b37a-1d9e1e4ba08c 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0146-01A 534449bb-4dc3-445d-9743-06217caa3627 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0146-01A-01-BS1 e1ecfb0e-cead-4393-9d46-36ace3452928 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0146-01A-01-TS1 0fd0511f-cbe2-4ec0-abb5-051d36ba12d8 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0146-01A-01D f74ee317-af98-4657-aba4-1b1ebac190a6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0146-01A-01R fce7a84c-2c14-4680-95e9-9ed353357299 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0146-01A-01T cc3b9e23-67f5-4c1e-a511-0e41c9d30c27 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0147-01A-02D 8b202927-94c4-4681-8b53-4a5ea1e68422 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0147-01A-02R c26e8e1b-73f0-4e11-b51a-ffda5563ae80 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0147-01A-02T ae9330c2-86a5-4e1b-beb3-e30d5526050a 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0147-01A-02W 22c2f326-506c-4659-87ae-fb0a1a4f5798 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0147-10A-01W f3c41997-ca7c-499c-9d92-9eed58f30d3a 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-03D ecb9464a-0a73-49f8-b3e4-30ec46d3a4b7 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-03R 6c2e91a2-84b7-4d2a-95f4-1d0f02c2da68 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-03T bf10a692-8e04-40f0-b7e3-965dae3fd6d5 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-03W 8fbc9ce0-6ce0-4b96-a903-fa088fcdd75b 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-04D b14b041c-214d-4312-82a1-3dbacbf3099b 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-04R d6bff964-700e-4176-a192-52eb717b2a52 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-04T 33163737-8572-4091-9224-fc1f386e4c8b 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-04W a410fd08-a2ae-4455-a904-c2a8ab20dff5 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-05D 8c128789-ff26-4d64-8c4a-05c5762b1d12 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-05R bb9849e3-bc99-48d6-8b52-1ca9df5fec95 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-05T 5a11480e-7d9b-4205-9b5e-f9a89f09da5d 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-01A-05W 0e814c9d-4e4b-43b0-b037-85111d1b247f 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-10A-01D d616d7e4-4b08-4922-9235-1eb6be23b88a 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0148-10A-01W ff9dd122-1aaa-46be-a126-dc495c253a2f 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0149-01A 4c8fc14c-9e01-49c7-aec7-e8be750c89c4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0149-01A-04-BS4 6eeb9e00-6db2-4177-a5f9-131fc52a23f2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0149-01A-05-BS5 1451180e-79e8-48a0-aff9-09367260fda3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0149-01A-05D dc9fc0cd-107a-4043-8c10-18cdcbee4986 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0149-01A-05R a438c42a-4c20-4e92-b0bb-2f2fca40fa8f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0149-01A-05T 835049dc-3abf-41aa-9a79-95a35604e94c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0150-01A-01D 1ab314a3-151f-4760-8f58-773b29bec943 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0150-01A-01R 478354d0-4748-44b4-b9e0-bb938b125519 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0150-01A-01T e1ac56d5-d5a6-4256-8ab9-126b592b9f20 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0150-10A-01D 9051062c-9c84-495e-80cb-1f213dc2d261 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0151 c57d6674-08d1-4eda-9ec1-ae439923d7cf 07/30/2010 GBM Item in special subset [schaefc]: NECROSIS_STUDY
TCGA-06-0151-01A-01D 0049f446-9d53-4bdc-9ca7-60ed9e2d86e2 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0151-01A-01D 0049f446-9d53-4bdc-9ca7-60ed9e2d86e2 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0151-01A-01R 99d64294-8440-40ff-af9b-3ebbeeeb1c40 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0151-01A-01R 99d64294-8440-40ff-af9b-3ebbeeeb1c40 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0151-01A-01T 2a589611-a28e-499e-8675-60e7debb100c 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0151-01A-01T 2a589611-a28e-499e-8675-60e7debb100c 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0151-10A-01D 8bbc6177-cb2a-4190-9de3-268ce77aa0dd 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0151-10A-01D 8bbc6177-cb2a-4190-9de3-268ce77aa0dd 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0152-02A-01D 13ab71eb-774d-41af-9274-be95e03e8b09 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0152-02A-01R e54fc273-1c24-485f-9391-2b1551215726 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0152-02A-31-2189-20 6ffa2e82-b35c-44cb-ab41-56efaa0d3e90 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-06-0154-01A-03D 8874ac6f-b3c5-4a61-bf57-42928e789af0 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0154-01A-03R f956a749-ad76-4d23-a291-3261382b49f8 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0154-01A-03T c3041b7d-82bd-4fa3-9597-0c7369acf031 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0154-10A-01D 0d7a0fb7-9b09-4f95-8257-d0c0f7c959b2 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-01A-02D 570e20c8-1de6-4d27-87b0-a5421bbe477f 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-01A-02R 91fd8841-c364-4685-895e-113cf5e8c141 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-01A-02T e13f617c-af49-4487-b451-bf518deb72fd 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-01A-03D 7c068503-625a-4d12-a464-fcb1fa65b7d1 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-01A-03R bde3e429-4afa-4855-8a6c-9862232ec313 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-01A-03T 8d5024b2-e70a-4b9f-9273-74f5f60271cf 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0156-10A-01D d9b4bae0-a6af-4b8b-8834-ef64bdf7a9c6 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0159 5f8f66a0-4068-4e9d-82fc-4fe1fc3f63aa 07/30/2010 GBM Item in special subset [schaefc]: NECROSIS_STUDY
TCGA-06-0159-01A-01D a7f1e5d2-2a26-427b-ae06-8605c68c8395 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0159-01A-01D a7f1e5d2-2a26-427b-ae06-8605c68c8395 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0159-01A-01R 432855cd-d42c-442c-907d-a965def67db0 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0159-01A-01R 432855cd-d42c-442c-907d-a965def67db0 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0159-01A-01T 02cece9b-d678-4efd-bbe5-aaed34b11a09 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0159-01A-01T 02cece9b-d678-4efd-bbe5-aaed34b11a09 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0159-10A-01D 5b755d14-b58c-44aa-901c-f9b7add56c16 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0159-10A-01D 5b755d14-b58c-44aa-901c-f9b7add56c16 03/14/2011 GBM Item is noncanonical Necrosis Study
TCGA-06-0160-01A-01D 27d31344-be63-4650-894b-b7884983edb7 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0160-01A-01R 8e928ed9-516f-49bc-ad3b-282e9e34f650 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0160-01A-01T 1d0e357a-a19e-491a-acd1-caf7438a5e98 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0160-10A-01D 02ebdcda-634d-479b-bc3f-64b64fb06d4e 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0162-01A 8879543f-c7c6-4db1-b1a6-581193434d3e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0162-01A-01-BS1 66e1810a-0f65-4cd9-bc19-fbc300cc26b4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0162-01A-01-TS1 31f194c0-f1cd-4fb9-9d8c-e0e7a1a86955 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0162-01A-01D 247d024e-dd20-426e-8a0c-f4802ef7383e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0162-01A-01R bacf9714-ee0e-486e-8b0c-382986361972 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0162-01A-01T fa3277b9-23ae-43e4-aa5a-5149fa3d06bb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0164-01A bee4c5be-7092-4e2b-9522-6ccc0465781e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0164-01A-01-BS1 21a9218f-5d72-4715-bb60-649349249dc4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0164-01A-01-TS1 2bcef24d-605c-4894-b17a-7c835ba030e4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0164-01A-01D 55c0ac0c-5273-4816-b67d-ab5eea11c3c4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0164-01A-01R efc5c8e7-ebab-4b56-b270-3fc529d242eb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0164-01A-01T d6c5baa3-6dc2-4fa4-b0f8-94c9fb2bb239 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0165-01A-01D e5e02cc7-d5c9-46cd-a011-57e15099f7c8 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0165-01A-01R b751c373-4960-4af9-8672-0ce78d9c3812 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0165-01A-01T 584f0350-2273-4000-992c-db3a24d1aad2 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0165-10A-01D 501b297f-8c36-4426-bd5f-c9b9767aeda0 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0167-01A-01D 8d5be18e-7317-4011-a852-177f6cfa6c76 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0167-01A-01R 7a7ec76d-36fb-4c6c-b4eb-6b7642aae81e 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0167-01A-01T 7582c144-b45f-411c-ac2b-df9970d8ece7 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0167-10A-01D bf3e3123-0673-4dd9-9096-8111647c3ea0 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0168-01A-02D 903f4722-da82-40be-80b1-1f90555a30d1 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0168-01A-02R 946f9b1f-e4e2-4891-96bb-7dc412055d6e 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0168-01A-02T e392c1da-7b8a-46f8-86b5-a76734fb0274 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0168-10A-01D 35f8e2c9-985d-4c30-b8d3-274d26eeabbb 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0171-02A-11D f92fa42c-ad2a-4a6a-b1ab-c0db23ac51ce 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0171-02A-11R c94995bb-004a-45ce-9a12-f3ae6cdd1527 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0171-02A-31-2189-20 080248c1-abed-4e34-b33a-51c45b9b4fd1 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-06-0175-01A d6c21f44-9eba-4d8e-a718-240a11e2f95f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0175-01A-01-BS1 e228bb17-b960-421f-899a-30d572ad92fb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0175-01A-01-TS1 4025a363-0b6b-4b70-97ac-1d0d7ce81e9f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0175-01A-01D 9ad5ba33-9c2c-452a-8b44-d00eeb1d8b22 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0175-01A-01R b5b7c0a0-f149-4c8d-b741-f3bd08ec8902 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0175-01A-01T 0170f7c8-e42d-45e0-bcb3-ebfca9f11b1c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0176-01A-03D 67306025-8d58-4148-9da8-717aca160c04 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0176-01A-03R 2c888eb9-f7da-4738-8b7f-b088fcda5845 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0176-01A-03T 40a53f8c-4360-4149-93df-344a59ee5271 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0176-10A-01D 6143a4d4-801c-44d0-9cd0-c6d1433ede13 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0177-01A 73e9a016-d819-42d7-9116-c43b601c89f3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0177-01A-01-BS1 a9d564af-eee1-4164-9a9d-505f7f22234f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0177-01A-01-TS1 30a60464-5548-4841-b6aa-fff8cc386b40 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0177-01A-01D 54abcd28-14a0-4973-8dd8-b16e03e2a3b3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0177-01A-01R 19ce9d1f-014f-4572-90fb-721d3a989f38 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0177-01A-01T ad3d8c01-adf8-4a56-8237-b37a6c8bb435 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A f70dc439-9ca1-43fc-b157-5f1440db81e3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A-01-BS1 3dd532ac-7760-4002-ae8f-4df92e42f939 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A-02-BS2 41d633aa-5570-4810-a7e5-beb4cff8ad6a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A-02D 3a8a0020-186f-426c-95b4-74806f232479 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A-02R 545a776a-211c-4603-8dfe-3168d124c171 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A-03-BS3 a6abd477-f974-4bc6-b9eb-3a59b6f66f3e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0179-01A-03T 54f5cf55-c0b5-486d-aad1-2948ddda67ca 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0182-01A e6865af6-d9fd-4637-b752-c03d5e8ca6e4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0182-01A-01-BS1 e0c458c1-64c3-481d-ba82-6b45abfb9b64 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0182-01A-01-TS1 de428d65-f4b5-4748-92f9-ec1da685514f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0182-01A-01D a9a7a515-a8e0-4f55-91d6-a9da3ef1d655 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0182-01A-01R 61fb1dc0-3aae-4490-b1e8-248afee1775a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0182-01A-01T 7ec23078-7157-4f2b-9ee0-22d2fc725880 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0189 e1481049-c04e-48fe-8110-ac1d0ee86e75 11/08/2012 GBM Qualified in error Subject qualified in error
TCGA-06-0190-01A-21-2214-20 7791eac4-ac36-4106-ad44-7983dd35bfdc 03/13/2012 GBM Item is noncanonical TPPT GBM MDA
TCGA-06-0190-02A-01D 8b832bd1-f7c6-4096-810a-c57832cf479c 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0190-02A-01R de5045aa-b00d-4660-a662-8df9f4799213 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0190-02A-31-2189-20 535d6439-be95-4634-a88f-9277c9647810 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-06-0194-01A 78796cc2-7139-41aa-881d-82864be7fc10 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0194-01A-01-BS1 ad6af015-1efb-4e70-a978-1aae9dee08e4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0194-01A-01-TS1 a664ea7a-1e73-4d61-8116-8eb02f0c3956 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0194-01A-01D b39bbb74-adb2-47ac-925b-531994d0a46f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0194-01A-01R ac5b80df-b6fe-4b20-bee7-cae0df29c531 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0194-01A-01T 9c19788c-8b62-41ea-ab09-dc405d418fe1 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0201-10A-01W-0250-10 a18a3a67-653c-4a0b-9aec-bef8e70ff459 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0201-10A-01W-0251-10
TCGA-06-0206-10A-01W-0250-10 a3a719c4-f77e-4470-9327-de2b11be3d35 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0206-10A-01W-0251-10
TCGA-06-0208-01B-01D ef3fd608-7bcb-4ed9-8c9c-b94f1ab7181e 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0208-01B-01R a6690713-60e6-4950-b352-f6efd27ad7bf 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0208-01B-01T d67295ab-2f51-4121-a150-8be193027118 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0208-10A-01D be3d20d7-da0c-4720-a521-f954fdb5b11c 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0208-10A-01W-0250-10 465320f4-a305-459d-ac72-8c8d9dbd4383 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0208-10A-01W-0251-10
TCGA-06-0209 a795a841-9fd6-4eac-b871-a8c70248700f 02/24/2012 GBM Prior malignancy Prior malignancy with systemic treatment
TCGA-06-0209 a795a841-9fd6-4eac-b871-a8c70248700f 09/02/2010 GBM Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-06-0209 a795a841-9fd6-4eac-b871-a8c70248700f 11/10/2012 GBM History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy with systemic Treatment and locoregional radiation
TCGA-06-0209-10A-01W-0250-10 9c9dad69-76bd-4a0a-81b1-b1acce769122 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0209-10A-01W-0251-10
TCGA-06-0210-01B-01D fbe5d5b9-ea80-4ead-9100-daf2b66377b5 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0210-01B-01R 184a1896-5145-44e5-808d-cd199c3629fb 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0210-01B-01T 6874cd1a-bc47-4799-ae3a-758858ead914 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0210-10A-01D 06c14955-1a5d-4e15-bfbf-be1509ee7369 03/14/2011 GBM Item in special subset Necrosis Study
TCGA-06-0210-10A-01W-0250-10 d4245014-9aa2-4bed-a077-e47b3ade2bc4 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0210-10A-01W-0251-10
TCGA-06-0211-01B-01D f8534274-0861-422f-8697-9572be606b3f 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0211-01B-01R 5ee792d6-20e4-4000-8357-734b0969ce9b 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0211-01B-01T 07ded71f-9b9e-4992-a36c-03394f6ce9b7 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0211-10A-01D f37b3486-b71d-4a2f-9e53-96ecd11eff98 03/14/2011 GBM Item in special subset Portioning Study
TCGA-06-0211-10A-01W-0250-10 eff0b500-73c0-49e7-9984-d8a5e72682a9 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0211-10A-01W-0251-10
TCGA-06-0213-10A-01W-0250-10 b82e75c8-3b40-4c22-92b2-3b982136fb1a 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0213-10A-01W-0251-10
TCGA-06-0214-10A-01W-0250-10 107b4dcf-dab5-4f6a-b533-f41533332f06 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0214-10A-01W-0251-10
TCGA-06-0216-01A-01D a888f9ea-0399-45fd-9cc3-c5fff386ab9f 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-01A-01R d7745c6b-b2aa-47ea-aa5e-3b7505bc8411 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-01A-01T 439655ba-3dd7-4a88-9b3c-a25a10369e2a 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-01B-01G 48b9b178-c32d-4366-bccb-25ab36e92001 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-01B-01W a35fc052-cfc4-4351-879b-9e184cbc3094 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-10A-01D 9de7d6b2-5442-4a31-9b80-73bca4fac0fe 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-10A-01G 29be564e-30e4-47fe-9215-a538d8721afd 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-10A-01W 9699b730-00e6-4752-9d49-6e6435dc0f5b 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0216-10A-01W-0250-10 200b76d3-d377-46d0-b39c-8813c615088d 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0216-10A-01W-0347-10,TCGA-06-0216-10A-01W-0251-10,TCGA-06-0216-10A-01W-0410-10
TCGA-06-0219-10A-01W-0250-10 00e2d188-c21e-4263-9f0d-9b213ccf3ad3 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0219-10A-01W-0251-10
TCGA-06-0221-02A-11D 0b0ce338-9e5f-4e8e-890d-71c31a28d8af 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0221-02A-11R 218e5512-32c7-4f9a-b963-005394e4dcd0 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-06-0221-02A-12-2189-20 065f5fe1-6fdc-4ee6-9faa-3db372a9f8fe 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-06-0221-10A-01W-0250-10 d35def1b-fb8f-47ca-93d7-65b892d7a264 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0221-10A-01W-0251-10
TCGA-06-0237-10A-01W-0250-10 6eee0b34-3cff-409d-9b6a-ae68cf60d8b4 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0237-10A-01W-0251-10
TCGA-06-0240-01A-02R e2dc32cd-0bff-45b5-be7f-860bdfd265cf 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0240-01A-02T 5f952db3-f62d-4dc1-881d-4d8c0898289c 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0240-01A-03D 9d57357f-a770-40fb-86bb-23a083ebd6c3 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0240-10A-01D 6889fa03-3a22-4950-8e92-a0fab215a993 03/14/2011 GBM Item is noncanonical Tumor Adjacent Normal
TCGA-06-0240-10A-01W-0250-10 05c2fe02-14d7-4b4b-bb71-362561bf9172 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0240-10A-01W-0251-10
TCGA-06-0241-10A-01W-0250-10 115ed518-1257-4242-9227-e1de4deb1f4e 10/08/2013 GBM Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-06-0241-10A-01W-0251-10
TCGA-06-0394-01A b485dabb-e1fc-4fdb-9cdb-67b28cab02c8 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0394-01A-01-BS1 c959acd5-a4f4-4619-a8a2-646cb9a370bc 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0394-01A-01-TS1 80e563b5-5b98-475f-9503-0e2d2bad2af2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0394-01A-01D b917214f-40cb-4682-8354-55a228c2e438 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0394-01A-01R baa3fc6e-db51-48f8-b6a6-8003549f61d6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0394-01A-01T ca6cebfa-99e3-4719-bdf4-817013956ddd 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0397-01A 25823199-8d66-4471-ade6-1e4cf9447dc4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0397-01A-01-BS1 31e9e144-9eec-4495-99a2-f820979a7b67 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0397-01A-01-TS1 0e8c5b5f-c755-433b-bc06-4eb7a6e0f2e5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0397-01A-01D 79868ebb-680e-4c23-9bb0-59c5941e26e9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0397-01A-01R 12218b7c-f204-42be-94bd-699ad67c04d0 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0397-01A-01T a6e3fb5d-bb43-4b80-a4a3-d4eefa1dfe91 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0402-01A e692a792-ba6d-4944-880c-63b7d487eb7e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0402-01A-01-BS1 d6cda6cf-fc19-4891-9764-cf41b0537c90 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0402-01A-01-TS1 8bcdde7b-0dbc-419c-bd8e-9705ba082b37 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0402-01A-01D 44790530-de31-465e-af72-b28fd78be3c6 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0402-01A-01R b81221a2-b8d2-4b2b-981b-8720f4755534 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0402-01A-01T bc17e81b-aa2d-40ed-972d-2e04a6902588 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0409-01A b47f7fa7-67e1-4dcd-936b-a0f32042db8d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0409-01A-01-BS1 11124514-a34a-4f01-adf4-12cadad14f81 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0409-01A-02-BS2 2f0f9237-0760-4bef-976f-035a946d7672 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0409-01A-02D b28e7e21-ccaf-4030-9548-bec5a1fe6450 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0409-01A-02R 90389292-522e-4cc4-a35f-c3bbd93aac20 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0409-01A-02T d0b2a0d5-6f67-4ab3-9d78-de941873c668 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0410-01A 0a50cc43-f6d9-4d36-9b12-28f65e4f9296 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0410-01A-01-BS1 ff118f1a-e9f0-4c36-ad17-c1a986104819 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0410-01A-01-TS1 4c6a160d-4d9a-447b-b7ff-d37ad84a84a4 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0410-01A-01D d3479ca9-523b-440a-bc4b-c20dfa868d3f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0410-01A-01R d9957484-b18b-4d8b-85d4-a492dc908c75 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0410-01A-01T 18b53546-8bd7-4569-86ab-74d32985d6f8 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0412-01A a527355f-57e3-483b-8277-9a04e5c35951 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0412-01A-01-BS1 0967438b-7da0-4a92-be8c-4946e58c6eb1 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0412-01A-01-TS1 07095043-2693-4747-9f7a-79cf95c95d64 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0412-01A-01D ab165f30-5082-478e-be27-1e025cdc04a2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0412-01A-01R b1b91594-9c48-4445-8bea-97c952cb36d2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0412-01A-01T 30434b12-6501-41b3-b886-f6a498066c84 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0413-01A 6830a11d-7aa9-4214-8371-118f8815bd45 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0413-01A-01-BS1 b6255e14-eb55-4618-a32a-3287ab86bcd7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0413-01A-01-TS1 dc705ddc-2bfc-425b-a366-8c84864cb585 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0413-01A-01D a74bc026-13bb-408d-952e-d7096f0d0445 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0413-01A-01R f1be74c7-0930-4bcf-a265-737c1690fa55 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0413-01A-01T a4a5bcc9-9b28-43ba-8ca3-3e3c1e4b7388 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0414-01A 9f37de49-e132-4e0e-b5e9-6d213804d83f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0414-01A-01-BS1 8505a2a3-e211-47a7-9786-66afe6b8c796 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0414-01A-01-TS1 10d59d57-f4ce-44ee-b336-0330708d9df1 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0414-01A-01D 692c2b87-49d5-4e76-b9aa-543bd6e6c1a8 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0414-01A-01R 191a8223-d53f-4c02-a25d-24635dcf06eb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0414-01A-01T a137a34a-2784-4bb3-88fc-f6c942f701d3 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-06-0673-11A-01D 189b4162-6352-4fbd-b037-5507efd3f033 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0673-11A-01R 50624f34-4458-4c6c-95f9-b6f4a731209a 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0673-11A-01T 5a8a3f14-c831-48f1-9288-7c8a9f3f5edc 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0675-11A-01D c50d668e-80c6-4ac0-934e-bd32b72897f2 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0675-11A-01R c93913bc-5afb-4fcb-9fef-88c91ac89a16 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0675-11A-01T 177f711b-168f-4ddf-a282-17c8106f8b92 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0676-11A-02D ea602e39-dfb1-428c-ac05-59ed1b250286 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0676-11A-02R 096787ab-ba8b-43a7-a069-c3f9dfd05112 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0676-11A-02T b28d0c58-fea5-42ed-8053-6a6496de7788 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0678-11A-01D 5d31c722-b7d8-4b6d-94ba-8c050af238a8 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0678-11A-01R 8e2b2f52-4525-4a49-8a68-68ebecf12eb0 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0678-11A-01T e120a048-8c1b-439e-b1d8-b7ca6ea2dba2 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0680-11A-01D 7ceebbf4-5bfe-4d7d-8280-079113c0688d 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0680-11A-01R 43836a01-05a2-42f0-a904-52fcbf868316 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0680-11A-01T 69229103-19a0-4a5b-9825-ef9601da16ee 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0681-11A-01D 723ad809-63ed-4f73-9ff4-3e836f30e6be 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0681-11A-01R 793ebc55-834c-4456-9eed-70c55d2f6a46 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0681-11A-01T 23f84a3c-bc89-4719-bce1-ee53f860a215 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-06-0744 5613f5f6-086d-470b-8f77-6dcb7f8625b7 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-06-1804 9348e446-0e43-4210-b07e-c534980cbf62 09/18/2011 GBM Item in special subset Case came in as GBM. BCR was notified that case was LGG. Program Office determined this will be a Notification vs. a Redaction
TCGA-06-2557 6c28f086-6a25-40b6-93eb-bba0014acda6 03/09/2012 GBM Prior malignancy Prior Prostate malignancy as per pathology report.
TCGA-06-6391 7a4c0a14-ac97-4c2b-a9cc-68cb561b2494 03/09/2012 GBM Prior malignancy Prior Breast Cancer as per pathology report treatment not specified.
TCGA-06-6391 7a4c0a14-ac97-4c2b-a9cc-68cb561b2494 11/18/2014 GBM History of unacceptable prior treatment related to a prior/other malignancy Patient had prior breast malignancy with systemic radiation
TCGA-06-6700 3dddfc44-7bb1-4974-8a65-a84fd4bac484 03/09/2012 GBM Prior malignancy Prior Prostate malignancy as per pathology report treatment not specified.
TCGA-08-0351 91063e7e-60db-47a5-aeca-af7c37b1074e 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-08-0375 0ce23e2c-8e64-4391-8148-de823bce0d5f 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-08-0509-01A 80abf544-1956-477f-b2af-ba49b3dc9a86 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0509-01A-01-BS1 e5823051-ab51-4dbe-ac65-e826e87da4e5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0509-01A-01-TS1 27f6ae4c-e445-4e2e-a94b-31d449ba69c9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0509-01A-01D ab93c07e-9184-4958-85ad-8d9a85a1c804 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0509-01A-01R 8c1a3317-7d75-4543-aa5a-e056a12a13a9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0509-01A-01T 0d6386aa-f62b-4534-8e07-fd47e377de03 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0510-01A aa025730-e2d7-43e9-a084-069d6a18c036 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0510-01A-01-BS1 aecbceda-3dff-4db3-96be-e2863b375cdf 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0510-01A-01-TS1 1a6b3aca-d6e8-4251-b018-96aec8e37177 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0510-01A-01D d8b7dacb-f2b4-460b-8d7e-4c26fbd51a07 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0510-01A-01R ea048bf0-ed44-48dc-868e-473897e7d1c2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0510-01A-01T e839f404-8bb0-4108-9abb-70e2a202f2bb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0511-01A 1037f32e-7ef9-4604-9345-7bdad094860d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0511-01A-01-BS1 817e57b6-1b58-47ab-b947-93a6c723d205 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0511-01A-01-TS1 9240ad7b-5a75-4b8e-8715-c7045577a78d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0511-01A-01D 488dac2f-2435-41b9-b4c4-9d4cca98907e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0511-01A-01R 5898cf0f-e00b-4582-bb64-2fa4b90bdfea 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0511-01A-01T 9a928ac4-b18a-49fd-978a-4f19eea220ba 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0512-01A 0f78eea7-b8b1-4d0d-b3ea-b127ffb9d849 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0512-01A-01-BS1 3cefc0c0-6659-479d-80fb-89ca3730be10 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0512-01A-01-TS1 7eff781e-3a88-43be-aec8-a80c1fc87228 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0512-01A-01D ecf3eded-4cdc-48e3-8de2-7c4770c8d869 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0512-01A-01R f6e1ff08-86f4-4814-bcbf-0c322c305c7e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0512-01A-01T 410be804-7a05-4b55-a63f-eaef2cf592b5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0514-01A 25ebc29a-7598-4ae4-ba7f-618d448882cc 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0514-01A-01-BS1 64aa2895-fae1-4816-a24e-1fdb3cb8fc12 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0514-01A-01-TS1 2bf76577-04dc-447d-826f-c9d5e0564a4d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0514-01A-01D 7e4571f8-e34e-4297-87b9-6fe110988de0 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0514-01A-01R 37e1fd37-93f5-4d23-b253-711ba5130a54 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0514-01A-01T 118df547-4da1-4386-8415-ccc92be6d319 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0516-01A 3072febc-2a89-4ea4-aeae-3b4d9ca1ae56 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0516-01A-01-BS1 5d791a65-4b0c-4a28-bf5a-73ae5172e044 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0516-01A-01-TS1 b05317d6-90dd-455a-8d53-f1889498ef15 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0516-01A-01D 6663f875-67d7-4b2b-b55d-817bc21778cb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0516-01A-01R aaae179a-6078-4a36-b509-7923a454d20f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0516-01A-01T 2944d5c9-de1a-44d5-9cb2-fbdd7cd28c08 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0517-01A 5751f532-5294-4209-89f9-972900b58c1f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0517-01A-01-BS1 041cb0cb-f432-4842-8253-08f0cd005a6c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0517-01A-01-TS1 753fddeb-4339-4f4c-8314-cc5afafc6b03 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0517-01A-01D 3469ffa9-a914-47b9-b61d-8277bd5fa1cc 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0517-01A-01R 4f6b6c60-0cff-49a4-9869-c9845b07d631 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0517-01A-01T 2f2428ca-2dbc-4bad-9125-274adfd6740a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0518-01A 66f4dacd-4b71-47ec-809d-9341c04fc46c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0518-01A-01-BS1 ffdc987e-b406-4ae1-95ca-2e71f5831bf1 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0518-01A-01-TS1 7e77b568-cbe9-4c80-83c2-8f3362cf86d0 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0518-01A-01D 00f842aa-a509-45b2-a14b-12f5298201de 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0518-01A-01R 507498c8-3d09-4ee5-8c07-4201a5cd156c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0518-01A-01T eac6fca7-b6cf-4c82-8477-a8464ce895b5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0520-01A b386bc2d-f8fd-4eb4-86ff-dd581d0c1d1a 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0520-01A-01-BS1 f1703e2a-8221-42d8-9146-cc1ae23dca87 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0520-01A-01-TS1 4f43f61b-1f3c-4ec2-96eb-dd0418a94129 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0520-01A-01D 6fc570ce-c0ad-42a4-b651-20e305da8a56 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0520-01A-01R debe7072-406b-4333-a7fe-b9fe36175b1d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0520-01A-01T c398d867-fd2a-4f51-ae8b-ee191dee3761 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0521-01A 90759e2d-616f-4d38-9aa1-a5273c7f0aaa 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0521-01A-01-BS1 836f1c00-d977-4e41-96d6-3f24d0481075 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0521-01A-01-TS1 5a7e0c3f-6f7c-4543-bdbb-3f80f5dbf67f 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0521-01A-01D 94813333-a34b-4bc9-b04b-45a8893f4843 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0521-01A-01R 5abcfcfb-9b9e-4a4d-86a3-0975f19f2b08 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0521-01A-01T d5b10f7c-6f86-4e32-8f52-4be9eb201d3e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0522-01A d9fb7e11-67d9-4546-8c80-34345a060f71 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0522-01A-01-BS1 040eb751-66bd-42f1-a46b-005281080794 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0522-01A-01-TS1 0a576133-ce2b-40bd-8d80-de7d19fb9d61 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0522-01A-01D 798a8f48-f3bc-4377-8f51-d24fe25b7bab 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0522-01A-01R dd18e999-f73e-4102-ad98-ea9303977099 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0522-01A-01T 9cb5f882-b405-49d4-bc9c-fdfc84a557b0 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0524-01A 2917df9d-4909-41ba-9ddf-3dd294f860f9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0524-01A-01-BS1 e0513a37-53fa-44a8-ae60-ebc7090dc587 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0524-01A-01-TS1 0edf27bd-4e13-4cfc-89af-cf59241efa3e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0524-01A-01D 405b8dde-f105-46fb-9a42-3f01a8d23cee 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0524-01A-01R 10c76f63-43f8-4351-b3c5-065dc658ea6b 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0524-01A-01T c107070b-2321-4e5b-8d4b-01d26099fe9d 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0525-01A 292c688f-4815-484c-b5a2-4a2feafaae65 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0525-01A-01-BS1 714386f8-9528-487f-b1b6-3a4393d75646 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0525-01A-01-TS1 4ca56355-5f29-40ce-8006-da1f125f511c 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0525-01A-01D a679773b-7596-4582-acd5-4f272cf146bc 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0525-01A-01R 2d77284e-96b6-4e71-a4a8-3360b7ee2bae 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0525-01A-01T ca13027d-e114-4ba9-a9da-f14e8cb7e7ec 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0529-01A c7d0bb98-7109-4aa3-be8f-8744caeae324 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0529-01A-01-BS1 21abafaf-bc88-42a0-b910-1fb683018832 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0529-01A-02-BS2 9f2a81e6-8611-402a-9aa7-e1d9e2d07b60 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0529-01A-02D 3bd561b7-7922-4804-b668-e060fe25485e 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0529-01A-02R be1ac6e5-c171-4974-9bd4-b080a32e5004 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0529-01A-02T f71ddb25-f8f3-4ed4-bf55-d908783216d7 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0531-01A 13045620-8c7c-4162-8626-51787b387fb2 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0531-01A-01-BS1 2a749986-3b79-48fa-a7bd-2fa5f6e13fc5 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0531-01A-01-TS1 be7a3c67-d6bb-4313-bdc3-7a63a0917ba9 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0531-01A-01D 645d5a87-d592-49c5-ae08-becaff252a83 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0531-01A-01R 32347d0f-d16c-443b-9b99-56b9ab555869 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0531-01A-01T de6f3cc4-0033-4bf5-a9a7-7a6fbf59addb 07/12/2012 GBM Item is noncanonical No Matching Normal
TCGA-08-0623-11A-01D 62df06c4-d8fc-4d90-b718-b244e7603e4b 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0623-11A-01R c2a7628a-c843-4cd5-9f0c-97d251f00922 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0623-11A-01T 961cb4d4-2fb8-4692-a047-3df03748c345 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0625-11A-01D a78ec592-649d-4f1c-a157-5dd58bec8023 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0625-11A-01R 2e90c14c-3b45-45b3-996f-ab612f7dbbb7 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0625-11A-01T 6ca11dd3-82ed-4774-9eba-871384494439 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0626-11A-01D 58db51bb-f101-42ff-a265-c1a25084ddfd 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0626-11A-01R 8a4aa64e-9d00-4269-81f9-25db0f1a1b68 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0626-11A-01T fee02d65-9599-4723-a604-a4e6501a3869 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0627-11A-01D 751fc2eb-a9ce-433e-b0b2-da2160e7b30a 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0627-11A-01R c891092a-7554-4724-83c5-a6235a43a746 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-08-0627-11A-01T 7e9de253-bec7-4258-aa83-2df112ccf270 03/14/2011 GBM Item is noncanonical Epileptic Brain Normal
TCGA-09-0364-10A-01D-0508-04 11ae3d81-c268-486f-a3cc-5f2a9b590b00 08/23/2013 OV Barcode incorrect Incorrect Plate Number, should be 0357
TCGA-09-0367-10A-01D-0508-04 49f7ca46-21e9-49f7-8617-50abe362ddd0 08/23/2013 OV Barcode incorrect Incorrect Plate Number, should be 0357
TCGA-09-0369-10C-01D-0508-04 87b8a409-8871-46f4-8531-d331e60e3d79 08/23/2013 OV Barcode incorrect Incorrect Plate Number, should be 0357
TCGA-09-1662-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1664-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1664-01A-22-2223-28 61b9cfce-8942-4e87-abe0-17b4b59c373a 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-09-1664-01A-23-2225-29 5fd6e744-76b5-4073-9908-44a8c709ee03 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-09-1665-01B-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1666-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1670-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1673-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1674-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-1675 0fc8777c-8f12-472f-a0ea-085139b35d1f 09/18/2011 OV Prior malignancy Prior malignancy of metastatic breast cancer
TCGA-09-2043-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2044-01B-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2045-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2049 05eb8bd5-d31b-4595-921a-366e53ea5a8b 12/08/2010 OV Molecular analysis outside specification [intgen.org]:Molecular analysis outside specification
TCGA-09-2049-01D-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2051-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2054-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2055-01A-11-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2056 ea6405c4-0fe4-4f37-bef2-275072f91e39 03/20/2012 OV Prior malignancy NA
TCGA-09-2056 ea6405c4-0fe4-4f37-bef2-275072f91e39 11/10/2012 OV History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy right breast cancer treated with chemo and radiation per path report.
TCGA-09-2056-01B-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-09-2056-01B-31-2223-28 ff8b8f52-113e-4fb1-9bea-7f1cc7b2375c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-10-0925-01A-11-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-10-0926-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-10-0931-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-10-0933-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-10-0936-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0720-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0725-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0791 90118207-8f11-4784-ac1b-0deec2e7af3a 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-13-0791-02A-01D dea51e0c-f937-4a39-8d43-c9c07b8c7503 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0791-02A-01G ceb2ec4c-d113-4e08-aa5d-5c3259db1ffe 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0791-02A-01R a481062e-11b4-4990-af2f-39906693795e 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0791-02A-01T af7b9d93-544b-4ad4-8f65-f9b8dc82a7c7 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0791-02A-01W 0788860e-067a-49a3-8dfd-1e45ef1caca1 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0793-01A-03-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0794-01A-03-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0797-01A-03-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0799-01A-03-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0800-01A-03-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0801-01A-03-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0802-01A-03-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0804-01A-03-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0884-01B-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0886-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0887-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0888-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0891-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0894-01B-03-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0897-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0899-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0901-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0903-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0906-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0910-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0911-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0913 3e8a51bf-7e1f-4eab-af83-3c60d04db1bf 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-13-0913-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0913-01A-22-2214-20 0c76e11e-e654-49d5-9469-aec43bc8eb96 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-13-0913-02A-01D 05a8815b-ca5f-43c1-849c-e065ce0bec3d 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0913-02A-01G ab365309-5d9c-49f5-8852-dd185fc83a0c 03/14/2011 OV Item is noncanonical Overy Triplet
TCGA-13-0913-02A-01R 194a6538-dd75-4ba9-8682-0fb6c5cc552e 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0913-02A-01T d411e337-9bc2-4bf8-a55a-1af712a49009 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0913-02A-01W eee57520-ab19-4c63-ab5a-619940227d09 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-0914 7f36eff2-aa69-4c4d-8101-8801c812a36b 07/17/2014 OV Item is noncanonical Incomplete distribution. Only Repli-G shipped.
TCGA-13-0916-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0920-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0921-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-0922 78821fb5-0669-42c7-b62b-b61d6b7d7ac6 07/17/2014 OV Item is noncanonical Incomplete distribution. Only Repli-G shipped.
TCGA-13-1403-10A-01W-0494-09 dec1df73-7426-44f6-90b3-c3b8a2b0181c 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1403-10A-01W-0495-09
TCGA-13-1404-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1404-01A-31-2222-28 9c24f632-63bd-44eb-92bc-cb4f46e84768 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1404-10A-01W-0494-09 110bb57d-72e0-4147-8670-5352bab3e669 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1404-10A-01W-0495-09
TCGA-13-1405-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1405-10A-01W-0494-09 0bf65c40-0515-4a3d-b70e-d7ff6368edbf 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1405-10A-01W-0495-09
TCGA-13-1407-10A-01W-0494-09 b3887ec0-e60f-43e4-97c5-39acaed73070 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1407-10A-01W-0495-09
TCGA-13-1408-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1408-10A-01W-0494-09 c1dfc529-3a61-4aa9-aeba-dec51027b024 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1408-10A-01W-0495-09
TCGA-13-1409-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1409-01A-31-2222-28 90fc8789-ed0a-46dd-b4b8-490ac6347611 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1409-10A-01W-0494-09 122637e1-c58f-4681-a0e0-f71e0979dfc2 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1409-10A-01W-0495-09
TCGA-13-1410-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1410-01A-31-2222-28 ef1c6dd6-bdf1-4855-a922-bc32bc7784be 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1410-10A-01W-0494-09 ade7ac24-4400-4f33-803b-f7ff4b7c60ef 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1410-10A-01W-0495-09
TCGA-13-1411-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1411-10A-01W-0494-09 c00c6e64-f12c-46df-a863-3939c96bc71a 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1411-10A-01W-0495-09
TCGA-13-1412-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1412-10A-01W-0494-09 c5e33836-e440-41c7-8017-e30ad31254f3 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-13-1412-10A-01W-0495-09
TCGA-13-1477-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1481-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1482-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1482-01A-31-2222-28 949bbc28-b845-4064-b9a5-36c63f1996b6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1483-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1483-01A-31-2222-28 b91316e1-409a-4643-9909-cb464dd3f8c6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1484-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1484-01A-31-2224-29 ec0d1752-b446-42e2-bac8-7efb08491ef7 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1485-01A-31-2222-28 c656ef31-d4fb-4735-8d32-94b00557e35e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1487-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1487-01A-31-2222-28 66dbb6bd-dcc3-4baa-b074-9fcd9a911dfa 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1488-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1488-01A-31-2222-28 7b30a4d7-3b18-40df-a497-07952f3edf94 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1488-01A-32-2224-29 93aac168-81c8-4db1-9d36-d763252ae86d 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1489 7248cd60-be22-44bc-bc58-f644db0940a2 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-13-1489-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1489-01A-31-2214-20 c35fe897-f2eb-4dcb-a571-89f2c27ffa6a 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-13-1489-01A-41-2222-28 7da442df-95b9-416d-bebd-c2a45b530274 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1489-01A-42-2224-29 fec21c14-b283-4442-a720-bcd59a8bd52a 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1489-02A-01D 79ffec89-15eb-4636-b0e7-4f1707a1969e 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-1489-02A-01G 2a523024-70b5-4f8d-b756-423e2d12b76a 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-1489-02A-01R 58ffa935-a8c9-43b2-85bf-5b2227dea9b8 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-1489-02A-01T 37234d5a-e297-4f0b-a5a3-7b9652d65896 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-1489-02A-01W eee7d616-11d6-4fcb-8dc4-bdbd9eafd1d4 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-13-1491-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1492-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1492-01A-31-2222-28 80bb7b41-698e-4fdd-96a0-1bd8135b8b26 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1494-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1494-01A-31-2222-28 46ba083f-4b51-4881-a38d-6b17064c69cc 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1494-01A-32-2224-29 70ddb5ce-fbd4-4bf5-b82f-da76a342eb07 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1495-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1495-01A-31-2224-29 a839564b-1b93-4911-b086-abc7c8b46eaa 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1496-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1497-01A-31-2222-28 f5a15fa5-dfa8-43b0-a993-85961e6e68fe 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1497-01A-32-2224-29 6c943e07-082a-4ebc-af2c-82632f8046de 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1498-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1499-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1499-01A-31-2224-29 13e5bbb3-3ef3-4163-84f2-ae60e4e51de4 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-13-1500-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1500-01A-31-2222-28 b7773db9-5590-4544-a181-d484ce483f83 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1501-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1501-01A-31-2222-28 5e4f80d4-5b21-47f2-b17c-246e39c13d47 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1504-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1504-01A-31-2222-28 a54fa67f-da55-40c1-9a30-8df92f64928e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1505-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1506-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1507-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1507-01A-31-2222-28 3560d2a1-8df5-4672-a60b-36ff04afb342 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1509-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1511-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-1511-01A-31-2222-28 6669a5f9-ce0d-4891-b6cb-9a501f70b6eb 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-1512-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-2059 f4b56568-a74a-4a2e-89d9-11722ecf5948 09/02/2010 OV Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-13-2059-01A-03-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-2059-01A-41-2223-28 74102bd2-e5da-42d1-8d74-ebe27a4e7a41 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-2060-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-2060-01A-31-2223-28 147b481e-3d6f-4647-816f-7db4cdaf7e5e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-2061-01A-03-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-2061-01A-41-2223-28 a8e5b166-b923-4b56-8d8b-534fe74a9fd5 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-2065 8d1dcf21-efd3-4fbe-ad44-f43a19239383 09/02/2010 OV Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-13-2065-01A-03-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-2065-01A-41-2223-28 3df3bca8-901b-4213-83f8-468a37e7b4bb 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-2066-01A-03-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-13-2066-01A-41-2223-28 1e0a0e0b-6350-4f36-95cf-1151b3c6ccd6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-13-2071-01A-31-2224-29 6e532cba-95b1-4c98-a2fd-454d10350188 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-14-0733-10A-01G d4d1022a-0710-446f-bd81-2db53f13203b 10/27/2011 GBM Molecular analysis outside specification Shipped to Rubicon, but failed metrics (low yield). Case was uploaded, withdrawal was initiated after upload. Worked with DCC to remove data.
TCGA-14-0736-02A-01D d49b5d99-84a5-4fd3-8077-cd5f92ab63d3 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-14-0736-02A-01R 02233640-599d-4df4-abe5-94550766a599 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-14-0736-02A-21-2189-20 269ae6d5-648c-4854-aa50-207345e3a075 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-14-1034-02B-01D 2728a1bb-6c63-4893-9c49-3bd6ee2b9cb1 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-14-1034-02B-01R b98d68dc-cf0b-4099-b2b9-320860098a4d 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-14-1034-02B-21-2189-20 e233f309-922d-473c-8aae-bf1c73b1e88c 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-14-1402-02A-01D d3b18018-650a-4bd1-9d02-513ff58b8d9f 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-14-1402-02A-01R f85ba609-21bb-4207-89e9-1bf42bfe175b 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-14-1451 06c427a1-8c2d-4003-b744-139114a04440 07/27/2011 GBM Neoadjuvant therapy Subject positive for neoadjuvant therapy.
TCGA-14-1454 c2399f5d-dc29-42e9-81f1-1d164d4cc55d 07/27/2011 GBM Neoadjuvant therapy Subject positive for neoadjuvant therapy.
TCGA-14-1823 a515cf2d-e918-4958-9bf6-e611b425a97e 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-14-3476 872511fb-98cd-4fba-82f6-4c3689c75ae2 09/15/2010 GBM Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-15-1444 4c42dc4e-66b7-40bf-9fbe-b92543248198 05/15/2011 GBM Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-15-1449 2749c671-dee1-4d91-b3fa-4b50accf7a11 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-16-1045 cd73f38a-f6ff-4e7b-bd43-ec7b82dbe7df 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-16-1047 8e8688f7-bf69-432b-a5ac-4f5f4d5c10ba 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-16-1460 827453a9-7388-4336-9ac5-4defcb904607 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-18-3406 95b83006-02c9-4c4d-bf84-a45115f7d86d 10/31/2012 LUSC Prior malignancy Prior malignancy L LUSC. No systemic chemotherapy or radiation.
TCGA-18-3407 4e1ad82e-23c8-44bb-b74e-a3d0b1126b96 10/31/2012 LUSC Prior malignancy Prior malignancy R tongue treated with radiation.
TCGA-18-3407 4e1ad82e-23c8-44bb-b74e-a3d0b1126b96 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy R tongue treated with radiation.
TCGA-18-3409 b09e872a-e837-49ec-8a27-84dcdcabf347 10/31/2012 LUSC Prior malignancy Prior malignancy basal cell carcinoma of the forehead. No systemic chemotherapy or radiation. Prior malignancy basaloid squamous cell carcinoma of the anal canal treated with chemotherapy and radiation.
TCGA-18-3409 b09e872a-e837-49ec-8a27-84dcdcabf347 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy basal cell carcinoma of the forehead. No systemic chemotherapy or radiation. Prior malignancy basaloid squamous cell carcinoma of the anal canal treated with chemotherapy and radiation.
TCGA-18-3410 99599b60-4f5c-456b-8755-371b1aa7074e 10/31/2012 LUSC Prior malignancy Prior malignancy squamous cell carcinoma of the foot. No systemic chemotherapy or radiation.
TCGA-18-3416 6eb61cab-8e83-4c18-a59a-ae0985ec9d2e 10/31/2012 LUSC Prior malignancy Prior malignancy melanoma of the left chest. Prior malignancy melanoma of the arm. Unknown treatment history.
TCGA-18-4083 a33f0741-2161-4818-89f2-ec8ccae57949 11/10/2012 LUSC Synchronous malignancy Pt with synchronous malignancy of the larynx.
TCGA-18-4721-01A-21-2193-20 980eebae-fe8b-4121-8744-92b2448cb72b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-18-5592-01A-21-2194-20 faeb872c-4711-4218-a772-c660855358f7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-18-5595 628b1bc3-825b-4d0e-a4cd-57eeaf98e798 10/31/2012 LUSC Prior malignancy Prior malignancy cancer of the pharynx treated with cisplatin.
TCGA-18-5595 628b1bc3-825b-4d0e-a4cd-57eeaf98e798 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy cancer of the pharynx treated with cisplatin.
TCGA-18-5595-01A-21-2194-20 cf74338e-67f3-4979-a898-8a8c20bc9485 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-19-0957-02A-11D 4d86bc25-12a4-4d17-a858-f60dc8535a65 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-19-0957-02A-11R 33f423ee-40ec-47ee-ac5c-195beae41d3a 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-19-0957-02A-23-2189-20 962b6e59-32b5-46d1-81c7-16100a5b8fa7 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-19-1389-02A-13-2189-20 46546d0c-c68d-4896-874d-a43c73367b03 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-19-1389-02A-21D 8653c279-c5ce-4224-b2e5-7e508567e1ff 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-19-1389-02A-21R 2aea8527-b041-43c6-9a1a-fdfb9adc4fa5 12/15/2011 GBM Item is noncanonical GBM Recurrent/Triplet
TCGA-19-2619 f2de4316-026c-4c2d-b091-47bc0ec8612a 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-19-4065-01A-01D cd3a31a0-26f3-4a11-aa53-151b62d0fe0b 12/15/2011 GBM Item is noncanonical GBM Triplet
TCGA-19-4065-01A-01R 1620dbd8-650e-445e-98af-38337762ff13 12/15/2011 GBM Item is noncanonical GBM Triplet
TCGA-19-4065-01A-21-2214-20 2d894d78-a75e-4789-acea-4066b7030818 03/13/2012 GBM Item is noncanonical TPPT GBM MDA
TCGA-19-4065-02A-11D 046fe484-5563-446f-99cc-5f9a4a56577c 12/15/2011 GBM Item is noncanonical GBM Triplet
TCGA-19-4065-02A-11R 573ea431-3af5-498d-8e1c-3042f93c14c8 12/15/2011 GBM Item is noncanonical GBM Triplet
TCGA-19-4065-02A-13-2189-20 3166696a-a000-4194-a5cd-45e54777385d 03/12/2012 GBM Item is noncanonical GBM Proteomics Recurrent MDA
TCGA-19-4065-10A-01D b40e7dfb-d32f-4750-81a9-80668586890d 12/15/2011 GBM Item is noncanonical GBM Triplet
TCGA-19-5947 13b4d676-ee9b-499b-94bb-2365830fb37e 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-19-5947-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5950-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5951-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5952-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5953 aa703529-7153-4f74-8577-2601876e3374 10/31/2012 GBM Normal tissue origin incorrect Samples were created as tssDNA from Normal Tissue. Actually are tssDNA extracted from Blood. Should have been 10A instead of 11A.
TCGA-19-5954-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5955-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5956-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5958-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5959-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-19-5960-11A (none) 05/21/2011 GBM Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-20-0987-01A-02T-0436-07 e21e16b8-66f0-4aa7-a168-8037de3495fa 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-20-0990-01A-01T-0436-07 ec51b122-7262-4c42-8e2b-625ccec6b0dc 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-20-0991-01A-01T-0436-07 4d62a406-52ff-4114-8533-d456984e3412 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-20-1682-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-20-1683-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-20-1684-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-20-1685-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-20-1686-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-20-1687 9bf16a89-2fc7-4c08-93bc-3105eec5c3cc 09/18/2011 OV Prior malignancy Prior malignancy of breast cancer
TCGA-20-1687-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-21-1070 28f899c5-ea17-4df6-83e6-e744e04d0ea1 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with chemo and radiation per path report
TCGA-21-1070 28f899c5-ea17-4df6-83e6-e744e04d0ea1 12/06/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-21-1070-01A-21-2193-20 c31cbb43-8115-476d-94eb-969f05a749ce 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1071-01A-21-2193-20 d9fa8294-49b1-4474-bbfb-ffdf6d807382 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1072-01A-21-2193-20 7ba5ebaa-df07-4f54-8721-67523cfddc60 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1075-01A-21-2193-20 11303d09-57ac-4b08-a3a4-efddc42857a3 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1076-01A-01D 74916ee7-3546-426a-be7c-5826733a8cbd 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1076-01A-01R 708fea2e-607d-4221-9525-2828d05365ff 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1076-01A-01T e9b5e920-a384-4f4d-93f3-c286c40e0e3a 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1076-01A-41-2193-20 865ca095-4591-4ca4-8237-a31e6481ccca 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1076-11A-01D 2d534fea-6b06-4adc-9bc2-100e8c633a91 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1077 f516991c-5139-4b3e-b605-5a3d90688209 06/16/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-21-1077 f516991c-5139-4b3e-b605-5a3d90688209 12/06/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-21-1078 0ab8d063-62b4-4d47-82aa-e3351a60029d 06/16/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-21-1078 0ab8d063-62b4-4d47-82aa-e3351a60029d 12/06/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-21-1078-01A-21-2193-20 7c470e40-177f-45c5-96bc-e826294882c5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1079-01A-01D decf0d88-0cbe-4cca-bda6-e0558dee0e1d 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1079-01A-01R b11ed052-fc60-4793-b925-829a5b092901 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1079-01A-01T a4d1337e-54a9-4f41-a3eb-42f9fd9ed07e 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1079-01A-21-2193-20 9af4adc0-d07e-4e5d-a656-cfb61bfa2c82 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1079-11A-01D abf21454-3866-4f6a-a165-f9993004f43d 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-21-1080-01A-21-2193-20 19c9ff90-4114-44a5-97be-310997f17334 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1081 2afa2fd8-e4d9-4e7b-b387-7e2451764d5d 09/02/2010 LUSC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-21-1081-01A-21-2193-20 2d90e6b8-02bf-4665-9803-285243e1ba55 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1082-01A-21-2193-20 cc44dbbd-5a78-4440-82b5-a2c2d6ef4d7c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-1083 0398eae1-7216-4595-80a5-6b117d96e070 06/16/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-21-1083 0398eae1-7216-4595-80a5-6b117d96e070 12/06/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-21-1083-01A-21-2193-20 3e8610c1-5e34-4ea1-ad30-37225b06e71a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-5782-01A-21-2194-20 5ad0c478-996f-4211-a829-ff7b0fec72d2 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-5784-01A-21-2194-20 29d0b45f-ad9b-49a7-af41-979364bc1728 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-5786-01A-21-2194-20 98c3c72d-b20b-400d-a53e-8e7d24c3e79a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-5787-01A-21-2194-20 37941bbd-aee2-4a9d-891a-a0aa0e8c7714 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-21-A5DI a7cd7b0f-ab76-4f3f-a2d5-5ec04fe6c4f3 06/16/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-22-0940-01A-21-2193-20 3d8cb3f0-482e-4acd-bb89-e8530456cd3c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-0944-01A-01D aba91c63-0dbf-43aa-a165-7edcf8a634b4 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-0944-01A-01R bfdf791f-80ce-45bb-8731-377c6da15a7e 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-0944-01A-01T 96553d0a-d94a-46ac-9ae2-3856ec5c56b1 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-0944-11A-01D 8b1ba57c-fdd5-4f80-b88e-0088145c3227 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1000 972476b7-d7f3-4865-b978-0c13f29457cb 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ radation
TCGA-22-1000 972476b7-d7f3-4865-b978-0c13f29457cb 12/06/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-22-1000-01A-01D 4f7bc702-52de-40c3-976c-2accc0a879eb 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1000-01A-01R ac1860cc-17c6-49ac-8b0b-0ac1d0c455e9 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1000-01A-01T d20150a8-bfb8-49c2-9ca7-4433bfca10a3 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1000-01A-21-2193-20 10ac4555-d3e6-4d70-a6ca-2253c0e92de1 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-1000-11A-01D 70ea4fc2-f84f-43ea-9235-5a0748814cf8 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1002-01A-01D 28b912af-a630-4219-9aa1-d479508b0cc0 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1002-01A-01R 4dae830c-a6cc-403b-b259-c9ef7179f7d4 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1002-01A-01T f2402c60-3d82-4053-a1a3-58a49b4302d1 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1002-11A-01D bc226b91-5b76-498e-94f1-64619b7e3e2b 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1005-01A-01D 579db5ec-b747-4435-9534-280e7aeb897a 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1005-01A-01R 9956ae45-ab62-4658-8df7-2df905a7b11d 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1005-01A-01T b2dbcf54-2c0f-4f22-98c0-4a490e307033 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1005-11A-01D 509098f4-d589-4664-a4d8-6f4fbf98ffdf 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1011-01A-01D 9de5f031-6c27-4048-b49e-591e8ea7e1fa 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1011-01A-01R 07c9892c-5f7c-412f-9e47-8b47d1db4c2b 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1011-01A-01T bd049a35-5bf8-463f-9237-b84e45eda038 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1011-01A-31-2193-20 fcc5d2fc-0775-4e47-9ded-959aba2b92f5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-1011-11A-01D f17e14d2-ea96-456c-a307-455983c2e162 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1012-01A-01D 3d3d7a9e-5719-4593-b6e4-e68343b88a3f 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-22-1012-01A-01R 0b18e84c-4bb6-4d81-99ac-bf43c351fc26 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-22-1012-01A-01T 7c063a26-71e9-4eea-8867-f1732d922fe6 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-22-1012-11A-01D 0e36ccf2-8a55-4996-86f3-993ea39c90d7 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 70-80%
TCGA-22-1016-01A-01D e364ac31-ea3c-4f5f-b136-8bf1dcb9e99a 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1016-01A-01R 6fd3e50d-b815-4e83-a951-6cebec8bbf38 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1016-01A-01T 87c0463e-91e8-4850-b871-1d063d6ebbb7 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1016-11A-01D 0623e8e7-a885-4c79-82f7-385be4d5f7bc 03/14/2011 LUSC Item is noncanonical Lung Squamous Cell Carcinoma 60-70%
TCGA-22-1017 25f64b80-0672-4980-9875-956b1699309b 09/02/2010 LUSC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-22-1017 25f64b80-0672-4980-9875-956b1699309b 10/31/2012 LUSC Prior malignancy Prior malignancy and neo-adjuvant treatment per enrollment form.
TCGA-22-1017 25f64b80-0672-4980-9875-956b1699309b 11/10/2012 LUSC Neoadjuvant therapy Prior malignancy and neo-adjuvant treatment per enrollment form.
TCGA-22-4591-01A-21-2193-20 5be370a5-e710-4625-8781-43856b8e39af 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-4596-01A-21-2194-20 4f5b1160-c56c-4696-90a5-2dffc0569b5f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-4605-01A-11-2193-20 5e7c3893-5bf5-4bbb-a98f-ea293538f5ff 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-4607-01A-21-2194-20 79c272f1-478c-4a0a-845f-ba113df49b55 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-4609-01A-11-2193-20 f445dc4e-7f34-47ee-98d7-7f9586084719 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5471 bece6b8e-5d6c-4dd6-85a3-9b3a9c670aa7 10/31/2012 LUSC Prior malignancy Prior malignancy melanoma of the neck. No systemic chemotherapy or radiation.
TCGA-22-5471-01A-21-2194-20 43c5c2ec-d9a9-4fa2-8f12-fa74a31d2e3f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5472 bd3bf142-7c14-4538-8a76-3c6e140fa01a 10/31/2012 LUSC Prior malignancy Prior malignancy SCC of the L cheek. No systemic chemotherapy or radiation.
TCGA-22-5472-01A-21-2194-20 61b44402-a6de-458c-9d45-4b4c258b1590 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5473-01A-21-2194-20 a79a1a5c-7c23-4c61-9e70-6f1e6c1f5317 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5474-01A-21-2194-20 78ec1e12-ed4e-44f3-abb8-aff8b543e2d1 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5477-01A-21-2194-20 5162d956-a988-4b03-ae52-d57aa76b1025 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5478-01A-21-2194-20 7554f5f0-1c1a-4f71-9d7a-836266435c78 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5479-01A-11-2194-20 78c6397c-c479-4743-af4b-61c1bbdc4d3f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5480-01A-21-2194-20 52b7abd6-8f9d-4aac-bb99-f0f2c596dac8 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5482-01A-21-2194-20 2536d089-b6cf-464e-bd43-9c97b0d8948f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5483-01A-21-2194-20 6ff0360e-5a35-4886-8277-c2883374ebb0 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5485-01A-21-2194-20 74b2de24-102f-449b-bbf8-ed2e5aaedb63 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5489-01A-21-2194-20 04508643-b5be-4165-9d6e-4f3687afdfd7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5491-01A-21-2194-20 82d12699-72d1-4283-b45e-35680eb3670b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-22-5492-01A-21-2194-20 d68eb7ee-e5c5-413b-973b-82cf3ae37d55 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-23-1021-01B-01T-0436-07 a3f492a8-ae16-4682-8aa8-9958fb936f0a 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1022-01A-01T-0436-07 f8be8484-9311-447b-9ab2-cc72825acffa 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1023 9e18238f-ae85-4b75-ae87-d92da9731a40 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-23-1023-01R 8a53cd24-5041-418b-811b-33b72c165798 04/07/2014 OV Item is noncanonical Ovarian Triplet Sample TCGA-23-1023-01R is a recurrent sample that for historical reasons has retained the -01R designation rather than the conventional -02R designation used elsewhere in TCGA.
TCGA-23-1023-01R-01D f441fe4f-acca-43ad-a6d5-5a851908864d 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-23-1023-01R-01G 69361bfa-af62-4d23-a6cf-7062ed36e8e3 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-23-1023-01R-01T 72547c58-29c0-48a7-b187-be74f3efa436 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-23-1023-01R-01W c3e57c8c-0b27-4426-92b1-96ee5c0d4329 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-23-1024-01A-02T-0436-07 f92c7501-70d9-4939-8ab2-89e9263ed90e 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1026-01B-01T-0436-07 4ea21d7d-bb3a-44df-a6bc-d180398f34c9 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1027-01A-02T-0436-07 d1a0f56a-ae86-4e4a-8cf8-c6fefb52942a 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1028-01A-01T-0436-07 36c21f80-d09b-407f-847b-8d89765e6505 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1030-01A-02T-0436-07 04942990-d133-4086-8cf2-3a1c8449621a 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1031-01A-01T-0436-07 fe7d4d40-34a9-4ac4-8b9d-c7337d8c5dc6 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1032-01A-02T-0436-07 504ab9f8-1067-4597-9f1e-ca11a928dd3b 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1107-01A-01T-0436-07 711b8cfc-fe73-450d-a34c-e5acdd8d9243 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1109-01A-01T-0436-07 e3262753-dfb9-4672-95c2-a2679a65bde6 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1109-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1110-01A-01T-0436-07 30622010-ce76-483a-8779-a9ce9b19d94f 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1110-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1110-01A-31-2224-29 5ccda884-eabd-4905-bd68-5e9ea938c008 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-23-1111-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1113-01A-01T-0436-07 b00e9c2f-11ed-44b6-8838-672c212dad44 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1116 70fe08bd-a0b4-4a88-b82e-813b176f8e40 09/18/2011 OV Prior malignancy Prior malignancy of breast cancer
TCGA-23-1116-01A-01T-0436-07 91090e5d-f6b0-430d-94c9-100e93402cef 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1117-01A-02R-0361-03 30fce59e-eff3-47da-92da-3c9f4bdaf5c1 10/07/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot.
TCGA-23-1117-01A-02T-0436-07 bf5bf9b6-b5f7-4323-82e8-2b8c81e75841 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1118-01A-01T-0436-07 fd1ebbca-cbc3-4699-81af-f411297c6376 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1119-01A-02T-0436-07 c5bbe74d-b2e1-4a03-ab2b-10e62e71b08c 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1120-01A-02T-0436-07 ca370f8b-0433-43d5-8908-1fd4524ac9fa 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1121-01A-01T-0436-07 55ea90d4-f7f7-4f4b-84b8-f9c2650a427e 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1121-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1121-01A-31-2222-28 f142f418-e88e-4c66-bcae-8d789d10920b 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-23-1122-01A-01T-0436-07 0e3ba53b-bfd7-4406-9782-481d16c2eff8 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1122-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1122-01A-31-2222-28 0b3f0bf9-7b5b-46ed-91ce-86836913e8ff 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-23-1123-01A-01T-0436-07 e903e452-c38c-4d17-b92f-cfc405ba733e 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1123-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1123-01A-21-2225-29 3a99a31d-7b3b-47ff-b39e-a87d0bed5f29 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-23-1124-01A-01T-0436-07 e0f4eced-ee1f-475e-a07a-8a278f35295d 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-23-1124-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-1124-01A-31-2224-29 f2801f96-13ce-49b7-b558-be97665044b3 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-23-1809-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2077-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2078-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2079-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2081-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2641-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2643-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2645-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2647-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-23-2649-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-0966-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-0968-01A-01T-0436-07 a44ea5e0-f075-4c05-ad33-048170b1f197 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-0970-01B-01T-0436-07 5501d956-0cd9-4a4f-b761-946061001bee 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-0970-01B-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-0975-01A-02T-0436-07 e115751c-9e50-44ac-9c80-4183f5a42ae9 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-0979-01A-01R-0361-03 9d22c12c-d437-43d5-9e27-5afa2d2ac2bb 10/07/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot.
TCGA-24-0979-01A-01T-0436-07 1f10aaa7-9234-402a-b9fb-ef0034991db1 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-0979-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-0980-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-0982-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1103-01A-01T-0436-07 8700bbff-8ba3-4f49-a6e4-89f405a1a704 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-1103-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1103-01A-31-2222-28 fe3528cf-b07b-468c-b439-57f63a9c40db 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1103-01A-32-2224-29 baded899-6457-4d71-9d88-b83cdf37a2b4 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1104-01A-01T-0436-07 123bd736-46d2-4a9e-8dd8-9503f1d65638 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-1104-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1104-01A-31-2224-29 67617e82-a476-4f70-8aa8-df3cccc7dcdd 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1105-01A-01T-0436-07 868212aa-ffbd-4a96-93b9-66cbd13aba8a 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-24-1105-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1105-01A-31-2224-29 b2f9c71d-831b-44bf-b722-577793d12692 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1413-10A-01W-0494-09 7f19696f-884c-4b4d-85ec-a1e675d98d2b 10/08/2013 OV Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-24-1413-10A-01W-0495-09
TCGA-24-1416-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1416-01A-31-2222-28 0e37f852-237e-4de9-9563-3329c6b1c46a 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1417-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1419-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1422-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1422-01A-31-2222-28 1e8c7e38-66d8-4c90-804e-2190cb65a5a6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1423-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1424-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1427-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1428-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1428-01A-31-2224-29 ee7a4f67-7b6f-4ac6-8df4-8e0009b6ee73 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1430-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1430-01A-31-2222-28 f45d647c-f43c-4776-8272-e96dc2b46b01 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1430-01A-32-2224-29 c9fe7c28-390b-4b2d-917e-4852ec2c2122 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1431-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1431-01A-31-2222-28 0aca14cc-f7f8-4abc-b674-468fd7c5ef33 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1434-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1435-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1435-01A-31-2222-28 16c69ca9-4e62-41fb-9f98-4a9b6e8fa302 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1435-01A-32-2224-29 9da2220e-65b6-428f-8159-a181281adc61 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1436-01A-21-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1436-01A-31-2222-28 db425575-f6ba-418e-893b-bfee814afd43 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1463-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1464-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1464-01A-31-2222-28 f6787a21-07f2-416c-8f86-11aa9b07111c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1466-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1466-01A-31-2224-29 43d4ae15-62a5-4eac-8b66-f9e52eb4048e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1467-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1467-01A-31-2224-29 3c1a61f6-2863-4ffe-b995-d09e169e1081 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1469-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1470-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1471-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1474-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1474-01A-31-2222-28 151e7c2b-5c90-4cc7-8b8e-4139ddcd51fe 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1544-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1544-01A-31-2222-28 62a5637a-b1d6-4719-8828-358fa1520556 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1545-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1545-01A-31-2224-29 e631ae7a-4a43-434d-81bd-598bbbea5a32 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1546-01A-21-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1546-01A-31-2224-29 8a713a39-bbbb-4d67-a380-5c77e15d0949 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1548-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1548-01A-22-2223-28 5141a5e0-ab77-4926-830f-9563eea8ef6c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1549-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1550-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1550-01A-31-2224-29 3b5af711-2e6a-45dd-88f0-2a28065facb1 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1551-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1551-01A-31-2224-29 119326ea-d899-4a23-a0ad-f43f37ed45a8 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1552-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1552-01A-31-2224-29 b036764c-730c-4f7b-918a-949862b45b23 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1553-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1553-01A-31-2222-28 2b2bf1cb-670f-4576-aa56-df44085a1bf1 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1553-01A-32-2224-29 a8998b5d-08a6-495d-9d40-85bc38a6c176 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1555-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1555-01A-31-2222-28 8a41c5c2-2c07-4a00-a402-703e84051452 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1555-01A-32-2224-29 e1d32c98-e60f-43e7-89b8-2f2f5bdcbd15 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1556-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1556-01A-31-2224-29 e940a5f1-4524-42e3-a58a-23ed26785ec6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1557-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1557-01A-31-2222-28 e3c34430-ed2d-4f77-b56f-14c8f919fdfe 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1558-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1558-01A-31-2222-28 3de22307-75cd-40d4-b0e6-ef1c8028753e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1560-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1562-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1562-01A-31-2222-28 79f7eaa0-9299-4198-8f5f-607e6196c9ac 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1562-01A-32-2224-29 e601c4db-ae1a-47c5-9919-69a97fb282a1 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1563-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1563-01A-31-2224-29 d96ff2e8-122c-4f18-af20-3a1971e7eb99 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1564-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1565-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1565-01A-31-2222-28 5690b2f7-3e2c-46c2-bad4-9ad5faa5804c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1567-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1603-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1603-01A-31-2224-29 959cb419-1217-4a2c-aea7-64523dde0921 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1604-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1604-01A-31-2224-29 d67f6ac2-c2e7-43f5-ba9c-1712bde650c6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1614-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1616-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1842-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1844-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1845-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1846-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1849-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1850-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1920-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1920-01A-31-2223-28 42e972fa-503a-4cda-b1ae-46a5055ad6f8 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1923-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1923-01A-31-2224-29 b8c1d546-15df-44fe-8238-a00dbe659601 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-1924-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1927-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-1927-01A-31-2223-28 e858aead-9848-4063-abec-6daa00bf1d1b 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-1928 b45c543a-40d9-423a-a7fa-98e4b325b487 09/02/2010 OV Prior malignancy [intgen.org]: Prior Malignancy
TCGA-24-1930-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2020-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2020-01A-31-2224-29 99f28dea-6122-412e-89e0-5946e150b6f3 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2023-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2023-01A-31-2224-29 e3d4e324-866e-4030-84f1-0c61a0532f23 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2024-01A-03-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2024-01A-41-2222-28 dbf380df-c1af-49e8-9550-8a8401419b6c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-2024-01A-42-2224-29 e792b2cf-0c20-44a5-a5d5-a3adb42069a4 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2026-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2027-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2027-01A-31-2224-29 88f8b75f-bb12-4528-bddc-3cb6c6032743 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2029 bbbf1184-1e19-479a-b31f-daa692d52e02 09/02/2010 OV Prior malignancy [intgen.org]: Prior Malignancy
TCGA-24-2029-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2030-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2030-01A-31-2222-28 db0a2f02-8b2d-4b94-8ccd-441264cd3596 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-2030-01A-32-2224-29 74d4fd3d-a5cf-4572-a308-3beefa67f133 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2033-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2033-01A-31-2223-28 82e08fd1-7bfa-4abf-a40b-811b3507e4e9 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-2036 c9226204-cb61-40b8-8a94-a7e71c14ea3a 11/10/2012 OV History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with systemic treatment per path report.
TCGA-24-2036-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2038-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2254-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2260-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2260-01A-31-2224-29 cc187d8d-edb1-4227-8e94-c280a0e8a105 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2261-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2261-01A-31-2223-28 6ad8f503-0ccd-4066-8dbf-31b397a3a4f0 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-2262-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2267-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2267-01A-31-2224-29 ffa48e8e-67cd-4fe4-9536-0277612d6a44 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2271-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2280 97ad0360-3be4-401a-a94c-7f2800a1b519 09/02/2010 OV Prior malignancy [intgen.org]: Prior Malignancy
TCGA-24-2281-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2288-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2288-01A-31-2224-29 9aab4da1-978c-422e-896a-1f7ebbfaea79 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2289-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2289-01A-31-2222-28 42ac6095-a84c-49aa-9017-24484d481ef0 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-2289-01A-32-2224-29 85ec0c5a-7369-49f2-ba5c-ec687cadde51 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2290-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2290-01A-31-2222-28 a38b6931-bfde-494e-84f4-32f44664aa4d 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-24-2290-01A-32-2224-29 f6f173d7-c907-42f0-bd24-0ec85797cc1f 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2293 bdd792e7-d75f-4aa3-b38e-f0708e112075 09/18/2011 OV Prior malignancy Prior malignancy of Ovarian cancer
TCGA-24-2293-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2295-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2295-01A-31-2224-29 9e042624-021f-46cf-ac8c-f9a92bbe2850 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-24-2297-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2298 7e4e7914-ec23-4c55-98d6-3c5eecffa8e4 09/18/2011 OV Prior malignancy Prior malignancy of breast carcinoma
TCGA-24-2298-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-24-2298-01A-31-2223-28 ee7e8441-6b32-4068-816a-4477e5299a15 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1312-01A-11-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1312-01A-21-2223-28 31a205e7-3476-460c-8d00-95e8d0d505d5 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1312-01A-22-2225-29 08a4dc9b-e968-4a4a-b55e-e4d0bbc57031 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1313-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1313-01A-22-2223-28 43c32883-0be3-4982-b90a-039a656a34e6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1314-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1315-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1316-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1316-01A-22-2225-29 37b4dc80-76b9-49e7-8cd1-8d3070eecd03 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1318-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1318-01A-22-2223-28 2d1acc2b-41a6-4236-a108-68ea8cd8d902 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1319-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1319-01A-22-2225-29 a51096ad-88f4-4c3f-9934-87e346b2ce2c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1320-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1320-01A-22-2225-29 8092b10e-291b-4ed2-ac9f-80da11158101 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1321-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1321-01A-22-2225-29 01b727ba-3ce9-44d3-b28d-89518f1c0a94 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1322-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1322-01A-22-2223-28 e91842df-9b99-4683-bc7e-234796968b64 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1323-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1323-01A-22-2223-28 52df303d-5193-4560-8852-0bdc59f5d559 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1325-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1326-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1328-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1329-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1329-01A-22-2223-28 b84a1bf9-1bf2-433b-9954-a8f931a32442 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1623-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1623-01A-31-2222-28 95680840-bcd1-42fd-b87c-a9ec3672a0aa 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1623-01A-32-2224-29 4bdb8fed-36e7-4911-ae71-dbb78452bd2e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1625-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1626-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1627-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1628-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1628-01A-31-2222-28 339a1639-92d7-425d-acc9-0ffb382659ec 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1628-01A-32-2224-29 7917bbb1-c00c-4851-9dbe-c62d65ecf6c8 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1630-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1630-01A-31-2224-29 9b3f77d0-b301-4e33-8c02-ef8dbe319ebc 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1631-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1631-01A-31-2222-28 e5b52438-2647-4eb9-a981-f02eef23bdaf 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-1632-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1633-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1635-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-1635-01A-31-2224-29 193a3e36-bd98-4e50-86ad-2af1d876ee71 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-1878-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2042-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2390 01abf2cf-541c-4610-8ce8-318016db6e59 09/02/2010 OV Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-25-2390-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2391-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2393-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2396-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2396-01A-31-2223-28 1f5e1fa0-a97e-4b78-8e76-5371d1df893a 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-2397-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2397-01A-31-2223-28 6c08ff20-b0a1-473f-b922-42b36df7bb25 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-2398-01A-21-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2398-01A-31-2224-29 ee40e979-6f9a-4b0d-a1f6-620e14080c39 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-2399-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2399-01A-31-2223-28 73826680-1f98-4f06-b961-cc6f7e0f31a6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-2400-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2400-01A-31-2224-29 e82c809a-897d-4032-8637-fcc8b85a1192 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-2401-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2404-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2404-01A-31-2222-28 230a8431-03ad-42cc-a3b3-0498b09f3c3e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-2404-01A-32-2225-29 957bf23d-b060-4ce7-b469-9ad3e8a360a2 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-25-2408-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2409-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-25-2409-01A-31-2222-28 11fedffc-3b9b-4094-a945-136225269ddd 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-25-2409-01A-32-2225-29 a6d9de12-eaac-4b14-bf81-d00f175c170f 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-26-1442 c29d73c0-c885-4105-bf74-38e9178e71c9 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
TCGA-26-5132 2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8 03/09/2012 GBM Prior malignancy Prior Prostate malignancy as per pathology report.
TCGA-26-6173 60e69f41-571e-4a1b-ae75-9d49eed620ca 10/31/2012 GBM Normal tissue origin incorrect Samples were created as tssDNA from Normal Tissue. Actually are tssDNA extracted from Blood. Should have been 10A instead of 11A.
TCGA-26-6174 4b606edf-07fc-4665-a7cd-a794004e5aca 10/31/2012 GBM Normal tissue origin incorrect Samples were created as tssDNA from Normal Tissue. Actually are tssDNA extracted from Blood. Should have been 10A instead of 11A.
TCGA-27-2526 69d0a566-5fbf-45f6-a240-649b06868e27 11/08/2012 GBM Qualified in error Subject qualified in error
TCGA-28-2499 d88b35a3-a291-457a-b15b-a314859b25c5 09/02/2010 GBM Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-28-2512 4ca9c0f2-1be9-4376-aa27-d9db948d3f68 09/02/2010 GBM Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-29-1688-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1688-01A-31-2222-28 c7099cdf-c1b4-4ba0-83d5-dd18ccad1a1e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1688-01A-32-2224-29 3f3f9a73-447e-4e60-8b49-2a60fdd5e972 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1690-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1690-01A-31-2222-28 7e4332ff-69df-4c96-8d9c-1752efd88941 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1691 b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b 09/18/2011 OV Prior malignancy Prior malignancy of breast cancer
TCGA-29-1691-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1693-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1693-01A-31-2222-28 62a4ef57-38ea-4839-b0a4-892999a742b5 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1693-01A-32-2224-29 9c68f95e-5798-4952-937b-0a38e6d7680b 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1694-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1695-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1696-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1696-01A-31-2222-28 e55c4023-0ce2-423f-8ad2-ff99a1cdfc23 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1697-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1697-01A-31-2222-28 ef464eaf-7c95-485e-a457-6bd3a34487ad 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1697-01A-32-2224-29 39d0ff61-a421-42d9-b610-944946335123 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1698-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1698-01A-31-2222-28 32dac92a-4431-49f0-8186-1c34ab518f32 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1699-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1701-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1702-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1702-01A-31-2222-28 43604b7d-6fab-4c95-9e96-8a0f1fc496c3 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1703-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1705 f9c835db-2ab6-4bf5-826f-48723493c0ec 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-29-1705-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1705-01A-22-2214-20 daae8ca1-a6fd-43cc-a82e-32ffe02803c7 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-29-1705-01A-31-2222-28 be0ec3f0-d265-48fd-a330-c2f582412eda 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1705-02A-01D 89e9ada1-3a4d-4e48-a903-b2d21b30ad5d 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1705-02A-01G 031fe4b0-2a52-417f-a970-f7f365ef92bd 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1705-02A-01R 656f95dd-960a-46c9-88d9-060adfc1de0b 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1705-02A-01T 3b4b38dd-bc06-42da-a95e-2ca9b225cb31 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1705-02A-01W cdb8ce0d-24aa-46e9-b235-21553198b7bf 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1707 7fd6ab8a-201e-431d-a886-6ab553b6ca36 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-29-1707-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1707-01A-22-2214-20 26e9028d-8002-4408-82e8-68bf43f27fec 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-29-1707-02A-01D cd196065-ab2b-4a39-ab46-2d24852c48e2 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1707-02A-01G f5534712-24f0-4eab-af37-6ebc7eb871cc 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1707-02A-01R 65b5f9e2-4887-4358-a9bf-4aa3bcaf363a 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1707-02A-01T 123d79e2-a1ae-4a43-9e6b-8b66283883d3 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1707-02A-01W e2fde7bb-4899-4889-b2ed-7ed35e3620b9 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1710 4261267c-7042-4c6e-83ed-12fb401003fc 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-29-1710-01A-31-2214-20 34b987ae-5e5a-435b-b1f3-0cf9623f1337 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-29-1710-01A-41-2222-28 f4a87640-4a69-4277-8708-7bbeccbcd333 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1710-02A-01D f11115eb-4277-4c0c-813e-53877d4bf8f9 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1710-02A-01G ca289a0f-9644-4116-a1f1-0d94aae8b96c 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1710-02A-01R c7958cbc-278f-4bef-95e2-0b2ba53c1d3b 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1710-02A-01T ed7a0880-4155-468d-843b-3c75672645c6 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1710-02A-01W 7ae582fc-6914-42f6-b8e7-6a30b813eafc 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1711-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1711-01A-31-2222-28 684e6503-a365-47da-a77d-1b4c8334567a 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1761-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1762-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1762-01A-31-2222-28 70c78fb7-8f3c-4967-ac9f-7338a14ba079 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1762-01A-32-2224-29 f02fdd34-1c0b-4e17-877e-682161a68d64 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1763-01A-31-2222-28 64cf3f44-13f4-4c62-8ce8-d43013b9c483 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1763-01A-32-2224-29 fdaec0b7-28fd-4ec6-8f5e-211c56d7c48b 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1764-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1766-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1766-01A-31-2222-28 cc542c29-a041-4135-a92d-8ed9aa018860 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1768-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1768-01A-31-2222-28 6aa424a0-5f3f-45fe-b152-ac2875c40942 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1768-01A-32-2224-29 e03e0e38-26ce-45de-bbec-ac9283565f64 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1769-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1769-01A-31-2222-28 9c50b3ce-27ca-4fcf-b7d2-6b7d262b169c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1770 5abb6d80-fc39-49a4-8db5-3db24543feb6 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-29-1770-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1770-01A-31-2222-28 a5a35a8e-3e1a-4cc0-b3d3-f7516ce6bc35 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1770-02A-01D 45a142ee-dbe6-4d47-aa56-8391e36b1f7b 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1770-02A-01G 27f99cc1-5b5a-4dd6-af5d-645dcfafe9e1 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1770-02A-01R f13c7818-cb57-4775-8f05-2defd481f8a2 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1770-02A-01T 0e2c71a8-3711-4ec8-a17c-bb93939e1a67 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1770-02A-01W 0d2478bd-38e1-4961-ae81-435c8242c09b 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-1771-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1771-01A-31-2222-28 88c8369e-962f-4a1f-9d08-6cd5a72bf093 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1774-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1774-01A-31-2224-29 f747ee0b-6389-4d27-8f3e-b15c570a7dfd 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1775-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1775-01A-31-2224-29 e394735d-99f7-4eff-ad0d-e3bcb8b40a8e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1776-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1776-01A-31-2224-29 09e6fdc6-8d70-4899-9715-9730c2514aed 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1777-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1777-01A-31-2224-29 ee5d54d8-baeb-42a8-b24b-e46e542898fa 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-1778-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1781 f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6 09/18/2011 OV Prior malignancy Prior malignancy of breast cancer
TCGA-29-1781-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1783-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1785-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-1785-01A-31-2222-28 68b0d1f4-37f9-46d2-8acc-89bb9532ec42 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-1785-01A-32-2224-29 18736757-18f9-4303-a890-e5afdd682107 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-2414 a2319490-b85d-4219-a1b0-fa1ec432d5c8 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-29-2414-01A-31-2214-20 2433c714-344b-4fa6-91a4-2cab830a4485 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-29-2414-01A-41-2224-29 55150972-c11a-488b-9247-815bac130708 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-2414-02A-01D 235130e0-2fb8-41f5-af2c-b58bd1d73cb4 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-2414-02A-01G d9af58c1-0dd5-47db-b7b1-773b895834c0 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-2414-02A-01R 4db51ece-d641-4e3d-a214-ec7728b6397d 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-2414-02A-01T a863a633-00e1-4fa9-9b34-51b91ce10c39 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-2414-02A-01W 57f26303-dc24-45c6-aff1-77edfb9bfa0a 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-29-2425 40635bf3-d8ba-4833-b623-547e55e5d07e 09/18/2011 OV Prior malignancy Prior malignancy of breast cancer
TCGA-29-2425-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2427-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2427-01A-31-2222-28 04f1d4d5-a497-4531-b95d-acb6bfcfdddf 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-2427-01A-32-2225-29 1e98e6f8-b6ce-4670-95c2-5fd57e2f4310 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-2428 b0585c7a-7205-4dac-9d54-6da89674accb 09/18/2011 OV Prior malignancy Prior malignancy of high grade endometrial carcinoma
TCGA-29-2428-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2429-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2431-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2431-01A-31-2223-28 6b8f54f6-da5f-4c5d-8f96-8a15929b1981 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-29-2432-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2432-01A-31-2224-29 465929cc-9c2d-4a48-b799-7c83f9c293df 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-29-2434-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2435 8fa35df3-f544-4c47-bdd1-e4d6fc6662be 07/17/2014 OV Item is noncanonical Incomplete distribution. Only Repli-G and proteomics shipped.
TCGA-29-2435-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-29-2436-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-2G-AAFE 1d25c24e-bd3c-4023-85c1-b158f76324f1 08/21/2014 TGCT History of unacceptable prior treatment related to a prior/other malignancy Patient recieved chemotherapy (Bleomycine, Etoposide, and Cisplatin) for the prior maligancy (opposite testicle)
TCGA-2L-AAQM 7240d5da-b54e-436b-8069-f2c9f516b75e 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-30-1718-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1855-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1856-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1859-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1860-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1861-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1866-01A-31-2224-29 c2048b59-1edb-49d3-8194-95048707fd5d 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-30-1869 84f5876d-82b0-45ff-8f3d-a10653683454 09/02/2010 OV Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-30-1869-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1887-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1887-01A-31-2222-28 884576bc-c289-4c5a-b4ea-ea663ce7a7f3 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-30-1891-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-30-1891-01A-31-2222-28 27346e91-c096-436d-ba99-4cc2aac0d329 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-30-1892-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-31-1944-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-31-1946-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-31-1950-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-31-1951-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-31-1955-01A-01T-0709-07 1d49c32f-754d-4867-b109-37485652d535 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-31-1955-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-31-1956-01A-01T-0709-07 e1967607-af06-449f-aa2a-f24963ee57eb 07/18/2013 OV Barcode incorrect Incorrect plate number, should be 0438
TCGA-32-2495 e7d728e5-1a9f-4f27-9604-272e1235e08a 10/31/2012 GBM Neoadjuvant therapy Per enrollment form, patient received neo-adjuvant therapy.
TCGA-32-2495 e7d728e5-1a9f-4f27-9604-272e1235e08a 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma. Current TCGA tissue is reported as treated tissue.
TCGA-32-4209 5438322c-9db0-4974-ba01-801020559f97 11/10/2012 GBM Case submitted is found to be a recurrence after submission Per enrollment form, patient had a prior diagnosis of a lower grade glioma. Current TCGA tissue is reported as treated tissue.
TCGA-33-4532 6ee6ca0a-8702-480d-b2d1-9224e7dd9211 10/31/2012 LUSC Prior malignancy Prior malignancy of the lip and nose. No systemic chemotherapy or radiation.
TCGA-33-4532-01A-21-2193-20 145f9405-fb5b-432d-8928-063e0d3a7b43 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-4533 b4ff0f49-b787-48ec-91cc-ee26786ff1bf 02/26/2015 LUSC Case submitted is found to be a recurrence after submission Other Malignancy form states patient had prior lung squamous malignancy in same lung 9.5 years before TCGA tumor procurement.
TCGA-33-4533 b4ff0f49-b787-48ec-91cc-ee26786ff1bf 10/31/2012 LUSC Prior malignancy Prior malignancy L LUSC. No systemic chemotherapy or radiation.
TCGA-33-4538 c70a5975-c37b-47cc-9113-427a754807d8 11/10/2012 LUSC Neoadjuvant therapy Patient received neo-adjuvant treatment prior to resection of TCGA tumor per enrollment form.
TCGA-33-4547-01A-21-2193-20 843b8ba9-57ff-4db6-98fb-1c2a508f98b7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-4566-01A-21-2193-20 585632a4-48ad-4dda-89f6-c6ad289305f0 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-4579 1169b8c3-e5ae-47a8-91db-0ce62a5958e2 10/31/2012 LUSC Prior malignancy Prior malignancy SCC of the nasal cavity. No systemic chemotherapy or radiation.
TCGA-33-4582-01A-21-2193-20 f6afdaa8-47c3-4483-9a13-62fdc67f4c16 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-4586-01A-21-2193-20 c153a3c3-eaff-4a5b-b4fd-dc4d467669e7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-4589 49f975ea-a1cf-4a9b-bf13-030c68cc99e4 10/31/2012 LUSC Prior malignancy Prior malignancy SCC of the tongue treated with locoregional radiation.
TCGA-33-4589 49f975ea-a1cf-4a9b-bf13-030c68cc99e4 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy SCC of the tongue treated with locoregional radiation.
TCGA-33-4589-01A-21-2193-20 78114d62-a9cb-4bfa-8c47-a84e9c53802f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-6737 afedf3fb-fc77-45a7-bdcd-2c78706a0f8a 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy Hairy Cell Leukemia treated with 2-CdA and Pentostatin.
TCGA-33-6737 afedf3fb-fc77-45a7-bdcd-2c78706a0f8a 11/18/2011 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-33-6737-01A-13-2194-20 f15f6e1d-a3f0-4de4-9060-833a3989022f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-33-6738-01A-13-2194-20 5dcec6e8-27e0-4674-b842-8f2d2542d907 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-2596-01A-21-2193-20 9d1b859e-95d7-43d1-b71a-c0a0c240ccda 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-2604 cee6e9f6-6d7e-4096-a9bc-2cce004fb218 09/02/2010 LUSC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-34-2604 cee6e9f6-6d7e-4096-a9bc-2cce004fb218 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated w/ locoregional radiation.
TCGA-34-2604-01A-21-2193-20 cf27663d-6ff3-4102-948c-c0c712af54d0 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-2605 9335e4df-9974-47ec-84c4-256cd33522f2 09/02/2010 LUSC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-34-2605-01A-21-2193-20 79a77711-5efb-4811-9e36-c6823526a48a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-2608-01A-11-2193-20 f3b4f474-f6b9-47aa-bcf8-a06304109a51 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-2609 257650bd-2e2b-4680-b77b-f9268b3af4ee 09/02/2010 LUSC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-34-2609-01A-21-2193-20 ce27724e-e32d-4576-a458-17ee97966504 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5231-01A-22-2194-20 70790e8d-ce93-491e-8b1f-f3a5b60871b5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5232-01A-22-2194-20 df107ef1-536f-4ba9-aed3-7bed52caa45c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5234-01A-21-2194-20 a26c5140-ea1f-4fc1-adbb-a3c8203bd19c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5236-01A-22-2194-20 428e8766-529c-4372-8ea0-908252cd825c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5239-01A-22-2194-20 fc556f8e-523f-4dc1-926c-bdc0eb9debb9 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5241-01A-21-2194-20 0140324e-7bca-4fbb-b771-73ccd1a4c15a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5927-01A-13-2194-20 285a2366-5d39-41d4-ba6a-36515454fcb6 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5928-01A-13-2194-20 98d56989-dbfb-4d7a-91f5-13f9163bab5f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-5929-01A-13-2194-20 b2b7dd0b-8713-45ee-9dfe-351b895c2046 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-34-7107-01A-13-2194-20 b00c4a7d-5025-40e5-be42-dac01b3de7fe 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-35-3615-01A-21-2190-20 f47527bd-86b0-4807-818c-6b4971222e06 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-35-4122-01A-21-2190-20 a0dded2b-3083-4aea-a9b1-c8376ddf0db1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-35-4123-01A-21-2190-20 b3627ae3-6960-4e37-b443-bc30986e9d0d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-35-5375-01A-21-2190-20 1dec822b-8282-4b95-8d3b-76bd5ed3fbe0 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-36-1568-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1569-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1569-01A-31-2222-28 dff9debb-8a60-4220-bc49-93893df55007 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-1570-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1570-01A-31-2222-28 e155ad51-a0aa-4df0-8b97-c0167a22c283 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-1571-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1571-01A-31-2222-28 4baf7756-acee-4ba1-96f8-e5f8bc58e5d7 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-1575-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1576-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1576-01A-31-2224-29 bba33b1e-7259-4231-ad39-fadc4e0a87f6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-36-1577-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1577-01A-31-2222-28 c10d86d9-70af-4337-839a-f71458592e77 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-1578-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1578-01A-31-2222-28 51e2c6f8-a17a-4d54-960e-f5427c45baa3 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-1580-01A-21-1558 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1580-01A-31-2222-28 993ff814-5cbe-4110-a546-c58c63053d7c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-1581-01A-03-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-1581-01A-41-2224-29 ecd2b48d-6529-42ec-a218-09ab17844957 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-36-2529-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2529-01A-31-2224-29 805aa92f-1261-493f-a833-28285b8e2f65 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-36-2530-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2530-01A-31-2222-28 6036a08f-56d7-477e-8d10-a1df7c11dd89 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2530-01A-32-2225-29 5d917f89-6be7-4c18-8fc5-5634a71d9fd3 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-36-2532-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2532-01A-31-2223-28 f1fff6ad-6ead-4fd3-877f-e24198802a2c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2533-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2534-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2534-01A-31-2223-28 2cb93b62-d555-44fb-af09-b28c43a1a7fa 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2537-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2537-01A-31-2223-28 db98af3d-5a4e-498b-93a1-d78e133b614f 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2538 3ea880f4-7a78-4cb7-bfe4-54b3c30a812e 09/18/2011 OV Prior malignancy Prior malignancy of ovarian cancer
TCGA-36-2538-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2539 81d11171-5d9e-4950-98f8-b0ab0f2d7908 09/18/2011 OV Prior malignancy Prior malignancy of breast ductal and lobular carcinoma
TCGA-36-2539 81d11171-5d9e-4950-98f8-b0ab0f2d7908 10/31/2012 OV Prior malignancy Prior malignancy of L breast cancer. No systemic chemotherapy or radiation. Prior malignancy R breast cancer treated with taxoterene.
TCGA-36-2539 81d11171-5d9e-4950-98f8-b0ab0f2d7908 11/10/2012 OV History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of L breast cancer. No systemic chemotherapy or radiation. Prior malignancy R breast cancer treated with taxoterene.
TCGA-36-2539-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2540-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2542-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2542-01A-31-2223-28 c88ad596-e990-4790-bdbf-1c2c18d53dcb 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2543-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2543-01A-31-2224-29 06ef0724-7c41-4dd2-97c1-c1610ad0687e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-36-2544-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2544-01A-31-2223-28 74c16b08-051a-456e-93b0-d4b06932671d 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2545-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2545-01A-31-2223-28 c37feadf-61d4-44da-b037-73ff01c9f24e 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2547-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2547-01A-31-2223-28 b832c3b4-b8f7-4647-b5af-ff2d86b2c784 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2548-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2549-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2549-01A-31-2223-28 e46373f5-7bf1-4cbf-a476-f916219a2acb 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-36-2551-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-36-2552-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-37-3789-01A-21-2193-20 25a5c25c-2520-4a48-8f96-4b1798af4de6 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-37-3792-01A-21-2193-20 f7e9d4d4-3b43-4f96-aaaf-75dbc77f68d4 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-37-3915-10A-01D-1086-04 677f21bb-6528-4f5a-8914-b5a6255ae6ed 07/02/2013 LUSC Barcode incorrect Incorrect barcode and UUID (TCGA-37-3915-10A-01D-1086-04:677f21bb-6528-4f5a-8914-b5a6255ae6ed) replaced by correct barcode and uuid TCGA-18-4083-11A-01D-1086-04:1ee0824c-09b3-47ce-897d-627b97966809
TCGA-37-4129-01A-21-2193-20 8db5bd89-429b-4872-9ca0-fb72e95cf504 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-37-4133-01A-21-2193-20 759891ff-ab70-4687-bd59-b6df4d18f93f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-37-4135-01A-21-2193-20 7cdeb372-38d2-46a5-a868-cac875e0c524 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-37-4141-01A-11-2193-20 b464e455-cab7-456b-89dc-ca193fd7a25f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-37-5819-01A-21-2194-20 9218f291-efd3-41a3-a784-7934ea10fe03 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-38-4625-01A-21-2190-20 f5f1b4e7-6b05-4d28-a55b-8719ebb6a9c0 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-38-4626-01A-21-2190-20 f1a33481-d34e-4a5b-8b60-9bb49b4584b1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-38-4627-01A-21-2190-20 a7ef03a9-2a95-43d7-8dc4-3e98decdb223 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-38-4629 127bf818-f7e5-46b5-a9de-39f6d96b8b83 11/10/2012 LUAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of the larynx treated with chemotherapy and radiation.
TCGA-38-4629-01A-11-2190-20 b78fa417-a0aa-4ebf-b75f-6891c541fb6d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-38-4630 f1985735-a188-4567-a88a-530f9b80291b 11/10/2012 LUAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy uterine serous endometrial adenocarcinoma treated wtih systemic radiation.
TCGA-38-4631 2483621a-4db3-41ab-aa33-b9427ea8a0af 10/31/2012 LUAD Prior malignancy Prior malignancy R breast cancer. Prior malignancy L breast cancer. No systemic chemotherapy or radiation for either.
TCGA-38-6178 edf80622-aea2-4b50-bb69-691d6708aa83 10/31/2012 LUAD Prior malignancy Prior malignancy L ovarian cancer. No systemic chemotherapy or radiation.
TCGA-38-6178-01A-13-2191-20 672018b4-22a2-4763-8ce7-19bff0256138 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-38-7271 8214a0d1-5e2d-4a7a-acb1-e5580755db83 11/10/2012 LUAD Synchronous malignancy Pt with synchronous L breast cancer
TCGA-39-5011-01A-21-2194-20 543782e2-71d3-4cc2-80e4-11b9a0eb15ce 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5016-01A-21-2194-20 9d441074-5562-43c7-8158-903e11fb1eaa 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5019-01A-21-2194-20 a928f1c8-ed6b-4908-8174-03bf26fd1fa4 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5021-01A-21-2194-20 34e208a6-3752-47a1-87f3-ae1c02612d17 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5022-01A-22-2194-20 441d3e63-041c-48f0-bc13-9febd802aab8 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5024-01A-22-2194-20 82c886e2-5803-46e5-9553-949321c21d34 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5027-01A-22-2194-20 65da1c24-f058-4754-80b1-bb45247f835b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5028-01A-21-2194-20 424c5902-5b4c-4576-a19b-f3e7aab0ff1d 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5029-01A-21-2194-20 bcb62b1f-2852-4823-8028-9845e480e34f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5030-01A-21-2194-20 6bf62267-1f99-4080-ad9d-caf0f7b60b68 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5031-01A-21-2194-20 02171381-ad60-4e7b-a56d-c0a3f129dcaa 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5034-01A-21-2194-20 9088cd2b-f01a-4e61-949b-026e4be3479a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5035-01A-21-2194-20 3c25960c-f4f3-493f-8cff-b039e73b921e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5037-01A-21-2194-20 9864ab85-daea-4018-b513-0f577c9391f4 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-39-5039 ffb83f21-06d9-4e52-a2d0-e85c13f4037f 01/09/2011 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-39-5039 ffb83f21-06d9-4e52-a2d0-e85c13f4037f 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer, treated with hormone therapy and locoregional radiation.
TCGA-39-5040-01A-11-2194-20 d5a08f32-ad9a-45d2-8f8b-66283eafad42 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-3A-A9IJ 5f468c25-73c3-49d5-ba12-50653dfe2c41 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3A-A9IL 24a40289-96fd-4c1a-a953-45a46a0a0e9d 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3A-A9IN dd5074b2-462d-4267-8b9b-5a4c54e5978c 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3A-A9IO 13cf4e4c-8d5f-4854-a350-428fdf1ff340 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3A-A9IR 5898434d-cfa3-4515-a0c0-810d7e515120 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3A-A9IS cf825b86-7ec2-4e90-bcce-3b5637b90b70 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3A-A9IV 1c2341f3-558b-4555-90ff-c7a23ef85c0b 10/15/2014 PAAD Item does not meet study protocol This case is a neuroendocrine tumor and should not have been included in the PAAD study
TCGA-3G-AB0Q 67ff3aa1-9d52-4dc8-8501-ecd0d37a8735 06/30/2014 THYM Neoadjuvant therapy Patient recieved neoadjuvant chemotherapy prior to TCGA specimen.
TCGA-3G-AB0T acaaed1a-2667-4c56-919b-daf5574371bb 06/30/2014 THYM Neoadjuvant therapy Patient recieved neoadjuvant chemotherapy prior to TCGA specimen.
TCGA-3G-AB0T acaaed1a-2667-4c56-919b-daf5574371bb 10/09/2015 THYM Case submitted is found to be a recurrence after submission Distant metastasis submitted as a primary for TCGA. Case was initially diagnosed 5 years prior.
TCGA-3H-AB3K e90bfe17-2e5b-47ed-b986-b3d4181f2bf6 06/12/2014 MESO Neoadjuvant therapy Pleurodesis < 90 days from sample procurement
TCGA-3H-AB3L aaace369-0a47-4176-811b-61cd42bf647f 06/12/2014 MESO Neoadjuvant therapy Pleurodesis < 90 days from sample procurement
TCGA-42-2582 7922df77-f09a-488c-a1be-58646ceb9b3e 09/02/2010 OV Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-42-2582-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-42-2587 eef62876-7d17-496a-8971-2c7008d77014 09/02/2010 OV Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-42-2587-01A-21-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-42-2588 654d02ab-05b4-4863-99d9-04d087ff91b4 09/02/2010 OV Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-42-2588-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-42-2588-01A-31-2224-29 45c62e7c-965f-4f20-b5b2-1f8cc342cbf1 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-42-2589-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-42-2590-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-42-2590-01A-31-2224-29 03e03d75-e92a-4e27-b05c-2e6ec1ebf032 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-42-2591-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-42-2593 3db7ecdd-315f-4475-a375-f6044a4b0070 09/02/2010 OV Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy Patient had received methotrexate for arthritis, not as part of cancer therapy.
TCGA-42-2593-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-43-2578 37f5457e-21d9-4b79-95d5-ded6f2e43087 10/31/2012 LUSC Prior malignancy Prior malignancy R LUAD. No systemic chemotherapy or radiaiton.
TCGA-43-2578-01A-21-2193-20 8533dc60-fcd4-4b70-af5d-624df2d66eb2 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-2581-01A-21-2193-20 25c27349-3d97-4602-aa07-8187a7c97788 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-3394-01A-21-2193-20 16838c14-8069-48d4-b57a-f06db613503b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-5668 f5ad138c-1714-41e9-9c2d-c88050bec407 10/31/2012 LUSC Prior malignancy Prior malignancy basal cell carcinoma of the skin. No systemic chemotherapy or radiation.
TCGA-43-5668-01A-21-2194-20 e34afcb4-f3ec-4f28-b419-cf55da46f62e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-5670-01A-11-2194-20 75fb3562-d7fc-459c-acc9-5b66d16eb7fa 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-6143-01A-13-2194-20 01f9ec9b-2018-4773-aac3-afc9218f8057 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-6770-01A-13-2195-20 ebc6f011-b3ec-4c3a-b834-042da6b23280 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-6771-01A-13-2195-20 6d6d5925-f180-4866-bcb1-f954a2da17f7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-7656-01A-13-2195-20 8f489848-549d-41e4-9a75-db8aea47589f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-7657 dbece124-c042-4adc-8136-90e7940ee6ad 10/31/2012 LUSC Prior malignancy Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-43-7658 a6ec75d4-1c90-4527-bfae-aa91d2dae082 10/31/2012 LUSC Prior malignancy Prior malignancy basal cell carcinoma of the nose. No systemic chemotherapy or radiation.
TCGA-43-7658-01A-13-2195-20 68a07bc1-8c04-4887-a120-c3efa5e439d2 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-43-A474 ae2c650c-600b-4c58-893b-7fd73d44af47 07/16/2013 LUSC Prior malignancy Patient had a prior skin malignancy. No systemic radiation or chemotherapy.
TCGA-44-2656-01A-11-2190-20 84750167-98a3-4be6-a407-39a6c9629a14 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-2657-01A-21-2190-20 54935339-ba0b-4d0e-ae3a-5805916ef135 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-2661 f3501466-cf32-4866-b5fb-e94dd32341bc 11/10/2012 LUAD History of unacceptable prior treatment related to a prior/other malignancy Pt with synchronous R breast cancer treated with Femara prior to procurement of tumor submitted to TCGA.
TCGA-44-2661 f3501466-cf32-4866-b5fb-e94dd32341bc 11/10/2012 LUAD Synchronous malignancy Pt with synchronous R breast cancer treated with Femara prior to procurement of tumor submitted to TCGA.
TCGA-44-2661-01A-21-2190-20 39162d9a-aa2f-4aa6-a495-9d3d5f159771 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-2664 93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f 09/02/2010 LUAD Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-44-2664-01A-21-2190-20 d81b36d5-1923-49b3-8881-306793fb7c77 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-2665-01A-21-2190-20 80b4100c-7cdf-42f6-a01f-056acc9f2244 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-2668-01A-21-2190-20 2e058de2-768c-4a90-9105-a30e5a3cd627 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-3396-01A-31-2190-20 a9183121-98c3-4e97-942d-85eb5b1255f5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-3398-01A-31-2190-20 16bb1a7a-a8b2-44a0-bccc-574b6e418d1c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-3917 7099597a-b208-45b5-b9e0-11ab40d5e497 09/02/2010 LUAD Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-44-3917-01A-21-2190-20 b32ab08b-b364-456f-8494-46ca48fb5352 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-3918-01A-21-2190-20 4f270bce-0b0e-4f5d-bc5d-1524fbea5234 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-3919-01A-11-2190-20 e72f62a3-8f58-4df4-b339-198051b6c95f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-4112-01A-21-2190-20 cc482acb-598e-44b9-86f9-c287fd6766d5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-5643-01A-41-2191-20 65fa1532-4925-48b2-888f-3509654957e7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-5644-01A-41-2191-20 07d9b06a-f8d3-46d8-b864-4dfd4430540b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-5645-01A-41-2191-20 ec945497-65c8-47ca-81d7-22be0f1f8c7c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6144-01A-13-2191-20 faa409af-7bc8-4e0e-8c38-7ab58e895727 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6145-01A-13-2191-20 6dda9f9a-db50-4dfe-90e5-2c06a8f65018 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6146 0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-44-6146-01A-13-2191-20 39d5ffa0-85ff-4d42-a064-1c083c1c24fd 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6147 889aec8e-14ba-48d9-8fe1-f2416e82b333 07/11/2011 LUAD Prior malignancy [intgen.org]: Prior Malignancy
TCGA-44-6147 889aec8e-14ba-48d9-8fe1-f2416e82b333 11/10/2012 LUAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of bowel carcinoid tumor treated with sandostatin. Prior malignancyR KIRP. No systemic chemotherapy or radiation .
TCGA-44-6147-01A-13-2191-20 af82f02d-660f-4906-9b42-be16c0615693 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6148-01A-13-2191-20 2227fc80-a405-473b-b25c-dbcfe1624040 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6774-01A-23-2191-20 dafb8264-54ef-4fe8-b549-3c5079a42773 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6775-01A-13-2191-20 f098943b-8859-4329-b980-14784b42131f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6776 c2a1de2e-6451-4c95-8ce6-263f2b7e6eff 11/10/2012 LUAD Synchronous malignancy Pt with synchronous lymphoma
TCGA-44-6776-01A-13-2191-20 b08fc3a5-06b6-42af-8195-585acfcf1d4e 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6777-01A-13-2191-20 137825b5-a029-4638-8150-bca2c02f6ded 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6778-01A-13-2191-20 3380c662-2c5f-4dc7-b438-5286e2984b36 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-6779-01A-13-2191-20 1976e376-25dc-481c-b1b0-ba2b390944d5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7659-01A-13-2192-20 15ecd6a2-ab28-4b96-b20f-5a9163f6c14a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7660-01A-13-2192-20 c423ffaa-5b81-4218-b7bb-85c8e7be4efe 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7661 cbfef004-b437-4d51-9d88-a2db50aa6481 11/10/2012 LUAD Synchronous malignancy Pt with synchronous endometrial cancer.
TCGA-44-7661-01A-13-2192-20 ad484c0c-edb6-47f3-8e06-3adf0a4c3654 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7662-01A-13-2192-20 318204fb-9dc7-4024-b09a-5b507bf8f217 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7667-01A-23-2192-20 6ab603ca-baa9-46a5-a40f-367048fb7cc9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7669-01A-23-2192-20 58a516e2-5056-4dbf-b60e-76ce109984db 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7670 9b38eded-3f46-4aaa-9991-68008d97bdbe 10/31/2012 LUAD Prior malignancy Prior malignancy of the vulva. No systemic chemotherapy or radiation.
TCGA-44-7670-01A-11-2192-20 3a023cd3-de1f-4b19-afd9-685baf90aab7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7671 ebb33753-9d38-4368-9033-3e55f129d00d 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-44-7671-01A-21-2192-20 d73aab66-a9f7-4bf5-969a-aceb01abb8ff 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-7672-01A-21-2192-20 ee5f6e2a-0d90-4e2c-8631-00b3a10b0d43 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-44-8119 230dc42d-681c-4e31-9d2e-c724e61829fb 10/31/2012 LUAD Prior malignancy Prior malignancy skin cancer upper lip. No systemic chemotherapy or radiation.
TCGA-46-6025-01A-13-2194-20 55f36d96-6b14-4aee-97fe-a846962e8512 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-46-6026-01A-13-2194-20 1f974ba9-6993-4575-8372-32673ea3fdd9 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-49-4486-01A-21-2190-20 5c48d536-cfad-4535-a47d-08c42362aae5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4487-01A-22-2190-20 09b4e4df-58df-4faa-8e4d-21bc4799f467 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4488-01A-21-2190-20 911a1ccb-8917-4b18-a0a4-65def5a2160b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4494-01A-21-2190-20 4af63e96-7fed-4a64-bf86-cdeb2dff3877 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4501 0780eb43-d5b5-4c3d-9825-beacba5cc723 10/31/2012 LUAD Prior malignancy Prior malignancy lymphoma. No systemic chemotherapy or radiation.
TCGA-49-4501-01A-21-2190-20 b9a9cb4c-96f6-47a0-adc8-55d6a6604b92 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4505-01A-21-2190-20 1cb8eafc-ac9d-4901-a44f-a2dbb6ee7f8b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4506-01A-21-2190-20 4a70d495-2aa6-41b6-a4b9-535fb1741255 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4507-01A-21-2190-20 bb4a85f4-2747-4228-b9fe-cc9057b6d9bd 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4510-01A-21-2190-20 b44fa59f-1f6d-4dfb-a709-c9eeb73258d8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4512-01A-22-2190-20 bd1ea6e2-9316-47f3-b830-e1ddb98e3190 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-4514-01A-22-2190-20 d035e74e-e911-44a9-a749-b51b50693629 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-6742 21fb46f9-4bbb-441c-af19-a687e9138344 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-49-6742-01A-13-2191-20 0dc5925e-c817-4e3a-8f07-864c4ef1df6d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-6743-01A-13-2191-20 f61515e3-5fb1-4313-be4a-53e182f95765 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-6744-01A-13-2191-20 85fe0aa0-d71a-43d8-bbb9-100597b54b04 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-6745 9c7875ad-ab71-4d48-b2e3-e4c7a46393e9 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-49-6745-01A-13-2191-20 98d5f3f8-4922-47c7-9f92-946acd7e9db8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-6761-01A-13-2191-20 2ca5d0c2-9d41-40ec-95d1-ea7fb78a728c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-49-6767-01A-13-2191-20 dfc22417-6b41-42df-b53e-3fea9dadcd19 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-4G-AAZF 1932bc1e-2a15-4f74-978e-d49c366604a4 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-4G-AAZG c60eb7be-c85c-4338-a20b-51948d43bf2a 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-4G-AAZR 57500d4c-4bb3-4f32-ae3a-a0b78f18c526 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-50-5044-01A-31-2190-20 fee0d27e-2ada-467b-b39e-e1ed30a27a9b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5045-01A-31-2190-20 f5230fa4-0c05-484a-a17b-debebbcab1f4 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5049-01A-21-2190-20 db4fab65-7a1b-4386-b755-35ff900b9ca8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5051-01A-22-2190-20 55ebc73e-1a0b-4e52-872a-e0d8a1e13226 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5066-01A-21-2190-20 125106f7-3b1d-4bd3-ab00-f8cc72798de9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5068-01A-21-2190-20 72359d96-a06f-4d72-8d58-009a5d06d25b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5072 1575148b-0f63-44ee-86fd-93ae1a02be0b 10/02/2011 LUAD Neoadjuvant therapy [intgen.org]: Neoadjuvant therapy
TCGA-50-5072-01A-22-2190-20 5c0a5c7e-afab-4817-8118-46a95f8a8ae9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5930-01A-31-2191-20 d78804ea-2fb0-415f-9c69-0db95fcade3f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5931-01A-31-2191-20 10e7fc5f-f750-4d81-8314-5efd5d7e0efa 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5932 ebcba7f2-ce13-4bae-97cd-91a6b1dcd465 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-50-5932-01A-31-2191-20 3bffc9f0-f53c-4f65-bdfc-9100a4d15510 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5933-01A-31-2191-20 47959745-d225-4df7-b32c-e66bc6db4f7d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5935 100430c8-1446-45c8-af36-b6dbb3ddd0c1 10/31/2012 LUAD Prior malignancy Prior malignancy cervical cancer. No systemic chemotherapy or radiation.
TCGA-50-5936-01A-31-2191-20 321627c2-4c05-4e79-ab55-5fe72402662c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5939 12b79b4f-c28c-418e-a1e7-e622f33fdcc2 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-50-5939-01A-31-2191-20 a1c702d2-d557-477f-9df0-f51e18f54163 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5941-01A-31-2191-20 ac85d41b-26b4-438a-86a6-94d8cc001368 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5942-01A-31-2191-20 41451a71-047f-4417-8d68-7cc15598a207 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5944-01A-13-2191-20 e17609bb-ee34-4c92-9a72-41f40b80fb45 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-5946-01A-13-2191-20 754a4160-e44d-4f89-a135-c7400eb8badc 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6590-01A-23-2191-20 b33cf148-e9bc-473b-b51f-037b348e7e49 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6591-01A-13-2191-20 4fdef60d-ba82-4b43-85b0-840c42622ab7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6592-01A-13-2191-20 14deca38-5943-4ef6-8735-ba83e03eb3a7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6593-01A-13-2191-20 fc327353-7dfc-40e7-81ee-43307e7d12bf 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6594-01A-13-2191-20 1b4ed202-75b7-4591-8b58-dbb2dba7376f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6595-01A-23-2191-20 9425139b-c220-4c94-a144-db0ab41b827a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6597 0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0 11/10/2012 LUAD Synchronous malignancy Pt with synchronous R lung carcinoid tumor.
TCGA-50-6597-01A-23-2191-20 5971b955-c7c4-4efa-a0e5-4e27bd9abce9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-6673-01A-13-2191-20 bbe974cc-029f-48c4-b5d6-7f489e831af7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-50-7109-01A-13-2192-20 cd785e69-967c-4ae7-9137-aaf65ebab433 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-51-6867 3b195845-0050-49cb-b639-1fe85a131ebe 10/31/2012 LUSC Prior malignancy Prior malignancy cancer of the larynx treated with locoregional radiation.
TCGA-51-6867 3b195845-0050-49cb-b639-1fe85a131ebe 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy cancer of the larynx treated with locoregional radiation.
TCGA-51-6867-01A-13-2194-20 df2fd16f-c857-4ec5-8ed8-07db1d345f50 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-52-7810-01A-13-2195-20 6e66e4f7-d938-4cf6-85e3-ea40f8838b95 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-52-7811-01A-13-2195-20 feb2a011-9826-4922-8fdb-e702a929a793 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-52-7812-01A-13-2195-20 e78b8041-fe48-46e1-b651-a19c69be92e6 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-53-7624-01A-13-2192-20 4ca5de57-b4b9-4bdb-8272-40b134e5f812 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-53-7626-01A-23-2192-20 431635c1-f187-4a27-9013-502373adccd8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-53-7813-01A-13-2192-20 a9fcd075-f885-4617-b67a-11b039062e93 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-1592 a41c46da-7ed4-4192-bd16-b3cbb94a5133 09/15/2010 LUAD Prior malignancy [intgen.org]: Prior Malignancy
TCGA-55-1592-01A-21-2190-20 08e59b04-61a9-4a1b-9fd9-bb07ffe2551a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-1594-01A-21-2190-20 273089ef-4fc5-462c-a77e-e3076a998e4d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-1595 d31aeefc-b59b-42e9-9919-750b17a70a3d 09/15/2010 LUAD Prior malignancy [intgen.org]: Prior Malignancy
TCGA-55-1595 d31aeefc-b59b-42e9-9919-750b17a70a3d 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy of R breast cancer treated with locoregional radiation. (TCGA tumor from L lung.)
TCGA-55-1596-01A-21-2190-20 443a13de-0a5e-4da3-8913-e8c6fbc51aa2 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-5899-01A-21-2190-20 53a204a4-caa0-4a30-b31d-5e408a4a4df1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6543-01A-13-2191-20 094e7995-ee01-40b2-aced-0db808ad9a56 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6712-01A-13-2191-20 55dfe466-08c8-4196-9e3e-61851f50100e 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6969-01A-13-2191-20 4d784c19-acc2-42e0-a078-396eeb07c20c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6970-01A-13-2191-20 978d1436-06b6-4591-8538-a8504b820bcd 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6971-01A-13-2191-20 324f133e-3269-4bea-939d-2c5ebac520cf 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6978 5134c56f-8286-4ec8-8348-237cee7dad5e 10/31/2012 LUAD Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-55-6978-01A-13-2191-20 d49d649a-ddee-4f58-b56f-2e0fe6bf220e 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6979 5af499be-d2b9-4eaf-9a9f-435dccb51917 10/31/2012 LUAD Prior malignancy Prior malignancy thryoid cancer. No systemic chemotherapy or radiation.
TCGA-55-6979-01A-13-2191-20 4283cc72-754c-4dec-b8c3-93b5cbaf6a95 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6981-01A-13-2191-20 1ee6ed8b-3ce5-4565-9948-33bdc5e40c92 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-6982-01A-13-2191-20 1615fbef-fcaa-4509-a01f-0f00f69c6106 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7573 8e41153b-9faf-45c3-8397-8a428ef5c0d5 10/31/2012 LUAD Prior malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation.
TCGA-55-7573-01A-11-2192-20 8a3614c0-ea67-4f95-97af-e64ef9de981a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7574-01A-11-2192-20 253ddce6-582d-4108-9c27-1575e415d37f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7724 294cb595-0907-44c7-bbef-985a27c1e6e2 03/20/2012 LUAD Prior malignancy Uterus. No chemo or radiation.
TCGA-55-7725 9fcdccae-676e-4071-93c3-23d2d3ab0c00 03/20/2012 LUAD Prior malignancy Throat CA with locoregional radiation. Jaw CA with no chemo or radiation.
TCGA-55-7725 9fcdccae-676e-4071-93c3-23d2d3ab0c00 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy of the throat treated with locoregional radiation. Prior malignancy of the jaw. No systemic chemotherapy or radiation .
TCGA-55-7726 923b37e4-fcf7-46a0-8cb2-9139711fec7b 03/20/2012 LUAD Prior malignancy Left eyelid CA. No chemo or radiation.
TCGA-55-7728-01A-13-2192-20 95cddb98-de35-4aa2-898f-427b5d9c34bf 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7815-01A-13-2192-20 dc4e6e89-07fb-418a-b96c-14825cd8bca2 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7910-01A-13-2192-20 8454f2fd-cc01-4eb8-b206-9499ed8f7bbb 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7911-01A-13-2192-20 75ec6f61-ec15-409e-a0a6-e4b5618375e5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-55-7914 69dba721-a168-47a4-b7ff-80a448bad654 03/20/2012 LUAD Prior malignancy R breast CA. No chemo or radiation.
TCGA-55-8090 4d51ee44-e6f4-4bcb-be28-e9df54b39a8d 11/10/2012 LUAD Synchronous malignancy Pt with synchronous LUAD.
TCGA-55-8091 d12b6930-9ae4-4fe7-ad69-d183135c91ab 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-55-8203 9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0 10/31/2012 LUAD Prior malignancy Prior malignancy chronic lymphocytic leukemia. Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-55-8207 b256e065-c681-4f82-8b68-a8ef7c413791 11/10/2012 LUAD Synchronous malignancy Pt with synchronous COAD.
TCGA-55-8511 1f1df7ea-00b9-4432-86de-da773d1451e5 10/31/2012 LUAD Prior malignancy Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-55-8619 772324a5-5513-454d-ad6b-605798f69b73 10/31/2012 LUAD Prior malignancy Prior malignancy melanoma of the L arm. No systemic chemotherapy or radiation. Patient with synchronous mucinous adenocarcinoma R lung.
TCGA-55-8619 772324a5-5513-454d-ad6b-605798f69b73 11/10/2012 LUAD Synchronous malignancy Prior malignancy melanoma of the L arm. No systemic chemotherapy or radiation. Patient with synchronous mucinous adenocarcinoma R lung.
TCGA-55-8621 8d535aa6-6d59-4965-b5ed-17217d8f5930 10/31/2012 LUAD Prior malignancy Prior malignancy kidney cancer. No systemic treatment or radiation.
TCGA-56-5897-01A-12-2194-20 59c57cc0-8672-4e6d-8248-65c676f2db8b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-5898-01A-12-2194-20 f1648030-8469-478a-99e6-13ec906dca7e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-6545-01A-13-2194-20 acdc06c7-b306-4fc8-9a28-68b2a9a78d4c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-6546-01A-13-2194-20 d3df09a4-a843-49d4-84b3-e7822b797bdc 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-7221 1dba835e-cbe9-41e0-883d-50bf86bc7821 10/31/2012 LUSC Prior malignancy Prior malignancy basal cell carcinoma of the skin. No systemic chemotherapy or radiation.
TCGA-56-7221-01A-13-2195-20 ce08b9c6-00c0-45d0-b84d-f0bce0fdc469 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-7222-01A-13-2195-20 727b199a-6c1b-4d39-9e96-e983ca7ba1c9 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-7730-01A-13-2195-20 4b68ddb5-5d40-4009-8269-2262e4b2a97a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-56-8305 d5e94dcf-994f-48a0-b491-bbbf1c2a6783 10/31/2012 LUSC Prior malignancy Prior malignancy B-cell chronic lymphocytic leukemia. No systemic chemotherapy or radiation.
TCGA-56-8308 399c936e-ba68-4040-98d4-917a87dad603 10/31/2012 LUSC Prior malignancy Prior malignancy melanoma of the R eye. No systemic chemotherapy or radiation.
TCGA-56-8504 9ee64a87-7224-461c-94da-29710d73164f 10/31/2012 LUSC Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-56-8623 513c5f34-dc6e-4caa-81cc-907fd6a825b1 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls.  Their analysis suggests that the purity of the tumor is very low.  Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A a5370483-6bdd-4e2a-9b4b-ec1eb381052b 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11D 2327bab1-e352-4c43-ab40-6162e8632c26 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11D-2386-00 (none) 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11D-2391-01 2aa6f51a-e0fa-4bdb-830c-80b79c59cfc9 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11D-2395-08 e2bca154-9ff3-42a6-a5bc-0daa14080c92 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11D-2398-05 dd64f5ba-b9b8-4e7b-81eb-fa9318febede 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11H 5a676d7d-0b8d-48fb-b898-0eb023a871e1 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11H-2402-13 6f688bcb-0534-4a50-a39d-a3a149165694 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11R 51ded92f-852f-4445-96b2-dd9db1544a9d 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11R-2403-07 00d6443c-c6a8-427c-8137-55df848ff2b1 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11R-A28V-07 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11W 1577d666-1852-49cf-a101-076d851b8ce4 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-01A-11W-A29C-08 7d5ca750-1b71-4887-b4a1-865ecf47566c 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A 39c2e6c5-379e-4ffa-b02c-e1db298b34f7 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A-01D a4d9f761-ece9-4a6b-8818-ecf4a8f7d380 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A-01D-2386-00 (none) 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A-01D-2391-01 a3219216-997d-44a5-be11-0672c8b3ed04 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A-01D-2395-08 d9fffb10-ae12-43ad-983b-1e2336f915a3 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A-01W 84099332-37fa-4bd3-8ab4-77ae7e065a3e 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-10A-01W-A29C-08 a1b2b194-842c-438e-b81b-069963ef2b96 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A 26368154-1ed7-4471-87b9-d50d5fe8046b 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01D f1090757-a85d-4702-a16f-0ee35284c45d 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01D-2386-00 (none) 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01D-2391-01 7c9e5386-1540-40f2-96ed-c06d752598df 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01D-2395-08 3cffe6b0-3aef-413a-a9a9-4a2fcefff6ad 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01H 258a054e-b0ec-4215-81c9-8e1c715abc9b 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01H-2402-13 77eccef5-254d-4ddc-a70f-576436278e0a 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01R 7402c87f-c9b7-451f-9b8d-a8979bf0d98b 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01R-A28V-07 9fe04d07-57ba-434f-8254-184fe00ab23e 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01W c2fc5209-3582-42d3-a8cc-c583d52b4d62 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-56-8623-11A-01W-A29C-08 9ab7e83a-6ff4-4343-9478-4f82cdc34809 09/05/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signature of the tumor DNA and RNA cluster with the normal controls. Their analysis suggests that the purity of the tumor is very low. Therefore, the data from this patient should be used with caution.
TCGA-57-1586-01A-03-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2348-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2348-01A-31-2223-28 0ffad1e7-4b9c-44a5-abe4-fc4d9b004d05 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-59-2349-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2351-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2351-01A-31-2223-28 e7e42437-004a-4d1c-bbef-8914f5e12529 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-59-2352-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2352-01A-31-2223-28 e228148f-8d85-42e7-9922-49e46fa571fc 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-59-2354-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2363-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2372-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-59-2372-01A-31-2223-28 e38c5978-68af-4f22-9405-bac96c49bce6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-5A-A8ZF 7f08f522-08ff-4b30-aa5b-e69cf15041c9 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-5A-A8ZG c8e57f03-ac69-49bb-954b-4c40fe371f75 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-5L-AAT1 16fc3677-0393-4ed1-ad3f-c8355f056369 11/25/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy Patient had prior breast malignancy (in opposite breast) with systemic chemotherapy (Tamoxifen).
TCGA-60-2695 acae4e48-57de-40c5-9ae5-4386144ebaea 10/11/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-60-2695-01A-21-2193-20 ec5712a3-b8ad-4fad-a544-e815bffacece 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2696 bff77f70-973a-4b49-8fd9-4a767f5df2c0 10/11/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-60-2696 bff77f70-973a-4b49-8fd9-4a767f5df2c0 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated w/ tamoxifen and radiation and tymus cancer treated w/ cancerrboplatin and Paclitaxel
TCGA-60-2696-01A-21-2193-20 3a198ed8-723a-4655-8fb2-74e042bea193 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2697 3c112114-6a8b-4aea-9349-6dffbaad078d 11/10/2012 LUSC Neoadjuvant therapy Patient received neo-adjuvant vincristine, CCNU, cytoxan, doxirubicin, and cisplatinum prior to resection of TCGA tumor
TCGA-60-2697-01A-21-2193-20 7125f62c-3ad3-45a5-aa83-a9052c5669ed 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2698 fd9ee494-65fe-4de4-adff-7952a059b17f 10/11/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-60-2698-01A-21-2193-20 f57a7f9b-23c2-4a93-9322-9df5bc51eb99 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2703-01A-21-2193-20 68eb1b05-eb54-4b64-a7e5-6e76e09e6b11 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2704-01A-21-2193-20 ffb8aceb-b5f5-4722-8051-74a36e32cfe3 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2706-01A-21-2193-20 ef42af10-10c8-4c5f-92f7-aa8fec60634a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2708-01A-21-2193-20 64455e1c-360e-4627-8c8a-55c27c7705c3 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2709-01A-22-2193-20 6542146d-b4b9-4ed7-9fcf-b511ad1c43d7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2710 b28e3be1-9843-4204-b999-b3e2a909c7bd 11/18/2011 LUSC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-60-2710-01A-21-2193-20 fe48e710-052c-48da-a9ba-7705e7451700 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2711 1f11de87-a5fe-49fd-80c1-e279b2bc69de 10/11/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-60-2711-01A-21-2193-20 00a75e05-8928-432f-ae8f-3acbb88a182b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2712 f355cd59-eaa9-46c7-ab07-b90a7afc875c 10/11/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-60-2712 f355cd59-eaa9-46c7-ab07-b90a7afc875c 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L breast cancer treated w/ locoregional radiation (TCGA tumor is in L upper lobe of lung)
TCGA-60-2712-01A-21-2193-20 048d4992-bd37-46bb-97c0-7cfaf69cc61d 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2713-01A-21-2193-20 aef657e5-4555-4842-946a-7883c8f8b362 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2714 705a4688-f10f-4e6a-aed9-6efc3b3b9989 11/10/2012 LUSC Neoadjuvant therapy Patient received neo-adjuvant carboplatin, taxol, and cisplatin prior to resection of TCGA tumor
TCGA-60-2714-01A-21-2193-20 089deb86-da03-40f6-83c0-c6cc33a47ab3 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2715 f3e67161-1532-4b50-a9b5-0da80410c4d7 09/02/2010 LUSC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-60-2715 f3e67161-1532-4b50-a9b5-0da80410c4d7 11/10/2012 LUSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of the larynx treated w/ chemotherapy and radiation.
TCGA-60-2716-01A-21-2193-20 b1371353-26af-4c41-b52e-dc7a0848ec98 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2719-01A-21-2193-20 7d294b6d-9ac2-4e67-a2e0-5a7530db840c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2720-01A-21-2193-20 2c8e7971-12b3-4301-856d-38e55ed745d5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2721 bcd78677-98d5-4403-8313-e1fbd76e8ef7 10/11/2010 LUSC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-60-2721-01A-21-2193-20 d292d1eb-ee65-4573-8662-faedf11fa9ad 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2724-01A-21-2193-20 ec285ff7-4d23-4739-9946-065f534d6fe8 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2725-01A-21-2193-20 dc18de9c-9edf-48c8-9a00-3598aad84aa5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-60-2726-01A-21-2193-20 49bf0bf2-031f-4d67-83a4-abc14322c298 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-61-1721 1c0318d9-0472-4840-add4-46bb9f914a30 09/02/2010 OV Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-61-1721-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1722-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1724-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1724-01A-31-2222-28 9e3b9aa6-f2da-4386-b9fe-ec5918f8a18d 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1724-01A-32-2224-29 f7d9b04c-cfa7-4645-93a8-34f122bfd911 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1727-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1727-01A-31-2222-28 36848c04-1241-43fc-9ab2-fdb9ee8aac63 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1730-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1733-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1734-01B-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1736-01B-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1738-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1740-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1741-01A-11-1563 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1741-01A-31-2222-28 685337ee-974b-4590-9514-1d7d10a9e880 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1741-01A-32-2224-29 3db2bb16-c06a-4caf-a3d8-ef37c87f15f8 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1743-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1895-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1899-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1900-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1900-01A-31-2224-29 19e0a8cb-4029-4cc3-8ccc-cdbd1473cdb2 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1903-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1906-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1907-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1907-01A-31-2222-28 39fc861e-ae0c-4da0-9221-6b134d2ff915 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1907-01A-32-2224-29 482f5447-50bb-414d-b51b-8055b7c6a72d 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1910-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1910-01A-31-2223-28 aed3673e-f7c5-46ea-9f62-46500d4fb367 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1911-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1911-01A-31-2222-28 e69fc82f-1c19-4d2e-b913-a2c28de06088 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1911-01A-32-2224-29 c52e76d5-6ff4-478c-8877-1eb00ec48266 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1913-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1914-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1914-01A-31-2222-28 91698dd8-00e6-4c01-b380-41a9513cbe47 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1914-01A-32-2224-29 59e1366b-a39d-42fa-a869-2554fd2e485c 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1915-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1915-01A-31-2223-28 4c4fc168-65c7-42b5-bd64-ddef79df88fe 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1916 b25b3379-df8f-4900-9bce-0f8df50f549b 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-61-1916-01A-01D f6396baf-7f40-46dc-8f6c-6b44102fea13 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-01A-01G 0efd0264-e301-4788-8800-1a5d28921908 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-01A-01R 44221d02-b7fa-493c-b09c-504b07baa8b4 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-01A-01T eb411706-2cfe-4541-b2ed-9da16741630b 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-01A-01W 96ce5d84-c1cc-495e-b909-4b0f2217f6e0 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1916-02A-01D a477f412-0769-4662-a2ea-b676497df4fa 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-02A-01G 3f333c10-0df1-4c43-ae32-c055d7b214cf 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-02A-01R c0927d9f-0feb-4a0c-9c11-8cb93556cccd 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-02A-01T 3c5c2ee4-f661-446d-b1bc-66a789a48667 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-02A-01W bdef3fee-0388-486e-94f0-f635092ed0c5 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-11A-01D 5c5c379e-bbb3-4daa-9d8d-7b8450b0c45b 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1916-11A-01W 330b914e-2f04-45e5-a7ea-ed8f445c52ad 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-1918-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1918-01A-31-2223-28 afe1cac7-97ac-4202-bd07-25484442aac8 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1919-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1919-01A-31-2224-29 5004cd4b-2380-438e-8279-49310d4e32f6 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-1995-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-1995-01A-31-2222-28 9b9dc0d3-a4b5-4339-bfe5-d487cc8a62b9 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-1995-01A-32-2224-29 6da0c9ce-a4d9-453e-b718-f0cf944a4662 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-2000-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2003-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2008 3ac45a71-c463-4f0f-b030-58c475a34418 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-61-2008-01A-31-2214-20 53527bf6-168b-469b-bbb3-d5e7640ee38a 03/13/2012 OV Item is noncanonical TPPT OV MDA
TCGA-61-2008-01A-41-2222-28 fa508192-7d9f-4160-aa08-e718750292ca 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-2008-01A-42-2224-29 686a37a6-8eab-4ad8-9bb2-716aaf7dbc13 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-2008-02A-01D 20d052bd-a3b3-475c-b500-969daf386266 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2008-02A-01G 566090f3-dde3-4d0c-a419-d3a3d03cbe31 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2008-02A-01R 1f57d960-8019-4aa5-a498-11c034287817 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2008-02A-01T 4a0eb2be-9c64-4bea-93de-d7a63dad3229 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2008-02A-01W f247b565-11a8-499c-a644-caef051ac8a8 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2009-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2012-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2017-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2018-01A-21-1559 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2087-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2087-01A-31-2223-28 47904cfe-b0c7-4a8a-a50b-f68708fd6bef 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-2088-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2088-01A-31-2223-28 fd16fec0-e7a9-475f-9e71-34d464948e31 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-2092-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2094-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2094-01A-31-2223-28 edd113ce-8440-4394-a1a8-8913bf4347dc 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-2095 778ce436-a825-4689-81c1-b7c965404163 01/28/2011 OV Item in special subset This is part of the ovarian triplet set.
TCGA-61-2095-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2095-01A-31-2224-29 232cec13-acce-4d73-b54d-27fb4534f37b 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-2095-02A-01D c17dbaf4-e742-4625-8aab-c2c31747b3c2 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2095-02A-01G 59ce4d2b-1c52-47a1-86cb-9ae6a1418543 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2095-02A-01R 1be913de-cde6-48dd-926b-140c0e37e4e0 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2095-02A-01T 87f3f7c9-2ef0-4026-8091-7bd91c01c994 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2095-02A-01W 039afcdf-bd7c-4b3f-b7ff-9b419c972be4 03/14/2011 OV Item is noncanonical Ovary Triplet
TCGA-61-2095-11A 43c556ed-873c-4a2d-9f33-68e2e7790ba1 04/06/2011 OV Item in special subset [intgen.org]: Normal Tissue contained Tumor
TCGA-61-2096-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2096-01A-31-2224-29 6fa76dd3-c6b0-46f6-bf47-cb1a696ad2a7 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-2098-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2101-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2102-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2104-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2109-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2111-01A-21-1560 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2113-01A-21-1562 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2610-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2610-02A-01R ca233df8-458c-43dd-aa9a-7b19a03a26a9 03/18/2011 OV Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-61-2612-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2612-01A-31-2224-29 527e23f2-d535-4960-aa73-b6ffb2680ab2 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV PNNL
TCGA-61-2613-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-61-2613-01A-31-2223-28 e4c44bcb-67ec-43e3-ac95-7885ac849e34 04/19/2012 OV Item is noncanonical CPTAC Proteomics OV JHU
TCGA-61-2614-01A-21-1561 (none) 03/14/2011 OV Item is noncanonical OV Proteomics MDA
TCGA-63-5128-01A-21-2194-20 c514a02d-1b88-48ad-8d47-e225eda23780 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-63-5131-01A-21-2194-20 494e308b-4cd4-44ac-b556-9ea1a95be212 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-63-6202-01A-13-2194-20 52080758-70e0-4463-8ef4-ebb8ba5e19d2 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-63-7020-01A-13-2194-20 ff0190fb-eb34-4331-9068-2c02bf067253 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-63-7021-01A-13-2194-20 81db3e1a-0540-49d0-a6fa-c2561c14fe7c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-63-7022-01A-13-2194-20 51130a95-5996-4288-ab16-504f6d8b8314 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-63-7023-01A-13-2194-20 ab830587-6698-4cd1-9690-d620819ef10f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-64-1676-01A-21-2190-20 390c2548-0e2b-4b46-9bfb-2993a7570bc9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-1677 8a16ddb3-4861-4128-bed9-0b1f94fe8cf7 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy thyroid cancer treated with locoregional radiation
TCGA-64-1677 8a16ddb3-4861-4128-bed9-0b1f94fe8cf7 12/08/2010 LUAD Prior malignancy [intgen.org]: Prior Malignancy
TCGA-64-1677-01A-21-2190-20 b3712c9a-2e1b-4cb2-8f49-f69cec4c5ca9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-1678-01A-21-2190-20 011bb13f-e0e8-4f4b-b7a5-4867bbe3b30a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-1679-01A-11-2190-20 112ea78d-4339-4119-bc19-7f011fee944d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-1680-01A-11-2190-20 9a98e01f-f8aa-4b09-856a-572743a2db89 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-1681-01A-21-2190-20 6fc61107-6515-4cc3-a63e-5e1fe083c3eb 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-5774-01A-41-2191-20 2bb2dd1a-8bd9-45d0-9c34-9bf98476b90a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-5775 c8544fb3-b26e-4672-bb81-a271db724b04 02/01/2012 LUAD Neoadjuvant therapy NA
TCGA-64-5778-01A-41-2191-20 423b6125-bdf6-483c-8aad-4f0c5c2703bc 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-5779-01A-41-2191-20 5e3fb226-21a1-4b99-948a-55d119066615 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-5781-01A-41-2191-20 d161ad96-a846-4f14-b954-316e4dfaffcd 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-64-5815-01A-41-2191-20 c1fc598f-efaa-4a42-a646-a7bac6f73085 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-66-2727-01A-21-2193-20 d494adb7-9e76-4717-b142-47521c544e9a 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2737-01A-41-2193-20 46aec886-20f0-47f3-ba36-3ba0b036f764 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2758-01A-11-2193-20 4dda1522-0094-4b54-b413-ad6d92df3ad9 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2766-01A-21-2193-20 ba82b423-e845-4d6f-b8bf-aa44344e0e2e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2767-01A-21-2193-20 2046ba58-db49-44ba-b6ae-fb9eee38a211 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2768-01A-21-2193-20 28068872-a9b1-4e43-b5a4-92d1cdd03408 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2769-01A-11-2193-20 5de8582a-34f9-4ea2-943d-bf46f07c06e0 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2770-01A-21-2193-20 e858ee92-0438-48e9-a70d-80ef2c0ad539 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2773-01A-21-2193-20 1d33bdef-845d-4bf8-bc13-72113614a4c8 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2777-01A-21-2193-20 129560c0-36c3-4f01-98ed-606e583390d4 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2778-01A-11-2193-20 f5dca0d5-550d-4107-b6ad-9d347a39afa5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2781-01A-21-2193-20 b307a0f2-a455-4b20-b866-8da02f3d8fd4 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2782-01A-21-2193-20 6cafe140-32f0-40b7-8d8b-60e7c76e4c0c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2783-01A-21-2193-20 74291822-bcab-4871-ad7c-cf2023ec7c2f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2785-01A-21-2193-20 a8bd2e87-dee1-4801-8742-25eacf7d7484 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2788-01A-21-2193-20 c1620625-664d-4fec-9ddc-ace245378ca7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2790-01A-21-2193-20 03a83493-5aa7-4c60-9fb0-9d4112d0fec2 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2791-01A-21-2193-20 cd4f93c9-f2fe-4271-ab18-78e528cfb9ad 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2794-01A-21-2193-20 ab258a4f-7597-4592-81c1-9f8aa1b7bf0c 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2795-01A-11-2193-20 e145986b-e6d4-4e31-bf1e-b242af22f436 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-66-2800-01A-21-2193-20 46d73760-a073-4776-a709-4c8a47d0d076 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-67-3771-01A-21-2190-20 15deae70-aafb-4ace-8e1c-7d694473d742 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-67-3776 102fba48-b23a-46d4-8371-71c11c1a6654 07/17/2014 LUAD Item is noncanonical Incomplete distribution. Only Repli-G shipped.
TCGA-67-3776-01A 4de555b2-bfe5-49a1-81cb-a47b455dc404 04/26/2011 LUAD Sample compromised [intgen.org]: Sample compromised
TCGA-67-3776-10A a37f80ce-b748-48fc-bc85-087b8d2f2cdc 04/26/2011 LUAD Sample compromised [intgen.org]: Sample compromised
TCGA-67-6215-01A-13-2191-20 72400518-bc32-4d05-9abd-9233e7cbff29 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-67-6216-01A-13-2191-20 5fd7748f-8145-4251-a040-26d19aef9c87 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-67-6217 108a71cf-b9db-47cd-aa74-c03ec989b41b 11/10/2012 LUAD Synchronous malignancy Pt with synchronous cancer of the thymus.
TCGA-67-6217-01A-13-2191-20 e34ffd31-b15e-42f7-aa41-414b5cd519b1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-68-7756-01A-13-2195-20 ed06c7b1-cc32-46c2-810c-310112f4c7a8 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-68-8250 7b982d5e-3a7d-40ac-bd25-6044c62879b6 11/10/2012 LUSC Synchronous malignancy Pt with synchronous R LUAD, mixed subtype and L LUSC.
TCGA-69-7760-01A-21-2192-20 aea6b973-08b3-429f-bc71-0977e6a86960 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-69-7761-01A-31-2192-20 63dc187d-2053-4f13-ab84-7053b9f2baa5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-69-7763-01A-13-2192-20 e5fc0052-b756-4073-b7b7-b4f5d78c16ed 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-69-7764-01A-13-2192-20 f1fe363c-ae3d-4fab-bc18-d16a781851ed 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-69-7765-01A-13-2192-20 c579c28f-8254-4e78-be5e-c673baf0f14b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-70-6722-01A-13-2194-20 7f55ab0d-c1e6-40bb-822c-a2a007f6f2aa 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-70-6723-01A-13-2194-20 c11267c5-85c9-41fc-9d22-9531b264afa3 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-71-6725-01A-13-2191-20 c40a352a-a90e-4015-9049-4dda961025ae 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-72-4231-01A-01D fc18904f-fbc9-471d-a89a-60d70db127db 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4231-01A-01R 231a17a5-944f-42f3-87d9-79003a21d618 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4232-01A-01D d94ece08-f820-49e4-998c-f32dca23b56c 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4232-01A-01R 57621893-ec1b-456c-ae83-d2a758657b71 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4233-01A-01D ebde95ff-59b5-4c4f-83e5-07f8aea4f45c 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4233-01A-01R 34961d28-5457-424d-8969-5ba8eefbae96 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4234-01A-01D 19eda20f-6624-4c10-9d00-34831f78762a 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4234-01A-01R fcd9b8ed-7872-43a2-8b2c-4c0b2de119bb 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4235-01A-01D 24c06164-1cb5-47bf-b9ca-08ae694b19f8 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4235-01A-01R b13bfb10-75b5-47b1-94a9-32967e114bce 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4236-01A-01D 7ef0d77d-b68a-4dbc-9504-7e58cd662f2c 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4236-01A-01R 5dae980d-af57-48dd-b595-62bb705b3249 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4237-01A-01D 937d7145-8e2e-4ed2-b47c-1618ad6a07f9 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4237-01A-01R ccc87a47-c3cc-4a6c-8b27-d16d678ba1f0 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4238-01A-01D 74d7cc29-b6b1-4b45-953e-220aefd50796 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4238-01A-01R b03f0403-dbeb-469d-8118-0fc2e563ea9a 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4240-01A-01D ac00b710-0fc5-473e-8f3e-5a94b5545f8f 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4240-01A-01R 67d6ffdf-7180-4493-9598-456dbf559343 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4241-01A-01D 8a2a8c2e-50e1-4553-8d00-8170738b0fa9 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-72-4241-01A-01R 3d32be21-4766-44e6-aa88-0b6b003e1f36 03/14/2011 OV Item is noncanonical miRNA Extraction Validation
TCGA-73-4658 afb91740-2668-46d7-ba01-bb26153ad1c7 10/31/2012 LUAD Prior malignancy Prior malignancy L LUAD. No systemic chemotherapy or radiation.
TCGA-73-4658-01A-21-2190-20 8ac764a5-e8cc-4992-b647-9b07d95e7b70 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-73-4659-01A-21-2190-20 b4bf2bd5-e32e-4f30-973b-72fc8a2f426b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-73-4662 294ff941-aea1-4588-9a0e-e9f5393e2bb6 11/10/2012 LUAD Synchronous malignancy Pt with synchronous L breast cancer
TCGA-73-4670 1b354837-4925-4480-ac32-6b44d0957314 09/02/2015 LUAD Neoadjuvant therapy Patient was diagnosed with stage IV LUAD with brain mets. The patient presented with brain symptoms and was given brain radiation 1 month prior to lung primary resection. The lung primary had no prior direct treatment.
TCGA-73-4670-01A-21-2190-20 c58a6915-0ec4-4525-b15e-ad20f3f427d8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-73-4675-01A-21-2190-20 bb338195-b226-4ce4-a231-92bca76edd63 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-73-4676 195a5afb-b79f-44d2-9d12-884487630c2b 01/24/2012 LUAD Neoadjuvant therapy [intgen.org]: Patient received neo-adjuvant chemo for tumor submitted to TCGA.
TCGA-73-4676-01A-21-2190-20 94a6f867-15a8-41a7-b9e1-5853e970678a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-73-7498 ad74c0e8-8878-4efc-997d-981cd547bc5b 11/10/2012 LUAD Synchronous malignancy Pt with synchronous R bronchioalveolar carcinoma
TCGA-73-7498-01A-23-2192-20 29736b88-08c0-4418-bfde-9f7ea3b7e8be 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-73-7499-01A-13-2192-20 f5f257c7-0d45-4305-a9eb-388dccb46c7a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-5122-01A-21-2190-20 3b21e011-4b11-4ef6-978f-391c837ccbc5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-5125-01A-21-2190-20 8a8e4b62-7ad5-4108-a6f3-e38c47fec526 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6203-01A-13-2191-20 b8ce0a35-56d2-4294-881d-63f96342f51b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6205-01A-13-2191-20 d5765a3d-3aa3-4076-ac67-bb67763af157 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6206-01A-13-2191-20 40123d1f-93e7-4182-a279-66c8cbb2d6c3 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6207-01A-13-2191-20 6ba7b19d-fe29-467f-ba50-78ac47ad8a4d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6211-01A-13-2191-20 7510fd86-91a5-47ed-88bc-64b774eebc6c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6212-01A-13-2191-20 5383ef0c-7d86-4025-93f5-71098359a488 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-6214-01A-23-2192-20 85c494c4-bc37-424f-bae2-c374c44b8da9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-7027-01A-13-2191-20 5f83ce7b-d3b2-4053-8d30-753fd9820a93 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-7030-01A-13-2191-20 7b85c15a-ee62-464b-a28c-03499ea5d340 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-75-7031-01A-13-2192-20 1ae37e42-5c58-4388-89da-a30726493ed1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-77-6842-01A-13-2194-20 0b3eb76b-445c-4a34-9e9c-d626c5a79b80 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-6843-01A-13-2194-20 ad48f945-91c3-4ef1-8ecd-4dfbb5449718 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-6844-01A-13-2194-20 7490a6fd-28ce-444d-800c-5d8da101263e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-6845-01A-13-2194-20 53a0c948-51c5-45f0-ae9e-a27679f2849f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7139-01A-13-2195-20 170fc88b-90da-456b-b2d2-b8675c357b8e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7140 107f6b9a-2883-4499-a40a-ec25bc834a06 01/24/2012 LUSC Prior malignancy [intgen.org]: Patient had prior malignancy of basal cell carcinoma; treated surgically only.
TCGA-77-7141-01A-13-2195-20 0f4cb2ec-80f5-4ecf-b1fe-87862265e560 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7142-01A-13-2195-20 f8ffcd7b-8e62-42ab-a042-d9b8e2eb028e 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7335-01A-13-2195-20 cbbac7ba-2c9e-48da-a60b-d48636e498d9 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7337-01A-23-2195-20 52200f31-4605-44ce-838c-91729bfe62fb 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7338-01A-13-2195-20 79c97d84-243a-4530-b77f-9f1228a2217f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7463-01A-13-2195-20 a0e4c36a-85d9-44d7-9423-307a37ab300b 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-7465-01A-13-2195-20 9cbef841-960d-477c-8e8c-96a3c7353478 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-77-8138 283af87a-f962-47ab-8a7b-4fcd7e45cdf6 10/31/2012 LUSC Item does not meet study protocol Subjects history of prior malignancies is unknown, which does not meet study protocol criteria.
TCGA-77-A5GA ce137f49-d12b-4112-825a-e673545f54e5 06/16/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-78-7143-01A-13-2192-20 de7019fd-493c-4c57-a720-3b20049d5e82 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7145-01A-13-2192-20 470c8ea8-5563-4fa6-8ae2-e44d589a0de2 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7146-01A-13-2192-20 067d2d3a-828e-426a-87bf-86018e3bc83b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7147-01A-13-2192-20 86f70a35-27ae-46fe-bae0-152228134cd1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7148-01A-13-2192-20 3c3ea12a-d4d9-48b5-a19e-552c41a626c4 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7149-01A-13-2192-20 71dc1546-3861-4b65-9151-152972f6872e 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7150-01A-23-2192-20 67bbd18a-fc5c-472d-9203-cf91078210d5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7152-01A-13-2192-20 fd44c328-915d-40a6-a1de-3ac0b666cca9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7153-01A-13-2192-20 bbd8169d-89fa-476d-b097-eeedd8a977e8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7154-01A-13-2192-20 d4d06599-d87f-4cf3-bb74-288516ccedee 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7155-01A-13-2192-20 815f2443-e1d3-43e0-ac43-6fab6279696c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7156-01A-13-2192-20 45d51359-305c-4ee3-b02d-b88154ee3e47 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7158-01A-13-2192-20 85bf5bc8-7e43-4cb3-a654-152c901477ea 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7159-01A-13-2192-20 9cd6f033-15cc-4a73-97d9-38bc5c99fdd7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7160-01A-13-2192-20 d370d747-9c80-4bba-af93-4aa5db7c587c 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7161-01A-13-2192-20 7dfad617-4921-46ff-9151-2b34915859e7 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7162-01A-23-2192-20 78e8850d-ff5b-4199-b9ac-f098ddf67561 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7163-01A-23-2192-20 1a4d9a2b-2eaf-4e8e-a463-2a9060163096 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7166 b40d0849-f4ef-4a14-9732-9beb708cb46b 10/31/2012 LUAD Prior malignancy Prior malignancy basal cell carcinoma or the ear and nose. No systemic chemotherapy or radiation.
TCGA-78-7166-01A-23-2192-20 bbde7e4b-5d2e-4fa1-8548-7b4f87d96cfb 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7167-01A-13-2192-20 07fd6c8a-3e19-45c8-9a15-b46cb4365d43 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7535-01A-13-2192-20 ff5b1536-6edf-4479-b3f2-50d59414eae6 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7536-01A-13-2192-20 a35de618-0eec-4f5b-afbc-7111491df9b8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7537-01A-13-2192-20 d853bbc6-ad3a-4e47-8387-91d27e06d8bc 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7539-01A-13-2192-20 d9129bfe-b2b1-4c6c-bf9a-249921abce2b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7540-01A-13-2192-20 9e24367f-3036-45d3-85fe-46808f92fe25 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7542-01A-23-2192-20 ed42ee40-c1b5-4241-98ca-ed13a0bf8861 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-7633 44218b35-219c-4ad9-a01e-fde14067c4c0 11/10/2012 LUAD Synchronous malignancy Pt with synchronous L papillary adenocarcinoma
TCGA-78-7633-01A-13-2192-20 46727f4d-0ce9-401f-ac87-531f1ea3dc11 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-78-8660 781f40c9-c099-4c96-8269-ebe2a449c93d 10/31/2012 LUAD Prior malignancy Prior malignancy melanoma of the right arm. No systemic chemotherapy or radiation.
TCGA-79-5596-01A-11-2194-20 7ffba9b0-d42d-4078-b1a5-f83bcb3c39e1 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-80-5607 645903b5-ba37-48a1-985b-a019b8db3236 10/31/2012 LUAD Prior malignancy Prior malignancy colon cancer. No systemic chemotherapy or radiation.
TCGA-80-5607-01A-11-2190-20 aa426968-088a-443a-862c-171fdc182ca9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-80-5608-01A-11-2190-20 1e6ecda8-bdc5-4133-adf1-99b849623c7e 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-80-5611 e51f717f-72e8-400e-9f35-fc5dc32fdf71 10/31/2012 LUAD Prior malignancy Prior malignancy treated with loco-regional radiation to the neck.
TCGA-80-5611 e51f717f-72e8-400e-9f35-fc5dc32fdf71 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy treated with loco-regional radiation to the neck.
TCGA-80-5611-01A-31-2191-20 0829a330-1be5-44b1-80ac-2a426e24bac3 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-83-5908-01A-31-2191-20 bd5509b4-f8fb-4e68-a735-c42b23cdbbf8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-85-6175-01A-13-2194-20 1251f240-d00c-412d-bd87-07cffed92f72 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-6560-01A-13-2194-20 e70edfac-57af-42e6-a823-2b20b8e9e203 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-6561-01A-13-2194-20 9a0f38cb-9131-4cb6-8874-853dd8c89a48 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-6798-01A-13-2194-20 8e798033-e911-4140-9060-f2bdcfddb539 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7696-01A-13-2195-20 f20b163a-ad2d-46b0-869e-f6a742d4b8ac 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7697-01A-13-2195-20 2be75562-f756-4876-a44a-9c363f34530f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7698-01A-13-2195-20 4906559e-b052-4afa-863c-afa098b38d54 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7699-01A-13-2195-20 097a545f-3da7-43fa-a441-f6417346ecb5 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7710-01A-13-2195-20 d8a44db0-50c4-4f6e-bae7-6d42afa90554 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7843-01A-13-2195-20 777f34fc-0425-4901-a25e-8f841fa64f26 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7844-01A-13-2195-20 8e02f3ec-c4a3-447b-b2f3-c215bd907ac7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-85-7950-01A-13-2195-20 a454299d-b074-4dd9-adf3-3e48f4473543 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-86-6562-01A-13-2191-20 1534f1f0-bd71-43e0-8185-ec0809746d2f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-6851-01A-13-2191-20 be82da85-37a8-4c75-9cf7-ef9ec0acddba 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-7701-01A-13-2192-20 e2450111-6105-461c-bf1f-70106b4eb4e5 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-7711-01A-13-2192-20 12e8ae79-b62d-4a85-a4f9-30fadb5e0dc0 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-7713-01A-13-2192-20 3aed5efc-311a-4163-a44d-6f2972340d19 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-7953-01A-13-2192-20 2b5c0a28-53db-48a3-8f06-2878f99f42b3 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-7954-01A-13-2192-20 478cc583-9ef7-409b-9cda-4d1f64f447a4 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-7955-01A-21-2192-20 a7ef7d69-1adb-4014-82ef-d078c1121456 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-86-8076 8609edfc-119d-4d63-9188-c86aabd5ca52 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-90-6837 0e515ab8-99f9-43d9-a621-8fe9ede828ec 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A 0120344d-7346-409f-8518-ef7b13f867ff 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11D a97debd8-fbee-453f-bc69-b7fb6a82fd52 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11D-1941-02 3f2c122a-ec03-4102-9372-e1fc10f24519 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11D-1943-01 2d975715-bd19-40d7-922f-7baff9b42323 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11D-1945-08 60311583-a64f-4fea-b6d0-a4a50bbacd6e 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11D-1947-05 14ed8af0-3c28-45f9-8ffb-9852e9669804 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11H 07263f7e-70c6-4770-a205-189e3da0db3e 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11H-1948-13 ba280f24-7829-4ecd-b255-b93547a1ac46 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11R 922955d3-59ab-48c8-82f7-eb0f293fae2b 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11R-1949-07 91c5d28b-85af-49ff-8307-140707d13d0e 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11W 9372df66-a11d-4130-bbe4-bb974223a809 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-11W-1984-08 b9625f6e-27d3-4aca-8d50-cdad8985cd90 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-01A-13-2194-20 56eec851-cabd-46ab-af62-812dae018005 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-90-6837-01A-13-2194-20 56eec851-cabd-46ab-af62-812dae018005 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A b471831a-eda9-425a-a3f2-55d62f599945 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A-01D 3ba890ac-e77f-43cb-9c61-261ffcf691f0 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A-01D-1941-02 9f9ddc96-b741-4d1f-bb16-0a43fc2a8df2 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A-01D-1943-01 870232a0-e907-4e5d-abba-15c9259190d9 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A-01D-1945-08 987044e8-c464-4ee7-a350-3ebf4e72897e 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A-01W cabaeadf-9733-4d74-bd3d-bf540aea0bfb 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-10A-01W-1985-08 34162874-b7d5-40a0-806f-82dbe1b0ef0c 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A 0945bee5-8d09-44a3-ac01-8e8064d2b094 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01D 2c2113a0-3bf1-4a6b-9fac-2641a517899d 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01D-1941-02 bc9488ee-8a3a-4a38-ad1b-8ec2d31c8f4a 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01D-1943-01 adb5f857-94a2-4a35-af55-2c2d6417e064 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01D-1945-08 96151621-a6b3-4fdc-921d-1260680db414 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01D-1947-05 e690f806-b34b-4910-aff2-770d6a61a4cf 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01H 8fe774b6-8e06-4a0e-80f0-df65f843e0e2 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01H-2124-13 4997473b-8e48-4b0f-9927-6f84163c13b0 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01R 300448ff-df63-4b80-9a14-42a3189efac2 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01R-1949-07 6178dbb9-01d2-4ba3-8315-f2add186879a 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01W ca07d453-5c6c-4504-acd9-bd84fad62168 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-6837-11A-01W-1984-08 bebbd78d-7473-43d1-af19-f540c919a12f 09/04/2014 LUSC BCR Notification Possible tumor/normal sample swap, cross-contamination, and/or sample purity issues. The sequencing and characterization centers have reported that molecular signatures from the DNA and RNA from the tumor and normal tissue, as well as DNA from the blood derived normal, do not cluster with the expected sample types. This suggests the tumor and normal samples may not be labeled correctly; all genotyping results confirm that all samples are from the same patient. Data from this patient should be used with caution.
TCGA-90-7766 3fdf941e-40ec-43b6-b6e3-31a0861bd5b8 10/31/2012 LUSC Prior malignancy Prior malignancy of a gynecological cancer. No systemic chemotherapy or radiation.
TCGA-90-7766-01A-23-2195-20 dd8497bc-44e4-4128-80b0-64b3ca838c64 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-90-7767-01A-13-2195-20 4a4135f8-825b-457a-a65c-edf07e0215cb 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-90-7769-01A-13-2195-20 71d2cccb-ba7a-47f2-96d0-11b7b3f0c20f 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-90-7964 6e6b8596-76aa-49f5-a997-46ebc0e43934 11/10/2012 LUSC Synchronous malignancy Pt with synchronous R LUAD.
TCGA-91-6828-01A-13-2191-20 868a423e-7b37-44b0-af6a-7331066e88d3 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6829-01A-23-2191-20 36a9dbe9-dfd6-41d7-9f76-04dcf1c93755 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6830-01A-13-2191-20 a05658f0-5ddb-449d-b36a-383e17b9b95b 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6831-01A-13-2191-20 71cf2558-e5c1-4a83-bdec-6c3d8b3de2c1 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6835-01A-13-2191-20 9fc7b7be-5f60-4b40-adc9-b54df34d01cd 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6836 0b31dbdf-0623-48e4-a0ec-017650dceda7 11/10/2012 LUAD Synchronous malignancy Pt with synchronous thyroid cancer.
TCGA-91-6836-01A-23-2191-20 8534a1e1-144d-4978-b452-dffe629915fa 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6840-01A-13-2191-20 461b2f41-f117-4d06-93b3-5654fb4af5fa 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6847-01A-13-2191-20 c9e583e9-c014-4508-acdc-11a8b46c6034 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6848-01A-13-2191-20 46b0370f-a666-4cce-a746-8701a344a36e 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-6849-01A-13-2191-20 0f7b0379-6a78-482e-909f-c85766abcb9d 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-91-7771 c0fdb152-25d2-404b-bec7-a43ece381f5b 11/10/2012 LUAD Synchronous malignancy Pt with synchronous thymoma.
TCGA-91-7771-01A-13-2192-20 6a99d37c-55d6-4316-9280-f852f974a786 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-92-7340-01A-23-2195-20 bbdcf945-baf7-42ed-ab05-6f2dcb81c323 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-93-7348-01A-23-2192-20 048615c7-c08c-4199-b394-c59160337d67 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-93-8067 bbe88801-34f3-46d2-bbfd-b46c3901ed71 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-93-8067 bbe88801-34f3-46d2-bbfd-b46c3901ed71 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-94-7033 3351b902-9b7e-4b90-bf6b-bcf74be00bc1 10/31/2012 LUSC Prior malignancy Prior malignancy bladder cancer treated with locoregional intravesical therapy
TCGA-94-7033 3351b902-9b7e-4b90-bf6b-bcf74be00bc1 11/10/2012 LUSC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated with locoregional intravesical therapy
TCGA-94-7033-01A-13-2194-20 95f1fbdc-e59b-4825-b63e-c71b23b2f6e9 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-94-7557 ea741488-5475-4a3d-b9fe-81722f129974 10/31/2012 LUSC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous LUAD, mixed subtype.
TCGA-94-7557 ea741488-5475-4a3d-b9fe-81722f129974 11/10/2012 LUSC Synchronous malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous LUAD, mixed subtype.
TCGA-94-7557-01A-13-2195-20 b55c5cd9-2ac9-4b08-bebd-acd943bf9521 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-94-7943 aecf85cc-058c-46f3-9cdc-3573ac3b8438 10/31/2012 LUSC Prior malignancy Prior malignancy lung cancer. No systemic chemotherapy or radiation.
TCGA-94-7943-01A-13-2195-20 78584fca-e293-47bf-b2a0-bcaa476544a7 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-95-7039-01A-13-2192-20 89356e0b-28f3-4115-9a1a-ba5788b848b8 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-95-7043 c650b1ff-8a4c-4ee9-b7c1-268c28c83827 11/10/2012 LUAD Synchronous malignancy Pt with synchronous R LUAD-mixed subtype.
TCGA-95-7043-01A-13-2192-20 e4b22dc8-a344-4b20-a743-9af3e4308605 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-95-7562 193201a3-1447-47b1-bdf1-11ae0eb3b2f3 10/31/2012 LUAD Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-95-7562 193201a3-1447-47b1-bdf1-11ae0eb3b2f3 11/10/2012 LUAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-95-7567-01A-13-2192-20 b1812676-0dc7-4038-937b-1e11d9f3a8eb 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-95-7944-01A-12-2192-20 4e9e76ae-0854-4d55-8ac1-1e156220d369 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-95-7947 e0acafdd-06d0-48a6-bd68-577ef666a419 10/31/2012 LUAD Prior malignancy Prior malignancy cancer of the larynx. No systemic chemotherapy or radiation.
TCGA-95-7947-01A-13-2192-20 394b67ed-76b7-4d7a-9d58-bf5a790b05d4 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-95-7948 a52e99d6-a61a-439d-b0b1-ca7a0eabcb04 10/31/2012 LUAD Prior malignancy Prior malignancy cancer of the spleen. No systemic chemotherapy or radiation. Patient with synchronous L breast cancer.
TCGA-95-7948 a52e99d6-a61a-439d-b0b1-ca7a0eabcb04 11/10/2012 LUAD Synchronous malignancy PM of the spleen. No systemic chemo or radiation. Pt with synchronous L breast cancer.
TCGA-95-7948-01A-13-2192-20 32138cac-7e19-47d7-9a9a-c7270643ea2f 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-96-7544-01A-13-2195-20 f2806a36-bdd6-48dc-9c91-c5eddff6a4ec 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-96-7545 4ca13c92-84b4-4edf-842a-b20b7e713415 10/31/2012 LUSC Prior malignancy Prior malignancy bilateral LUAD. Prior malignancy R LUAD. No systemic chemotherapy or radiation.
TCGA-96-A4JK 613adbb3-c2d1-4992-9953-c4fadd249001 08/14/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy Patient was given BCG for the prior bladder cancer, which was not approved by the lung group as an acceptable prior treatment. (per Kristen Leraas/BCR TCGA-2222)
TCGA-97-7546-01A-13-2192-20 936aa67d-90fe-464a-876e-74c37cd2d9bb 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-7552-01A-13-2192-20 ae55fdf1-f35a-4930-a339-0c51f52b791a 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-7553-01A-23-2192-20 45376060-6ebe-467c-ac0c-af4b2f3a9670 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-7554-01A-13-2192-20 b2825831-dc98-4443-9963-3f8399f86ea9 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-7937-01A-13-2192-20 c239f617-19b3-4f8e-933e-492103f7ee83 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-7938-01A-13-2192-20 4bfded3e-651d-476f-a780-b8345171b8cc 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-7941-01A-13-2192-20 803df9cc-873d-4ea2-8895-3090f505e2fd 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-97-8172 cbf1f718-6bb7-4daf-b9d6-fb294281decb 10/31/2012 LUAD Prior malignancy Prior malignancy breast cancer. No systemic chemotherapy or radiation.
TCGA-98-7454-01A-13-2195-20 fed5fc80-909c-45a8-a5d1-06c865837c32 03/12/2012 LUSC Item is noncanonical LUSC Proteomics MDA
TCGA-98-8020 ffb53b81-c1ed-473c-bdcd-b325b02e22ae 10/31/2012 LUSC Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-99-7458-01A-13-2192-20 603528a1-05bf-43b5-a90b-1b8266f2a925 03/12/2012 LUAD Item is noncanonical LUAD Proteomics MDA
TCGA-A2-A0YT 14b95463-2108-4921-afc2-e29eef52b18f 08/19/2011 BRCA Neoadjuvant therapy Subject is positive for neoadjuvant therapy.
TCGA-A2-A0YT 14b95463-2108-4921-afc2-e29eef52b18f 12/14/2010 BRCA Prior malignancy Case had Prior malignancy
TCGA-A3-3306-01A-02-1737-20 16211caa-d5f8-4c55-a3a4-be3355122480 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3307 7ac1d6c6-9ade-49af-8794-10b5b96b2b05 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3308-01A-03-1737-20 b838468b-dfd5-49d4-bd7e-e74266201951 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3311-01A-03-1737-20 462b80e9-9015-43b7-b847-2fe3fdd384ea 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3313-01A-03-1737-20 dfdab8aa-668a-4a3f-ab2d-af868ed4c820 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3316-01A-03-1737-20 6330a1ab-f8cf-41f3-8046-d46d307c2e34 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3317-01A-03-1737-20 e37059b2-7a6d-4240-88e5-e7f755a68e41 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3319-01A-03-1737-20 9e45d6b9-e09f-4b75-8946-332f7bc8034e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3320-01A-03-1737-20 e6f15260-dcb7-4c5a-af56-5f26049f1dd0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3322-01A-03-1737-20 b58f34a0-7cbd-4bba-b2a5-48da31285610 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3323-01A-03-1737-20 020726a9-b511-4129-9ad2-f1978efea06f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3324-01A-03-1737-20 93d63239-8ec0-41ec-881d-739a4cc09f83 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3325 9868ae73-3459-4aa6-b71a-39953cdbbe1a 11/10/2012 KIRC Synchronous malignancy Pt with synchronous SCC of the neck. No prior malignancy.
TCGA-A3-3326-01A-03-1737-20 f1a88434-8fc2-4c36-998b-ece89d2a0bfe 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3328 8d02978a-10cb-4bbf-8980-78aebe70bcd1 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3329 21eea125-1298-42d3-a50c-57d596e0420d 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3329 21eea125-1298-42d3-a50c-57d596e0420d 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ radiation
TCGA-A3-3329-01A-02-1737-20 0dd97442-3dad-411c-af6a-cf4380df97af 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3331-01A-03-1737-20 02c85a94-cbff-4a74-95bf-282e6dfcc597 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3335-01A-02-1737-20 a49aaffa-7cff-4440-a7c8-77590c005403 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3336 4ca5ff6a-ace1-4349-b269-b8e3aae16785 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Patient with synchronous non-Hodgkins Lymphoma treated w/ R-CHOP prior to procurement of TCGA tumor
TCGA-A3-3336 4ca5ff6a-ace1-4349-b269-b8e3aae16785 11/10/2012 KIRC Synchronous malignancy Patient with synchronous non-Hodgkins Lymphoma treated w/ R-CHOP prior to procurement of TCGA tumor
TCGA-A3-3336-01A-02-1737-20 9220327b-238b-4d85-bc6c-8dc0cdc8ca78 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3343 d4815225-0ac0-4295-a70d-74162066c0bd 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3343 d4815225-0ac0-4295-a70d-74162066c0bd 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/hormone therapy
TCGA-A3-3346-01A-03-1737-20 da27c634-7826-42a3-8b86-3c2bf7372513 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3347-01A-03-1737-20 83476cd5-f19f-4b6d-b670-08d2d975f304 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3349-01A-03-1737-20 2216921f-4864-45cd-ab5d-dc4337d21e90 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3351-01A-03-1737-20 52f39dab-34d9-42e6-a3a1-cfdfa39f320e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3352-01A-02-1737-20 18c7d39f-1d22-41af-a242-9b85cd07e02f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3357-01A-03-1737-20 0a391787-d50b-4d9b-8645-3c4e16c2b014 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3358 8a575e00-5dc5-416d-a8f5-2cdfb8e62c31 10/31/2012 KIRC Prior malignancy Prior malignancy cervical cancer. No systemic chemotherapy or radiation.
TCGA-A3-3359 e4cc8898-d1d8-4f6d-b01c-04cd30f0cd8f 09/02/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-A3-3362-01A-03-1737-20 96a10a56-098d-4a6a-969f-2a192aa24c81 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3363-01A-03-1737-20 55544522-fc45-49a1-8383-46de7554eb7d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3365-01A-03-1737-20 d5f95d7f-2fde-49dd-9e17-b435d7f424dd 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3367-01A-03-1737-20 7859c03e-1ee8-4726-93c6-3956f7e2f661 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3370-01A-03-1737-20 d8677058-4115-4f4e-9ed1-47861df01165 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3372-01A-03-1737-20 6f6c93b1-1da4-4128-b35b-5278fb3f99dd 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3373-01A-03-1737-20 828193ea-5a4f-427b-b2c4-a6834b773afb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3374-01A-03-1737-20 5a6b7298-ee72-4e78-bbf1-b41b6ccd59fa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3376-01A-03-1737-20 ebb58b2a-a5fc-4b84-8c88-a99a0f6a5dfb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3378-01A-03-1737-20 40a5b47c-745c-43cf-bacd-ea370eacacbc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3380-01A-03-1737-20 7be83762-afd6-4792-8fa9-cedc578e1833 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3382-01A-03-1737-20 2dbba60a-dd51-4d2c-920c-bf5ad38eb109 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3383-01A-03-1737-20 c737b9b0-9ea0-40a7-bc59-435a0c22f5a4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3385-01A-03-1737-20 260f47d1-d278-48ea-af55-97a32e22782e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A3-3387-01A-02-1737-20 92a71abf-59cc-4b5c-a6f8-1393abab9d80 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-A4-7288 e53893e7-cfaf-49bb-917f-6d549652b319 10/31/2012 KIRP Prior malignancy Prior malignancy R breast cancer. No systemic chemotherapy or radiation.
TCGA-A4-7584 0843841b-afab-4831-9084-a850db85287c 11/10/2012 KIRP Synchronous malignancy Pt with synchronous prostate cancer.
TCGA-A4-7734 d8b73891-05e0-4ab5-ab2e-0acf8d03595c 03/20/2012 KIRP Prior malignancy NA
TCGA-A5-A0GI 3b21b47e-a15c-4b10-9702-62a14afdfb8c 12/14/2010 UCEC Prior malignancy Case had Prior malignancy
TCGA-A5-A0GM 976bb47a-d999-4e24-ad08-452fea73c846 12/14/2010 UCEC Prior malignancy Case had Prior malignancy
TCGA-A6-2670-01A-03D (none) 08/20/2012 COAD Item is noncanonical miRNA Extraction Validation
TCGA-A6-2671-01A-21-1932-20 17bc7ed8-abea-48b8-b5a8-e7c0b7187594 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2672-01A-21-1932-20 4c7976a5-79b2-4584-83da-19e654a760ac 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2676-01A-21-1932-20 918b538c-161d-4350-80d7-6bccf9ef28a9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2677 d976782c-90c1-421d-b83c-7fc2617e2709 11/10/2012 COAD Synchronous malignancy Synchronous malignancy L KIRC treated with locoregional radiation
TCGA-A6-2677-01A-21-1932-20 dbd495a5-ae07-4ffa-9f7d-e52de952d777 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2678-01A-21-1932-20 db2e5de9-500d-4eb2-8928-2bfd6e1689a1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2680-01A-21-1932-20 6e22e6bb-7ef3-4830-96ad-04584f6dff69 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2681-01A-21-1932-20 01342a10-847b-4a31-a7de-1844e32bce5d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2682 77a44132-af22-4115-9fa2-78f2f74bf687 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer. No systemicchemotherapy or radiation.
TCGA-A6-2683-01A-21-1932-20 518a7668-dfba-44a9-8d0a-2a996ea210e4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2684-01A-21-1932-20 e38720b2-c875-4c6a-a050-fa8859d98fd7 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2685-01A-21-1932-20 dde7e976-40ec-4999-a5be-79cde4b5eef1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-2686-01A-21-1932-20 a5040de9-85e7-41f1-89e2-3fcbe4ff059a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-3807-01A-21-1933-20 529170f6-6b5a-41d2-8623-dda23029678b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-3807-01A-22-2150-27 77a6e910-fde6-434a-ad29-8a217668bba3 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-A6-3808-01A-21-1933-20 7c53deb6-181a-4fd1-a1ab-e2e62339e620 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-3808-01A-22-2150-27 1939c2d7-0df4-4110-99e0-09a3c0929aa2 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-A6-3809-01A-21-1933-20 af8a4650-d40c-4e75-8d06-58f0dc5b7602 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-3810-01A-21-1933-20 caf0daa7-8916-4b63-a714-fd998364b7ff 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-3810-01A-22-2150-27 683e5429-3018-451b-8faa-2bc131463e75 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-A6-4105 95d4f0c4-5997-4ffb-b876-0ddfeee972bb 10/31/2012 COAD Prior malignancy Prior malignancy skin cancer L eyelid. No systemic chemotherapy or radiation.
TCGA-A6-5656-01A-22-1933-20 41148113-a2f3-48b5-81c1-f19bc5be2715 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5657-01A-21-1933-20 4fe95952-5302-4ad3-ab1a-e2e4154d9c57 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5659-01A-21-1933-20 18709dd5-aede-484b-9442-b4542ff91010 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5660-01A-21-1933-20 4782330f-a60f-4918-8a2c-9a47635c8bc2 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5661-01A-21-1933-20 36aea7cc-fd1d-4a4e-a28e-83fd75d66d13 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5662-01A-21-1933-20 8809c0c6-50a0-4683-aa40-a170369f0fad 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5664-01A-22-1933-20 938eca88-2b34-4855-930c-204396d20edc 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5665-01A-21-1934-20 506f6c0d-69da-465c-82f6-2f00425227a2 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5666-01A-21-1934-20 c7ff17b2-8919-4387-9825-f82d81acc135 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-5667-01A-11-1933-20 a4f0e57c-97d6-4961-a2ef-54ec3cc7f33a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6137-01A-13-1934-20 a04c5b1f-fadc-40bd-84d3-4a0dcc84ec76 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6138-01A-13-1934-20 cb17c7ec-dee9-49be-87c3-3f0cb7bfc9b8 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6140-01A-13-1934-20 ef5bb022-a1db-4892-848b-6ad7a7b0a9b6 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6141-01A-13-1934-20 8abc7e1d-65ec-48fa-a469-65d2a8f30c64 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6142-01A-13-1934-20 f89dbb8b-6159-4838-94c0-1bb9f41dbe69 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6648-01A-13-1935-20 79ebb3bb-91f6-424b-b9fe-32ccb4970052 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6649 39b6ae01-c97b-4234-8a28-208fdf170432 10/31/2012 COAD Prior malignancy Prior malignancy basal cell carcinoma. No systemic chemotherapy or radiation.
TCGA-A6-6649-01A-13-1935-20 81245cf6-3701-48f4-83c3-3fac7992eee4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6650-01A-13-1935-20 601d8662-a8b9-444a-a4dd-b31d6ac23bc3 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6651-01A-13-1935-20 8877ebd8-30df-4af2-a41b-b7f487a3be40 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6652-01A-13-1935-20 d9b48bae-f2fe-42c2-95b9-c9a2d1d0aca0 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6653-01A-13-1935-20 9cacfbf0-9d05-4e4a-929d-287b90d85f7f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6654-01A-41-1936-20 86e7fb40-2e52-439f-959b-d7ddcf476306 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6780-01A-13-1935-20 956b15f5-8f07-4645-a50d-2634ce5321f4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6781-01A-13-1935-20 78365184-5ea4-4e3c-b6ac-960a41631882 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A6-6782-01A-13-1935-20 f8505ce3-10e8-4e64-a32b-66d223cf398e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-A7-A0CD 09765b0a-94f6-47d2-af56-93368084ac3a 12/14/2010 BRCA Prior malignancy Case had prior malignancy
TCGA-A7-A0DC cb9f5e50-f49d-4899-8895-9367afcc1015 12/03/2014 BRCA Item does not meet study protocol Tumor is DCIS and not invasive which is required by the TCGA BRCA study
TCGA-A8-A06T 2c04a2f5-321e-4dea-8e00-268325da65cb 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A06U 6bc4c56d-aac5-49a2-9913-9538d06d898f 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A07E 853456d8-2367-404e-abc9-020fe8bbd209 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A084 3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-A8-A084 3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A08F 0a017f15-1c6b-45e7-8d55-e0a71df1b2e8 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-A8-A08F 0a017f15-1c6b-45e7-8d55-e0a71df1b2e8 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A08S 2779fa01-ac93-4e80-a997-3385f72172c3 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-A8-A08S 2779fa01-ac93-4e80-a997-3385f72172c3 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A091 f39edd06-1016-4e8e-a42e-12f7e699ddc5 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A093 02f5ae33-a563-4ecb-9e33-dfa500a44931 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A09C 80f3f48a-cc21-415c-b181-c77e7ba1c563 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A09E dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-A8-A09E dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A09I 1557183c-aedd-4df6-b98a-3654667f7b69 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-A8-A09K 6f959c92-b79f-4f84-9ee5-d07d3212d52d 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-A8-A09K 6f959c92-b79f-4f84-9ee5-d07d3212d52d 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-AA-3489-01A-22-1932-20 92224981-9fb1-4e37-86bc-6803260acbca 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3492-01A-21-1932-20 ac6de845-6818-40fa-9b68-6cafa5df6120 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3496 639e1050-088a-48fe-a0ef-4a01a3468cac 10/31/2012 COAD Prior malignancy Prior malignancy colon cancer. No systemic tchemotherapy or radiation.
TCGA-AA-3496-01A-22-1932-20 c1939096-2366-4ecf-b466-0edc1dd6cd6e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3502-01A-21-1932-20 f604e17d-1640-4555-a6a6-f5a736fd6a10 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3506 28033279-cc74-4775-afdf-2497f6ddb55c 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with radiation.
TCGA-AA-3506 28033279-cc74-4775-afdf-2497f6ddb55c 12/19/2010 COAD Prior malignancy [intgen.org]: Prior Malignancy
TCGA-AA-3506-01A-21-1932-20 312e8c6a-ec9c-4702-a79d-c953614cfa41 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3510-01A-21-1932-20 bc73e15e-6f32-4a15-8ce2-00603f3d90e6 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3511-01A-22-1932-20 ef6d6add-9776-46cb-902c-ace609eb8a7d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3514-01A-11-1932-20 ac7bffcc-8b6c-42d3-a7f2-ab9d88307bad 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3516 d9d7f0d4-fa64-48f2-8037-52cbf0b34ad8 10/31/2012 COAD Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation. Prior malignancy rectal cancer treated w/ systemic chemotherapy.
TCGA-AA-3516 d9d7f0d4-fa64-48f2-8037-52cbf0b34ad8 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation. Prior malignancy rectal cancer treated w/ systemic chemotherapy.
TCGA-AA-3517-01A-21-1932-20 5bbac71c-e962-41ac-bc3f-b6404ad52f0f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3518-01A-11-2150-27 b745c6b2-48b1-49d5-8491-39da86ed821f 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3519-01A-11-1932-20 46e39bf4-0da5-4044-98c1-5bd6b00c64e5 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3520-01A-21-1932-20 1546738c-9d81-43dd-b647-f208f6ea5ef4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3521 ad440651-a2de-4bb1-90da-1e5e8975ab59 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3521 ad440651-a2de-4bb1-90da-1e5e8975ab59 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3521-01A-21-1932-20 d327d512-a4eb-4c12-acad-2603b139d942 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3522 d7ba64d7-b4e5-488d-9f28-bcb7bf3c0f35 10/31/2012 COAD Prior malignancy Prior malignancy malignant melanoma of the trunk. No systemic chemotherapy or radiation.
TCGA-AA-3522-01A-21-1932-20 162477ff-7158-4d08-b334-18e6a0bf517e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3524 03efbc94-a43d-4db0-9377-e397348430a6 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3524 03efbc94-a43d-4db0-9377-e397348430a6 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3525 b107565b-7558-4745-952b-689178367e1c 06/16/2014 COAD Case submitted is found to be a recurrence after submission patient had a prior colon malignancy
TCGA-AA-3525 b107565b-7558-4745-952b-689178367e1c 10/31/2012 COAD Prior malignancy Prior malignancy colon cancer. No systemic chemotherapy or radiation.
TCGA-AA-3525-01A-11-1932-20 31389203-2465-475b-8551-c713df850c35 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3525-01A-12-2150-27 da1bb2b6-c6d4-455a-9468-08198f86756b 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3526-01A-11-2150-27 40a77161-ca29-47f0-ab89-c0fd342f13c1 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3527 269e8ca8-722d-449b-ace1-6545bd72bdd6 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer. No systemic chemotherapy or radiation.
TCGA-AA-3529-01A-11-1932-20 2d42cb17-9fc2-48ab-abf3-7c1c3ac50e5b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3529-01A-12-2150-27 75bbb475-8e48-4dc0-a0f0-4ea890462c33 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3530 1ad0b9b9-7ded-4281-b114-9dcc6138c037 10/31/2012 COAD Prior malignancy Prior malignancy testicular cancer treated w/ radiation
TCGA-AA-3530 1ad0b9b9-7ded-4281-b114-9dcc6138c037 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy testicular cancer treated w/ radiation
TCGA-AA-3530-01A-21-1932-20 25fbe6f6-7d18-4fff-bee2-8b4e6e775305 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3531 401a37f3-6630-4400-a811-a262351e37de 10/31/2012 COAD Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-AA-3531-01A-21-1932-20 c5a21ce5-5687-413d-be6b-f5975982b63e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3531-01A-22-2150-27 ec6731b4-c794-4268-bc9d-51598ba06337 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3532-01A-21-1932-20 ea93b799-b27e-4cea-917c-1653db4976b7 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3534-01A-21-1932-20 9617da3c-34e3-4952-9f06-cd7ee49c9d94 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3534-01A-22-2150-27 91a6a5fb-56cf-4fef-b6d5-ab7353ff6e38 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3543 912b61a1-6a5b-451c-b753-9c3dac03e8cb 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3543 912b61a1-6a5b-451c-b753-9c3dac03e8cb 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3548-01A-21-1932-20 d1481024-1f20-473a-ac89-47e40692fd18 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3552 265d7b06-65fe-42c5-ad21-e6b160e94718 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3552 265d7b06-65fe-42c5-ad21-e6b160e94718 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormone therapy
TCGA-AA-3552-01A-21-1932-20 f8846296-cad4-44e2-ba04-5733a799c48f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3552-01A-22-2150-27 96012188-5aa2-4a6c-981c-8d2757053297 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3553-01A-21-1932-20 c19a9e66-28b7-4b52-868f-07a3da2aaa6d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3554 ba49b428-246d-46d2-b549-39a5fc8f7003 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer treated w/ hormone therapy (mistletoe) and radiation.
TCGA-AA-3554 ba49b428-246d-46d2-b549-39a5fc8f7003 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated w/ hormone therapy (mistletoe) and radiation.
TCGA-AA-3554-01A-21-1932-20 e59b3eac-b0a6-4b53-914b-237d4cd4e2f6 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3554-01A-22-2150-27 2b45d33f-d78b-4076-a6d8-0ffd850cceb3 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3555-01A-21-1932-20 98a69f16-394b-4f27-ada5-0941c5dd2e43 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3556 fd16b634-2e04-44a3-862d-fb03cd73c057 10/31/2012 COAD Prior malignancy Prior malignancy treated w/ systemic chemotherapy.
TCGA-AA-3556 fd16b634-2e04-44a3-862d-fb03cd73c057 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy treated w/ systemic chemotherapy.
TCGA-AA-3558-01A-21-1932-20 5d0e27b3-9973-4472-a2ef-21b25f086c06 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3558-01A-22-2150-27 154d00dd-d52f-4b7b-9649-8c1d4de3782e 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3560 2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2 10/31/2012 COAD Prior malignancy Prior malignancy stomach cancer. No systemic chemotherapy or radiation.
TCGA-AA-3560-01A-21-1932-20 f7a4db77-8dbf-48ce-b928-473dc55a9cba 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3561-01A-21-1932-20 ce8a9965-3e77-4f82-b617-a969849fdf5c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3561-01A-22-2150-27 1783ec55-d52c-4394-9b33-7f7523f87520 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3562 127f738d-afa1-42f6-a9a0-f33806667b84 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer treated with unknown hormone therapy. Pt with synchronous colon cancer.
TCGA-AA-3562 127f738d-afa1-42f6-a9a0-f33806667b84 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with unknown hormone therapy. Pt with synchronous colon cancer.
TCGA-AA-3562 127f738d-afa1-42f6-a9a0-f33806667b84 11/10/2012 COAD Synchronous malignancy Prior malignancy breast cancer treated with unknown hormone therapy. Pt with synchronous colon cancer.
TCGA-AA-3562-01A-11-1932-20 679e009d-2904-4062-8804-6ca2371d9140 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3655-01A-11-1932-20 6dc51d9a-3904-48b0-9d73-5845e81438cc 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3662 d9fb85c3-ade1-47bf-8159-170f81eb130f 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer treated with unknown hormone therapy.
TCGA-AA-3662 d9fb85c3-ade1-47bf-8159-170f81eb130f 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with unknown hormone therapy.
TCGA-AA-3664-01A-21-1932-20 ec7646bc-e9cd-4844-b261-7ff81070df97 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3664-01A-22-2150-27 9f7db77b-59bc-41f0-a509-7437d5da44bc 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3666-01A-31-2150-27 6aabadff-5290-4cc2-89be-2075597f725e 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3672 c46971a1-cbac-425d-bac2-f4142c92522e 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer treated with unknown hormone therapy.
TCGA-AA-3672 c46971a1-cbac-425d-bac2-f4142c92522e 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with unknown hormone therapy.
TCGA-AA-3672-01A-21-1932-20 6824f9fa-dc90-423d-a3b4-93868cb4f67a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3672-01A-22-2150-27 cc8e7ab8-c190-4de2-9190-a7293ee81349 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3675 41658cf8-0de1-4a97-bb60-0f0107c84e00 10/31/2012 COAD Prior malignancy Unknown prior malignancy.
TCGA-AA-3678-01A-21-1932-20 ce6dc6d2-1c37-4b57-87e9-cb6d466056b9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3681-01A-21-1932-20 af72d118-6292-4640-b80c-ca63a29caa4d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3684-01A-31-2150-27 16958bc1-6804-444c-9178-195ef908360b 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3688 2c9996bb-af6e-4424-881a-e81b9c9aeb78 11/10/2012 COAD Synchronous malignancy Synchronous malignancy of the colon
TCGA-AA-3688-01A-21-1932-20 84c1e382-edcb-45ef-86f9-c275b58ad725 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3692 bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d 11/10/2012 COAD Synchronous malignancy Synchronous malignancy of the rectum
TCGA-AA-3695-01A-21-1932-20 ee5f928b-9473-4172-beb1-e83393e13819 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3695-01A-22-2150-27 075d832b-58e4-4308-814f-c4d07dd37fdb 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3696-01A-21-1932-20 c115d2ce-11c6-4acf-b7cc-b6ba911751eb 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3697 dde411b2-5d2b-4638-8149-89bc1eb3c7ad 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer treated with chemotherapy and radiation.
TCGA-AA-3697 dde411b2-5d2b-4638-8149-89bc1eb3c7ad 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with chemotherapy and radiation.
TCGA-AA-3697-01A-21-1932-20 6d265e00-dc3b-48f8-b128-7690d891cd5e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3710-01A-21-1932-20 35735d44-e6d5-4cef-a934-893011f55db3 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3710-01A-22-2150-27 98062f36-9403-43a5-9215-16f8d0e90cf3 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3712-01A-22-1932-20 60d62192-7908-4c63-b78e-f7cf14e6b2be 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3713 57a2044d-20cc-4d02-b268-ce570a0fabe3 10/31/2012 COAD Prior malignancy Prior malignancy of the retroperitoneum and peritoneum and sigmoid colon. No systemic chemotherapy or radiation.
TCGA-AA-3713-01A-22-1932-20 3e29566d-34e1-43b2-8e76-ba659c5b2051 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3715 e394e9ec-7288-4ede-9ef8-41b631d100dd 10/31/2012 COAD Prior malignancy Prior malignancy kidney and bladder cancers. No systemic chemotherapy or radiation.
TCGA-AA-3715-01A-21-1932-20 181f4a32-8d6a-425c-87c2-3fd95ebbee6b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3715-01A-22-2150-27 04ada15f-8aaa-4d0e-bc1d-b2237821e5a6 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3811-01A-21-1932-20 a0b112f1-7457-488f-a4be-af809b6ceb36 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3812-01A-21-1934-20 eb8e4109-e60f-4c5e-944e-a32dfebb22f8 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3814 f38d49b7-6cad-4460-abd0-3685a3b2d941 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer. No systemic chemotherapy or radiation.
TCGA-AA-3814-01A-21-1933-20 17eeb81d-a242-417a-8881-0fc170bc6027 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3815-01A-21-1933-20 a8034f17-d5d2-4427-911d-2bce0f803a4b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3818-01A-21-1933-20 c5d268e0-8967-4bf5-9019-c7846ef6d7ba 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3818-01A-22-2150-27 dc0055bd-52e5-4451-bd3d-1d1845defc92 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3819-01A-21-1933-20 b7ed0e2b-8358-4d48-906a-ff9dc47dbb65 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3831-01A-21-1933-20 a50aff4b-61ff-4df9-abd8-bb07f6538ddd 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3833-01A-21-1933-20 824fc23c-3275-4a2f-95b1-cd4ce3de96bf 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3837-01A-21-1933-20 dd5effd4-9545-4f07-9968-679054af934a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3841-01A-21-1933-20 3d15881d-2dee-426d-a878-fab07b1685dd 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3844 4f786107-3cf5-4ab3-bba4-f399dee23f0e 10/31/2012 COAD Prior malignancy Prior malignancy malignant melanoma of the leg. No systemic chemotherapy or radiation.
TCGA-AA-3844-01A-21-1933-20 c966b406-cf1d-4590-812b-17ec3bff1e62 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3845-01A-21-1933-20 b9cf7555-5099-4873-8d81-a7c6c6a5d3c8 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3848-01A-21-1933-20 ff35c662-daee-422a-b271-ebabe4c0ee6a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3848-01A-22-2150-27 8589ef24-bdfd-43fd-a5c3-6d62ac7f5a0c 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3850-01A-21-1933-20 9b4ba498-fefe-428b-a407-e5f419352c00 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3852-01A-21-1933-20 e17ea0d7-2a8c-4b69-884c-7918aa20f66a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3854-01A-21-1933-20 9f766d5e-dab4-4bbb-8c79-836489764406 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3856-01A-21-1933-20 9c70d6eb-e8da-444e-ad46-d9d1462e5b9f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3860 ac6a3df9-41b1-4e5a-a15e-f44481384c23 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer treated with system chemotherapy, hormone therapy, and radiation.
TCGA-AA-3860 ac6a3df9-41b1-4e5a-a15e-f44481384c23 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with system chemotherapy, hormone therapy, and radiation.
TCGA-AA-3861-01A-21-1933-20 c549fd23-c7d2-44d4-971b-c7c3521920bb 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3862 05ff79c5-1127-4cac-8f4c-84089a3f2cde 10/31/2012 COAD Prior malignancy Prior malignancy kidney cancer. No systemic chemotherapy or radiation.
TCGA-AA-3862-01A-21-1933-20 ea94cdbe-91c4-4e06-b63e-be9163479833 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3864-01A-21-1933-20 0504e753-ebf2-4bfd-bb13-bbaf50eb28ba 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3864-01A-22-2150-27 f96c8363-391c-4f3d-b849-b59427b966e4 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3866-01A-21-1933-20 00b5971a-d871-40bf-8f0c-d7a984f7cc3e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3867 d655bbf6-c710-411d-aff5-ceb0fb6e6680 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-AA-3869-01A-21-1933-20 8ff6422f-b857-47d7-8cce-b3a7fe47b689 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3870 beb63625-d9bf-4ccd-bc53-635b53d24240 10/31/2012 COAD Prior malignancy Prior malignancy breast cancer treated w/ radiation
TCGA-AA-3870 beb63625-d9bf-4ccd-bc53-635b53d24240 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated w/ radiation
TCGA-AA-3872-01A-21-1933-20 95a0fb41-ddc8-42f9-9409-3da6a943ba84 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3930-01A-21-1933-20 898a2721-6e1d-437e-8d35-e34fd1f44ee4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3939 81555ac5-9cc2-49ae-9033-657f56243f20 10/31/2012 COAD Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-AA-3947-01A-21-1933-20 9609c50d-fd23-4eea-a82e-d391fbcec2f2 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3950 cc53bf9e-5e27-4305-a08b-552120c10aa5 10/31/2012 COAD Prior malignancy Prior malignancy stomach cancer. No systemic chemotherapy or radiation.
TCGA-AA-3950-01A-11-1933-20 372f4a39-676b-4e46-a857-eb2a40814d10 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3952 c1e141af-bdd1-4176-8c0e-cf1ab0c1d9d3 10/31/2012 COAD Prior malignancy Prior malignancy oral cancer. No systemic chemotherapy or radiation.
TCGA-AA-3955-01A-11-1933-20 b7c86deb-7d50-4520-8c64-8c0637376884 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3967 86a9e44f-728e-48e4-9e1b-682b023f7c0a 09/02/2010 COAD Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-AA-3968-01A-21-1933-20 cfdc5790-7eeb-4c6b-92ca-e111810f9c04 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3971-01A-21-1933-20 79e357f8-f3c0-4525-932d-8b6d9a88296d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3972 93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1 10/31/2012 COAD Prior malignancy Prior malignancy mycosis fungoides. No systemic chemotherapy or radiation.
TCGA-AA-3972 93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy ascending colon cancer treated w/ systemic chemotherapy. Prior malignancy mycosis fungoides. No systemic chemotherapy or radiation.
TCGA-AA-3972-01A-21-1933-20 98a6010b-a151-49e1-802b-f8f0e47b7483 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3973-01A-21-1933-20 5fd59f2c-5a57-4bf8-ae33-39f4cfdb1bb0 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3975-01A-21-1933-20 a6cea7dd-238d-4c9c-9e50-f1ea367ac8e1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3976 14efca0c-882d-4fba-b15c-64af6e213b80 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer. No systemic treatment or radiation.
TCGA-AA-3979 af17788e-a562-43aa-bd36-fd3e031f483c 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy larnyx treated w/ radiation.
TCGA-AA-3982-01A-11-1933-20 08d2c7c6-f314-4035-94e4-bbbae637999e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3986 04d7a52f-a89b-4114-a608-a6254b4d604f 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer. No systemic treatment or radiation.
TCGA-AA-3986-01A-11-1933-20 a2d3f5c0-4fce-4859-ad7b-041334d2757b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3986-01A-12-2150-27 5c5b2fb1-76f4-425e-9e8b-f15f44bf75d5 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-3989-01A-21-1933-20 150273c6-0465-47c3-83b6-84fb1eae2d0f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AA-3989-01A-22-2150-27 71541f7c-2505-49de-8bc3-6c37ac75db05 02/07/2012 COAD Item is noncanonical COAD Proteomics VUMC
TCGA-AA-A00L 381cf7f3-cd7b-4660-8175-ff8062f7bf78 02/22/2013 COAD Prior malignancy Patient had a prior prostate cancer. No radiation or systemic chemotherapy.
TCGA-AA-A00L 381cf7f3-cd7b-4660-8175-ff8062f7bf78 10/28/2010 COAD Prior malignancy No Note Specified
TCGA-AA-A00Z af3a0634-4292-45bd-b948-6b6bd2d58090 10/28/2010 COAD Prior malignancy No Note Specified
TCGA-AA-A024 d4e1472a-7b5f-46f4-acb7-b961f634e28e 10/28/2010 COAD Prior malignancy No Note Specified Patient had a prior malignancy of the bronchus and lung lower lobe. No radiation or systemic chemotherapy.
TCGA-AB-2802 b93cb62a-a7dc-406d-8482-6b51a92ea3c3 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2803 fb4c9803-3690-4f6a-9402-72a4f36d64d1 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2804 2fcda6a9-813b-41b2-aae4-ca42c9986287 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2805 ada38f3e-8020-4394-9e7c-50d06dd04769 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2806 e78ff499-037b-450a-ac04-6fb3a9e124a4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2807 9aedadd8-98e2-4cff-b1a3-64506bf1d95c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2808 eefba73e-bf2c-4cac-bd29-8ab3d392aa5b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2809 7b4ce492-ff40-4bf1-b3e8-75ff83e8746d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2810 865cda60-ec30-4562-b681-0e90737a97ca 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2811 7cf64c74-47e6-4913-b91b-25198e36b7c8 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2812 11ed5289-050e-434a-a24e-79854b0d9dcc 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2813 69da7e4d-57d3-40d6-92af-3cd1aaf9e0ec 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2814 e591adad-8331-4198-94c4-d03ea01f70c5 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2815 a7a567fa-847e-49c6-b404-f2257e00b00d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2816 61db06eb-299a-48b3-8c71-4bea78169b4c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2817 d5fe3b27-c6a6-4a35-a173-3f7b73c2ed14 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2818 ef853801-83be-4011-ba4d-6e2fe7153b05 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2819 96686a1a-16d0-4cdc-b1f7-5dbbf4cf1c9f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2820 a086aba1-0df5-497b-85e7-bc84aac1acec 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2821 f6f9ed0d-2b3c-45b7-b214-853b5a207bac 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2822 15b2be7d-bd75-4236-b896-2ef25edd14b8 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2823 a05e93e6-ad8b-4893-b27d-c9cd329ad564 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2824 35ac682e-230a-4d90-9d95-c86216782b63 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2825 c5f2311c-020a-47cd-a065-7fbc34488405 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2826 23e96996-f438-4e81-b3b0-d12a0c046fcd 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2827 12677872-92fb-44ff-93b9-25a93fc3b188 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2828 fc4ae4f8-f66b-4137-9821-e579b339cbf6 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2829 8dc1781e-1794-4f33-84aa-fea032f92bae 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2830 9f0a0548-e8b4-4c44-94e7-9d5e793e5601 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2831 457bf6de-ea0e-4588-a06f-055c808de158 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2832 9a18743d-f16b-4320-952f-af15725c17ca 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2833 93cb13d2-863f-4c0b-956b-055ce612ae78 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2834 e54de1c4-6cdc-4106-ab5d-1d7c745e690f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2835 d6ef326a-e3c6-42ad-84b9-3f7f07313101 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2836 58b78fa2-7bf7-4735-bcbc-0eef3e5e3d70 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2837 97007400-de05-402e-8ff7-96893ba02643 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2838 53fad992-1808-47bf-a59a-307c7e5fbed8 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2839 cb262c7c-2646-45e3-bea9-376e48eefe65 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2840 81dabf1f-e666-48c6-a912-2ea5bfecf585 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2841 9072cf34-8632-4b57-acc8-58e8fe21c136 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2842 02e4f2da-9977-4251-81da-9e9f3a2310de 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2843 ef009667-aaaf-4138-a170-e446012e0930 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2844 3e698caf-4d86-43f5-b657-5f4cef64fc5f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2845 b5cbd66f-948d-45a3-af3b-f17e2b35d85e 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2846 02634746-93b2-4cc4-9912-4a6d0bcd2e15 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2847 5b846aad-6133-4133-a78b-65be81332cb4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2848 e562ecf8-f358-4de9-97a4-f7a94e71d4eb 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2849 c21aab2a-36a0-464c-aa7d-d0c6937cab29 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2850 ece0c0d5-c1aa-44eb-9fe3-9c3ae50cfaa6 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2851 7994d0a6-cef5-4391-a121-5a0853a34fa7 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2853 a24d14d9-4f17-4625-93d0-b0624610d83d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2854 86850627-ca22-48ef-9b05-8e00e75d10ca 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2855 cf30bef9-bdb4-4a5e-963c-eb6a0cc323db 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2856 669abe06-4971-4b44-96ab-3bdf48788054 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2857 bb8cff3b-c3e6-4fc9-b9dd-9d04d76458c6 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2858 697668df-f834-4a06-8f5a-de999b06a254 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2859 b147ea90-5643-4680-ac90-d6e8f7166792 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2860 cd2b601d-e05d-4c12-8468-f67e11051b5e 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2861 68449d03-6f2e-4b17-a2bf-c0494df32303 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2862 e5a70f71-1dd4-49e5-9113-1404fa9fc791 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2863 3f67b6bc-8886-459a-be73-d702f977a8ba 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2864 88718579-8473-48f6-ba0a-17fcfed36e14 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2865 380a053f-03e4-4773-9e59-5e0af8edd9a5 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2866 f58f22e9-76b0-441f-951f-6bc795f2b7bc 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2867 8eee4228-4d30-480a-8743-5a3d98eb1741 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2868 de53c6ef-6901-4916-8898-1a530813873b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2869 e44e2ac3-4a83-40b0-b266-a36626ffd6ae 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2870 d442e36b-6d15-4fc3-9641-5feac119db94 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2871 b4bc4666-13ba-4864-be9b-89ff8a0a1bd8 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2872 558a239b-fe8b-4b56-9137-4cacf8324995 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2873 2216fd35-fea8-4d0c-9673-fbe2146fb40c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2874 67cf58e9-203e-455a-a25d-5e38d08028bc 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2875 ffc915b8-cacd-4974-a040-ee496f0efc0e 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2876 80017c88-e07f-4bf6-ad00-87f3e5473d6d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2877 5088a594-ae6e-4f03-8cfd-97d9c62b2196 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2878 6cf73307-dcf9-43fb-8848-618ae5c1723b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2879 87b2e470-fff6-4429-b77b-0552a1856337 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2880 e4ad3f09-7e23-4a84-b8f3-3faf2db890f4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2881 fff35c80-88cd-4923-80c1-0273ba5bed0f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2882 a45a91f6-55a5-4a5e-ba54-0ac0b4e87d8c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2883 e3956736-adbc-49a2-a4a8-a6ae93b8faf3 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2884 ffc73551-55e9-4bbb-bd15-76088551964b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2885 1d9e9adc-734a-47a3-ad00-b3050770ba37 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2886 8e57db50-eb17-4d95-8806-081290ea3cfc 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2887 b3503688-662e-43cf-be58-72edb097db8a 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2888 88765a3f-631d-4e47-a012-e2470633a505 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2889 46692ac0-8993-4cd3-9590-32ec9dd2c802 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2890 3c25d91d-0e1b-46db-a842-06275c5db258 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2891 79378590-e28e-403b-bbde-c76c0195a980 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2892 f3c7fc84-3df8-4ff7-a378-26ec5d9e08a5 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2893 a2aee2ef-c3c6-4832-bc3f-3648575af5c6 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2894 848fbfa9-1ff6-481f-910f-0423d52763da 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2895 137dfe0a-2a2b-423c-9a8a-78233b6ead74 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2896 8ff807a6-b63f-4a71-9ff3-b47ac91a0114 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2897 995bdb1e-c67e-43eb-9fbd-16eb290926d5 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2898 a85837e6-f98d-4a80-b7c1-49b0a6313dd7 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2899 64f0c38f-7f87-4c4b-9e37-66f32645dde4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2900 9dbd2ef7-77da-42ef-90d2-8d30b4330f94 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2901 008ddf20-f7fb-4673-b2ed-b5d5212fbf09 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2903 b55cf9ae-9e1a-4301-8f09-9acb7951ecd6 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2904 336a3daa-0d18-4b1d-a091-b96f864d022a 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2905 ae2392a3-b8c2-4ddb-8cec-a28cb3fcd80b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2906 5b5d770e-db72-4ee8-a89a-db80fb31d3cd 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2907 e843a0ea-45a5-4c11-92a1-08ff12eb4531 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2908 712dbdd5-c4e2-4b3c-9976-8f50234441b1 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2909 ab60901b-d2ad-401a-9742-52df35ce1de0 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2910 48f730a5-26c3-4716-964e-36fa9af26966 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2911 036b18ea-3cf7-4f3e-a84c-c6aea5e4fcd7 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2912 196d4b0c-a4ec-4915-b706-ada86ab483ae 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2913 42e2ed30-e08b-4d24-9e83-d1c3ecbd0fb4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2914 81769d23-74f4-4ca1-8fcf-3e03aa1bf3c9 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2915 1a93dd15-f404-484c-b67c-98169d5522c7 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2916 d1848a5f-053a-4db4-ab4e-c5eb311bc3a0 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2917 f6810357-a598-4a39-8cbd-067795b8d860 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2918 cf2e5c6a-a7d8-428f-800a-fb94dcfc5fe4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2919 a42bc793-f21d-45d1-9ab3-bfa9de25612e 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2920 153bc9ff-39c9-4890-a085-a46c530a7e97 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2921 cb97312b-0bd2-4fbd-b3a6-05c5a17a0a34 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2922 0622830d-cf64-4e62-9c7d-9919088d13c4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2923 b22398fb-1374-41d8-8029-8b7d56466a59 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2924 27bb612c-a74a-4088-b0ea-1dbe28e7a725 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2925 34631deb-9ed3-49fa-afab-baa0570237cd 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2926 2df3d38b-5393-41e1-bd15-8dd372c111c0 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2927 f3a80377-1d76-4754-8018-45cf49937cb8 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2928 96b43e99-d81e-44d2-aac5-a6eb92727368 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2929 f81ce06d-8ace-4f19-aaf8-75a4219a5a60 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2930 75343469-9740-4b3f-83f9-82507f697fd9 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2931 cfb6e5b0-34ed-4f8a-9057-c48de5e28645 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2932 96607b17-2894-4153-adde-3d970f47fe50 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2933 21bd7197-2504-4710-8c13-a9da9f71b0d5 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2934 c00bdbdc-a65d-494d-a9d7-4309c28277ca 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2935 dd37ccd0-31d9-4605-8b8e-618bedc80c38 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2936 b8492e1a-aa02-4585-a5be-75f9833c8c3f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2937 4cf1e489-dd24-4227-b306-4bc5266a224c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2938 fcc2192a-1f54-49c5-b3e6-e9bd8025df67 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2939 c7afc0d0-ca32-4be1-9477-ad106290c460 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2940 95a4f9f6-d6c7-4d9d-ae34-e4a91d8927e9 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2941 404dafe8-369c-4659-a088-c85dccb7ad3b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2942 6d271451-affa-4c76-bce5-6bf8622d83a9 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2943 638b78d6-4523-4dd3-8d8a-8c46682f3fd1 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2944 0fc33d1f-3cee-4481-b7a2-15b53ff85083 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2945 99703a58-0a57-4889-88d2-13e59f84debe 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2946 06d713a5-61fe-450b-bb81-721ab8aa0013 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2947 fef46ade-e2a8-430e-9e6b-65da64baf266 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2948 ebf4703c-7517-492f-8ea3-134e798ac820 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2949 b351345a-18c2-42ed-8911-c37267c9cb58 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2950 83ae044d-2975-478c-902c-776858c2ba3a 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2952 300fa3a7-3c42-4edc-8992-400188e762b4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2954 0957ffd1-d7d2-465d-8ba1-37ae0ce15734 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2955 c532cfda-a8fa-4a8a-92ba-33ad8b47404d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2956 c1f908ce-f6d5-4557-a4bf-956b71b8bf61 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2957 c887d68c-da8e-4f15-a524-3b6674b145ed 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2959 31ac4afd-8195-479a-97da-92edaa89a85e 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2963 dc7c0a9b-ef72-4188-a711-69dbf70c744c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2964 1c9b389c-4740-449c-a10e-a840e8531e7b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2965 05924106-07f6-44ca-ba15-7452b8a657e4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2966 b1c32911-5ca8-4b77-8063-a97c30a3a348 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2967 9c022254-f9f7-4c61-be48-48c60a92448e 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2968 bc93cff5-a2c9-4fc5-8965-5570574ac1a2 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2969 929de9a5-3224-4851-8ff0-8a92354c1f16 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2970 088c2e4e-fc4e-4252-84ed-e3ca2c401958 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2971 5ece14fd-3d7f-4ecb-96aa-2c44d8f15ca4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2972 a436f4d7-018e-44e3-a615-9c33fcc1167d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2973 b234d53e-cc20-41c0-9f21-31db53570a37 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2974 ff7839bb-176e-4483-ac6e-7fae9f6e2e54 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2975 93ff9379-d1a1-412f-a776-c53397ba0dc3 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2976 c0c52e79-813b-45a9-8021-343aaa6663f6 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2977 f95063bc-a640-4980-99a7-84645902daf4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2978 90fc467c-2b0d-461d-a1b8-c2a519354367 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2979 ce7e25dc-5df9-48c5-8f9f-756f6cf765eb 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2980 882ecf72-433b-46fa-9bc4-628c2d943cd1 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2981 be6dd0e8-9966-4961-987d-4d64d15ff9ca 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2982 ae9bbada-d987-4757-a081-74f005821c09 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2983 082ca353-a5ae-421f-ae58-098257a1425f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2984 810d293b-7dfc-4e91-ab29-042457632399 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2985 2ca0c154-c4fb-4b6d-845f-f2a5a4cc2416 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2986 233400c5-6a47-40e2-bf2a-8b7fc9df462b 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2987 c147d12e-5e96-484e-bbe7-dc2f11f889bf 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2988 4b8ff65f-b563-4519-b984-c7cf26b3ad73 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2989 e2e610ce-31c3-4fc0-917d-92d48feb600a 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2990 d1bf3b65-493e-4249-8cb3-7c9f8ce4dc48 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2991 28bb21f0-2851-4b7e-9f8a-6d0a016318e2 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2992 bec60bdd-34e7-467c-8662-f3a1bb1a4361 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2993 74d13c8f-6cd4-44e1-9767-a136fa411448 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2994 b5f20ec2-ff5d-4aac-8db6-49887506f0b3 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2995 eb14339d-fefa-46c3-99a6-55268384361a 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2996 5d10ca47-abc6-4953-9620-1c63542354bf 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2997 5e491ce4-d8da-495b-a3aa-177e06cd69d0 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2998 ba9a95cf-44ce-4126-ba21-4970dfa12593 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-2999 646631ce-7a1f-4274-abb7-780b939e182f 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3000 92c7e4d6-eb53-46c5-9721-5edccd60bcc9 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3001 66392380-a9fe-45b7-9191-60993f3f77f4 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3002 478f29b1-6604-4e75-a492-47c384799f44 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3005 e49a1768-bf1e-49c0-bca3-4e076928281c 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3006 c9943335-86a8-4286-891c-c2331d75dc0d 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3007 d3988699-70d6-43e1-b84b-9e38b4d2d2b1 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3008 898a092e-89fe-4010-afea-14c605f99481 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3009 c9b92f8f-4599-47d1-9d12-31e42166a091 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3011 e08f84fe-0013-4734-9966-cd734e6fedc5 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AB-3012 3997c824-8b85-4e1d-b4b1-d32c26155296 11/13/2012 LAML Alternate sample pipeline Biospecimens from this case belong to Batch 25 and were processed into analyte outside of the normal TCGA standardized laboratory pipeline. Users should note that the resulting characterization data may exhibit features (e.g. batch effects) due to this difference.
TCGA-AD-5900-01A-31-1936-20 273ab8a0-9989-43bc-9e79-edb69099a366 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AD-6548 c113808a-773f-4179-82d6-9083518404b5 11/10/2012 COAD Synchronous malignancy Pt with synchronous malignancy of the splenic flexure
TCGA-AD-6548-01A-13-1935-20 d69ad443-851a-4135-bdd6-ba16f3f085b9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AD-6888 13eff2e5-e33a-485f-9ba4-8a7ccb3c7528 10/31/2012 COAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous malignancy of the cecum.
TCGA-AD-6888 13eff2e5-e33a-485f-9ba4-8a7ccb3c7528 11/10/2012 COAD Synchronous malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous malignancy of the cecum.
TCGA-AD-6889-01A-13-1936-20 e85f1682-82f4-4387-acd9-256ef1cb77b7 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AD-6895 4f601d7b-8db1-4c6d-9374-21dcd804980d 10/31/2012 COAD Prior malignancy Prior malignancy basal cell carcinoma of the scalp. No systemic chemotherapy or radiation.
TCGA-AD-6899-01A-13-1936-20 1d1aace7-b6d0-47fa-bb03-cc3bd9b999b4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AD-6964 5e7074a6-5011-4dc5-950c-41365dbc6d09 10/31/2012 COAD Prior malignancy Prior malignancy SCC of the inguinal lymph nodes. No systemic chemotherapy or radiation.
TCGA-AD-6965-01A-13-1936-20 84312752-8913-4d90-9f1c-ade4b9c3c6a3 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AF-2689-01A-21-1932-20 6b9823dc-e228-4463-95e9-e8ff3695d453 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-2690-01A-11-1932-20 ff789af3-4462-4320-87ba-c8656483bb1d 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-2691-01A-41-2150-27 8875d1a6-8801-4b0a-a9ba-02e1e782476e 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AF-2692 71a32fca-d48f-4ea3-8df7-69f9dda8fa91 04/06/2011 READ Item in special subset Case came in as Rectal. BCR was notified that case was Colon. Program Office determined this will be a Notification vs. a Redaction
TCGA-AF-2692-01A-41-2150-27 f6033497-995e-4069-85fc-1bbbf0c7dc8b 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AF-2693 2faf928d-453a-4d07-b058-b5d4e1d13845 06/21/2011 READ Item in special subset Case came in as Rectal. BCR was notified that case was Colon. Program Office determined this will be a Notification vs. a Redaction
TCGA-AF-3400-01A-21-1932-20 8a274607-faf0-4a32-b2ed-c00f64aa12dc 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-3400-01A-41-2150-27 b8366970-8000-4360-9577-8211692c7262 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AF-3912 a4faf514-50af-43ed-b294-350ee0756250 09/02/2010 READ Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-AF-3912 a4faf514-50af-43ed-b294-350ee0756250 11/10/2012 READ Qualification metrics changed Changes to qualification metrics
TCGA-AF-3913 03a9dd9d-62ae-4acd-9272-389274858f3d 10/31/2012 READ Prior malignancy Prior malignancy prostate cancer treated with chemotherapy.
TCGA-AF-3913 03a9dd9d-62ae-4acd-9272-389274858f3d 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with chemotherapy.
TCGA-AF-3913-01A-11-1933-20 29749c5a-0c6f-4220-8073-f61c04e619ba 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-3913-01A-12-2150-27 c732728b-fd9c-4eab-8743-e8d4ad313135 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AF-3914 3f2ca278-c74a-4aa7-b029-189d9d0b510c 09/02/2010 READ Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-AF-3914-01A-21-1933-20 a2fb0f54-c76b-4329-89fd-336e33d9b3f9 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-5654-01A-41-1936-20 9cc49381-7ae7-4410-8f64-29d6dd342216 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-6136-01A-13-1934-20 7c8bc842-9a45-43cb-88ac-4cccef61812a 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-6655-01A-13-1935-20 c8fcd407-737b-4d87-9f32-92b12d065357 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AF-6672-01A-41-1936-20 3296bef2-b13e-4ded-9769-85188a4c73b8 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3574-01A-21-1932-20 ad4a41e9-7ed8-4f6e-a9c7-bd57956019df 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3574-01A-22-2150-27 50ceec0a-07ba-4d4a-9003-dacc2ecfc06a 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AG-3578-01A-21-1932-20 785e523a-ee48-4a18-b915-2579ab754aa7 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3580 594a52b0-c929-4e50-ae27-7542e32667ae 06/20/2014 READ Prior malignancy Prior malignancy pancreas cancer treated with radiation
TCGA-AG-3580 594a52b0-c929-4e50-ae27-7542e32667ae 11/10/2012 READ History of acceptable prior treatment related to a prior/other malignancy Prior malignancy pancreas cancer treated w/radiation.
TCGA-AG-3580-01A-21-1932-20 f405d10b-3db0-4e6c-8482-30cbb34a5ccc 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3580-01A-22-2150-27 af8b8483-3cda-451d-aeb1-13454a874d0f 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AG-3581-01A-21-1932-20 30e575c9-301e-43db-8848-b6678a8b0461 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3582-01A-21-1932-20 066aad0f-cca9-444d-b1fc-f5009c540a36 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3583-01A-21-1932-20 5457eb78-16ae-4b07-b97e-5938a58eeb73 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3584-01A-21-1932-20 4e59778b-cecc-4750-a303-70acc7fb709b 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3584-01A-22-2150-27 4091ef2d-f308-4a00-9626-cd192cfb2561 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AG-3586-01A-11-1932-20 37f18e98-6e79-410f-a27d-7b21c360b499 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3587-01A-21-1932-20 c1e3cf7d-efae-4b65-b8d6-8c6fed8520ee 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3591-01A-21-1932-20 f7321762-9f8d-4d57-9ac0-f304ed47b132 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3593-01A-21-1932-20 c3fb0891-94d5-4e28-afa8-c2f55bd2e730 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3593-01A-22-2150-27 ac42ae28-836a-4852-911b-98eed1329686 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AG-3594-01A-11-1932-20 4f1635b2-d017-45ba-aa28-2e0b7654c07c 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3594-01A-12-2150-27 dd09bfe9-8eb8-448b-b379-6f6c4d7b8d60 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AG-3598-01A-21-1932-20 0c9248bb-60cd-48b3-b6f1-1f57dd957716 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3599-01A-11-1932-20 748919c1-198f-4629-b6ed-00ae6efe0d90 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3600-01A-21-1932-20 07c02738-805b-4b39-b346-1e0064a45002 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3601-01A-21-1932-20 220938ad-cc39-4c83-91df-743391c1423b 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3602 c69dec57-7a84-481b-bcfe-61a771d0a9d1 11/23/2010 READ Molecular analysis outside specification IGC new notification of 11/10/2010
TCGA-AG-3602-01A-11-1932-20 31555d2a-9d6f-4b48-a5ab-6ec4268c25ca 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3605-01A-21-1932-20 7fdaa0db-2040-40d1-b3a6-9973d7cc8b71 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3609-01A-11-1932-20 6eaaeaef-e16e-4da1-b43e-db6f3ac63862 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3611 fb632146-92c7-40d9-acc3-6dc4a2d499be 06/20/2014 READ Prior malignancy Prostate cancer treated with hormone therapy and radiation.
TCGA-AG-3611 fb632146-92c7-40d9-acc3-6dc4a2d499be 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormone therapy and radiation.
TCGA-AG-3612 1543c1da-bde4-41c1-a510-56b62db8cca8 06/20/2014 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with systemic chemotherapy and radiation
TCGA-AG-3612 1543c1da-bde4-41c1-a510-56b62db8cca8 06/20/2014 READ Prior malignancy Prior malignancy breast cancer treated with systemic chemotherapy and radiation.
TCGA-AG-3612 1543c1da-bde4-41c1-a510-56b62db8cca8 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated w/ systemic chemotherapy and radiation.
TCGA-AG-3612-01A-21-1932-20 f32e09ef-2096-4675-bb35-b3ddce542462 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3725-01A-12-1932-20 b903214e-3501-4780-a96c-d93fdafa4e0d 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3727-01A-21-1932-20 b793305c-a762-4fdc-b48d-ad429707c227 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3731-01A-12-1932-20 43f5e46e-9be5-41ba-b848-b89388d48449 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3742-01A-12-1932-20 0367ddf5-91ba-4c53-b886-0af15fd5e0a1 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3878-01A-11-1933-20 56baa72a-a060-403c-8972-db553ff82f84 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3881-01A-21-1933-20 c8846521-c048-414d-ae86-bf2ef752df82 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3882-01A-21-1933-20 92160496-4f62-4416-87cd-d00dad95ad57 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3885-01A-21-1933-20 5f4858bb-3755-4aec-85a4-3dc78d0b7143 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3890 e2d395f8-bf13-4fe4-8031-683b0eedd875 11/10/2012 READ Synchronous malignancy Pt with synchronous skin cancer.
TCGA-AG-3891 d461e83a-7f09-4e4c-ac49-f05766a6051a 09/02/2010 READ Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-AG-3891-01A-21-1933-20 cebaa564-d946-4bdf-93b1-801625a14f10 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3893-01A-21-1933-20 3d99963b-ba22-4bfd-9052-828c6a445f97 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3896-01A-21-1933-20 0d26a1b6-7770-4e21-b745-d3ae37c4f621 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3898-01A-21-1933-20 a96c5001-7795-4fff-9891-12929a19d1ee 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3901-01A-21-1933-20 d26ea972-d5f7-49c3-993c-6d61544fda3a 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3902-01A-21-1933-20 6ae4e8e3-983b-4a24-a04d-baf17d1dc3de 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-3906 ec2abe34-6566-4c2f-8d06-ade2e858b301 09/02/2010 READ Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-AG-4001-01A-11-1933-20 01c4968e-079c-404f-89f3-167f9b72cdf0 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-4005-01A-21-1933-20 f9e22c3c-80b1-428b-afc5-260c2490409b 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-4007-01A-21-1933-20 f339da32-1f0a-4600-91b5-c2a0973dda69 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-4007-01A-22-2150-27 ce391c4b-a368-438f-8135-23b94464f8ac 02/07/2012 READ Item is noncanonical READ Proteomics VUMC
TCGA-AG-4008 72802851-9340-4c5f-a90b-23b7afd7577a 10/31/2012 READ Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-AG-4008-01A-21-1933-20 48e799c8-e7aa-4fc1-bd4b-62fb6ae82e1e 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-4009 d63a90d4-730f-4916-af02-d06854221d7a 09/02/2010 READ Qualification metrics changed [intgen.org]: Changes to qualification metrics
TCGA-AG-4015-01A-21-1933-20 78187105-3493-48a3-bc31-91a479cc6d14 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-4021-01A-21-1933-20 be104a34-f7ff-4753-a035-398f21cd968c 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-4022-01A-21-1933-20 92044878-ab70-404a-b157-b37dfe5295b2 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AG-A00H 9f4574ec-a58a-4410-8735-c5e5bc4ca7e0 02/22/2013 READ Prior malignancy Patient had a prior prostate cancer. No radiation or systemic chemotherapy.
TCGA-AG-A00H 9f4574ec-a58a-4410-8735-c5e5bc4ca7e0 06/16/2014 READ History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AG-A00H 9f4574ec-a58a-4410-8735-c5e5bc4ca7e0 10/28/2010 READ Prior malignancy No Note Specified
TCGA-AG-A014 51c37449-6a2e-4c3d-a7cc-06f901e1224f 02/22/2013 READ Prior malignancy Patient had a prior prostate cancer. No radiation or systemic chemotherapy.
TCGA-AG-A014 51c37449-6a2e-4c3d-a7cc-06f901e1224f 06/16/2014 READ History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AG-A014 51c37449-6a2e-4c3d-a7cc-06f901e1224f 10/28/2010 READ Prior malignancy No Note Specified
TCGA-AG-A015 09daff79-6493-45c1-8cba-9381259e2bea 02/22/2013 READ Prior malignancy Patient had a prior melanoma of trunk, and skin cancer in the head and neck. No radiation or systemic chemotherapy.
TCGA-AG-A015 09daff79-6493-45c1-8cba-9381259e2bea 10/28/2010 READ Prior malignancy No Note Specified
TCGA-AG-A01N 1118490d-75aa-43cc-b2a2-c2af61829ffc 02/22/2013 READ Prior malignancy Patient had a prior cancer in the sigmoid colon. No radiation or systemic chemotherapy.
TCGA-AG-A01N 1118490d-75aa-43cc-b2a2-c2af61829ffc 10/28/2010 READ Prior malignancy No Note Specified
TCGA-AG-A023 3bc6e336-f58e-4dc4-8414-7318e55016ed 06/16/2014 READ History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AG-A023 3bc6e336-f58e-4dc4-8414-7318e55016ed 10/28/2010 READ Prior malignancy No Note Specified
TCGA-AG-A026-01A-01D-A008-01 019c7dd9-7f20-43e9-839b-bd326f076460 10/08/2013 READ Permanently missing item or object There are no biospecimen records associated with this aliquot.
TCGA-AG-A026-10A-01D-A008-01 24a21e13-d14a-4349-b611-28c86151371f 10/08/2013 READ Permanently missing item or object There are no biospecimen records associated with this aliquot. A biospecimen record for this participant and receiving center is TCGA-AG-A026-10A-01D-A080-01
TCGA-AH-6544-01A-13-1935-20 7d7cac26-03d7-43a7-8b19-d0db02ddea0a 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AH-6547-01A-13-1935-20 09179c32-67e5-4606-a52d-28cc98ea8be7 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AH-6549-01A-13-1935-20 cdcd1e83-4edd-4864-bcbb-7d3aa5022c9d 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AH-6643-01A-13-1935-20 537a77bc-999e-4fc7-8e9b-97f389351495 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AH-6644-01A-13-1935-20 55e7c2db-bdc4-4407-9ad3-7968ec43ccc2 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AH-6897-01A-13-1936-20 1dd8f2cb-ba69-43f9-88dd-f34a507adadb 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-AK-3425 1b3f2411-52cd-4482-bea2-95cf72020c6f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ systemic chemotherapy and radiation
TCGA-AK-3425 1b3f2411-52cd-4482-bea2-95cf72020c6f 12/08/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-AK-3427 97fee782-9aa3-41c7-8b7b-53c9c69bdabc 12/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3427-01A-03-1737-20 2622f6ce-247a-488f-b4e8-eccdde5db56e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3428-01A-03-1737-20 d0d1d58a-5211-4b3d-93e5-fee8f6f63067 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3429 b3a6acab-00ad-48b7-94c2-bd56b461b48f 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3430 503a9c0b-64b8-41b9-a44f-9cbff9cefbad 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3434-01A-03-1737-20 80536c57-4e47-4035-ba49-84acc2df41d8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3436 b2feca3f-8602-4a30-92bf-958ab2a2bd5d 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3436-01A-03-1737-20 6e271200-142c-4fd1-8442-12578955b50f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3444-01A-03-1737-20 85001b63-dbc9-4689-ba78-f70078d3554e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3447 d7abeadd-ca92-4e18-ae06-70baf9ce42e0 12/08/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3450 0709749f-a30a-4fdd-a409-d12be09a5899 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy L LUAD treated w/ locoregional radiation.
TCGA-AK-3450 0709749f-a30a-4fdd-a409-d12be09a5899 12/08/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-AK-3451 fa543627-9e3c-4af9-bb33-f0cdd9fbc9cc 09/09/2010 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-AK-3451-01A-03-1737-20 9e5b7562-e854-4f4e-9f93-271a96f3ccc4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AK-3454 28e9b6f9-ab6a-400b-a6a9-79095a443591 10/31/2012 KIRC Prior malignancy Prior malignancy R uteter. No systemic chemotherapy or radiation.
TCGA-AK-3455 2ed3296a-5b10-40d8-8af4-90dc031657cd 10/31/2012 KIRC Prior malignancy Prior malignancy R KIRC. No systemic chemotherapy or radiation.
TCGA-AK-3456-01A-03-1737-20 0e03b634-82a6-4ac8-a4a2-b333f09d020b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-AL-3468 2272c592-b9b6-4483-9f7f-6e185699b900 11/10/2012 KIRP History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of leukemia treated w/ systemic chemotherapy.
TCGA-AL-3468 2272c592-b9b6-4483-9f7f-6e185699b900 12/08/2010 KIRP Prior malignancy [intgen.org]: Prior Malignancy
TCGA-AL-A5DJ b06cdf61-61c9-4035-a55d-1ef21dc21069 06/16/2014 KIRP History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AM-5820-01A-21-1934-20 4de28058-09ed-4735-89a4-4b321992c6d8 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AM-5821-01A-21-1934-20 f1b80fd7-b9e2-42b2-9e28-b6b57ef25358 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AO-A0J5 c1442467-d618-435f-8792-b1a18f696f1a 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-AO-A0JI e17c565c-9857-4df3-a352-903b53093c85 10/28/2010 BRCA Prior malignancy No Note Specified
TCGA-AP-A053 af37d8f0-fea0-47f6-be0a-2fb55a5da5c4 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-AP-A053 af37d8f0-fea0-47f6-be0a-2fb55a5da5c4 12/14/2010 UCEC Prior malignancy Case had Prior malignancy
TCGA-AP-A05D f7e06a10-74ca-4f52-a944-b3f22c016998 01/25/2011 UCEC Prior malignancy from Jay Bowen/NWCH
TCGA-AQ-A04L-10A-01D-A10M-09 a73828ae-0081-42cf-b3cb-a190e7b7f17b 01/11/2013 BRCA Item is noncanonical The BAM associated with TCGA-AQ-A04L-10A-01D-A12J-09 was derived from a pool of two aliquots: TCGA-AQ-A04L-10A-01D-A12J-09 and TCGA-AQ-A04L-10A-01D-A10M-09
TCGA-AQ-A04L-10A-01D-A12J-09 c2f7e5fb-0cff-43dd-959e-00f6b1d4b257 01/11/2013 BRCA Item is noncanonical The BAM associated with TCGA-AQ-A04L-10A-01D-A12J-09 was derived from a pool of two aliquots: TCGA-AQ-A04L-10A-01D-A12J-09 and TCGA-AQ-A04L-10A-01D-A10M-09
TCGA-AQ-A0Y5 d0b78f3f-a198-437a-ab8c-204345d3b75d 06/16/2014 BRCA Neoadjuvant therapy systemic treatment
TCGA-AR-A2LL 70fc011c-0f22-4026-9d72-87351126203a 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-AR-A2LR d093173f-08ab-4138-bf3c-399c45a6e163 05/14/2015 BRCA History of unacceptable prior treatment related to a prior/other malignancy Patient had prior primary breast cancer in the same breast as the TCGA primary and received chemotherapy (Adriamycin and Cytoxan)
TCGA-AU-6004-01A-13-1934-20 acf19722-4b5d-4cb9-af2c-36be4abe43ea 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AX-A06D 905291b0-f077-48f7-9c14-5cfa9d8a3e6e 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-AX-A1CP e297551c-a662-4677-b00d-0d9be232adca 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AX-A1CR 3abaa1b6-7513-40e0-b79c-b968e788e932 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AX-A2H8 da0474b3-48ab-4398-ae4b-f15e27e99b2d 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AX-A2HF 7a077812-f6ee-4820-a084-1a52c7ef062c 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AX-A3G3 16745dfb-8b28-4f5d-9ef1-2aa31ccb7293 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-AY-4071 315ef7f6-ca21-4d87-8f19-40bd455885ec 12/08/2010 COAD Item in special subset Case came in as Colon. BCR was notified that case was Rectal. Program Office determined this will be a Notification vs. a Redaction and no changes to sample type, etc.
TCGA-AY-5543-01A-31-1936-20 70e16eeb-b825-4172-ac8e-fcda94a32ed3 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AY-6196-01A-13-1934-20 44519207-e135-45fd-bfff-f5f1ae3e98ac 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AY-6197-01A-13-1934-20 80b53d11-1ba7-40d9-bc9b-215648aca90a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AY-6386-01A-13-1934-20 ce91940f-cc89-4715-b113-0d4e34251618 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4308-01A-21-1933-20 c0fd7055-fd67-479b-88a3-d417d87c19e8 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4313 1fd75c4d-e74c-410c-a150-814722c6c1cc 10/31/2012 COAD Prior malignancy Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-AZ-4315-01A-21-1933-20 29105e0e-21dd-425c-9f45-31951fcc4910 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4323-01A-22-1933-20 638f2f32-ba24-46d2-9ffb-08541ee1b798 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4614-01A-21-1933-20 75dfee73-65bd-4555-9801-4b58e5919fe1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4615-01A-21-1933-20 dae464ba-2ca1-4075-b01f-a3473f1792df 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4616-01A-41-1936-20 7acabb0a-ad34-4433-a446-f26593d8df7a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4681 6fbc2b46-6762-4778-aa7e-782162c5397c 11/10/2012 COAD Synchronous malignancy Pt with synchronous malignancy of the rectum.
TCGA-AZ-4682-01B-31-1936-20 7ef279ce-b2f1-4217-a057-90fbaccf8a68 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-4684-01A-31-1936-20 b0be2733-98a3-46b0-a8ce-c04c762e03e2 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-5407-01A-22-1933-20 f84b21ad-f485-494d-845d-791d5a3d6fb4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6598-01A-13-1935-20 5d725c4f-1183-4b59-8a9f-1ca38b550d06 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6599-01A-13-1935-20 c2811862-1803-4ab4-92c5-48d194c4f468 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6600-01A-13-1935-20 1c6a24d4-2c5a-4572-92c4-df9fa0b2aa85 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6601 7ad0617e-bc4a-4869-8419-744f04d9b7a3 10/02/2011 COAD Prior malignancy Case indicates 3 prior malignancies. Prostate indicates locoregional therapy, previous colon cancer treatment was resection, it is unknown what type of treatment the patient had for bladder
TCGA-AZ-6601 7ad0617e-bc4a-4869-8419-744f04d9b7a3 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ radiation. (Tumor sent to TCGA was from sigmoid colon.) Prior malignancy bladder cancer. Prior malignancy colon cancer. No systemic chemotherapy or radiation.
TCGA-AZ-6601-01A-13-1935-20 8a22c622-112f-44d4-b6e6-bbcf83986ba9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6603-01A-13-1935-20 c3177d93-1dc2-42d6-8c5e-2d42fcf429bf 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6605-01A-13-1935-20 15c156dd-91c8-41b6-9b33-8514b2a93056 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6606-01A-13-1935-20 00e9e5ce-d84e-4eb0-a151-5f4f6631a271 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6607-01A-13-1935-20 ac5e5a4d-e149-40f5-ab3b-7df392fcc81f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-AZ-6608 f1e6ce83-b4a0-4643-8e8e-a1ef8a158a27 10/31/2012 COAD Prior malignancy Prior malignancy Hodgkins lymphoma treated with chemotherapy and radiation.
TCGA-AZ-6608 f1e6ce83-b4a0-4643-8e8e-a1ef8a158a27 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy Hodgkins lymphoma treated with chemotherapy and radiation.
TCGA-AZ-6608-01A-13-1935-20 945781d0-6a0b-4602-a66f-484192542192 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-B0-4688-01A-02-1738-20 cb0749ca-a4ef-449d-b8f2-16d85120ef28 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4690-01A-02-1738-20 fbc08dbb-8333-491c-88e5-38268568d9f7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4691-01A-02-1738-20 5a569c96-f06a-413f-a926-8351b2a5bb6b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4693-01A-02-1738-20 f0acb3f0-37bf-4a7b-bd8a-20d9a6c30568 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4694-01A-02-1738-20 0e99587f-0c9b-4c73-b3c3-33ec34ab9405 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4696-01A-02-1738-20 1f4528b1-44c0-459d-a71e-b3c11575b6f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4697-01A-02-1738-20 b5f9435c-4113-452d-83fa-d3933030d015 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4698-01A-02-1738-20 2708cabe-63de-4322-be86-4d43341a33d9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4699-01A-02-1738-20 4d068cd2-2a92-481a-b15f-c4244022ecb6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4700-01A-11-1738-20 573a87f6-c909-48e0-adeb-ca1140b5b1cf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4701-01A-02-1738-20 443a8905-c067-4f52-ac83-1628cbd52cbc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4703-01A-02-1738-20 d062e018-3d7e-4d3a-a472-4b931556b2f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4706-01A-02-1738-20 e5674c04-a488-4500-85fa-34c229238643 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4707 4cfe9a35-80f2-422b-82e8-8f4b12ded992 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-B0-4707-01A-02-1738-20 b99dd5cb-d6f4-4aa4-af26-e9be00f7073a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4710-01A-02-1738-20 d17296c0-c26c-4bce-94d2-7f1fd4ed1859 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4712 3f72d63f-ad48-4500-baf6-897b1d6dda7d 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with radiation.
TCGA-B0-4712 3f72d63f-ad48-4500-baf6-897b1d6dda7d 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with radiation.
TCGA-B0-4712-01A-02-1738-20 9fa6e096-3a86-46fc-8192-76a6da505148 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4713-01A-02-1738-20 b23f6894-9d65-4858-8d8e-3b9be0ca8286 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4714-01A-02-1738-20 fde8c824-a5a7-457e-a27d-80ff256fd81d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4718-01A-02-1738-20 a53b0875-2277-4d35-84a8-a64fa95ce66c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4810-01A-21-1738-20 05bfb262-52c1-45ec-a753-d9dab9a1cd0c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4811-01A-21-1738-20 9e06873b-c18e-4ddd-a4a5-02b023de795b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4813-01A-21-1738-20 b2a570c4-1588-4c61-957f-400a569519df 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4814-01A-21-1738-20 3756b506-c18b-4f67-9cb4-89b666a032b6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4815 ff127be4-631a-4e0e-a971-842f9eb6760e 10/31/2012 KIRC Prior malignancy Prior malignancy of the pituitary gland. No systemic chemotherapy or radiation.
TCGA-B0-4815-01A-21-1738-20 4ef1cb41-5101-4cec-8045-7a708cefe25b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4816-01A-21-1738-20 e3264f18-0d44-405e-9b06-88cd0300543c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4817-01A-21-1738-20 dee1cedb-ed34-4e09-aea1-31c728568fda 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4818-01A-21-1739-20 df8f15d9-53eb-4a6e-9d6c-d5ad3632c74e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4819-01A-21-1739-20 42303efd-7799-4403-bcca-83d0898202db 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4821-01A-21-1739-20 fd91748c-814d-4344-a7f2-0b45847b9a6c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4822-01A-21-1739-20 bba5d145-5f17-4a12-9c5e-2e30d68f8de7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4823-01A-03-1738-20 9ffe08a3-770e-402a-962b-d70162896daf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4824-01A-21-1739-20 299066df-06c3-4755-b2ca-18b98688d127 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4827-01A-03-1738-20 c82c9e7b-5521-444b-9e3f-980a0535aa9f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4828-01A-21-1739-20 aa9fac41-26c9-4a79-a87e-1416d7f57fa2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4833-01A-21-1739-20 7fc6be37-c28f-4a96-b934-ecd53230f53a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4834-01A-21-1739-20 4a9f563d-fb73-436a-b97e-ed14a4153f22 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4836-01A-21-1739-20 5e3254fe-06a0-4b5a-b0c3-8d9d49c9b4ec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4837-01A-21-1739-20 43c4af68-6cbf-43c2-b2b0-f8ba43f2aaa1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4838-01A-21-1739-20 2ab1091c-44ae-4145-894e-10e81d0cb30a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4839-01A-21-1739-20 26549998-3cfb-4048-8a06-19b87fd6cbb1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4841-01A-21-1739-20 1f0a861a-fbdf-4fae-b89e-dc9d2bd5d685 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4842-01A-03-1738-20 1f8995f5-9131-4b33-9d51-69e0c6e8be3f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4843-01A-21-1739-20 7752edc0-5347-46ce-9aeb-af55385f7f8a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4844-01A-21-1739-20 50c7cca0-c55f-4a42-bce0-1355516396f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4845-01A-21-1739-20 176cd46e-bd51-45ef-9ec0-19ee3b1037a5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4846-01A-21-1739-20 dd697fe7-8590-4dba-8645-ce936c78ddc5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4847-01A-21-1739-20 73855aed-d517-4fea-bbb8-9ff9d88c240e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4848-01A-21-1739-20 a5c906ba-a476-4ae7-801e-daa9cb73b8b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4849-01A-21-1739-20 b8358dc4-ec6f-4c3c-9efa-75147b1e96b6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4852-01A-21-1739-20 7699bb69-0ed2-4036-97fe-044d373e75d3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-4945-01A-21-1739-20 aef7aed3-c951-423c-8cee-b8786e4c4821 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5075-01A-21-1740-20 4989b969-47a4-4514-9d62-8d24338d0375 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5077-01A-21-1740-20 90b38871-dbc1-428b-9b6c-10e4fe18c66a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5080-01A-21-1740-20 281ab0c4-c16f-4f86-89bc-d23923fde487 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5081-01A-21-1740-20 ae5eb149-05ce-41ee-a8a5-ad8e6cf5aea4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5084-01A-21-1740-20 4178e2f2-9adf-4551-83b7-f7ba199acf17 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5085-01A-21-1740-20 8d37d999-ebfb-4365-a52e-c07584eed65d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5088 0022478c-4dfd-4cbe-a05e-fb20310844e3 10/31/2012 KIRC Prior malignancy Prior malignancy malignant melanoma of the head/neck. No systemic chemotherapy or radiation.
TCGA-B0-5088-01A-21-1740-20 9a5d45e5-0212-401e-bfe9-f8ff9a11edc7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5092-01A-21-1740-20 7cadb19e-dd38-4e69-882c-2b2c55b3958f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5094-01A-21-1740-20 95e7b6b5-deaa-473f-a6c1-cc7d56c9190d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5095-01A-21-1740-20 110928d3-0030-46a3-9738-974ef410826a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5096-01A-03-1740-20 0dc02012-9bcf-4cee-a511-4882129191c9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5097-01A-21-1740-20 3ae72181-156a-4cf5-a45a-4e8bcc7336f5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5098-01A-21-1740-20 86b78da6-19ca-4522-a7d9-783fab70a387 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5099-01A-21-1740-20 68c99534-d96c-4753-8d35-9cc26bcd67a0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5100-01A-21-1740-20 57edfd41-958c-4a27-adb7-6b0372d0fb57 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5102-01A-21-1740-20 e0bf77b4-3095-448a-9417-6f6032cb8fb5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5104-01A-21-1740-20 e6209d01-e80b-4cf3-b93c-b2880abe2239 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5106-01A-21-1740-20 463570d8-686a-4b07-8c1f-3eed11b64df6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5107-01A-21-1740-20 200fc171-d93c-4045-b69d-450b7e8f5ed9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5108-01A-21-1740-20 4b349bac-dda2-4ddf-9815-c2389d2cbcca 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5109-01A-03-1740-20 7fab4cfc-fea7-4624-9ce6-527f9aca8f60 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5110-01A-21-1740-20 8d3f47ca-373d-428e-8d24-ea0d697b516f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5113-01A-21-1740-20 f65735cf-72fb-490c-abe2-5973759d4ee5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5115-01A-21-1740-20 3e1e4309-097d-403e-83fd-ecd0c45e3c87 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5116-01A-03-1740-20 ccb762ad-c2fa-4138-80a5-fe3994d13651 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5117-01A-21-1740-20 46129b23-fa90-4c0d-9191-d9d26287c34b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5119-01A-03-1740-20 2e3b9519-3f98-4f5a-a75b-7e07cd3f7781 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5120-01A-21-1740-20 e466f011-79a1-4158-b796-f8e9dda32d68 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5121-01A-03-1740-20 b501ca20-c446-4f59-ac92-f32dce633a98 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5399-01A-21-1741-20 94e57906-e27c-4513-923a-e9a0cd709b2d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5400-01A-21-1741-20 94da797a-7440-4175-ad79-7eed8bd581d0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5402-01A-21-1741-20 ace6514d-5971-4e4d-8184-0c96f0e94d7f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5690-01A-13-1741-20 d91bf511-bcc4-4d74-8e6b-7306cb8c494b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5691 31a0dd95-8199-4d25-b40d-4b353644af46 10/31/2012 KIRC Prior malignancy Prior malignancy L LUAD. No systemic chemotherapy or radiation.
TCGA-B0-5691-01A-13-1741-20 356831cc-5707-453e-b580-25d762d95e3c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5692-01A-13-1741-20 30121cac-9b7b-4120-a045-e4a4f4e10749 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5693 db058eb4-9c5e-4226-92d1-de24aea83630 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-B0-5693-01A-13-1741-20 5aec168d-3a06-4266-89a4-e1cb201a746d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5694 11111b58-c7df-4291-ad8a-4baec9ff7d1f 11/10/2012 KIRC Synchronous malignancy Pt with synchronous bilateral LUSC.
TCGA-B0-5694-01A-13-1741-20 c89bea79-a7de-45c0-af36-028aa178d0ac 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5695 fb9bafa5-7133-4955-8156-4eb6763dc8e1 11/10/2012 KIRC Synchronous malignancy Pt with synchronous chronic lymphocyctic leukemia.
TCGA-B0-5695-01A-13-1741-20 ea556872-4e9c-42cf-a35a-cd004db2bb09 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5696-01A-13-1741-20 e505fa8c-61e2-489d-9477-4ecb118d83d8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5697-01A-13-1742-20 15296fb4-c486-458f-b91f-f5f75774ab35 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5698 d26f3a6b-72f4-4e48-815e-57b8b211112d 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R LUSC.
TCGA-B0-5698-01A-13-1741-20 ceb765f5-5bec-4318-834c-c98c22487b50 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5699-01A-13-1741-20 7359cdec-10e0-4e85-9b8b-b8d158ba9d83 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5700-01A-13-1741-20 c5ed6049-225b-4f0c-8f17-a704a33a5c70 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5701-01A-13-1741-20 59b73057-8a42-42c6-917a-5d8946b7a7aa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5702-01A-13-1741-20 0f2f2325-ee0d-450d-8e9c-2c10fe75abec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5703-01A-13-1742-20 5dc97b12-b71e-43f8-a6b0-4344fef448ba 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5705-01A-13-1742-20 bf0b180b-cafe-49c0-a424-aa7a1bf8f438 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5706-01A-13-1742-20 d71ce946-fa69-4ef5-876e-98ca0b07528c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5707-01A-13-1742-20 064cd791-aa56-4b56-b052-e9eb5df76692 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5709-01A-13-1742-20 6ad14377-07e0-4d29-a047-dec57771f8ea 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5710-01A-13-1742-20 413cecd4-e92a-482e-b9e3-a6b202f53d5c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5711-01A-13-1742-20 7f78aa70-ce51-4103-a7cd-7158dfd0376c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5712-01A-13-1742-20 d4d925ec-9d9d-4bad-8528-3354bc5570c8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5713-01A-13-1742-20 6ad5107c-7c8e-4603-9179-39904d47b417 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B0-5812 326745d8-98ca-4f4d-b217-96aea9faa1ad 11/10/2012 KIRC Synchronous malignancy Pt with synchronous L KIRC.
TCGA-B0-5812-01A-13-1742-20 533ca77c-49af-4517-816e-db70c9e59088 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B1-A47M 072507cf-1249-4b28-86d4-3ab97822a74c 04/25/2013 KIRP Prior malignancy Patient had a prior colon adenocarcinoma. No systemic chemotherapy or radiation.
TCGA-B1-A47O 6a6c1569-1045-4ed3-acdb-5c45e47614ca 06/16/2014 KIRP History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-B2-3923-01A-03-1737-20 9e136a54-511b-412d-ae6b-d9be6c8f53b0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-3924-01A-03-1737-20 af7a6247-4d5c-4b84-b528-60581fb506b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4098-01A-03-1737-20 a8a65f31-baa1-455f-b604-4fc27c9e5b8e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4099-01A-11-1738-20 6acb0118-1b91-48a6-b5db-66a786c0e51e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4101-01A-03-1737-20 23447bd7-4415-4b03-86a9-a89033837c84 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-4102-01A-03-1737-20 ba82eba0-3155-474b-80d4-e33d2f69b37b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5633-01A-21-1741-20 2bb03c87-a6cd-4b3e-8ad9-700acfb67353 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5635 597c81a3-5820-48b0-9a9c-c45257c7ad70 10/31/2012 KIRC Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-B2-5635-01A-21-1741-20 5fee0715-102e-4ba9-9d48-1acddc8a079b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5636-01A-03-1741-20 5ee596e6-faa2-4622-8786-aeb769c01310 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5639 73cb1350-7590-4f79-bb86-3f395466652e 01/24/2012 KIRC Neoadjuvant therapy [intgen.org]: Patient received palliative neo-adjuvant radiation to the field where tumor was located.
TCGA-B2-5639-01A-21-1741-20 4270d9bd-75a6-40c3-a900-dc5233d9794f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B2-5641-01A-21-1741-20 da2d6171-9d4a-47f3-9c0a-eae0d55a81a4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5377-01A-21-1741-20 8b618e44-ee89-4f9a-b6f2-1239cbd668b0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5378-01A-21-1741-20 5cc943a6-4192-43bb-9e3b-5dc198f87152 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5832-01A-13-1742-20 96c36e23-d573-4d7a-ba24-66d12687f8a2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5834-01A-13-1742-20 39d6d6d4-3d29-4a67-b560-ae8d0cc603d4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5835-01A-13-1742-20 f6c378eb-caa6-49b7-81c7-e82dac01ca35 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5836-01A-13-1742-20 9e9a511a-6ab0-492f-9fda-0c9aa2d9118d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5838-01A-13-1742-20 c0c58f6a-2e14-4ad5-b622-883a5341cc60 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5843-01A-13-1742-20 39f3e6a4-160e-4398-8d84-363f0a26aa91 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B4-5844-01A-13-1742-20 4717e85e-e8fa-4772-9ee8-e088f1d53970 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B5-A0KB e604f5d4-f2c0-4404-9073-b8dbc8396778 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-B6-A1KC-01A 0cc10a1e-a90a-4c55-87a2-a74d47474a4a 02/27/2014 BRCA Item does not meet study protocol TCGA-B6-A1KC-01A was not pathology reviewed and should not be used. TCGA-B6-A1KC-01B should be used instead.
TCGA-B8-4143-01A-21-1738-20 de6aa790-f3d4-49d5-b3c6-64055a498cf7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4146-01B-13-1738-20 123c39da-edb4-4e50-b4e9-3e3d903becec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4148 18325fdc-594b-4545-a77d-adb07a32ec73 05/28/2011 KIRC Molecular analysis outside specification [intgen.org]: Molecular Results off Spec
TCGA-B8-4153-01B-13-1738-20 d2de8a92-68dd-4d67-a0b1-421b9a9f2e50 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4620-01A-03-1738-20 083bb823-89a5-46ee-9191-289301cf1f91 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4621 65d56c51-1d58-419e-8c77-a037fc588f5b 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-B8-4621 65d56c51-1d58-419e-8c77-a037fc588f5b 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-B8-4621-01A-03-1738-20 961b9a19-83eb-4f29-8ab5-7ad11ed6c795 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-4622-01A-03-1738-20 30e2b06b-5f6e-4976-94d4-a2a6edbbe8b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5158-01A-21-1740-20 41941de7-218b-4275-983c-ce73253e203c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5159-01A-21-1740-20 72f1e6e4-cef0-4264-b718-82d8be8245b5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5162 d62d39f9-c896-4758-a785-e236f0154f14 10/31/2012 KIRC Neoadjuvant therapy Prior malignancy R kidney and prostate, no systemic therapy or radiation. Neo-adjuvant sutent given for TCGA tumor.
TCGA-B8-5162 d62d39f9-c896-4758-a785-e236f0154f14 12/06/2010 KIRC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy / Subject was positive for neo-adjuvant therapy
TCGA-B8-5162-01A-21-1740-20 37894361-b6e8-403b-ae5b-61a680088fcb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5163-01A-21-1740-20 4aeba2cd-ce47-4695-a684-f64c2e0bfe6f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5164-01A-21-1740-20 0d8fd09c-0213-45aa-94fc-4cfcf52d78cf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5165-01A-21-1740-20 74a72bf2-d7e1-4fe1-b7ab-5b2939265e32 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5545-01A-03-1741-20 a90c3786-b227-4015-a1c1-03d6401806a2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5546-01A-21-1741-20 f144f7ce-fa15-4632-a0bd-2d93bf4fedcf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5549-01A-21-1741-20 7da3accf-78b5-4111-b2f3-974b90de0f7d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5550-01A-21-1741-20 cf353041-af01-46f3-be8b-2c53079cd59d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5551-01A-21-1741-20 436a8460-d131-4e31-a9c5-a2a66294180c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5552-01B-21-1741-20 000378c1-cd16-45c9-bcfa-e65eae6e9700 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-5553-01A-21-1741-20 ff25ff21-80d0-419d-9306-fd04a43942a5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-B8-A54K a2663a86-a006-4867-9e88-2b523df48303 06/16/2014 KIRC History of unacceptable prior treatment related to a prior/other malignancy BCG given to prior bladder cancer
TCGA-B9-5155 56ae2434-e84a-494b-a784-2c2009be8ae6 10/31/2012 KIRP Prior malignancy Prior malignancy L kidney cancer. No systemic chemotherapy or radiation.
TCGA-B9-A44B b809c2f2-185c-496a-a1d4-589294443a1d 04/25/2013 KIRP Prior malignancy Patient had a prior prostate adenocarcinoma. No systemic chemotherapy or radiation.
TCGA-BA-4074-01A-21-2072-20 134af33b-10f9-41fd-9adc-c7476116801b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-4075 6fa62461-e721-415a-8b0f-363b84292b82 02/05/2011 HNSC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-BA-4075 6fa62461-e721-415a-8b0f-363b84292b82 09/26/2014 HNSC History of unacceptable prior treatment related to a prior/other malignancy Patient diagnosed with tongue cancer several months prior to procurement of the TCGA specimen and had prior treatment (chemo and radiation). This is a possible recurrence.
TCGA-BA-4077 4bfbce2b-9d0b-4e8a-950f-fd8e0ba3e05a 02/05/2011 HNSC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BA-4077 4bfbce2b-9d0b-4e8a-950f-fd8e0ba3e05a 09/06/2012 HNSC Case submitted is found to be a recurrence after submission Per 6-12-2012 audit, case submitted is most likely a recurrence.
TCGA-BA-4077 4bfbce2b-9d0b-4e8a-950f-fd8e0ba3e05a 11/10/2012 HNSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of tongue cancer treated with cisplatin and locoregional radiation. Tumor submitted to TCGA possibly recurrence of Prior malignancy .
TCGA-BA-4078-01A-21-2072-20 1491f9f3-0857-41e0-ab6d-9b55c751f2c8 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5149-01A-21-2072-20 a6f180e2-7cb7-46ae-b8dd-02a512e8e0bb 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5151-01A-21-2072-20 2698cd26-f27a-4b61-a07d-b4add8f3704d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5152-01A-11-2072-20 b1adb413-d6ac-4119-b608-0bccda5f33b9 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5153-01A-21-2072-20 c381ca49-8a9a-435a-950b-847ba6b9c6e5 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5555-01A-21-2072-20 9a0a0567-be08-428b-a561-b8469da9be80 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5556-01A-21-2072-20 30bc25d4-7800-423a-8a53-fd14b5144f06 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5557 7e0575ce-670b-4035-8a90-4d35279707b2 10/31/2012 HNSC Prior malignancy Prior malignancy R tongue. No systemic chemotherapy or radiation.
TCGA-BA-5557-01A-21-2072-20 70ceb6aa-b043-49b1-9f01-8aedd0010d10 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-5559 17b17d91-c3df-4b89-9c10-4db069aff656 10/31/2012 HNSC Prior malignancy Prior malignancy SCC. No systemic chemotherapy or radiation.
TCGA-BA-5559-01A-21-2072-20 82f9f66c-a3ad-48b8-b599-118e126b993e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-6869-01A-13-2073-20 43eca143-38f1-46af-b1d6-21e12a8e2555 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-6870 730c3b27-24d5-4a80-b659-db54cd2bc4fa 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of bilateral lung cancers.
TCGA-BA-6870-01A-13-2073-20 26b3a3bd-433c-4b01-8bc6-874f2bbad541 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-6871 bd62a587-6fe1-47ce-918d-055f2b38bb0e 10/31/2012 HNSC Prior malignancy Prior malignancy prostate cancer and R KIRC. No systemic chemotherapy or radiation.
TCGA-BA-6871-01A-13-2073-20 d8cdcbf0-9668-45ea-b597-1079c6c6b375 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-6872-01A-13-2073-20 9f257273-9fbf-4686-b62b-6aaf6acdf494 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BA-6873-01A-13-2073-20 1d9e0196-277f-4e5e-8ab9-e431529b8c2e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BB-4217-01A-21-2072-20 728aa093-785b-48bb-be29-cf6c2c4271e6 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-BC-A110 cf028bce-d20d-42b8-8507-1ec94a391e85 04/25/2013 LIHC Prior malignancy Patient had a prior Wilms tumor. No systemic chemotherapy or radiation.
TCGA-BC-A112 a2c17e87-d8bc-4160-88ae-e3e894d013e4 04/25/2013 LIHC History of acceptable prior treatment related to a prior/other malignancy Patient had a prior prostate adenocarcinoma and received regional radiation. No systemic chemotherapy.
TCGA-BD-A3ER 9457a9a1-3dd1-4d88-b1e1-d20aae4491dd 04/25/2013 LIHC History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior prostate adenocarcinoma treated with systemic chemotherapy.
TCGA-BG-A0M8 e055db71-f3da-43d3-a9b2-2f65dfb23d3e 02/16/2015 UCEC History of unacceptable prior treatment related to a prior/other malignancy During Enrollment it was found that patient had a prior left breast ductal malignany that was treated with systemic pharma treatment (Adriamycin/Cytoxan) 7 years prior to TCGA tumor procurement
TCGA-BG-A0MS a798a8cc-4e72-4a8c-9e20-74a14deafd12 05/05/2015 UCEC History of unacceptable prior treatment related to a prior/other malignancy Prior to resection of TCGA tumor, patient had pharmaceutical treatment for a prior left breast cancer. Following the mastectomy, patient had 5 years of Tamoxifen and 6-8 cycles of chemotherapy.
TCGA-BG-A220 41dcafa0-b196-46dd-ab07-58cb747c9ebc 05/17/2013 UCEC History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior kidney clear cell carcinoma treated with locoregional radation and systemic chemotherapy.
TCGA-BG-A220 41dcafa0-b196-46dd-ab07-58cb747c9ebc 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-BG-A221 e7e667be-9b31-4870-9c38-740098f37213 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-BH-A0B6 fa4e082a-d213-412e-8d91-842a6f4bef12 02/26/2015 BRCA History of unacceptable prior treatment related to a prior/other malignancy During Enrollment it was found that patient recieved systemic tamoxifen 3 years prior to resection of TCGA tumor (left breast) for a prior right breast malignancy.
TCGA-BH-A0HM (none) 01/25/2013 BRCA Molecular analysis outside specification No aliquots from subject UUID: 2d7390d0-4adf-44f4-a246-fb46bd56d34d should have been shipped, because DNA analyte UUID: b3edf23f-faad-4d53-808b-401bbd76445e failed to qualify at the BCR due to insufficient normal DNA yield. However, RNA aliquots TCGA-BH-A0HM-01A-11R-A10U-07 and TCGA-BH-A0HM-01A-11R-A10V-13 inadvertently shipped when RNA aliquot UUID: 737d212c-43cd-4925-a6a5-568964075a0d was incorrectly assigned tcgaBarcode TCGA-C4-A0EZ-01A-21R-A10U-07 and RNA aliquot UUID: a979613c-5f14-47e9-a153-197552c289e6 was incorrectly assigned to TCGA-C4-A0EZ-01A-21R-A10V-13, which did pass for yield and QC.
TCGA-BH-A0HM-01A-11R-A10U-07 (none) 01/25/2013 BRCA Barcode incorrect RNA aliquot UUID: 737d212c-43cd-4925-a6a5-568964075a0d is from a patient that failed to qualify at the BCR due to insufficient normal DNA yield, but inadvertently shipped when incorrectly assigned tcgaBarcode TCGA-C4-A0EZ-01A-21R-A10U-07.
TCGA-BH-A0HM-01A-11R-A10V-13 (none) 01/25/2013 BRCA Barcode incorrect RNA aliquot UUID: a979613c-5f14-47e9-a153-197552c289e6 is from a patient that failed to qualify at the BCR due to insufficient normal DNA yield, but inadvertently shipped when incorrectly assigned tcgaBarcode TCGA-C4-A0EZ-01A-21R-A10V-13.
TCGA-BH-A1F5 e663954c-05a8-479a-a623-400c1eb5efc6 09/08/2015 BRCA History of unacceptable prior treatment related to a prior/other malignancy The patient had a prior thyroid cancer (~28 years prior) and a prior lung cancer (~23 years prior) to the TCGA cancer procurement. The TSS does not know if radiation or chemotherapy was given which is unacceptable for TCGA.
TCGA-BJ-A0ZF 8beee000-ecab-4a49-9c9d-bb8e677ae199 07/17/2015 THCA Item does not meet study protocol After pathology report review it was found that the case is a Follicular Carcinoma, not a follicular variant.
TCGA-BJ-A290 3cd2d4bd-8256-42fa-8272-db379d598007 02/22/2013 THCA Prior malignancy Patient had a prior prostate cancer. No radiation or systemic chemotherapy.
TCGA-BJ-A291 d4c68c1c-a3f3-4e0c-b555-d457378a1d24 02/22/2013 THCA Prior malignancy Patient had a prior skin cancer, NOS. No radiation or systemic chemotherapy.
TCGA-BL-A0C8 a6003b1c-56a9-430a-a5e2-b70af3f81bdb 01/22/2013 BLCA Item does not meet study protocol This is a non-muscle invasive pT1 bladder cancer submitted before the pT2 requirement
TCGA-BM-6198 a46be4e1-260c-4ce9-8b0f-1326d90c697f 10/31/2012 READ Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-BM-6198 a46be4e1-260c-4ce9-8b0f-1326d90c697f 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-BM-6198-01A-13-1934-20 6e04c1fa-718b-4df0-a801-bfee5b7e00c7 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-BP-4158 1cdb170b-9765-45ee-9e3e-388d0a419746 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated w/ hormones cancersodex, lupron and radiation
TCGA-BP-4158 1cdb170b-9765-45ee-9e3e-388d0a419746 11/22/2010 KIRC Prior malignancy IGC new notifications of 11/10/2010
TCGA-BP-4158-01A-03-1737-20 af5781bd-6cdc-4ddd-99c7-30fd4c0c2de1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4160 844d8b94-59b0-4787-97eb-474e3aa3e022 11/10/2012 KIRC Synchronous malignancy Prior malignancy prostate cancer treated w/ lupron. Synchronous R kidney cancer
TCGA-BP-4160 844d8b94-59b0-4787-97eb-474e3aa3e022 12/06/2010 KIRC Prior malignancy [intgen.org]: Subject has Hx of prior malignancy
TCGA-BP-4161-01A-03-1737-20 674b43f4-04f8-4354-a0de-458ce273aff9 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4164 ba96288c-60d3-4e56-8940-90c5b22d4ddc 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-BP-4164-01A-03-1737-20 f27b21a6-aa99-4a38-af7f-f89b6e66e65e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4165-01A-03-1737-20 040ed845-22bf-455f-b908-6da8c20616b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4169-01A-03-1737-20 af490ade-1a4d-4275-90f7-5aaa226c29fc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4170-01A-03-1737-20 7d5fd2fb-0e1b-46fc-a93e-9e53e435a9a3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4173-01A-03-1737-20 9cd3fc5f-398b-4023-bcd5-c201418b2c64 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4174-01A-03-1737-20 adf85281-7341-482f-a266-20497cdbdc1b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4325-01A-03-1737-20 8b3caafa-8af4-4d18-bf96-b78e278ee09c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4326-01A-03-1737-20 c7272a60-9daa-4a1c-bd36-587546b70c8f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4327 9b84d013-713b-4571-888c-12863fdd4a52 10/31/2012 KIRC Prior malignancy Prior malignancy colon cancer. No systemic chemotherapy or radiation.
TCGA-BP-4327-01A-03-1737-20 26511831-95bc-4abe-b4a5-8b21bcf0ef91 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4329-01A-03-1737-20 9011ac4c-2499-4c39-a579-6ee216704824 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4330-01A-03-1737-20 dcad5dbd-c88e-4651-b454-9c14e1db7183 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4331 39867756-0ef0-4408-a0e1-c85ae7adb8ee 04/02/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4331 39867756-0ef0-4408-a0e1-c85ae7adb8ee 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy squamous cell carcinoma of anus treated w/ 5-FU and mitomycin and locoregional radiation. Synchronous malig. of R kidney.
TCGA-BP-4331 39867756-0ef0-4408-a0e1-c85ae7adb8ee 11/10/2012 KIRC Synchronous malignancy Prior malignancy squamous cell carcinoma of anus treated w/ 5-FU and mitomycin and locoregional radiation. Synchronous malignancy of R KIRP.
TCGA-BP-4331-01A-03-1737-20 ef1c227c-4d03-4e25-a1a9-0cd0b231d1e7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4332-01A-03-1737-20 247045c4-617c-40f8-8395-2f0786eb031c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4334 e5eca191-f585-490d-81e3-9cced1047093 06/21/2011 KIRC Item in special subset Subsequent to most TCGA analysis, TSS noted that the case may be Chromophobe Renal Cell Carcinoma. Program Office determined this will be a Notification vs. a Redaction
TCGA-BP-4334-01A-03-1737-20 94399481-973f-4c06-80d2-accae70b17a4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4335-01A-03-1737-20 434984d0-d236-4bc4-813b-bd3dd729c555 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4337-01A-03-1737-20 224d6226-a93c-45be-851f-e132873d392a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4338-01A-03-1737-20 75f0afa0-c95a-4278-bd18-b35c0c8b2f17 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4341-01A-03-1737-20 d694f377-86b7-47fd-a3e8-18017f3ee718 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4342 c0e26587-3191-4396-a20b-da9e7de213f4 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated w/cisplatin, 5-FU, and radiation.
TCGA-BP-4342 c0e26587-3191-4396-a20b-da9e7de213f4 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4342-01A-03-1737-20 60705414-813c-498c-bf3c-97c40db3478a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4343-01A-03-1737-20 04650bc4-e8d0-480d-b1eb-b4275b120f94 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4344 513a4de3-427d-4823-8644-b6faf69a137f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated w/ mitomycin. Prior malignancy uterine cancer. No systemic chemotherapy or radiation.
TCGA-BP-4344 513a4de3-427d-4823-8644-b6faf69a137f 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4344-01A-03-1737-20 11d61a68-5ddf-43c9-a336-1a40ae080109 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4345-01A-03-1737-20 b51f444b-51a0-4901-a42d-286e0819323f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4346-01A-03-1737-20 28206fd9-253b-4f2b-94f1-1e558edd32ed 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4347-01A-03-1737-20 63348de4-1e61-4000-95b6-b43b937f7945 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4349-01A-03-1737-20 17e49511-4cef-48c8-8ee3-27dabaca0ce1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4351-01A-03-1737-20 a0748d1b-a752-4718-900e-31c703790ae1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4352-01A-03-1737-20 3aebcb7d-ac9f-44b1-b9ab-bebd4e09ebc7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4353 f9e6afeb-cf13-4dd7-8a1f-571ab610df4f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy lymphoma of L groin treated w/ systemic chemotherapy.
TCGA-BP-4353 f9e6afeb-cf13-4dd7-8a1f-571ab610df4f 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4353-01A-03-1737-20 bbba53ef-e89f-44b9-b099-492dd3670186 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4354 d9208e7b-0b47-43ff-a4e8-d4e591e286c4 11/10/2012 KIRC Neoadjuvant therapy Patient received neo-adjuvant gefinitib and sunitinib for tumor submitted to TCGA.
TCGA-BP-4354 d9208e7b-0b47-43ff-a4e8-d4e591e286c4 12/19/2010 KIRC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-BP-4354-01A-03-1737-20 10f73a76-335a-4453-bacb-9583e6023dc2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4355-01A-03-1738-20 960d0a23-8e93-4d10-88dc-fcd6f658e706 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4756-01A-21-1738-20 8c67e316-4e1d-4874-a55b-7f9bd4bf3b13 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4758-01A-21-1738-20 aa669d52-98ba-42d3-93e8-787733bc7c0b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4759-01A-21-1738-20 31e6ba1f-29b1-4063-9de4-e0adf88f344d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4760 4cfe4f31-f62c-423a-8b9f-17f455b15313 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation. Patient with synchronous malignancy of R KIRC.
TCGA-BP-4760 4cfe4f31-f62c-423a-8b9f-17f455b15313 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation. Patient with synchronous malignancy of R KIRC.
TCGA-BP-4760 4cfe4f31-f62c-423a-8b9f-17f455b15313 11/10/2012 KIRC Synchronous malignancy Prior malignancy prostate cancer treated with locoregional radiation. Patient with synchronous malignancy of R KIRC.
TCGA-BP-4760-01A-03-1738-20 20eede14-8679-4d83-81f9-9c1d5b950a88 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4761-01A-21-1738-20 ce230c92-748e-4040-8991-627700208b33 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4762 2dde6b93-11a8-424f-9b54-b1a81cd26895 10/31/2012 KIRC Prior malignancy Prior malignancy cancer R shoulder. Prior malignancy Leiomyoscarcoma R leg. No systemic chemotherapy or radiation for either.
TCGA-BP-4762-01A-11-1738-20 bd940189-3a7b-44ba-a659-fdde384a3274 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4763-01A-21-1738-20 f5100193-9a50-444c-beae-7576c0c0453c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4765-01A-21-1738-20 40882c39-369a-4e03-91c2-249b7281322c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4766-01A-21-1738-20 99f6d631-e005-4d8d-a1ae-989af4754b2e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4768-01A-21-1738-20 96cb4d2d-609e-4b1e-9419-131610ca437a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4769-01A-21-1738-20 b4a61eb2-266d-4045-a9a6-7365abee5431 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4770-01A-21-1738-20 9c83aa7c-d798-4563-9714-1884fbb56ad2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4771 31201e73-a922-4acd-b859-fa2f9ba0af93 05/18/2015 KIRC Neoadjuvant therapy Per the TSS, the patient had prior chemotherapy (but no additional info given). Also the patient had radiation (external beam) 2 months prior to the TCGA cancer procurement.
TCGA-BP-4771-01A-21-1738-20 4c226272-8648-40c6-8a8d-573345c19516 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4774-01A-21-1738-20 efc103d5-d048-4e41-a473-c4775d725115 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4775 c22d25c2-b836-4b91-8f4f-2062be002232 10/31/2012 KIRC Prior malignancy Prior malignancy DLBCL of the stomach. No systemic chemotherapy or radiation.
TCGA-BP-4775-01A-21-1738-20 13da54ae-88a6-42d7-b949-a872cfad9573 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4776-01A-21-1738-20 f9bdec2c-d3a1-403c-a192-9e782100b645 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4777-01A-21-1738-20 3d99a806-eab0-43c9-9a71-34150484e91e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4781-01A-21-1738-20 d8780152-4117-4036-a86e-e34b1627fa0a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4782 9a404208-c3d3-4e6b-b511-1a4ccf595c18 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R KIRC.
TCGA-BP-4784-01A-21-1738-20 f73d0fb0-8ed0-4803-888a-3ded7c53fdde 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4787-01A-21-1738-20 6c005cf1-c892-41a9-8e96-94fddc1bbe8f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4789-01A-21-1738-20 a5959caf-f793-48d1-ae2b-99bbe598089d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4790-01A-21-1738-20 f68d3386-1a3f-4856-ac90-4d38ce302dcb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4795 38469030-8539-4c76-b53b-57073569501c 10/31/2012 KIRC Prior malignancy Prior malignancy thyroid cancer. No systemic chemotherapy or radiation.
TCGA-BP-4797-01A-21-1738-20 2cbc04e7-27a6-494b-a94e-33d8160ffec2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4798-01A-21-1738-20 84ad006d-8482-45eb-978a-81b49604f39a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4799 e719b7f3-27c4-4017-9d34-a660776c2cd7 11/10/2012 KIRC Synchronous malignancy Pt with synchronous follicular lymphoma.
TCGA-BP-4799-01A-21-1738-20 c39ac284-5ce3-494c-9f49-15914eecb7f3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4801-01A-03-1738-20 f1c4c218-0bd0-4b20-9031-7df555ca2b07 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4803-01A-21-1739-20 653c3f46-d3b2-4b04-b71d-5a2a3656d686 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4804-01A-11-1739-20 7851ba4e-7820-4d2d-b075-a7f159353aff 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4807 33cf0893-0411-4758-aa90-602bfedf0850 10/31/2012 KIRC Prior malignancy Prior malignancy thyroid cancer. No systemic chemotherapy or radiation.
TCGA-BP-4807-01A-21-1739-20 709b2409-c5bd-4504-9d31-8f0ff8878b74 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4959-01A-21-1739-20 c4e51126-fd56-4831-aa68-3c0e5df56d29 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4960-01A-21-1739-20 3f3e1ccb-d1b4-4d45-93cb-44b64f35a13e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4961-01A-21-1739-20 dccc1e22-1980-4965-b9eb-eb6f2273c15e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4962-01A-21-1739-20 2e39c41f-0ca1-470c-8af4-7a017bc22529 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4963-01A-21-1739-20 6136fa38-252c-4540-b9cb-28539619ac90 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4964-01A-21-1739-20 c33ada60-72ff-4004-a6fe-e33f22750f89 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4965 ec6aa756-c875-49f5-89e4-365b3f18b589 10/31/2012 KIRC Prior malignancy Prior malignancy follicular lymphoma R groin treated with locoregional radiation
TCGA-BP-4965 ec6aa756-c875-49f5-89e4-365b3f18b589 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy follicular lymphoma R groin treated with locoregional radiation
TCGA-BP-4965-01A-21-1739-20 e9bcbff2-35fd-4337-80b0-9c1f5ce35647 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4967-01A-21-1739-20 a96547ac-4ae8-40d4-8914-9adac8591c06 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4968-01A-21-1739-20 3f8789e5-86f5-4238-9e79-94ac74d3fb8a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4969-01A-21-1739-20 8370cff5-689f-4997-b35a-0b445ce4cef7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4970-01A-21-1739-20 85853323-0c71-4746-969c-8b95f4ef1370 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4971-01A-21-1739-20 966f096c-bd20-4acb-93d5-a9a93baa243e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4972-01A-21-1740-20 13f57884-5751-44e3-a427-1e5e3e2c3612 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4973-01A-21-1740-20 7e70879c-ec68-4851-a2ce-3b6cf2ac427c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4974-01A-21-1740-20 2cdc2aad-46f7-4400-9e93-16ca117dab1d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4975-01A-21-1740-20 18271f38-78a1-40ea-8b8c-954ff3d62b93 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4976 2375ef64-8212-4ad4-97e8-bfa6d1db430f 04/02/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4976 2375ef64-8212-4ad4-97e8-bfa6d1db430f 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy colon cancer in unknown location treated w/ locoregional radiation. Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BP-4976-01A-21-1740-20 329d8f75-dadb-41b0-989e-01f22abfcc5b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4977-01A-21-1740-20 691526ae-c34d-4010-a97e-e531155df5dd 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4981-01A-21-1740-20 985de066-5d35-418f-b34b-e620be2dbf29 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4982-01A-21-1740-20 24527a31-1c21-4c4f-b398-3dd3f01a4522 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4983-01A-21-1740-20 99a02db5-19d0-4c9d-888e-a65bc5a9f8ba 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4985-01A-21-1740-20 043ac5c0-ba86-4e98-9688-d1d241c28d44 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4986 ccd44d97-f0d5-47cd-9c12-af458c750d23 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy R colon cancer treated with systemic chemotherapy.
TCGA-BP-4986 ccd44d97-f0d5-47cd-9c12-af458c750d23 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4986-01A-21-1740-20 5a7e475b-de82-4221-a614-4c71e19f5916 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4987-01A-21-1740-20 fc539d7a-1a7b-40e9-928a-a3b820917b0c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4988 9c8169e7-9193-41f5-878e-ed1af3b95422 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L lung adenocarcinoma treated with fludarabine and L lung bronchoalveolar cancer. No systemic chemotherapy or radiation.
TCGA-BP-4988 9c8169e7-9193-41f5-878e-ed1af3b95422 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4988-01A-21-1740-20 16f771b8-55aa-490c-b772-f3ec02f6b7ab 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4989-01A-21-1740-20 14b53f6f-6467-47aa-9690-18937c7b078d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4991-01A-21-1740-20 3e9b7386-9ad4-4bac-bccc-756b635839ea 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4992-01A-21-1740-20 47c4ffd0-04a8-4e4d-9261-0873ac2cab45 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4993 6ccd4657-ffa3-4e82-929f-9a7366a89578 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous R KIRC.
TCGA-BP-4993 6ccd4657-ffa3-4e82-929f-9a7366a89578 11/10/2012 KIRC Synchronous malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous R KIRC.
TCGA-BP-4993-01A-03-1739-20 390f12aa-59d1-4876-93ef-086c669d457e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4994 82f069c4-7928-4b7b-8a42-114db7de0501 06/21/2011 KIRC Item in special subset Subsequent to most TCGA analysis, TSS noted that the case may be Chromophobe Renal Cell Carcinoma. Program Office determined this will be a Notification vs. a Redaction
TCGA-BP-4994-01A-21-1740-20 f5e22cc3-5adc-40bb-be12-770904969079 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4995 9245a557-01ea-4446-b9e9-313f6ab18834 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy basil cell carcinoma of the neck with unknown chemotherapy per e-mail.
TCGA-BP-4995 9245a557-01ea-4446-b9e9-313f6ab18834 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4995-01A-21-1740-20 52dcb60f-7583-4ce1-ae95-af019526b8fa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4998-01A-21-1740-20 bdeb1ff3-1cf5-4560-80e5-713254f3fe78 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-4999 9aa63985-16ba-4d43-a6ec-4a35f2ff6513 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy melanoma of the L eye treated with locoregional radiation.
TCGA-BP-4999 9aa63985-16ba-4d43-a6ec-4a35f2ff6513 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-4999-01A-21-1740-20 fad769c2-11bf-4a57-ae6c-867aa422267c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5000-01A-21-1740-20 804406fd-a453-491e-8c10-0fdaf4c03f9e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5001-01A-21-1740-20 306667bc-b2b8-4c11-8eab-7a7c35f59d60 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5004-01A-21-1740-20 c7acc221-47e6-4fd9-8a4d-52a6582e790b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5006 b5f51cf6-1013-4d4b-aff1-4b7e8f6afd9c 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy basil cell cancer treated with unknown chemotherapy per e-mail.
TCGA-BP-5006 b5f51cf6-1013-4d4b-aff1-4b7e8f6afd9c 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-5006-01A-21-1740-20 1e27b24a-5e34-4c37-a886-2da9d0824c27 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5007-01A-21-1740-20 6704b452-ac70-40d8-8464-e60fb6756a03 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5008-01A-21-1740-20 d937a49c-f446-4f1c-a36f-4be1a507b327 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5009 57070e5b-0eb5-44b7-abb3-3007fa34543a 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy Hairy Cell Leukemia treated with Interferon.
TCGA-BP-5009 57070e5b-0eb5-44b7-abb3-3007fa34543a 12/19/2010 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-5009-01A-21-1740-20 06be1c91-747d-491d-b6ec-1147e5b5201b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5010-01A-03-1739-20 144e8999-4322-457f-aa97-f57af3ffd282 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5168 781acafa-a58b-4180-bbca-c5b675d51b17 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BP-5168-01A-21-1740-20 87fe49d8-eadf-4604-8330-0e6d8c5d50f7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5169-01A-21-1740-20 5cba849a-e38c-4195-b624-d8d6b69b9d27 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5170-01A-21-1740-20 aa421322-50f9-4099-acbd-9384747a50f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5173-01A-21-1740-20 db209dff-9608-4f28-88da-a08a45b91140 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5174-01A-21-1740-20 6ac66405-a827-47d0-a0c7-703c9d1f414d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5175-01A-21-1740-20 9f4d47d2-7de4-4926-ad7d-461be7737ba0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5176-01A-21-1740-20 ea856a3f-cf30-4abf-bdcb-fc41b0a5b7b2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5177-01A-21-1740-20 1d5bffc5-6e67-4bc9-9670-707c81f70bf2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5178 6e9e5e05-2bf8-4724-8e31-241f517289de 10/31/2012 KIRC Prior malignancy Prior malignancy chronic lymphocytic leukemia. No systemic chemotherapy or radiation.
TCGA-BP-5178-01A-21-1740-20 6eae97cf-2d1c-4350-8948-d7c4fc011f10 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5180-01A-21-1740-20 a658860b-353e-40e9-ba58-eca96555e989 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5181 5358b8c7-d69c-4485-9420-03416564187b 10/31/2012 KIRC Prior malignancy Prior malignancy L breast cancer treated with Arimidex and locoregional radiation.
TCGA-BP-5181 5358b8c7-d69c-4485-9420-03416564187b 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L breast cancer treated with Arimidex and locoregional radiation.
TCGA-BP-5181-01A-21-1740-20 43335a0d-b231-4dfb-865a-95ae9108b781 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5182-01A-21-1740-20 ba2a13be-35dd-46c9-84cf-947a3f88a790 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5183-01A-21-1740-20 b5dd7bce-2db2-4d29-b182-f4a1e6f49d11 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5184-01A-21-1740-20 b62cecd6-5408-4c8a-bd3b-cbc8dc39367e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5185-01A-21-1740-20 7199415a-1a03-4b95-899b-06a13be1d44b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5186-01A-21-1740-20 3a1b35fc-f161-4c43-88d2-a0627c14a623 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5187-01A-21-1741-20 09b9a6fa-2080-4ab5-ac93-99babaff9014 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5189 23c7555b-7a37-415d-bda8-3588078a0c2e 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BP-5189-01A-03-1740-20 5760a312-43d7-42fb-b03d-b2c6728ab74a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5190-01A-21-1741-20 60ae5978-788a-4a5e-9514-745ca6641cda 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5191 b9fc9eff-1228-482d-87a2-ebbb5c92733a 11/10/2012 KIRC Synchronous malignancy Pt with synchronous prostate cancer.
TCGA-BP-5191-01A-21-1741-20 fbb7e113-e460-4038-bb8c-ad92213c8f1e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5192-01A-21-1741-20 2e276db0-a903-46c0-8892-620fc0e94de6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5194-01A-03-1740-20 9004a9cd-9abe-4d82-b170-1ca87a76a952 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5195-01A-03-1741-20 8f347faf-21d3-447d-9d80-4cab2e44999a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5196-01A-21-1741-20 f2f9fbed-f0e5-46c2-bea5-9e0ec2e46d4b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5198-01A-21-1741-20 374b3c10-d46f-45e0-90f7-a515106650ce 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5199 d30f460b-8e85-4eb4-83b8-0a5d8bf4d10d 04/02/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BP-5199 d30f460b-8e85-4eb4-83b8-0a5d8bf4d10d 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L lung cancer with brian mets treated with etoposide and cisplatin and locoregional radiation.
TCGA-BP-5199-01A-21-1741-20 b8cb6f03-8bee-4536-94cd-86064a138c3f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5200-01A-21-1741-20 56c5d2f2-381d-4ab9-ba13-e6fd89334a12 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5201 54c9850c-9b67-42ea-a04b-16a88f786dfa 10/31/2012 KIRC Prior malignancy Prior malignancy melanoma of the chest wall. No systemic chemotherapy or radiation.
TCGA-BP-5201-01A-21-1741-20 79e08f1a-b74e-4a1c-95e3-bd4baced10c3 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BP-5202-01A-03-1741-20 95d23ab2-4aa6-4ebe-a0b1-f7288abca684 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-BQ-5886 f590f15b-21f5-4d99-9021-e5e1e0cc3758 10/31/2012 KIRP Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-BQ-5888 52495119-a052-4749-bed4-d4c81a6c3fb2 10/31/2012 KIRP Prior malignancy Prior malignancy L breast cancer. No systemic chemotherapy or radiation.
TCGA-BQ-5892 3b76c73f-f530-4a3a-91c4-31834747321e 10/31/2012 KIRP Prior malignancy Prior malignancy basal cell carcinoma of the skin. No systemic chemotherapy or radiation.
TCGA-BQ-7046 08a50ae7-179c-4241-8aed-79db6c218c90 10/31/2012 KIRP Prior malignancy Prior malignancy basal cell carcinoma of the face. No systemic chemotherapy or radiation.
TCGA-BQ-7049 93b05e07-fd17-44ce-8735-dcc28264b229 10/10/2011 KIRP Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BQ-7049 93b05e07-fd17-44ce-8735-dcc28264b229 11/10/2012 KIRP History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy basal cell cancer of the back. No chemotherapy or radiation. PM melanoma of the eye treated with antigen-bearing dentric cells.
TCGA-BQ-7055 552e78bb-dc9e-4c73-82bd-93a4bbea3a3a 10/31/2012 KIRP Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-BQ-7056 36182304-2db7-446a-929c-7e43a47d863a 10/10/2011 KIRP Prior malignancy [intgen.org]: Prior Malignancy
TCGA-BQ-7056 36182304-2db7-446a-929c-7e43a47d863a 11/10/2012 KIRP History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy malignant fibrous histiocytoma treated with Adriamycin and locoregional radiation.
TCGA-BQ-7058 3cad2139-0bc5-4c8f-994a-018be7e2e6ea 10/31/2012 KIRP Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation. Prior malignancy prostate cancer treated with locoregional androgen deprivation therapy and locoregional radiation.
TCGA-BQ-7058 3cad2139-0bc5-4c8f-994a-018be7e2e6ea 11/10/2012 KIRP History of acceptable prior treatment related to a prior/other malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation. Prior malignancy prostate cancer treated with locoregional androgen deprivation therapy and locoregional radiation.
TCGA-BT-A3PJ cb664eef-be6f-44ef-aa90-6f6da0e6440a 01/29/2013 BLCA Synchronous malignancy Synchronous prostate malignancy. No radiation or systemic chemotherapy.
TCGA-BT-A42C b9808ef9-e917-45f9-9e0f-b86f7834b5ff 01/29/2013 BLCA History of acceptable prior treatment related to a prior/other malignancy Patient received BCG treatment for a non-muscle invasive bladder cancer
TCGA-C4-A0EZ 05935f1d-77c2-46ca-b87a-7a84bce38afd 01/29/2013 BLCA Prior malignancy Patient had a melanoma of the lower limb. No radiation or systemic chemotherapy.
TCGA-C4-A0F7 ca554128-da9d-4f37-9560-ca083509e01d 01/29/2013 BLCA Prior malignancy Patient had an unspecified malignant neoplasm of the testis. No radiation or systemic chemotherapy.
TCGA-C8-A1HI 444374f8-9282-439c-af00-0f828edcbff3 12/11/2014 BRCA Neoadjuvant therapy During enrollment TSS discovered patient had 5FU, Epirubicin and cyclophosphamide prior to cancer procuemnt of the TCGA maliganncy.
TCGA-C8-A1HO b3354b72-2637-4edc-9a95-e55801d3ac13 07/29/2015 BRCA Neoadjuvant therapy The patient had neoadjuvant therapy (5-Fluorouracil, Epirubicin, and Cyclophosphamide) 2 months prior to TCGA cancer procurement.
TCGA-CA-5254-01A-22-1933-20 48dadf66-fa68-4010-a737-4649c1b1d660 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-5255-01A-12-1933-20 03a97a0d-ace5-436a-a6b9-f60e17103426 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-5256-01A-21-1933-20 95dd749b-c482-47b7-b945-eb47ca6b4f82 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-5796-01A-21-1934-20 3a849914-f9a4-4b36-a90b-83c2352d4ddf 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-5797-01A-21-1934-20 70ffec4f-a76b-402b-bde6-911101a404a1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-6715-01A-23-1936-20 61c3dcad-59d4-4e81-b245-3df51518c488 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-6716-01A-13-1935-20 37364281-7c7d-4086-afc3-f0aedbb145fd 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-6717-01A-13-1935-20 3615a9b1-b593-4657-8ee0-ad95b3976370 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-6718-01A-13-1935-20 c6b205f4-6975-477a-910d-f9494c23de8c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CA-6719-01A-13-1935-20 dfd620f8-20dc-4054-ba5e-575476534595 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CD-5813 152b9d8a-19fd-4665-b9e4-4fedfb1608cd 03/13/2011 STAD Item in special subset Sample is Signet Ring subtype. Program Office determined this will be a Notification.
TCGA-CF-A9FM aad167ab-4772-4616-afb3-265e00d4a3f0 02/05/2015 BLCA Item does not meet study protocol The path TNM for the primary was confirmed as T1N0M0. The surgeon recorded the TNM initially as T2N1M0 which is why the TSS submitted this case.
TCGA-CG-4444 5c087d33-0bd3-407d-8350-fabba6aec597 10/31/2012 STAD Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-CG-4460 3c3d4ef0-019a-423e-89b2-4ac5a7b567ab 10/31/2012 STAD Prior malignancy Prior malignancy ovarian cancer treated with chemotherapy.
TCGA-CG-4460 3c3d4ef0-019a-423e-89b2-4ac5a7b567ab 11/10/2012 STAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy ovarian cancer treated with chemotherapy.
TCGA-CG-4475 cad2adc1-0f41-4651-9c80-ae9961e2dc8d 10/31/2012 STAD Prior malignancy Prior malignancy of the prostate, bladder, and testicle. No systemic chemotherpay or radiation.
TCGA-CG-4476 442d7415-d095-4962-8296-a14390bad40a 10/31/2012 STAD Prior malignancy Prior malignancy of the prostate. No systemic chemotherpay or radiation.
TCGA-CG-4629 (none) 02/26/2013 LUAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of the larynx treated with chemotherapy and radiation.
TCGA-CG-4629 (none) 02/26/2013 LUAD Prior malignancy Prior malignancy of the larynx treated with chemotherapy and radiation.
TCGA-CG-4630 (none) 02/26/2013 LUAD History of unacceptable prior treatment related to a prior/other malignancy NA
TCGA-CG-4630 (none) 02/26/2013 LUAD Prior malignancy Prior malignancy uterine serous endometrial adenocarcinoma treated wtih systemic radiation.
TCGA-CG-5716 49587564-e30f-4f1c-b7b3-fc0989bb1a0a 10/31/2012 STAD Prior malignancy Prior malignancy prostate cancer treated with chemotherapy and radiation.
TCGA-CG-5716 49587564-e30f-4f1c-b7b3-fc0989bb1a0a 11/10/2012 STAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with chemotherapy and radiation.
TCGA-CG-5727 b75eb694-8e9d-4dbb-b536-7d278c728cbb 05/17/2013 STAD Synchronous malignancy Patient had a synchronous malignant neoplasm of the colon. No systemic radation or chemotherapy.
TCGA-CH-5753 928c48a0-68ee-4e28-ae83-9832e52850ca 11/10/2012 PRAD Synchronous malignancy Pt with synchronous Non-Hodgkins lymphoma of a lymph node. No systemic chemo or radiation.
TCGA-CH-5763 18e79a01-07a2-4cd5-b700-71d41724e041 10/31/2012 PRAD Prior malignancy Prior malignancy lung cancer. No systemic chemotherapy or radiation.
TCGA-CH-5764 ed73f136-42e8-4100-b432-d10370d07e8b 10/31/2012 PRAD Prior malignancy Prior malignancy esophageal cancer. No systemic chemotherapy or radiation.
TCGA-CH-5769-11A b41d906b-2fef-45c9-8b3a-c52b5856950e 03/12/2014 PRAD Pathology outside specification Normal tissue contains tumor
TCGA-CH-5772 ecf9f8be-7830-4626-8617-694c68ef4074 10/31/2012 PRAD Prior malignancy Prior malignancy colon cancer. No systemic chemotherapy or radiation.
TCGA-CH-5790 2b5ef82d-e137-43f6-bfef-b202f20ee187 10/31/2012 PRAD Prior malignancy Prior malignancy kidney cancer. No systemic treatment or radiation.
TCGA-CH-5791 829bed0c-c40d-44fd-aee8-6c7589db60f9 10/31/2012 PRAD Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-CI-6620 b26143d3-d458-4d5c-8446-fd2f05707352 05/19/2015 READ Neoadjuvant therapy TSS informed the BCR that the patient starting receiving chemotherapy (Leucovorin, Fluorouracil and Oxaliplatin) 1 month prior to TCGA cancer procurement and continued after surgery.
TCGA-CI-6621-01A-13-1935-20 99aff0b7-6ede-4d89-a6d1-5c2c62c87d5e 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-CJ-4634-01A-03-1738-20 4e48150c-3cce-4e50-8e66-cf03f7c69056 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4635-01A-03-1738-20 1c764337-0a77-43f3-aff2-59df7b707ac4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4636 2d8da564-e69f-4bfa-a1d3-227a294f3886 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4638-01A-03-1738-20 35666f7d-78a4-45ea-9b97-abf4fe4becf4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4640-01A-03-1738-20 35073bca-d686-4881-b1bb-36fb06254380 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 10/29/2010 KIRC Molecular analysis outside specification Molecular results off spec
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Pt with synchronous B-cell lymphoma treated with cyclophosphamide, Adriamycin, vincristine, prednisone, and Rituxin prior to procurment of TCGA tumor.
TCGA-CJ-4642 942c0088-c9a0-428c-a879-e16f8c5bfdb8 11/10/2012 KIRC Synchronous malignancy Pt with synchronous B-cell lymphoma treated with cyclophosphamide, Adriamycin, vincristine, prednisone, and Rituxin prior to procurment of TCGA tumor.
TCGA-CJ-4642-01B-03-1738-20 c251400a-a330-4bec-9097-be6d3d8081a2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4868-01A-21-1739-20 1009a8c5-1c9e-4077-9d5f-3952c2a7c941 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4869 06d86d68-0fd5-4c6e-8783-ed732a3291e8 02/05/2011 KIRC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-CJ-4869 06d86d68-0fd5-4c6e-8783-ed732a3291e8 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4869 06d86d68-0fd5-4c6e-8783-ed732a3291e8 10/31/2012 KIRC Neoadjuvant therapy Prior malignancy and neo-adjuvant therapy per e-mail. (No data in OC.)
TCGA-CJ-4869-01A-03-1739-20 b3abcf18-06f8-4971-8d1f-b8baa42c14fa 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4870-01A-21-1739-20 f8f5806e-287a-4fdf-93cf-4ca9d7affe9c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4871-01A-21-1739-20 773195ed-d001-4b7a-a297-09fab7099a7a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4872-01A-21-1739-20 ef59a075-02f4-4d9b-9cfe-777dcfa43a72 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4873-01A-21-1739-20 711a2ab5-898a-4e61-8544-451d574f6bc2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4874-01A-21-1739-20 8d66085c-74d6-41c6-8830-666d7013063e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4875-01A-21-1739-20 dc38f3cd-505f-49b4-8dea-aeee94fb3f1c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4876-01A-21-1739-20 e216cec1-b30a-4aab-afd4-bc0c1b7b758f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4878-01A-21-1739-20 83c99552-fdd7-4b9c-9bfb-fb8570c44d29 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4881-01A-21-1739-20 1a7f6ad8-97f3-416d-8d1e-1752bb6638f7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4882-01A-03-1739-20 159db16d-5e3e-4bcd-a5a2-07a96ca895f0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4884-01A-21-1739-20 6d50911f-9c1a-4030-b610-89a719b56131 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4885-01A-21-1739-20 fa006edc-8525-4d6e-ba13-e4c134464c4b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4886-01A-21-1739-20 a00ba6f0-2c30-4b10-adeb-73cc069e8445 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4887-01A-21-1739-20 42bf6823-a5cb-4c33-91aa-d70eb018287b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4888-01A-21-1739-20 97252db5-78f5-477c-ac3a-7c092dd94887 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4889-01A-21-1739-20 708465ee-ef9c-40de-ba2f-71514be59146 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4890-01A-21-1739-20 1403b7bb-a3a2-438c-bb7a-7a5fc629b054 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4891 d232f22d-a3e7-41c8-97e1-205de2b488aa 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4891-01A-21-1739-20 e92fbbf1-3320-4b68-b781-fc48afef80da 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4892-01A-21-1739-20 44f82cb9-ef4c-4db4-b422-ebf57eed8923 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4893-01A-21-1739-20 e7a4846e-fc06-4860-9889-1be8a401ef1a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4894 d1e4f4c0-08cc-4012-9372-9ab987d80dab 02/05/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-CJ-4894-01A-21-1739-20 46fefccc-e4e4-4978-94d4-947352fe01a5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4895-01A-21-1739-20 22064330-d7aa-4233-b7a9-cf0af042b915 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4897-01A-04-1739-20 0de5b055-e5c2-476d-acab-28786a73df23 01/09/2012 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4899-01A-21-1739-20 6f832a87-5075-47ec-ba25-548a651a38d0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4900 33cd8b05-2b9b-40dd-97a2-40d02e27ee90 02/05/2011 KIRC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-CJ-4900-01A-21-1739-20 8f37e702-a8bc-4cc0-8a4d-2e8fc0097327 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4901-01A-21-1739-20 00f49512-9a51-4cbd-b226-6841f35774c1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4902-01A-21-1739-20 bd711e1e-b075-4340-bdb1-517235e43f6d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4903-01A-21-1739-20 a694ae1f-4241-4b23-b4be-fc2ed41d84e7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4904 ec3b2a30-fcf6-45ef-bd9d-e6089a237c0f 11/10/2012 KIRC Synchronous malignancy Pt with synchronous carcinoid tumor of the intestine.
TCGA-CJ-4904-01A-03-1739-20 cea8dac4-2528-40b2-bdfb-219410a1ac12 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4905-01A-03-1739-20 9b07060d-54ab-411e-b7da-7ef6109db687 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4907-01A-21-1739-20 49f9282d-b523-4e77-af6e-17d74042f52f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4908-01A-21-1739-20 d63bf325-90ea-4d22-8272-8b0914dbb77a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4912-01A-21-1739-20 7ab6de82-86af-4737-bc64-98787c2b33e2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4913-01A-21-1739-20 0f73a4b3-8966-4cc9-b49b-367aff4a79cf 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4916-01A-21-1739-20 daba7c03-e941-4ff9-9d1a-20b476e9888a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4918-01A-21-1739-20 02e1794a-8cfb-490e-9af8-9dff35683336 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4920-01A-21-1739-20 08e06e35-8e6a-4167-8aa7-e02859c83d42 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-4923-01A-21-1739-20 756043d1-cc58-49ef-a948-9b8472ff0d4f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5671-01A-13-1742-20 4b882f59-a669-417e-a5d9-356622a845eb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5672-01A-13-1742-20 6efde3f2-9c26-48dd-8171-cb66673c5e83 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5675-01A-13-1742-20 b99e86e6-ae17-4281-9948-a8f105237a67 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5676-01A-13-1742-20 a18152a6-b906-493d-bda3-172b72f6549b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5677-01A-13-1742-20 77c4c9d8-a521-439f-9d60-0a09c56a562f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5678-01A-13-1742-20 f67614d8-c450-4aab-b81e-d47f55a6f34d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5679-01A-13-1742-20 70f8b600-310f-48ad-a296-656819936be8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5680-01A-13-1742-20 6ab4c822-53e9-47fa-8aea-09b03c5e58fc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5681-01A-13-1742-20 7280e1fd-d0cb-4e42-adcf-10b0fcdf72c8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5682-01A-13-1742-20 6ba42350-6550-458d-96c6-c7da867c65f5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5683-01A-13-1742-20 12ef7421-3991-4d0a-95b1-607bcf0da31a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5684-01A-13-1742-20 2055b0c3-576c-4764-b95b-3b6746112eec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5686-01A-13-1742-20 2b5fc01f-892f-4428-9e60-b66880059c84 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-5689 e865d40a-9989-436c-8426-88cc84c863e8 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-5689 e865d40a-9989-436c-8426-88cc84c863e8 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-5689-01A-13-1742-20 35cab9c3-34ee-434d-80ed-8ada59b8b930 01/09/2012 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6027 4467ae73-499a-4af0-8431-e059d6ed21a5 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-6027 4467ae73-499a-4af0-8431-e059d6ed21a5 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-CJ-6027-01A-13-1742-20 0780aac3-469d-4fd8-82a1-60a6642363ce 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6028-01A-13-1742-20 2a81c785-8223-442a-9356-6874f9c6d01b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6030 6ab00314-5228-43ba-9880-9d5177b64c61 10/31/2012 KIRC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-CJ-6030-01A-13-1742-20 64bab513-27ff-4cc2-b81a-319a0b3f4f48 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6031-01A-13-1742-20 d40c42ee-633f-4465-ad1c-2aa6ad9039ad 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6032-01A-13-1742-20 8f17ab9e-1351-49cd-b9b6-36ff8cdb0335 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CJ-6033-01A-13-1741-20 96223115-b21c-488c-a5ea-d7a556d0cf5d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CK-5912 c085da47-d634-491a-80ea-514e5a231f70 10/31/2012 COAD Prior malignancy Prior malignancy lung cancer. No systemic chemotherapy or radiation.
TCGA-CK-5914-01A-21-1934-20 e70edb10-70f4-4758-93c7-092c7b6e6f7c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CK-5916-01A-21-1934-20 82c5f476-0878-4b7e-9ac0-f77f0ef149fd 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CK-6746-01A-13-1936-20 b827bcb8-e37f-411a-99d3-51a004614503 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CK-6747-01A-13-1935-20 854e1dd9-fe91-41fa-9754-e16b91357c44 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CK-6748-01A-23-1935-20 1d8f53f2-ecb0-4e69-81fe-be7914508610 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CK-6751-01A-13-1935-20 73ce7786-43e7-4210-b457-83775b9e572e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CK-6754 (none) 06/16/2014 COAD Neoadjuvant therapy systemic treatment
TCGA-CL-5918-01A-21-1934-20 9ee94ebc-2248-415d-8a9f-a6acd97f3e52 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-CM-4743-01A-21-1933-20 6e9b52eb-0954-446a-b5e7-f7b5527b4435 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-4744-01A-31-1936-20 b46406b3-0c9c-442f-8708-f6461cfd2f52 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-4746-01A-31-1936-20 c15ebee4-46ec-4060-b38b-9f10438ccc28 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-4747-01A-31-1936-20 d3f508c7-5077-4212-ac63-df13dd86359d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-4748-01A-31-1936-20 dae0d9af-6cce-4332-bd7a-aa788ecc3cad 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-4750 c777a777-373a-4773-9566-6c373261f00a 04/06/2011 COAD Item in special subset Case came in as Colon. BCR was notified that case was Rectal. Program Office determined this will be a Notification vs. a Redaction
TCGA-CM-4750-01A-31-1936-20 706772c8-c84b-4720-8fdd-46316bbc7f02 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-4752-01A-31-1936-20 91a3211a-3b08-4f4a-9c26-e5f67056a4aa 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5341-01A-21-1933-20 0e704699-a5f7-46ed-ac81-6eabe1449e2b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5344-01A-22-1933-20 6ac4a069-9473-4089-b853-542315829ad9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5348-01A-22-1933-20 f411178e-d7f1-498f-9f26-32fef23d050f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5349-01A-22-1933-20 45f6a246-b9d6-4a9d-af60-1051f4997c9b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5860-01A-21-1934-20 62e55c9d-cd19-4933-861d-75c4e884ef23 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5861-01A-21-1934-20 8b501bd9-9c5e-4569-8354-9399db0c8428 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5862-01A-21-1934-20 b0c3f64d-325e-4850-93be-0e05f65e458d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5863 cc1d6ad3-b60d-482e-8fa4-0af26823007d 07/01/2011 COAD Pathology outside specification [intgen.org]: Pathology Results off Spec
TCGA-CM-5863-01A-41-1936-20 fef88501-c23b-42f3-8938-247c0184b4a2 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5864-01A-22-1934-20 557d8ed0-3dd3-4d8a-98da-5ef2e8e2f330 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-5868-01A-21-1934-20 1e203b73-efe2-4501-89a6-ea0fd4323131 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6161-01A-13-1934-20 86db6080-9fb4-405c-8d91-393806cb425d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6162-01A-13-1934-20 f3ec2db9-8521-4118-9c89-c3a58fbb0e01 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6163-01A-13-1934-20 e86cd788-d192-4f16-89ab-736491fa5aa6 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6164-01A-13-1934-20 5b3d9b0d-9e3d-4214-b157-d3cbffe866e3 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6165-01A-13-1934-20 510b4bc6-ced6-4950-89fa-ff642d41b19b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6166-01A-13-1934-20 3b35555d-4322-4838-ab10-297d7d958bb4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6167-01A-13-1934-20 82c32de2-f36d-4ecc-a8fb-8b55c50b1110 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6168-01A-13-1934-20 31ef1bdb-e061-4134-9f1f-47db6c56b7b9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6169-01A-13-1934-20 61409f76-7f50-479d-8f90-898d05042ad5 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6170-01A-13-1934-20 9622b5f0-79b7-4a54-b739-035db78d906e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6171-01A-13-1934-20 5053a7dc-bca2-4f2e-955a-f3f789810f5a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6172-01A-13-1934-20 27fcc244-8e31-4140-889b-05f6ff92d080 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6674-01A-13-1935-20 4fe8e007-ada8-4e0a-bee3-c6206e47153d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6675-01A-13-1935-20 63a03fd6-4412-4456-a425-4c118e52270f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6676-01A-13-1935-20 3230ddda-cb3b-47d8-a6b2-cfdaa43b3872 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6677-01A-13-1935-20 d335653c-5aae-4f67-8e1e-120517a21563 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6678-01A-13-1935-20 456f408b-27d3-4ba4-b31e-852764b68ada 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6679-01A-13-1935-20 28dba75b-678b-406e-8640-e3e70a366e2e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CM-6680-01A-13-1935-20 c0d0a433-3a06-4569-95bf-062c11fe160e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-CN-4722-01A-21-2072-20 ccc617df-d1bb-4e60-a50d-9f90c517808b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4723-01A-21-2072-20 0038cd03-9cea-42b1-8a59-0b892c06b88e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4725-01A-21-2072-20 4cb99645-e2e8-406a-aaa2-7bbf6deaf1b2 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4726-01A-21-2072-20 788613e5-67d4-4447-b19f-3c59c4f04573 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4727 12d05e8f-8d13-47c1-b713-2250f6abcef9 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the thryroid.
TCGA-CN-4727-01A-21-2072-20 05ef66c0-6cb5-4f62-961e-18621cfb8a4e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4728-01A-21-2072-20 e96ddeec-be69-4527-84b8-ae852be697f3 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4729-01A-21-2072-20 45426caa-e961-4b25-ac44-19359f201772 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4730-01A-21-2072-20 887b1a76-5d47-4bca-8f79-146080b1b5a0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4731-01A-21-2072-20 a2e36c90-dc42-43dc-87ff-c2818975606d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4733-01A-31-2072-20 6fb440b4-4a4c-436e-85de-7b73123d207a 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4734-01A-21-2072-20 a1377e1d-ae19-4dbd-9a5e-1520e2b56dce 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4735-01A-21-2072-20 cfe7bddf-517b-49fe-ab6e-d6d67eaab4ac 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4736-01A-21-2072-20 9b9aecd9-8b5b-4080-b541-f601f8a62c00 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4737-01A-21-2072-20 1f78ae85-cc29-4823-9b7c-15b8b65c447f 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4738-01A-31-2072-20 60d72bd4-7fd9-4d13-ae5f-b59a30bd25b6 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4739-01A-31-2072-20 c8e54083-5986-4ff8-8ff1-9e46baf3ff27 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4740-01A-21-2072-20 2a91346e-d491-4c0b-904b-ebfef28ad3ed 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4741-01A-21-2072-20 3196813d-9714-4bdb-8e1b-bcd9c56985ab 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-4742-01A-31-2072-20 80e25aac-4e76-4258-bff7-b33b76e13605 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5355-01A-21-2072-20 2afda804-955c-4417-a72a-bbc737a2850f 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5356-01A-21-2072-20 3aeb20f8-95ab-49bb-90d1-ba8061a68ec5 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5358-01A-21-2072-20 84549897-abf1-4ca6-bf72-a1ca2ccd80fc 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5359-01A-21-2072-20 d12c891c-f8e8-45de-892c-204f2f1cb25b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5360-01A-21-2072-20 00c07bec-fc78-457f-b47c-60e24126ad1c 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5361-01A-21-2072-20 b123455d-16be-47c7-9c76-e5bcd7f84e74 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5363-01A-21-2072-20 e0d98954-1a5b-4c53-8326-07e120511287 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5364-01A-21-2072-20 4ba3ce11-ea83-490d-a0b7-3f698227f417 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5365-01A-21-2072-20 516f802f-e081-4348-a37e-92e8f0d183dc 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5366-01A-21-2072-20 c89a3523-17c8-4b07-85c7-a6b76808ea4e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5367-01A-21-2072-20 728e6738-a5ab-478d-9e86-ec8438130f0d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5369-01A-21-2072-20 3e4de07d-3e7f-4541-862c-eabeec279aba 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5370-01A-21-2072-20 8b81b541-ec7a-4dec-a82f-d32d70cc55a6 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5373-01A-21-2072-20 a10fd44f-3dd9-4369-b895-d26728c6c465 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-5374-01A-21-2072-20 4af9d8ca-c6d3-424a-a497-8af9ef62e288 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6010-01A-13-2072-20 24bc3414-8b05-4fc1-87f0-d09d48ec81dc 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6011-01A-13-2072-20 ece0b257-2013-4c6b-a0aa-e5a39be276b5 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6012-01A-13-2072-20 bada788e-5112-4d21-a079-72729bd0cc83 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6013-01A-13-2072-20 acdd7eae-c26c-46c9-9dca-036ed3317718 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6016-01A-13-2072-20 4287095b-f884-4e06-bb4a-5acec69629da 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6017-01A-13-2073-20 37c059eb-214f-4ef8-bc23-5adbb5b68539 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6018-01A-13-2073-20 cc461669-c050-4ac4-aea2-8c61abba6dd5 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6019-01A-13-2073-20 0f11f2c0-780c-4fb3-97dd-88adcfc280e3 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6020-01A-13-2073-20 f036f69c-4824-4fd9-b7d4-b5b8d9fa7d0e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6021 9eb1997f-14f5-4230-ae4f-1ef1943e1723 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the R lung.
TCGA-CN-6021-01A-13-2073-20 6510b38b-1043-4206-bd60-4df712283c9d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6022 339f80f9-a542-4aaa-8bb8-3784493dd5ab 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the thryroid.
TCGA-CN-6022-01A-23-2073-20 5c83652d-2ec5-4e69-bfda-a12e8233a748 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6023 69efde94-a9f9-49ff-9c82-028c35940eda 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the thryroid.
TCGA-CN-6023-01A-13-2073-20 7cab894e-a455-470b-baac-a89752862906 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6024 2fc48edb-a428-49c3-9599-d00eb2b448ac 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the rectum.
TCGA-CN-6024-01A-13-2073-20 5f064674-2068-4a65-ba36-e3d93422bd1b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6988-01A-13-2073-20 36c808cd-a8e0-4b6d-a75d-7541b6b3ddfa 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6989-01A-13-2073-20 3fa453f1-33b1-4137-9220-b64c463e75e0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6992 547de7d8-c2f1-41d7-a0b4-cc6f39712301 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the thyroid.
TCGA-CN-6992-01A-13-2073-20 95f91d35-4b0d-4d4f-9061-f7c1208ee262 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6994-01A-13-2073-20 55d09fb7-9d34-4281-9774-1db104bc8690 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6995-01A-13-2073-20 0f180f38-3a5f-400e-b009-4ee42863f777 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6996-01A-13-2073-20 7e3c88db-be30-46b9-beb6-05703093bd91 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6997 171890ae-0391-4d8c-9bd2-090d866a2c5b 10/31/2012 HNSC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-CN-6997-01A-13-2073-20 9e687278-54e5-4e0c-90ee-1a60a73e53dc 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CN-6998-01A-24-2073-20 545c7679-7ec4-4048-9861-aaf7e59ea3c6 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5323 deefdd62-4d35-40c9-ad4c-0b593f35cff7 10/31/2012 HNSC Prior malignancy Prior malignancy verrucous carcinoma of the maxilla. No systemic chemotherapy or radiation.
TCGA-CQ-5323-01A-21-2072-20 f14670c8-f197-471f-aaf8-49d62317eea3 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5324-01A-21-2072-20 a805142a-a916-432f-a938-e718ef31fd2c 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5325-01A-21-2072-20 556da70c-e129-4ceb-8fba-0838238a68cd 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5326-01A-21-2072-20 aabf7172-aaea-4f27-a82f-bf9d0cf66827 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5327-01A-21-2072-20 cb991d19-c0f8-4ef9-87b0-4877e320fcdf 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5329-01A-21-2072-20 410dd7b7-70d3-4c73-bdac-e29fb6b1cc75 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5330-01A-21-2072-20 aba95b00-ddb3-4e23-bdd9-beea4f0597a7 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5331-01A-31-2072-20 6ec1f95a-f8af-4728-add3-d0f3b13fff58 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5332-01A-21-2072-20 4a7dbba1-6f6c-46c6-ae95-3022f6e18428 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-5334-01A-21-2072-20 65cae5f0-261c-42c9-a11a-1e814b24fe82 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6218-01A-13-2073-20 777c11e4-1a17-4d0c-9e26-4efd228c7816 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6219-01A-13-2073-20 f5256d9b-5642-457c-a4a2-33aeacce2ae9 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6220-01A-13-2073-20 cd5d65fd-cfc2-4edb-b4f2-a727e467b880 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6221 839b660c-98fe-4468-a2b3-408594350250 10/31/2012 HNSC Prior malignancy Prior malignancy follicular lymphoma, no treatment. Prior malignancy DLBCL treated with R-CHOP and radiation.
TCGA-CQ-6221 839b660c-98fe-4468-a2b3-408594350250 11/10/2012 HNSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy follicular lymphoma, no treatment. Prior malignancy DLBCL treated with R-CHOP and radiation.
TCGA-CQ-6221-01A-13-2073-20 3c9c2344-a177-4a7b-a832-faa628e94b92 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6222-01A-13-2073-20 730648f3-4206-46cb-8215-3d35b06c1bd8 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6224-01A-13-2073-20 62ed0b07-3cee-4599-902a-b97080f57195 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6225 90f44998-3c05-44b2-9501-bbd0f43c5147 09/26/2014 HNSC Case submitted is found to be a recurrence after submission Patient diagnosed and had prior treatment (radiation) 1 year prior to procurement of the TCGA specimen. The TSS did confirm the TCGA tumor was a recurrence.
TCGA-CQ-6225-01A-13-2073-20 9f8e53cd-0363-4fbf-81c3-6e3fe6ea88fb 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6227-01A-13-2073-20 dc1b330f-3d73-41bb-bf2a-322d34d9b039 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6228-01A-13-2073-20 c9ca18d0-2b82-4827-afb3-8b7839750d66 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-6229-01A-13-2073-20 2aa4211a-0fdc-4370-a40e-048ee23c0d69 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-7065-01A-13-2073-20 d3a3ffda-b7cf-43ac-83e3-76840867e6ac 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-7067 e0f4d67d-5ca3-4c21-9f52-04f660827d08 10/31/2012 HNSC Prior malignancy Prior malignancy skin cancer. No systemic chemotherapy or radiation.
TCGA-CQ-7068 8ebe8c25-5ef9-42d4-9414-8313227b673f 10/31/2012 HNSC Prior malignancy Prior malignancy oral cancer. No systemic chemotherapy or radiation.
TCGA-CQ-7068-01A-13-2073-20 05121261-9c76-46c1-85ed-de173c4967d3 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CQ-A4C7 134223bd-5c03-4854-a034-ebd2c527833e 04/25/2013 HNSC History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior prostate cancer that was treated with systemic chemotherapy. No radiation.
TCGA-CR-6472 0956bc67-dd55-4c54-a56a-f22f2856662a 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of thyroid cancer.
TCGA-CR-6478 467d5c94-1e67-4454-9e9c-9dffaa643032 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the esophagus.
TCGA-CS-6665 c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f 10/31/2012 LGG Prior malignancy Prior malignancy breast cancer treated with radiation
TCGA-CS-6665 c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f 11/10/2012 LGG History of acceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with radiation
TCGA-CS-6670 60b30a95-3e4c-413a-9de6-16a5bca163c4 09/26/2014 LGG Case submitted is found to be a recurrence after submission Patient diagnosed with oligodendroma 5 years prior to procurement of the TCGA specimen and had prior treatment (Temodar). The TSS did confirm the TCGA tumor was a recurrence.
TCGA-CU-A0YN 679a6869-2ce9-4472-8db1-8869e2c1a440 01/29/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-CU-A0YO 4a9ef220-922c-49cf-bbed-d173b214ed31 01/29/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-CU-A0YR 811b3950-36e7-485f-bc48-aca1eee2ddef 01/29/2013 BLCA Prior malignancy Patient was previously diagnosed with prostate cancer. No radiation or systemic chemotherapy.
TCGA-CU-A3KJ a75584bc-bef7-48f6-b4b3-c1472a3af768 01/29/2013 BLCA Prior malignancy Patient was previously diagnosed with non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-CU-A3KJ a75584bc-bef7-48f6-b4b3-c1472a3af768 01/29/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-CV-5430-01A-31-2072-20 e699cef6-551e-4764-b02c-3ee164c1f2e9 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5431-01A-31-2072-20 485fad24-98d5-49c8-9e7b-52356637a60b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5432-01A-31-2072-20 2e74ee14-ba7c-4cb4-b4e0-0da827cc9d08 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5434-01A-21-2072-20 efa9a042-0b83-41a9-91f4-458470322e0b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5436-01A-21-2072-20 8de0d8b5-b825-4cf0-aa69-e5d8c593f8a0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5439-01A-21-2072-20 0dcffda0-09e5-431c-b981-287d51788f70 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5440-01A-21-2072-20 26545707-1af2-4c9e-8edd-feaef7ed0c79 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5441-01A-21-2072-20 28f56d06-d4eb-433e-896d-a35480293af2 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5442-01A-21-2072-20 996b9719-6155-485f-9dad-f4b56e736d58 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5443-01A-21-2072-20 c65905e8-65ba-466c-9cce-acc91f1e5631 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5444-01A-11-2072-20 9b4fd241-2b89-4754-af8f-406791c5435e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5966-01A-13-2072-20 c450af22-ac04-4d4b-9348-8c33c403a76d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5970-01A-13-2072-20 771f462f-0884-4975-92df-c1b72c6d4497 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5971-01A-13-2072-20 c08d911b-9f10-4283-8aae-f456b7f87a10 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5973-01A-13-2072-20 65dedded-424d-4e99-8355-549e160cd189 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5976-01A-13-2072-20 07668857-f8a7-4345-bf7e-cd2798be11cd 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5977-01A-13-2072-20 7e9e3398-c975-42c8-9cec-474db6d7c302 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5978-01A-13-2072-20 450cf3ff-89af-4eeb-969e-0182eb363cda 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-5979-01A-13-2072-20 0f3b7a62-c0ae-41b0-95a3-903022b1ef69 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6003-01A-13-2072-20 f520a78f-d41e-406b-bdbb-a11d7ccde776 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6433-01A-13-2073-20 6224491a-efae-418b-b161-ea9467619b8b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6436-01A-13-2073-20 637f8c6c-3d39-4a4c-95f1-ebcfe3714d34 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6441-01A-13-2073-20 4d6822d0-2a24-4571-a1ff-4f9ba7ac3088 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6933-01A-13-2073-20 133df36d-925b-4f2e-b635-9d1e4d425bab 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6934-01A-13-2073-20 821d6cad-b27e-41e4-8b55-a90512555527 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6935-01A-13-2073-20 36ef1ae1-62bf-4e8b-b623-27396b1b48a5 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6936-01A-13-2073-20 46903c20-3804-4a14-8307-9828ce3577a9 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6937-01A-13-2073-20 b9f93c56-c014-4b03-bf29-9d48df12c746 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6938-01A-13-2073-20 6bb1269e-6d71-4883-b5a8-d846fba419a6 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6939-01A-13-2073-20 8c75eb36-8797-4291-8c06-b98c0908029a 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6940-01A-13-2073-20 64464adb-364c-436c-b6c4-a53ae6a6ad08 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6941-01A-13-2073-20 8d4dfd46-4938-4df7-b01a-a0f7e55330f2 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6942-01A-23-2073-20 963dcb03-848d-4be4-a344-3f1c1672c55a 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6943-01A-13-2073-20 9131fb5e-ef06-43a3-adbe-49c7f3d7e11c 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6945-01A-13-2073-20 8daa65f3-271e-43a0-a019-386dccdfff67 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6948-01A-13-2073-20 c74cb332-2757-4949-a646-5d2add119cdc 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6950-01A-13-2073-20 1e1211aa-00ec-4f11-9ae8-6606929b26c8 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6951-01A-13-2073-20 d31aef24-ca92-41c5-bdc2-2086f1d7a605 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6952-01A-13-2073-20 788875cc-eb72-42e1-a540-0014704623aa 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6953-01A-13-2073-20 2405d293-f786-47ee-9d71-b7b59615c91e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6954-01A-13-2073-20 cc5f1467-3498-4bc5-8fc7-d46cb19f9c84 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6955-01A-13-2073-20 cc33b7ff-72c6-4818-b309-53a28f0414b4 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6956-01A-23-2073-20 6c727466-ecfd-4f3a-aa76-fb64c8f04de0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6959-01A-13-2073-20 564d1e15-9d6e-41ac-bb53-0110b8402afa 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6960-01A-13-2073-20 85a4d97d-d8b1-44dd-ad8c-c4a0ce0b4b43 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6961-01A-23-2073-20 2ac465db-3fed-4b3f-bbbb-af5bca9973ff 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-6962-01A-13-2073-20 12fc3fd2-8ba0-4ebd-a64c-070e97192404 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7089-01A-13-2073-20 da5e13d5-07c7-45b7-be9b-fd24b159f22b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7090-01A-13-2073-20 e9a5d45a-a2dd-490e-a4db-a362c2ee1e5b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7091-01A-13-2073-20 15725b8a-6eb1-40aa-b600-a3f2275f0600 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7095-01A-23-2073-20 0a10bd0f-e068-479f-9873-3a366324fd98 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7097-01A-13-2073-20 b49b7dc4-361a-4667-ba78-64b3a0cf6866 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7099-01A-13-2073-20 2a013705-4ab2-43d8-8cec-79d4d05a8786 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7100-01A-13-2073-20 eca19799-a7f4-4893-9c75-f03f9051627f 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7101-01A-13-2073-20 c6d867a6-c1fb-41d8-bdb1-2d952b9f2a76 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7102-01A-13-2073-20 ecc2d54a-877c-4048-ad33-fec08d65a223 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7103-01A-23-2074-20 1b4ef73d-310b-4f69-a9b1-c2cd25c9dbcf 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7104-01A-13-2074-20 fbc9daa7-9208-4b6e-afad-acc44a9ac28e 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7177-01A-13-2074-20 45f7c1fc-b91c-4a6b-bb20-37bbb182b379 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7178-01A-23-2074-20 593dd051-4401-43fd-a57a-4ac702542e10 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7180-01A-13-2074-20 9d1786b5-caa1-43be-8299-f0084a86fddf 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7183-01A-13-2074-20 dccb7174-23c3-4564-83c8-8af1446e7ace 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7235-01A-13-2074-20 cd5d196b-a28c-4ad5-8f4e-3888cf76ffa1 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7236-01A-13-2074-20 dab878b6-d80f-4e45-92ca-3c2be97a28e9 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7238-01A-13-2074-20 c829aaac-b2ae-459a-8667-c088f997ba4a 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7242-01A-13-2074-20 cbebf0c8-d289-483d-aed1-24acbad90fec 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7243-01A-13-2074-20 b590fd72-eacb-492d-a17c-7c650d4bc024 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7245-01A-13-2074-20 9d94c9a4-9d71-4843-86f7-be076d939415 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7247-01A-13-2074-20 a49051d0-0aec-4c61-8402-84b35042f8b7 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7248-01A-13-2074-20 46d79df4-c243-48d2-bcd5-6751036d54e4 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7250-01A-13-2074-20 ab9a38a9-d90e-48b9-a93d-f464751fc21b 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7252-01A-13-2074-20 5f6dbd96-5725-42b2-b159-11614dd80ed6 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7253-01A-13-2074-20 22046511-3b07-4132-8b8d-0347919530ec 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7254-01A-13-2074-20 d0c0d9b7-46ae-48d8-b742-9cab85d33965 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7255-01A-13-2074-20 6211777e-024e-448a-9198-36d3e0610be2 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7261-01A-13-2074-20 1a6628a1-09e5-4fca-9917-f577d7ca08fe 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7263-01A-13-2074-20 be06c778-a1c7-413a-a6e5-04f4dcc5df84 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7406 2c6d6c93-fb6d-47f7-a868-5e9a82c75d4c 05/18/2015 HNSC Case submitted is found to be a recurrence after submission TSS confirmed the case sent for TCGA was a recurrence.
TCGA-CV-7406 2c6d6c93-fb6d-47f7-a868-5e9a82c75d4c 11/10/2012 HNSC Neoadjuvant therapy Patient was treated with neo-adjuvant cetuxinab and radiation.
TCGA-CV-7406-01A-13-2074-20 9d4195db-3775-41ea-9f5b-9e56f5fc25f4 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7407-01A-13-2074-20 0085659a-9e05-4939-bbc4-04c715fab9d1 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7410 06f0cf45-3840-44b2-bfc5-18eb980b8f68 09/26/2014 HNSC Neoadjuvant therapy Patient received neo-adjuvant radiation prior to resection.
TCGA-CV-7410-01A-23-2074-20 d95d78a4-b767-477c-803b-638b3d3e1625 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7411-01A-13-2074-20 c07ad897-cfa3-4353-bcb8-98af60ef5746 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7413-01A-13-2074-20 d62aa574-5bca-432f-88c9-9460fafaec9d 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7414-01A-13-2074-20 fefd264e-a552-4056-9257-accc5ff490bd 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7415-01A-13-2074-20 f7570713-26fd-42af-b2c0-66b686c8ac52 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7416 96415324-6859-41eb-8d07-be4e6f7d9781 11/10/2012 HNSC Neoadjuvant therapy Patient received neo-adjuvant radiation, cisplatin and flourouracil prior to procurement of TCGA tumor.
TCGA-CV-7416-01A-13-2074-20 9484da9c-1d78-46fd-a3fe-cf9b0ea55385 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7418-01A-13-2074-20 488be378-38ee-4ee8-bb4f-076fbef3c527 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7421-01A-13-2074-20 d7e280ad-b10d-4d08-81c3-9e407aaffa7d 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7422-01A-23-2074-20 731c80ed-dd52-46f9-986c-29f0003d9390 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7423-01A-13-2074-20 f59a1d70-46fb-4de7-85c8-9c208e95c0b2 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7424-01A-13-2074-20 4f72eb4c-f211-48a8-a8cd-be4606cdddb7 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7425-01A-13-2074-20 613f1692-2102-48c8-ac61-8794fdf2aa7e 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7427-01A-13-2074-20 ac8271cf-aa24-4244-b36c-3ceacaecb9d8 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7428-01A-13-2074-20 494ac343-3190-4ae9-95a8-6018d86906a5 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7429-01A-13-2074-20 fa96e4dd-c7bd-48cc-a891-bcdc3869f75a 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7430-01A-13-2074-20 b532a6b4-07af-437c-9312-03b35e5677d0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7432-01A-13-2074-20 975055c6-98df-48bc-83c9-b3d6d30851a2 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7433-01A-13-2074-20 5f5235e8-c6ad-4886-942f-062efc78a3ec 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7434-01A-13-2074-20 088909de-e899-436b-a2af-805bcca321c8 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7435-01A-13-2074-20 b8df7db3-81d5-43b3-b7f8-9830a8ed2201 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7437 a4cb2c52-15e2-45c8-aff9-23339217d167 11/10/2012 HNSC Neoadjuvant therapy Patient was treated with neo-adjuvant radiation.
TCGA-CV-7437-01A-23-2074-20 2cf68085-ba73-4fb6-9642-427689af635a 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7438-01A-23-2074-20 db9e267c-1b8b-4890-bbd4-2ffeabc719d1 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7440 6715b957-0d48-439c-8cd7-bd9b204d39b0 09/26/2014 HNSC Case submitted is found to be a recurrence after submission Patient diagnosed and had prior treatment (radiation) 1 year prior to procurement of the TCGA specimen. The TSS did confirm the TCGA tumor was a recurrence.
TCGA-CV-7440-01A-13-2074-20 ad129bd6-d55d-44c7-b2a5-d3556101acbc 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7446-01A-13-2074-20 66cc455e-0b9f-457a-b341-e0d825b64bbd 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CV-7568 fa2d4258-3ee4-4d53-8ef2-9700b5cf38d6 05/18/2015 HNSC Case submitted is found to be a recurrence after submission TSS confirmed the case sent for TCGA was a recurrence.
TCGA-CV-7568 fa2d4258-3ee4-4d53-8ef2-9700b5cf38d6 11/10/2012 HNSC Neoadjuvant therapy Patient was treated with neo-adjuvant radiation.
TCGA-CV-7568-01A-13-2074-20 080720ad-1ae9-4771-9805-8ab6cc531569 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CW-5580-01A-21-1741-20 aa97e126-0b18-44d1-8bdd-f19231ad17ee 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5581-01A-03-1741-20 ef407399-9c48-4179-8fae-db3d525bf435 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5583-01A-03-1741-20 47488fc1-1947-45b6-b7ef-e40cc6a17e0c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5584-01A-21-1741-20 c9976c78-5a6c-4a8f-a7a6-402bdc42f0c8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5585-01A-21-1741-20 6f1e29aa-f291-4583-b810-88bedde78d1f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5587-01A-21-1741-20 5953704f-af25-418c-88a8-658ec08de796 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5588-01A-21-1741-20 55709f9b-4d97-427e-9419-ff26af023ae8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5589-01A-21-1741-20 64d562b1-9f1b-4a0c-aaa2-356a2b6393f0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5590-01A-21-1741-20 828dcf1d-5bdf-45d9-8d92-0967384c1b93 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-5591-01A-21-1741-20 fa816bae-50dd-4dbf-9787-24bce5d334e1 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6087-01A-13-1742-20 21eba48f-71ab-4c94-9d17-db945445d1ec 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6088-01A-13-1742-20 1b7245a3-c52b-4696-8369-a29eb6987c11 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6090-01A-13-1742-20 6172753c-54b7-4b29-ba38-9a91eb36617d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6093-01A-13-1742-20 8120bc77-982c-4fa5-afc8-14bc96ddf4e4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6096 f6cd140f-e331-41a3-8a6d-b93076458a37 07/17/2014 KIRC Item is noncanonical Incomplete distribution. Only Repli-G and proteomics shipped.
TCGA-CW-6096-01A-13-1742-20 798b2d2e-3c8e-4f11-b048-da3266e5b712 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CW-6096-11A-01W dfc84859-fe4a-42f2-958b-005b50faf619 10/28/2011 KIRC Molecular analysis outside specification NA
TCGA-CW-6097-01A-13-1742-20 fd03af71-0731-458b-9219-a462a2380dd6 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CX-7082 47d1fcaf-3c01-43ba-9a21-0870b4ea2976 10/31/2012 HNSC Prior malignancy Prior malignancy of the R larynx treated with locoregional radiation. (TCGA tumor R oral cavity)
TCGA-CX-7082 47d1fcaf-3c01-43ba-9a21-0870b4ea2976 11/10/2012 HNSC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy of the R larynx treated with locoregional radiation. (TCGA tumor R oral cavity)
TCGA-CX-7085-01A-23-2073-20 3cfcfc1b-6c36-4f4b-8a22-ad0a90373d85 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CX-7086-01A-13-2073-20 2686e31a-9def-4043-bbbd-13851dc492d1 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CX-7219 3ce5b304-6068-43ba-9e70-e4357d6d7a2a 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the thyroid.
TCGA-CX-7219-01A-13-2074-20 176c527d-f822-4df2-b179-6c90d0edd0c2 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-CZ-4853-01A-03-1738-20 1d594413-a926-4446-8354-11ad4a89be5e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4854 2efcefca-5e52-4b3d-a48a-9e9c73cc0141 10/31/2012 KIRC Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-CZ-4854-01A-21-1738-20 8ce7c32e-78c1-40f0-ba8b-2c7e30bba545 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4856 fcecafa8-8b8b-4ae6-81bc-73acf05b211a 10/31/2012 KIRC Prior malignancy Prior malignancy breast cancer treated with locoregional radiation.
TCGA-CZ-4856 fcecafa8-8b8b-4ae6-81bc-73acf05b211a 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy breast cancer treated with locoregional radiation.
TCGA-CZ-4856-01A-03-1738-20 2aff5626-901d-4dd7-881d-7551cf59f121 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4857-01A-21-1738-20 679c1ab6-ec0a-47c6-b0ce-89406ffee17c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4858-01A-21-1738-20 94313271-144a-437b-96da-ffb5d9222c01 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4859-01A-03-1738-20 84bb9422-61e4-4b0e-a3c4-fe82643ea21d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4860-01A-21-1738-20 4234e620-8e3c-4597-8f16-716966f29cbc 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4861 226ce515-c12c-4195-bb5d-d6df2e135ff6 03/13/2011 KIRC Neoadjuvant therapy [intgen.org]: Subject was positive for neo-adjuvant therapy
TCGA-CZ-4861-01A-21-1738-20 c0a6affc-ff68-4146-9d82-3b233a23d6d0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4862 b10eb61b-50b8-4df5-8c46-386a1b58c6a6 10/31/2012 KIRC Prior malignancy Prior malignancy B-cell non-Hodgkins lymphoma of the forehead treated with locoregional radiation.
TCGA-CZ-4862 b10eb61b-50b8-4df5-8c46-386a1b58c6a6 11/10/2012 KIRC History of acceptable prior treatment related to a prior/other malignancy Prior malignancy B-cell non-Hodgkins lymphoma of the forehead treated with locoregional radiation.
TCGA-CZ-4862-01A-21-1738-20 6121d0d7-6152-4e62-a67f-2956dc74f012 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4863-01A-21-1738-20 28ba39dc-7aa1-451d-92e4-6805031c7784 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4864 7fc6b44d-ae66-409c-98e1-c1a518c33e95 09/26/2014 KIRC Case submitted is found to be a recurrence after submission Patient diagnosed with RCC 3 years prior to procurement of the TCGA specimen and had prior treatment (cryoablation). The TSS did confirm the TCGA tumor was a recurrence.
TCGA-CZ-4864-01A-21-1738-20 abdaba49-f2dd-4487-9cca-c43c421b8155 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4865 305eaef4-4644-46e3-a696-d2e4a972f691 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy Breast treated w/ taxol and radiation.
TCGA-CZ-4865-01A-03-1738-20 f056ed2a-e776-421f-b8c9-2dabbf1fa70d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-4866-01A-21-1739-20 68a3141b-8b6d-4b42-85ac-9bed66a1238b 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5451-01A-21-1741-20 31f3d889-65ca-484a-ba3b-3fec61a31ac8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5452-01A-21-1741-20 44675867-f3bd-4586-ad16-0ca9ea680107 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5453-01A-21-1741-20 89799ade-6a98-4324-ac18-c3db6912345a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5454-01A-21-1741-20 16ba26a3-58b6-4333-8930-e8fdaed6bb9d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5455-01A-21-1741-20 05f509e8-0e51-4f72-938b-e9a27cc86f5a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5456-01A-21-1741-20 5ec8b366-23c4-4469-9e24-89e2fe1c5af5 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5457-01A-21-1741-20 967d6c49-16b4-4dbb-af46-5c4078d34264 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5458-01A-21-1741-20 4e2483c3-bb07-40bd-93f4-98d5773422b7 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5459-01B-21-1741-20 f7ad17e2-0024-4664-bc64-9273e9096366 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5460-01A-21-1741-20 efafe88e-ae0d-4833-9448-d8a3c386cb25 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5461-01A-21-1741-20 1448104c-dfa4-4e0d-b825-5fa88572341a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5462-01A-21-1741-20 c9f9aeaf-71ff-4bba-ab6c-38c437b96846 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5463-01A-21-1741-20 1d9d71b3-1d04-442f-bf6d-51c620f2e706 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5464-01A-21-1741-20 1757eaeb-2160-46e1-9678-0ca41855f2bb 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5465-01A-21-1741-20 6dd4f073-00be-474a-bfde-0360719ad6b8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5466-01A-21-1741-20 019da2fa-0b60-4cc0-9a4b-01fff01ea1b8 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5467-01A-21-1741-20 bffdb92c-7525-433d-adc8-d71c3b2f7b20 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5468-01A-21-1741-20 220f379b-0963-4686-b7ca-83c22b7ed834 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5469-01A-21-1741-20 81b948b5-c234-4fe8-a747-6b0c40954925 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5470-01A-21-1741-20 379238c9-c4bf-4306-8228-ecaa6cd97a5e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5982-01A-13-1742-20 95c1d092-5e96-4b23-954e-bdf2edb7031d 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5984-01A-13-1742-20 3f097427-89ab-40cf-836f-07eec3911d37 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5985-01A-13-1742-20 612e8f1b-394f-4681-a143-469e79f80285 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5986-01A-13-1742-20 cfc2070d-2a8a-4f63-96d2-d0bef349e65e 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5987-01A-13-1742-20 edbac373-efd5-4b74-abcf-e0440df89583 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5988-01A-13-1742-20 5144b6fc-2a82-4876-98f7-b9d17c9f8c30 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-CZ-5989-01A-13-1742-20 e5b38120-7e4b-41b4-a2c4-d4a381ce1f77 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-D1-A0ZO b3d635b3-d7ac-4cf8-a318-0a9dd0073e89 05/17/2013 UCEC Prior malignancy NA
TCGA-D1-A102 f9cf4125-0db3-4b66-b51b-bc2f0240c9ef 05/17/2013 UCEC Prior malignancy Patient had a prior parotid gland tumor of unknown histology. No systemic radation or chemotherapy.
TCGA-D1-A2G5 016e515e-7f78-4997-9b97-3628464d9222 05/17/2013 UCEC Prior malignancy Patient had a prior kidney tumor. No systemic radation or chemotherapy.
TCGA-D1-A3JP 4846cb23-d7e7-47f4-972f-3abe229f7bdb 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-D3-A1Q3 29476d6a-0d06-4a18-8910-c0502f6539ff 06/20/2014 SKCM Neoadjuvant therapy Prior Interferon Treatment < 90 days from TCGA cancer procurement
TCGA-D3-A2JF c58638ed-a38c-4494-a41e-6ee5283a7a59 03/12/2013 SKCM Prior malignancy Patient had a prior squamous cell carincoma of the skin on the nose and leg. No radiation or systemic chemotherapy.
TCGA-D3-A2JF c58638ed-a38c-4494-a41e-6ee5283a7a59 06/16/2014 SKCM Neoadjuvant therapy systemic treatment
TCGA-D3-A2JG 47a16bf2-229b-4e9a-8b5e-3dcc61fa9106 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA
TCGA-D3-A3C8 16182443-12a1-4b0f-a6ab-33c2942e2991 03/12/2013 SKCM Prior malignancy Patient had a prior basaloid squamous cell carincoma of the head and neck, and a squamous cell carincoma of the head and neck. No radiation or systemic chemotherapy.
TCGA-D3-A3CC 2d36cea4-73e9-493b-8433-0c2b911c0521 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA
TCGA-D3-A3ML 0153f141-625e-4623-9f8a-296678002c63 04/18/2013 SKCM Prior malignancy Patient had a fibrosarcoma of the groin, basal cell carcinoma of the face and trunk, and prostate carcinoma. No radiation or systemic chemotherapy.
TCGA-D3-A3ML 0153f141-625e-4623-9f8a-296678002c63 06/16/2014 SKCM Neoadjuvant therapy systemic treatment
TCGA-D3-A3MU 714f58d6-14bf-4e60-96ac-104d4abd45ed 06/20/2014 SKCM Neoadjuvant therapy Prior Interferon Treatment < 90 days from TCGA cancer procurement
TCGA-D5-5538-01A-31-1936-20 efb7c196-6e8e-457a-aaf4-a8f68e253200 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-5539-01A-31-1936-20 64784bab-bf11-4580-b58d-25fdc5e44eff 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-5540-01A-31-1936-20 b9cfd72d-650c-40e3-a61a-34d9989d59a3 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-5541-01A-31-1936-20 75454405-2b8a-464f-b8a3-42f7b98f573a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6529-01A-13-1935-20 09d6b2f8-85cb-4fde-bef9-1d2e9ab5b2c4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6530-01A-13-1935-20 3a39dbe6-5972-4e50-b23e-0725cd674235 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6531-01A-13-1935-20 a1ac2790-5dbe-4fcc-a1d2-ddce97825709 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6532-01A-13-1935-20 625cd96b-8629-461d-a629-3ace1c284ce1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6533-01A-13-1935-20 bfbe5f2d-2917-41f9-a29f-f0094c2001f9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6534-01A-13-1935-20 0c4c0fa6-ba6f-4108-89da-1887eb92500d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6535-01A-13-1935-20 7faf1920-0ee1-4a6a-8e50-7ab94b7585b4 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6536-01A-13-1935-20 6cb21899-854b-4134-a146-103b542da615 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6537-01A-13-1935-20 703309f2-0773-4259-a5bc-7df897524d71 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6538-01A-13-1935-20 ae9e3ed9-563a-4fb7-96d9-26fe2b417ac5 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6539-01A-13-1935-20 83d9a5f2-0f3d-4308-9204-7629f2380934 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6540-01A-13-1935-20 4ea101a0-bff7-4513-a02b-e6e293d0e85c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6541-01A-13-1935-20 f189a67e-b20c-431c-aee8-98315321c7c0 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6898-01A-13-1936-20 6151b29e-c197-461f-b40e-3012e6455e96 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6920-01A-13-1936-20 b224219b-d4cb-4692-9e06-1c6f95a8a4b9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6922-01A-13-1936-20 fe96cf97-167e-4725-9fae-645e534cc520 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6923-01A-13-1936-20 bdab9c4f-df43-471d-958c-7f103a94b2ff 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6924-01A-13-1936-20 3264f4ed-0461-4dd5-a21d-c1ef7175ae23 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6926-01A-13-1936-20 8e9f1bf3-7101-4613-a375-fad52374546e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6927-01A-13-1936-20 3ffd8ecc-1fec-4ebf-9ba2-8691a6d57004 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6928-01A-13-1936-20 aa305ba5-6637-4cbc-9ede-4da5a85a3a4d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6930-01A-13-1936-20 d6d0ff2f-1f89-4321-88e3-14c6c0eb28be 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6931-01A-13-1936-20 cdadc4f9-5edc-4c32-a01b-c936dc791c91 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D5-6932-01A-13-1936-20 9671b734-1bfe-4c93-90b0-6ed856134dd7 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-D6-6515-01A-23-2073-20 a463576e-4418-4b55-9c57-c2ac5ffda4f6 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6516-01A-13-2073-20 e6f8727a-8351-4d3c-a9b7-c8f3b835e3b0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6517-01A-13-2073-20 9e3e9ea4-488e-4306-9beb-0650023f6cfb 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6823-01A-13-2073-20 48b633ea-61ae-45a0-9655-3458c0e249d7 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6824-01A-13-2073-20 c61340e7-1135-4682-99c6-6839bb7cd3f0 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6825-01A-23-2073-20 d382bccf-6e40-46c3-ac04-98c58d62d23d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6826-01A-13-2073-20 89f8e68e-61fa-44d5-8fa7-7a7569e1079d 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D6-6827-01A-13-2073-20 888202ae-5c7f-4fa3-9ddb-9d97e4c1e831 12/15/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-D8-A146 03da7a65-fa2f-42cb-a709-5fe8736f21d3 06/16/2014 BRCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-D9-A148 fed23055-1600-4128-8d73-e1aa902a9d1d 04/18/2013 SKCM Neoadjuvant therapy Patient received immunotherapy/vaccine for the TCGA tumor.
TCGA-D9-A148 fed23055-1600-4128-8d73-e1aa902a9d1d 06/16/2014 SKCM Neoadjuvant therapy systemic treatment
TCGA-D9-A1X3-01A (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A
TCGA-D9-A1X3-01A-01-TS1 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-01-TS1
TCGA-D9-A1X3-01A-11 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11
TCGA-D9-A1X3-01A-11D (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11D
TCGA-D9-A1X3-01A-11D-A18Y-02 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11D-A18Y-02
TCGA-D9-A1X3-01A-11D-A191-01 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11D-A191-01
TCGA-D9-A1X3-01A-11D-A197-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11D-A197-08
TCGA-D9-A1X3-01A-11D-A19C-05 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11D-A19C-05
TCGA-D9-A1X3-01A-11R (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11R
TCGA-D9-A1X3-01A-11R-A18S-07 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11R-A18S-07
TCGA-D9-A1X3-01A-11R-A18V-13 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11R-A18V-13
TCGA-D9-A1X3-01A-11W (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11W
TCGA-D9-A1X3-01A-11W-A20H-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-11W-A20H-08
TCGA-D9-A1X3-01A-21-A20M-20 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A1X3-06A-21-A20M-20
TCGA-D9-A4Z6-01A (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A
TCGA-D9-A4Z6-01A-01-TS1 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-01-TS1
TCGA-D9-A4Z6-01A-12 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12
TCGA-D9-A4Z6-01A-12D (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12D
TCGA-D9-A4Z6-01A-12D-A25O-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12D-A25O-08
TCGA-D9-A4Z6-01A-12D-A25P-01 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12D-A25P-01
TCGA-D9-A4Z6-01A-12D-A25S-05 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12D-A25S-05
TCGA-D9-A4Z6-01A-12R (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12R
TCGA-D9-A4Z6-01A-12R-A25Z-13 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12R-A25Z-13
TCGA-D9-A4Z6-01A-12R-A266-07 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12R-A266-07
TCGA-D9-A4Z6-01A-12W (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12W
TCGA-D9-A4Z6-01A-12W-A293-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-D9-A4Z6-06A-12W-A293-08
TCGA-DB-5270 b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4 06/16/2014 LGG Case submitted is found to be a recurrence after submission patient had a prior lower grade glioma
TCGA-DB-5270 b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4 10/10/2011 LGG Item does not meet study protocol [intgen.org]: Sample sent to TCGA was not the primary tumor. The initial surgery was a biopsy only with a diagnosis of a grade II oligodendroglioma where tumor was not completely removed. The patient did not receive any pharmaceutical or radiation therapy. Sample submitted was a progression of the tumor to a grade III oligodendroglioma
TCGA-DC-4745-01A-31-1936-20 77300929-ae0a-47dc-8414-3314da0acd31 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-4749-01A-31-1936-20 240f374f-7e6f-41c6-8835-54a856e47633 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-5337-01A-21-1933-20 8af558b5-f952-4a2d-b117-b438bf49c415 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-5869-01A-21-1934-20 32ab7a8e-0032-4724-a438-eda4bd39131c 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6155-01A-13-1934-20 794e050d-294b-4f3d-be85-a128d7e4745a 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6156-01A-13-1934-20 5d8d8b9e-6d18-4a1f-a644-a730f2d3dfcc 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6157-01A-13-1934-20 e87fa43f-4255-4223-9f3b-7cfd32356fea 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6158-01A-13-1934-20 b2b9c00d-a7ab-4acd-bdbf-655f468ea0d0 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6160-01A-13-1934-20 b21d80bb-bcb3-44c7-9836-1dd9f77dd822 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6681-01A-13-1935-20 075b3c96-ab97-4f67-87dd-b8c8fe4c5728 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6682-01A-13-1935-20 be1db6a4-a5d1-40d3-a0f6-236462c92173 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DC-6683-01A-13-1935-20 d1045b3c-8663-4db5-bd1c-8419c3612e25 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DE-A0XZ 3e9fda23-676d-4e78-8948-0c9df3d10064 02/22/2013 THCA Prior malignancy Patient had a prior melanoma on back. No radiation or systemic chemotherapy.
TCGA-DG-A2KH 6248f2a3-0da9-419f-ab77-c3f6f4353eb5 08/22/2014 CESC Item does not meet study protocol TSS confirmed TCGA tumor is villoglandular variant of endocervical adenocarcinoma, which was revealed at time of Enrollment. This tumor type is not acceptable for the CESC study within TCGA.
TCGA-DH-5141 2cf49bac-dea1-45ff-9e1d-09f5a2ac5215 06/16/2014 LGG Case submitted is found to be a recurrence after submission patient had a prior lower grade glioma
TCGA-DJ-A1QH f3c73dc9-6280-4619-a629-b575fdbdb0ca 12/19/2014 THCA Neoadjuvant therapy Patient recieved Radioactive Iodine 2 years prior to TCGA tumor resection.
TCGA-DJ-A3UU 45eefba8-9f7c-49e9-a3f5-d13cfa264ff6 02/22/2013 THCA Prior malignancy Patient had a prior basal cell carcinoma of the skin in head/neck region. Unknown radiation or systemic chemotherapy.
TCGA-DJ-A3UV f2bbb5fa-9997-45de-88d4-8f1e94c18f0d 02/22/2013 THCA History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior non-Hodgkins lymphoma that was treated with systemic chemotherapy.
TCGA-DJ-A3UW 5e085199-152a-40f5-a8f8-3a3a0f31c2e0 02/22/2013 THCA Prior malignancy Patient had a prior squamous cell carcinoma of the oral cavity. No radiation or systemic chemotherapy.
TCGA-DJ-A3V4 35277c30-010c-4d3f-9dfe-754bf72799d7 02/22/2013 THCA Prior malignancy Patient had a prior in situ ductal carcinoma of the breast. No radiation or systemic chemotherapy.
TCGA-DJ-A3V6 76c4d298-6f17-4f11-a706-cd844a0e0914 02/22/2013 THCA History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior non-Hodgkins lymphoma that was treated with systemic chemotherapy.
TCGA-DK-A1A5 904a8757-e0c5-41ef-b583-c8f170caaac1 01/29/2013 BLCA Prior malignancy Patient was previously diagnosed with basal cell carcinoma. No radiation or systemic chemotherapy.
TCGA-DK-A1AA 56d8a1b8-1268-4362-a7f1-77b76fbf1b59 01/29/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-DK-A2HX c728fac9-5452-4759-a4ed-a366e0f757cb 01/29/2013 BLCA Synchronous malignancy Patient had synchronous gastrointestinal stromal tumor. No systemic chemotherapy.
TCGA-DK-A2I6 de810af0-4c18-4e8f-9836-f8abc425e3eb 01/29/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-DK-A3IN fc0032db-b6d8-4da3-bd1b-beec4196abf0 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-DK-A3IQ e44f60ec-66c4-45a2-a003-0a1faf1d6e03 01/31/2013 BLCA Prior malignancy Patient was previously diagnosed with kidney papillary renal cell cancer. No radiation or systemic chemotherapy.
TCGA-DK-A3IS 9f75cc89-cc3f-4ae9-973d-da37c6417bfc 01/31/2013 BLCA Prior malignancy Patient had synchronous prostate cancer and prior basal cell carcinoma. No radiation or systemic chemotherapy.
TCGA-DK-A3IS 9f75cc89-cc3f-4ae9-973d-da37c6417bfc 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer and prior basal cell carcinoma. No radiation or systemic chemotherapy
TCGA-DK-A3IT 58520c66-7688-435a-b09f-653b18768c41 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-DK-A3IU f093f043-efd4-4cba-a87f-8cbb5c1acd9e 01/31/2013 BLCA Prior malignancy Patient had synchronous prostate cancer and prior history of non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-DK-A3IU f093f043-efd4-4cba-a87f-8cbb5c1acd9e 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer and prior history of non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-DK-A3IV f953dc5d-58bf-4936-b9fe-74b45e8c00e5 01/31/2013 BLCA Prior malignancy Patient was previously diagnosed with prostate cancer. No radiation or systemic chemotherapy.
TCGA-DK-A6B2 10c825d7-4e21-43e7-ac95-dda75fbdaf74 03/05/2015 BLCA Item does not meet study protocol TSS found during enrollment the patient had a PT2 prior to the procurement of the TCGA sample. The TSS considered this a progression, but this would not have been allowed in based on TCGA rules.
TCGA-DM-A285 99c532b0-6b42-4925-a344-fc7262c415ee 02/22/2013 COAD History of acceptable prior treatment related to a prior/other malignancy Patient had a prior cancer of the parotid gland treated with locoregional radiation. No systemic chemotherapy.
TCGA-DM-A286 224effcb-2d4b-429a-9247-42028ae577e5 07/17/2014 COAD Item is noncanonical Incomplete distribution. Only Repli-G shipped.
TCGA-DQ-5629 e95e9e7d-a1ed-46eb-9cf8-1d355bf0577f 07/11/2011 HNSC Neoadjuvant therapy [intgen.org]: Subject Positive for Neo-Adjuvant Therapy
TCGA-DQ-5629 e95e9e7d-a1ed-46eb-9cf8-1d355bf0577f 10/31/2012 HNSC Prior malignancy Prior malignancy cancer of the penis. No systemic chemotherapy or radiation.
TCGA-DQ-7588 8a3fdb52-63ef-48d7-95ff-167829825eb9 10/31/2012 HNSC Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-DQ-7589 4648225e-5b68-488a-969a-e8d812190c6f 10/31/2012 HNSC Prior malignancy Prior malignancy bladder cancer. No systemic chemotherapy or radiation.
TCGA-DQ-7591-01A-13-2074-20 28214166-081c-4a66-aab6-cf8e903b13b7 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-DQ-7592-01A-13-2074-20 20b58508-88b1-47ab-a816-6b4b16d021f3 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-DQ-7593 67eae8b3-3bd2-4e87-af78-ffe8221f318d 10/31/2012 HNSC Prior malignancy Prior malignancy melanoma R forearm. No systemic chemotherapy or radiation.
TCGA-DS-A1OC e711b88e-fa0e-4781-8549-7a53ed3a13a1 02/22/2013 CESC Prior malignancy Patient had a prior invasive breast cancer. No radiation or systemic chemotherapy.
TCGA-DT-5265-01A-22-1933-20 79e39a39-2c15-4fdb-8045-ef7bfa6f6b3b 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-DU-7011 cb598780-9e42-4167-b487-eec90ad4f36f 11/10/2012 LGG Case submitted is found to be a recurrence after submission Sample sent to TCGA was not the primary tumor, it was a recurrence.
TCGA-DU-7300 a144e4e4-2877-4340-a2bf-524adbde8bc8 10/31/2012 LGG Prior malignancy Prior malignancy melanoma. No systemic chemotherapy or radiation.
TCGA-DU-7300-10A-01W (none) 03/10/2012 LGG WGA Failure Sample 7300-10A is considered unacceptable because it had a higher proportion of homozygous calls then expected despite it being the 2nd WGA amplification during SNP analysis. The native DNA of the tumor and normal have been shipped and uploaded to all of the centers in Batch 189 and will be included in the canonical study. The WGA analyte is used as a control for the canonical study, but since the WGA analyte has disqualified through SNP analysis, the WGA analytes for case 7300 will not be shipped or uploaded.
TCGA-DV-5565 f6d28a1d-6691-4ac1-8afb-ab0e7dcef867 10/31/2012 KIRC Prior malignancy Prior malignancy pancreas cancer. Prior malignancy bilateral kidney cancer x2. No systemic chemotherapy or radiation for any malignancies.
TCGA-DV-5565-01A-21-1741-20 9e9158df-98f6-4f99-b31a-eab2b2ac50ab 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5566 4b2ec8aa-8460-440e-b75b-6b92ae7a3ffc 10/31/2012 KIRC Prior malignancy Prior malignancy pancreas cancer, R KIRC and L kidney cancer. No systemic chemotherapy or radiationfor any malignancies.
TCGA-DV-5566-01A-21-1741-20 1a05c3b4-f1e0-41f5-bcfc-a10a22ddfd58 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5567 aba26e6b-f11c-4ae6-a0d6-85bdd2060e8f 10/31/2012 KIRC Prior malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous L kidney cancer.
TCGA-DV-5567 aba26e6b-f11c-4ae6-a0d6-85bdd2060e8f 11/10/2012 KIRC Synchronous malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous L kidney cancer.
TCGA-DV-5567-01A-21-1741-20 21486ff6-8e01-4e31-b553-97b48bf3d8f4 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5568 16559faa-8103-4973-a47d-3435443e8ec1 04/21/2011 KIRC Prior malignancy [intgen.org]: Prior Malignancy
TCGA-DV-5568 16559faa-8103-4973-a47d-3435443e8ec1 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Prior malignancy of the eye treated with Avastin. Pt with synchronous bilateral KIRC.
TCGA-DV-5568-01A-21-1741-20 a8d6ad39-cac8-4bfc-84d8-d3dad59c76ab 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5569 fc052a9d-0134-46ce-af98-4703b61d63c4 10/31/2012 KIRC Prior malignancy Prior malignancy bilateral KIRC. No systemic chemotherapy or radiation.
TCGA-DV-5569-01A-21-1741-20 2b5131f9-bdc4-4ac7-a6e1-65b9f927d829 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5573 c6454371-1f84-4e8e-8c3a-2eac8380819e 10/31/2012 KIRC Prior malignancy Prior malignancy pancreas cancer. No systemic chemotherapy or radition. Prior malignancy R KIRC treated with IL-2. Patient with synchronous L KIRC.
TCGA-DV-5573 c6454371-1f84-4e8e-8c3a-2eac8380819e 11/10/2012 KIRC History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy pancreas cancer. No systemic chemotherapy or radition. Prior malignancy R KIRC treated with IL-2. Patient with synchronous L KIRC.
TCGA-DV-5573 c6454371-1f84-4e8e-8c3a-2eac8380819e 11/10/2012 KIRC Synchronous malignancy Prior malignancy pancreas cancer. No systemic chemotherapy or radition. Prior malignancy R KIRC treated with IL-2. Patient with synchronous L KIRC.
TCGA-DV-5573-01A-21-1741-20 dca20655-174a-4714-b5c8-b357aa4cdc34 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5574 ea854858-1dad-4b01-8e58-f19e6a7c41a3 10/31/2012 KIRC Prior malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5574 ea854858-1dad-4b01-8e58-f19e6a7c41a3 11/10/2012 KIRC Synchronous malignancy Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5574-01A-21-1741-20 77e8d72e-3ce3-4acb-895c-b29fb3886e9f 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5575 0ff579a1-e295-408d-b194-febbca798e34 11/10/2012 KIRC Synchronous malignancy Pt with synchronous R kidney cancer and pancreatic cancer.
TCGA-DV-5575-01A-21-1741-20 9bdfe4de-c81e-41ec-ad4f-d61a3e2ca2c2 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DV-5576 936c217f-f10b-43cf-bb6d-0a74ebec9b13 10/31/2012 KIRC Prior malignancy Prior malignancy R kidney cancer. Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5576 936c217f-f10b-43cf-bb6d-0a74ebec9b13 11/10/2012 KIRC Synchronous malignancy Prior malignancy R kidney cancer. Prior malignancy L KIRC. No systemic chemotherapy or radiation. Patient with synchronous pancreatic cancer.
TCGA-DV-5576-01A-21-1741-20 8f14a992-965a-4f5a-8289-812ef06db223 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-DW-5560 55b8d871-dbff-4c4a-8f73-82565588c23f 11/10/2012 KIRP Synchronous malignancy Pt with synchronous R KIRP.
TCGA-DW-5561 7f677700-65c8-4d17-b6ae-520869ba1bbd 10/31/2012 KIRP Prior malignancy Prior malignancy R KIRP. No systemic chemotherapy or radiation. Patient with synchronous L KIRP.
TCGA-DW-5561 7f677700-65c8-4d17-b6ae-520869ba1bbd 11/10/2012 KIRP Synchronous malignancy Prior malignancy R KIRP. No systemic chemotherapy or radiation. Patient with synchronous L KIRP.
TCGA-DW-7834 b11234b9-93d5-46df-bb67-110d6ed3e664 11/10/2012 KIRP Synchronous malignancy Pt with synchronous L KIRP and skin cancer.
TCGA-DW-7836 280d8569-0acb-47fa-a8f5-aa8540d89a94 10/31/2012 KIRP Prior malignancy Prior malignancy melanoma of the skin X2. Patient with synchronous R KIRP.
TCGA-DW-7836 280d8569-0acb-47fa-a8f5-aa8540d89a94 11/10/2012 KIRP Synchronous malignancy PM melanoma of the skin X2. Pt with synchronous R KIRP.
TCGA-DW-7837 10d3a64b-22d0-4846-8972-d78173deca2c 11/10/2012 KIRP Synchronous malignancy Pt with synchronous bilateral KIRP.
TCGA-DW-7838 e70c561a-1640-49d6-9662-f49b08118f1e 10/31/2012 KIRP Prior malignancy Prior malignancy basal cell carcinoma of the skin. No systemic chemotherapy or radiation. Patient with synchronous L KIRP.
TCGA-DW-7838 e70c561a-1640-49d6-9662-f49b08118f1e 11/10/2012 KIRP Synchronous malignancy PM BCC of the skin. No systemic chemo or radiation. Pt with synchronous L KIRP.
TCGA-DW-7839 5dfd6430-e602-415c-905a-a894076940e6 11/10/2012 KIRP Synchronous malignancy Pt with synchronous R KIRP.
TCGA-DW-7840 0d80fac4-f43e-4a67-b372-0af320966dbc 10/31/2012 KIRP Prior malignancy Prior malignancy L KIRP. No systemic chemotherapy or radiation. Patient with synchronous L kidney cancer.
TCGA-DW-7840 0d80fac4-f43e-4a67-b372-0af320966dbc 11/10/2012 KIRP Synchronous malignancy Prior malignancy L KIRP. No systemic chemotherapy or radiation. Patient with synchronous L kidney cancer.
TCGA-DW-7841 db7d3240-9fbd-432e-83ee-7226a6dcb9ce 11/10/2012 KIRP Synchronous malignancy Pt with synchronous bilateral KIRP.
TCGA-DW-7842 d4d1c1d8-efc3-4282-b986-d7343de7e78f 11/10/2012 KIRP Synchronous malignancy Pt with synchronous bilateral KIRP.
TCGA-DX-A6BK 6de12993-cfbf-443b-8220-73d8180d68f1 06/16/2014 SARC History of acceptable prior treatment related to a prior/other malignancy Prior tamoxifen for BRCA case
TCGA-DZ-6134 e5641df6-0d4f-4613-a012-c953f8b2017e 11/10/2012 KIRP Synchronous malignancy Pt with synchronous prostate cancer.
TCGA-E3-A3E5 90750006-fb25-4ccd-90df-9f300cd26a5b 02/22/2013 THCA Prior malignancy Patient had a prior in situ melanoma of the head and neck region. No radiation or systemic chemotherapy.
TCGA-EE-A180 7ee2f8d5-6c31-4f5f-a779-b43979e66d0b 03/12/2013 SKCM Prior malignancy Patient had a prior Merkel cell carcinoma. No radiation or systemic chemotherapy.
TCGA-EE-A184 3a8cfea5-1dcd-4dbb-bbd9-5bb602c54922 03/12/2013 SKCM Prior malignancy Patient had a prior adenocarcinoma of the rectum. No radiation or systemic chemotherapy.
TCGA-EE-A2GO 783eb662-7d7a-4637-8500-e2d86d73ec7b 03/12/2013 SKCM Prior malignancy Patient had a prior squamous cell carincoma of the left lower leg. No radiation or systemic chemotherapy.
TCGA-EE-A2MR 449c9d70-d8aa-41d4-beeb-0bbfc73a23d8 03/12/2013 SKCM Synchronous malignancy Patient had a basal cell carcinoma of the chest wall. No radiation or systemic chemotherapy.
TCGA-EF-5830-01A-21-1934-20 8c066e1f-1ed8-4ccb-8348-2a991ebe896b 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EF-5831-01A-21-1934-20 f8565333-a4ba-438f-8978-2199d33f6fb4 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6506-01A-13-1934-20 ca9bf1c5-12b0-4232-8fd1-2036d704f6c0 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6507-01A-13-1934-20 3d4373c5-82d8-401e-902f-586a6a0533c1 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6508-01A-13-1934-20 7ece26bd-48fe-4985-803e-ae3da072210e 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6509-01A-13-1934-20 70852b9e-4f94-49e7-9945-f5ed346fd15d 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6510-01A-13-1934-20 a9de89f8-375d-4b45-9ef3-057a5c4cdfc2 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6511-01A-13-1935-20 62f69dc3-df78-407a-9674-a67890ab1026 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6512-01A-13-1935-20 421e7caf-4a66-403d-afbc-b7f5d52d0b47 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6513-01A-13-1935-20 d43ff87f-f251-4d8f-85d4-1419e1e49ba3 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6514-01A-13-1935-20 37dd714e-da72-4b8f-a854-991a99bdd676 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6881-01A-13-1936-20 5d48c460-1138-42c9-847d-56083411321e 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6882-01A-13-1936-20 076f3b1a-8a91-4d24-a6ad-7b1a36dbf64f 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6884-01A-13-1936-20 0924e425-77cc-4d0a-a92c-cfb8ef29bf54 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6885-01A-13-1936-20 152ca927-c81e-4d93-96db-53cbf66458b8 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EI-6917-01A-13-1936-20 4eef8ce4-56ba-40ed-b9d6-6346305321c1 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-EJ-5542 5a92ec4c-36ee-4588-aca2-e3303f29c7ad 10/31/2012 PRAD Prior malignancy Prior malignancy melanoma. No systemic chemotherapy or radiation.
TCGA-EJ-7115-11A 2b6046f1-b8ff-4151-acd1-b380334210d7 03/10/2014 PRAD Pathology outside specification Normal tissue contains tumor
TCGA-EJ-7123 9519be01-d78d-462c-8a95-34149538afeb 10/31/2012 PRAD Prior malignancy Prior malignancy basal cell carcinoma of the nose. No systemic chemotherapy or radiation.
TCGA-EJ-7312 00dda860-53c3-4ab2-8294-73e291adf9d2 07/31/2014 PRAD History of unacceptable prior treatment related to a prior/other malignancy Patient had previous cancer in thyroid gland and unknown radiation and chemotherapy.
TCGA-EJ-7791 4fe004e5-49f9-4336-a690-6ebad512c813 10/31/2012 PRAD Prior malignancy Prior malignancy basal cell carcinoma L arm. Unknown treatment history.
TCGA-EJ-A46B 1170f449-dfb5-417a-a89b-b2229a2785db 09/03/2013 PRAD Pathology outside specification Upon re-review, no tumor was found in the tumor sample.
TCGA-EJ-A46B 1170f449-dfb5-417a-a89b-b2229a2785db 09/03/2013 PRAD Qualified in error Subject qualified in error due to absence of malignancy in the tumor
TCGA-EJ-A46E a608bf0e-a932-4541-8439-2ffb9f6294b0 09/03/2013 PRAD Pathology outside specification Upon re-review, no tumor was found in the tumor sample.
TCGA-EJ-A46E a608bf0e-a932-4541-8439-2ffb9f6294b0 09/03/2013 PRAD Qualified in error Subject qualified in error due to absence of malignancy in the tumor
TCGA-EJ-A46H cec1d2ff-36e6-497e-892c-b329724b4722 09/03/2013 PRAD Pathology outside specification Upon re-review, no tumor was found in the tumor sample.
TCGA-EJ-A46H cec1d2ff-36e6-497e-892c-b329724b4722 09/03/2013 PRAD Qualified in error Subject qualified in error due to absence of malignancy in the tumor
TCGA-EK-A2H0 c83c52f4-3815-4f49-8218-cf80aaa62e2f 06/18/2014 CESC Duplicate item please notify: case matches ZJ-A8QQ This case was the second biopsy procured.
TCGA-EK-A2RD 16363ef7-899d-4927-a74b-e7c03b3d8af1 06/16/2014 CESC Item does not meet study protocol RIN value below 7
TCGA-EL-A3CS 8b1987f7-75fd-4e24-be77-891bbd2d40a1 06/16/2014 THCA Case submitted is found to be a recurrence after submission patient had a prior thyroid maligancy with radiation
TCGA-EL-A3CS 8b1987f7-75fd-4e24-be77-891bbd2d40a1 06/16/2014 THCA Neoadjuvant therapy systemic treatment
TCGA-EL-A3CY ab17d69e-0078-4206-939e-e4784fdc9a96 06/16/2014 THCA Neoadjuvant therapy systemic treatment
TCGA-EL-A3D0 63986dd0-63ba-4ee5-aa25-8ff2cbb762d3 06/16/2014 THCA History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-EL-A3D5 e9ccf355-e68a-489c-a914-31b766bd0aef 06/16/2014 THCA History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-EM-A3AQ e8f56d0f-eee4-4def-a43a-dec91f4382a1 02/22/2013 THCA Prior malignancy Patient had a prior 0.9 mm melanoma of the calf. Sentinel node negative. No radiation or systemic chemotherapy.
TCGA-EO-A3KU db67a9cd-65ba-4d6f-a799-031b6b3df599 07/29/2015 UCEC Neoadjuvant therapy Patient received neoadjuvant therapy (Carboplatin and Taxol) 1 month prior to the TCGA cancer procurement.
TCGA-EP-A3JL a196a937-b17d-4d4a-965b-8af0f4f41367 04/25/2013 LIHC Prior malignancy Patient had a prior tumor in the back. No systemic chemotherapy or radiation.
TCGA-EQ-A4SO fe1ad544-3189-4495-86be-0c68f3234238 02/22/2013 STAD Prior malignancy Patient had a prior basal cell carcinoma of the skin. No radiation or systemic chemotherapy.
TCGA-ER-A193 8ab09143-daf6-40a9-85d3-0fe9de7b3e06 03/12/2013 SKCM Prior malignancy Patient had a prior squamous cell carincoma of the neck. No radiation or systemic chemotherapy.
TCGA-ER-A198 ea240769-e51c-45f5-a131-ba123e598622 03/12/2013 SKCM Prior malignancy Patient had a prior adenocarcinoma of the rectosigmoid junction. No radiation or systemic chemotherapy.
TCGA-ER-A19B f7368803-c545-4407-9a14-2220560a8f80 08/21/2015 SKCM Neoadjuvant therapy Patient received systemic pharma treatment (Temozolamide) 2 years prior to TCGA tumor resection.
TCGA-ER-A19T b85b14d7-3b5a-4800-af12-622ec03b9fe5 08/14/2014 SKCM Neoadjuvant therapy Interferon was given less than 90 days prior to cancer procurement, which is exclusionary. (per Kristen Leraas/BCR TCGA-2222)
TCGA-ER-A2NB bda2f09a-82c4-40ec-90e8-0bf63916a5c7 04/18/2013 SKCM Neoadjuvant therapy Patient received immunotherapy/vaccine for the TCGA tumor.
TCGA-ER-A2NC b9607824-a8d3-4915-ab73-962cdcfd8dc3 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA
TCGA-ER-A2ND 1b3f92b7-658a-4bbd-b086-20c1cd976d54 04/18/2013 SKCM Neoadjuvant therapy Patient received chemotherapy for the TCGA tumor.
TCGA-ER-A2NE 1068ad76-612e-40ee-b2fa-916da14b7916 04/18/2013 SKCM Neoadjuvant therapy Patient received chemotherapy for the TCGA tumor.
TCGA-ER-A2NF d32a4219-4cca-470f-b6b3-11447d9f5e0b 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA
TCGA-ER-A2NG f788f950-7953-47a6-b833-f9e5daa28fd3 04/18/2013 SKCM Neoadjuvant therapy Patient received immunotherapy/vaccine for the TCGA tumor.
TCGA-ER-A2NH 6c353b35-4f6d-4a36-bc8b-8a21dd0beecb 02/16/2015 SKCM Neoadjuvant therapy During Enrollment it was found that patient was treated with systemic therapy (neoadjuvant anti-CTLA-4 antibody ipilimumab therapy) prior to procurement of TCGA tumor.
TCGA-ER-A3ES b93f703e-be51-4469-aaac-2d4a87a37639 04/18/2013 SKCM Neoadjuvant therapy Patient received immunotherapy/vaccine for the TCGA tumor.
TCGA-ER-A3EV e35be832-6972-4677-b985-02e90d51141a 04/18/2013 SKCM Neoadjuvant therapy Patient received an unknown systemic therapy for the TCGA tumor.
TCGA-ES-A2HS 728aedb3-551a-4c16-9be3-7733a9539e9e 04/25/2013 LIHC History of acceptable prior treatment related to a prior/other malignancy Patient had a prior prostate adenocarcinoma treated with locoregional radiation. No systemic chemotherapy
TCGA-ET-A3BO c115df9d-cec4-4d7a-87f0-36a5c1f1d51f 02/22/2013 THCA Prior malignancy Patient had a prior basal cell carcinoma of the scalp. No radiation or systemic chemotherapy.
TCGA-ET-A3BV c14a0460-30b0-453b-ab81-da03ad4ad02e 02/22/2013 THCA Prior malignancy Patient had a prior carcinoid lung cancer. No radiation or systemic chemotherapy.
TCGA-EU-5904-01A-13-1742-20 54238142-e27f-4285-b762-3a47de6c1af0 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5905-01A-13-1742-20 0984427d-7af1-4ae6-9725-5cf16b05706c 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5906-01A-13-1742-20 4a199575-d30c-416a-b745-bdce432cad1a 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EU-5907-01A-13-1742-20 e43112b9-5cce-495c-9fd7-a51506a1ed01 12/14/2011 KIRC Item is noncanonical KIRC Proteomics MDA
TCGA-EW-A2FW e6f527a2-38eb-457e-bb39-3c5b9c0bcbec 05/14/2015 BRCA Neoadjuvant therapy Patient had hormone therapy (Exemestane) 2 months prior to TCGA specimen procurement
TCGA-EX-A449 eb0eb159-732e-43ff-a402-7f2d9f67daa8 02/22/2013 CESC History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior superficial spreading melanoma treated with locoregional radiation and systemic chemotherapy.
TCGA-EY-A1G7 6b2e93b9-8271-4205-842e-0b7292b8115a 05/16/2013 UCEC History of unacceptable prior treatment related to a prior/other malignancy Patient had a previous uterine adenocarcinoma of the uterus treated with locoregional radiation. No systemic chemotherapy.
TCGA-EY-A1G7 6b2e93b9-8271-4205-842e-0b7292b8115a 06/16/2014 UCEC Case submitted is found to be a recurrence after submission patient had a prior endometrial maligancy
TCGA-EY-A1G8 db3a4986-55d5-4ecc-be73-59725dce3c33 06/16/2014 UCEC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-EY-A1GK 972db411-9744-46f0-89c7-efe14135f1b4 05/16/2013 UCEC Prior malignancy Patient had a previous cancer of the ureter. No systemic radiation or chemotherapy.
TCGA-EY-A1GQ 8636db4d-a67b-4d8a-b02f-15fce553cf17 05/16/2013 UCEC Prior malignancy Patient had a previous melanoma of the foot. No systemic radiation or chemotherapy.
TCGA-EY-A212 37981e2c-4761-4f82-aaf2-4e6963a71603 05/16/2013 UCEC Prior malignancy Patient had a previous colorectal tumor. No systemic radiation or chemotherapy.
TCGA-EY-A214 4125e3e5-51c0-4577-9935-10cd086fc415 05/16/2013 UCEC History of acceptable prior treatment related to a prior/other malignancy Patient had a previous ductal carcinoma in situ treated with locoregional radiation. No systemic chemotherapy.
TCGA-EY-A214 4125e3e5-51c0-4577-9935-10cd086fc415 05/16/2013 UCEC Prior malignancy Patient had a previous ductal carcinoma in situ treated with locoregional radiation. No systemic chemotherapy.
TCGA-EY-A215 48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db 05/16/2013 UCEC Prior malignancy Patient had a previous chondrosarcoma. No systemic radiation or chemotherapy.
TCGA-F1-6177 c3cba26e-38c2-4569-afd6-6b045e604808 10/31/2012 STAD Prior malignancy Prior malignancy prostate cancer. No systemic chemotherapy or radiation.
TCGA-F2-6880 c60a4c63-607b-4d59-8625-bc5d20207647 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is normal pancreas with atrophy
TCGA-F2-7273 4c9e6085-41c3-4cfe-ad3d-5f94196a86e0 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is atrophic pancreas with a single focus of low-grade PanIN
TCGA-F2-7276 e4babd46-005a-4af3-8041-131648d9c2c6 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is atrophic pancreas with a single focus of low-grade PanIN
TCGA-F4-6459-01A-13-1934-20 b2489084-3ad8-4fd2-aa55-daf5dfcac0b0 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6460-01A-13-1934-20 83e880d0-e979-44fb-9ade-714e9725c25e 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6461-01A-13-1934-20 dc3cd22a-6462-4e53-9914-2f199587f9b5 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6463-01A-13-1934-20 052b38d9-671f-4698-b4c9-e5430d707ada 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6569-01A-23-1935-20 a013929b-5621-4b7f-b4a3-0f1dad106f5d 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6570-01A-13-1935-20 87971dce-6544-4a56-aeca-ddac549ae942 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6703-01A-13-1935-20 73ebdbe9-aeee-42c5-a92f-1be252bcb995 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6704-01A-13-1935-20 b346eb8b-4d6e-49e7-a4b7-719e352460ff 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6805-01A-13-1936-20 d90c8bc4-211f-41fb-9bce-f7a608d355d0 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6806-01A-13-1936-20 84e7d7d8-97f7-4a6d-a241-fd02c3d718db 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6807-01A-13-1936-20 c395d69c-f3e7-4b7f-82e4-3cc577d4fa07 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6808-01A-13-1936-20 24a3d917-0acd-479b-b9a1-6e82cd3bae6c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6809-01A-13-1935-20 20452b6f-a8d1-49e3-b27e-7f9293894461 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6854-01A-13-1935-20 51be499f-a141-42fc-ae63-5e67b68928ed 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6855-01A-13-1936-20 1dd5ad91-0e5b-46c0-a335-866859c9e1dd 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6856-01A-13-1936-20 41e5b474-574a-45da-a267-8e56d34c82cc 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F4-6857-01A-13-1936-20 8f426280-b0c1-446d-8ba5-20946b27f74c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-F5-6464-01A-13-1934-20 9651cc2b-626b-4c0d-bb20-84b8cccfce64 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6465-01A-13-1934-20 a90f40dc-e37a-4963-8c7f-f9011465e70f 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6571-01A-23-1935-20 d7be33fd-9c4a-4fa9-9d16-d21d2bee2bed 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6702-01A-13-1935-20 52efb145-f675-4b5a-9eca-99e0d5ff1afc 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6810-01A-13-1935-20 1e3f27fe-5896-4d1b-bf62-2125a2d21751 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6811-01A-13-1935-20 f40585c3-7632-4eab-8f99-2beb84645df7 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6812-01A-13-1935-20 0f9e5d11-cf02-4b1e-a447-fb80a16744a5 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6813-01A-13-1935-20 862ea152-fc71-492f-ac67-2c6317a38a9a 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6861-01A-13-1936-20 c8aebaf5-8ce4-4b4d-ae7f-5852518b41d7 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6863-01A-13-1936-20 b614b3a0-5e30-41eb-bc67-113831ff1f4e 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-F5-6864-01A-13-1936-20 20775ce7-d1a0-40c8-9b76-2082655d573d 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-FB-AAPP 1422bc35-4597-4e76-aa75-8e79613e67d5 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is a non-invasive IPMNs
TCGA-FD-A3B6 36054200-3fa4-4541-a25c-47282e4ef88d 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-FD-A3B7 ef5dd4b3-b77a-444a-b5b0-c999a5a3d129 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-FD-A3NA 14917461-dae4-44cb-909d-42ac45aef450 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-FD-A3SN 0fb043d3-d86b-4cd8-8c01-9e2b3e965bb0 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-FD-A3SQ 3071cb51-dcf5-41f7-b047-afc2dcbf0aaf 01/31/2013 BLCA Prior malignancy Patient had synchronous prostate cancer and reported a prior breast cancer. No radiation or systemic chemotherapy.
TCGA-FD-A3SQ 3071cb51-dcf5-41f7-b047-afc2dcbf0aaf 01/31/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer and reported a prior breast cancer. No radiation or systemic chemotherapy.
TCGA-FD-A3SS 7b98b829-fdc7-4719-bee9-c83f6154019c 01/31/2013 BLCA Prior malignancy Patient was previously diagnosed with basal cell carcinoma. No radiation or systemic chemotherapy.
TCGA-FD-A43P 41e8c196-ef93-47c6-ad06-0031f23d4347 02/01/2013 BLCA Prior malignancy Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-FD-A43P 41e8c196-ef93-47c6-ad06-0031f23d4347 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-FD-A43X 4ff4d9fe-eab8-4ab3-9ae4-9f15b2581a8f 02/01/2013 BLCA Prior malignancy Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-FG-5962 e09f93e1-1649-48fa-9e2e-d13ac6d50b97 10/31/2012 LGG Normal tissue origin incorrect Samples were created as tssDNA from Normal Tissue. Actually are tssDNA extracted from Blood. Should have been 10A instead of 11A.
TCGA-FG-5963-11A (none) 05/21/2011 LGG Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-FG-5964-11A (none) 05/21/2011 LGG Normal tissue origin incorrect [intgen.org]: Normal tissue origin incorrect Case classified as extracted DNA from Normal Tissue. Should be DNA extracted from Blood.
TCGA-FG-8187 0df37550-9421-4571-9844-51b457d7cb2b 02/01/2013 LGG Prior malignancy Patient had prior testicular germ cell tumor. No radiation or systemic chemotherapy.
TCGA-FG-8187 0df37550-9421-4571-9844-51b457d7cb2b 10/31/2012 LGG Prior malignancy Prior malignancy testicular cancer. No systemic chemotherapy or radiation.
TCGA-FI-A2CX dffc7091-bc27-452c-ad94-1ee214107593 05/16/2013 UCEC Prior malignancy Patient had a previous basaloid squamous cell carcinoma of the forehead. No systemic radiation or chemotherapy.
TCGA-FI-A2D5 dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a 05/16/2013 UCEC Synchronous malignancy Patient had synchronous lung adenocarcinoma, NOS. No systemic radiation or chemotherapy.
TCGA-FI-A2F4 43476c88-86bc-4a65-9327-f0d24a41c971 05/16/2013 UCEC Prior malignancy Patient had a previous pheochromocytoma of the adrenal gland. No systemic radiation or chemotherapy.
TCGA-FK-A3SD 63b01b43-a68a-4046-89b0-736ba4d08504 02/22/2013 THCA Prior malignancy Patient had a prior ductal carcinoma of the breast. No radiation or systemic chemotherapy.
TCGA-FR-A3YO 62e928c1-df8b-4771-ae46-5da40794daf2 04/18/2013 SKCM History of acceptable prior treatment related to a prior/other malignancy Patient received local radiation for a prior DCIS in the left breast.
TCGA-FS-A1ZF e0d36cc0-652c-4224-bb10-09d15c7bd8f1 03/12/2013 SKCM Prior malignancy Patient had a prior lymphoma. Unknown radiation or systemic chemotherapy.
TCGA-FS-A1ZS 31e94518-f6dd-4458-94d8-dda3cc7a0831 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FS-A1ZT 57882f61-4a32-49f1-afd4-61c70b184d8b 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FS-A1ZU 7ce09a09-074e-4f38-bed7-98ab34347fbe 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FS-A1ZW 49a6f6a6-bf6f-45cf-93dc-b006b4a0637d 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FS-A1ZY a3df4ba6-538e-4b53-a356-eb1ef743b2ab 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FS-A1ZZ f6ff5e77-60d8-4987-9a92-654fd4db81f1 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FS-A4F0 4eb16fb1-0fcf-4c47-80fa-b7acc3a59a12 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-FU-A3TX b75644c2-b515-41ce-9b03-842ef5208a17 02/22/2013 CESC Prior malignancy Patient had a prior melanoma of the cheek. No radiation or systemic chemotherapy.
TCGA-FV-A3I1 bfd20d71-18a5-4f01-8d56-84378ad92359 04/25/2013 LIHC Prior malignancy Patient had a prior colon adenocarcinoma. No systemic chemotherapy or radiation.
TCGA-FV-A3R2 17833039-0d7e-47f0-90e6-8cabae94c124 04/25/2013 LIHC Prior malignancy Patient had a prior papillary transitional cell bladder cancer. No systemic chemotherapy or radiation.
TCGA-FW-A3R5 e5bc45ce-8a14-40b5-b9b5-ce45609fef3a 03/12/2013 SKCM Prior malignancy Patient had a prior squamous cell carincoma of the cheek. No radiation or systemic chemotherapy.
TCGA-FX-A2QS-11A c69ac5db-43ea-4f28-a44a-d4c99dbe5e6f 01/22/2015 SARC Item does not meet study protocol Normal sample should not have shipped for methylation, please use exome and SNP only.
TCGA-FX-A3NK a46c2122-9eb3-429c-aaf7-24fcb1f7a6a1 04/18/2013 SARC Prior malignancy Patient had a prior unknown malignancy of the kidney. No radiation or systemic chemotherapy.
TCGA-FX-A48G-11A b02976ce-24e5-44ba-af08-5b40b1d03fc2 01/22/2015 SARC Item does not meet study protocol Normal sample should not have shipped for methylation, please use exome and SNP only.
TCGA-FZ-5921-01A-11D 1c4c5733-5b07-4b2c-afeb-09210cab1baf 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5921-11A-01D 92841169-c56b-4058-9355-9513df580f1c 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5922-01A-11D 0a002336-4c0a-405e-9dc6-39a4702f7755 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5922-11A-01D c851d4e8-c34d-4dba-9abf-65f452850546 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5923-01A-12D 46f85a4f-54bc-44a1-95df-8d8350600f13 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5923-11A-01D 806f6a37-189c-4661-abcf-e3e7328130d7 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5926-01A-11D 3764c248-7a16-411a-b1a4-23cfa1cb0432 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-FZ-5926-11A-01D 07749e0d-46dc-4e48-8c73-3d54e928c2db 05/15/2011 PAAD Item is noncanonical [intgen.org]: PAAD Pilot 1 to determine TCGA qualification metrics
TCGA-G2-A2ES 72d8eae8-9efb-45b2-acbd-82c6b5732e38 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-G3-A25W 06ac44e9-1226-4202-828b-6f224766d7ac 04/25/2013 LIHC Prior malignancy Patient had a prior papillary renal cell carcinoma. No systemic chemotherapy or radiation.
TCGA-G3-A3CG 8a14d153-bbf7-4512-a067-976edfb65f91 04/25/2013 LIHC History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior prostate adenocarcinoma treated wtih systemic chemotherapy and locoregional radiation.
TCGA-G3-A3CG 8a14d153-bbf7-4512-a067-976edfb65f91 04/25/2013 LIHC Neoadjuvant therapy Patient had peroperative neoadjuvant therapy for the TCGA tumor.
TCGA-G3-A3CG 8a14d153-bbf7-4512-a067-976edfb65f91 04/25/2013 LIHC Prior malignancy Patient had a prior sigmoid colon adenocarcinoma. No systemic chemotherapy or radiation.
TCGA-G3-AAV5 4dff4242-4a53-4f46-b200-7ed83f6b7808 09/02/2014 LIHC Neoadjuvant therapy TSS confirmed during enrollment that patient had chemoembolization prior to cancer procurement.
TCGA-G4-6293-01A-23-1934-20 a28042f6-f846-4e32-aa89-4115d41d8de7 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6294 41f8c9fd-ae52-4458-886b-faf37de77dd0 10/31/2012 COAD Prior malignancy Prior malignancy prostate. Unknown treatment history.
TCGA-G4-6294-01A-13-1934-20 9af3454f-134d-45de-b732-ee75eb8694a8 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6295-01A-23-1934-20 1671379b-e090-4374-a4dd-c675a8336616 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6297-01A-13-1934-20 fc5676e3-904b-4dbd-aa0c-fe97b3834dfa 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6298 ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1 10/31/2012 COAD Prior malignancy Prior malignancy prostate. Unknown treatment history.
TCGA-G4-6298-01A-13-1934-20 33bffc10-e247-4b28-9e80-68284a8b838f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6299-01A-13-1934-20 86754090-3c2f-4687-b169-c4dd65e9b018 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6302-01A-13-1934-20 d691d1cb-457f-484c-9052-7fd6638e973c 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6303-01A-13-1934-20 d2752a05-e63f-47c1-b5c8-af84e2387cc0 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6304-01A-13-1934-20 90a43b34-3787-40a5-9a41-844ec59d43c9 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6306-01A-13-1934-20 e4ca1f84-5992-48cb-8427-ac84ee5c367a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6307-01A-13-1934-20 afef7d4c-33f0-4792-ba03-8aea5091329a 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6309-01A-13-1934-20 0488cd65-bbf2-40ee-ad2c-8c8975490e37 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6310 14c13b05-abfe-472e-83a9-b28f60e58ad8 10/31/2012 COAD Prior malignancy Prior malignancy lymphoma treated with systemic chemotherapy.
TCGA-G4-6310 14c13b05-abfe-472e-83a9-b28f60e58ad8 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy lymphoma treated with systemic chemotherapy.
TCGA-G4-6310-01A-13-1934-20 d43cb6f5-6347-493f-b66b-39340a824c40 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6311-01A-13-1934-20 2c7d8a46-1903-43e9-8682-3850f2f70cce 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6314 abe658e0-33f9-4f57-849b-dec4d20964d6 10/31/2012 COAD Prior malignancy Prior malignancy bladder cancer treated with unknown locoregional pharmaceuticals and radiation.
TCGA-G4-6314 abe658e0-33f9-4f57-849b-dec4d20964d6 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy bladder cancer treated with unknown locoregional pharmaceuticals and radiation.
TCGA-G4-6314-01A-13-1934-20 e0b4f32e-9016-4218-8330-54eb1487c5d1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6315-01A-13-1934-20 3a0f6c15-921b-4bb9-b487-d8e9fd95a45b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6317-01A-13-1934-20 3b6b8330-9041-4668-ab38-7444e5fa0ea1 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6317-02A-13-2189-20 9a7ed113-6c6e-4b34-9799-ba3cf36d9a41 03/12/2012 COAD Item is noncanonical COAD Proteomics Recurrent MDA
TCGA-G4-6320-01A-13-1934-20 c7ff2ce9-a470-49d5-a2f8-a4213a814243 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6321 e7dbfca1-9657-4952-8e0d-dec6373dda5b 10/31/2012 COAD Prior malignancy Prior malignancy thyroid cancer treated with radioactive iodine
TCGA-G4-6321 e7dbfca1-9657-4952-8e0d-dec6373dda5b 11/10/2012 COAD History of acceptable prior treatment related to a prior/other malignancy Prior malignancy thyroid cancer treated with radioactive iodine
TCGA-G4-6321-01A-13-1934-20 153c6860-69d1-4263-9a6e-7a7561fe36ac 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6322-01A-13-1934-20 998483fd-e21b-41de-8bf6-5657574eadd5 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6323-01A-22-1934-20 3046737f-813f-498e-9352-a52c1b399a29 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6586 7570761b-c333-40df-ac8c-9b7f94c58ef9 10/31/2012 COAD Prior malignancy Prior malignancy basal cell carcinoma of the nose. No systemic chemotherapy or radiation.
TCGA-G4-6586-01A-13-1935-20 be15204a-63d4-4ff2-a2ac-a7bcf29cfaf2 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6588 93690a96-421c-4c59-85ba-fa6dd538c721 10/31/2012 COAD Prior malignancy Prior malignancy SCC of the back. No systemic chemotherapy or radiation.
TCGA-G4-6588-01A-13-1935-20 bb455f08-bdb4-4dcb-9cb3-19d62e423571 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6625 5eed7e8a-c219-4497-a99f-bfc48faca4d8 10/31/2012 COAD Prior malignancy Prior malignancy melanoma. No systemic chemotherapy or radiation. Prior malignancy R breast treated with chemotherapy.
TCGA-G4-6625 5eed7e8a-c219-4497-a99f-bfc48faca4d8 11/10/2012 COAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy R breast treated with chemotherapy.
TCGA-G4-6625-01A-13-1935-20 d4b97003-a1cd-401d-a058-a47beb4d5f0b 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6626-01A-13-1935-20 19ef30c8-cf88-4196-893c-7285e9c89378 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6627-01A-13-1935-20 a73dfddc-34f3-46c0-a466-0e12202e1c79 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G4-6628 2c0a725a-e829-4d84-89d9-d0d47f6cfa37 10/31/2012 COAD Prior malignancy Prior malignancy of the L colon. No systemic chemotherapy or radiation.
TCGA-G4-6628-01A-23-1935-20 6b1c0410-f724-4f90-be6c-5d711b3d913f 12/14/2011 COAD Item is noncanonical COAD Proteomics MDA
TCGA-G5-6233 ff427104-0727-483c-8513-243dec80db9d 10/31/2012 READ Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-G5-6233 ff427104-0727-483c-8513-243dec80db9d 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-G5-6233-01A-23-1934-20 94f8d9a1-074d-4db3-b21a-5a9f37d4599c 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-G5-6235 c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1 10/31/2012 READ Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-G5-6235 c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation.
TCGA-G5-6235-01A-13-1934-20 679a8fe4-6628-484f-8d59-991ec2b8e48e 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-G5-6572 2cf90e4e-b952-4a77-aaa9-39e4e2e5c4b3 07/16/2014 READ Case submitted is found to be a recurrence after submission The TSS confirmed they sent the BCR a recurrence and not a primary tumor.
TCGA-G5-6572 2cf90e4e-b952-4a77-aaa9-39e4e2e5c4b3 11/10/2012 READ Case submitted is found to be a recurrence after submission Sample submitted was a recurrent tumor. Primary tumor was not submitted. Metastasis of primary tumor (which occurred before the recurrent tumor) was also submitted. Primary and metastatic tumors were treated systemically prior to procurement of submitted tissue.
TCGA-G5-6572 2cf90e4e-b952-4a77-aaa9-39e4e2e5c4b3 11/10/2012 READ History of unacceptable prior treatment related to a prior/other malignancy Sample submitted was a recurrent tumor. Primary tumor was not submitted. Metastasis of primary tumor (which occurred before the recurrent tumor) was also submitted. Primary and metastatic tumors were treated systemically prior to procurement of submitted tissue.
TCGA-G5-6572-01A-23-1935-20 b9e4295e-d3d9-4ba3-a3af-80313a0ee4c3 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-G5-6572-01A-24-2214-20 71c5876f-6efc-4e15-a13d-b3f1cf994a0f 03/13/2012 READ Item is noncanonical TPPT READ MDA
TCGA-G5-6572-02A-13-2189-20 125cb77d-7136-4043-b7a1-463898db7281 03/12/2012 READ Item is noncanonical READ Proteomics Recurrent MDA
TCGA-G5-6641 0a2cb2f9-972c-450c-8b7a-115a4cb93658 10/31/2012 READ Prior malignancy Prior malignancy basal cell carcinoma of the lip. No systemic chemotherapy or radiation.
TCGA-G5-6641-01A-13-1935-20 74040a56-adc6-48b6-815d-0fac35217566 12/14/2011 READ Item is noncanonical READ Proteomics MDA
TCGA-G6-6237 (none) 06/16/2014 KIRC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-G6-6254 (none) 06/16/2014 KIRC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-G7-A8LE 44f39f41-cf63-421d-ad56-513beb72d9ca 07/14/2014 KIRP Case submitted is found to be a recurrence after submission TSS confirmed case is a recurrence
TCGA-G8-6906 3f5a897d-1eaa-4d4c-8324-27ac07c90927 09/26/2014 DLBC Case submitted is found to be a recurrence after submission Patient diagnosed and had prior treatment (CHOP) 7 years prior to procurement of the TCGA specimen. The TSS did confirm the TCGA tumor was a recurrence.
TCGA-G9-6351-11A c3834f6c-79ec-4a6d-afa0-bd5d93b7a8f0 09/03/2013 PRAD Pathology outside specification Normal tissue contains tumor
TCGA-G9-6362-11A 6a5e7727-4af9-461c-8144-f93e49fb5279 09/03/2013 PRAD Pathology outside specification Normal tissue contains tumor
TCGA-G9-6363-11A c0dabc00-b14e-456b-8eea-39ba512dea8a 09/03/2013 PRAD Pathology outside specification Normal tissue contains tumor
TCGA-G9-6364 f8d8b417-5945-42a5-850a-fbc04b4f0e61 11/10/2012 PRAD Synchronous malignancy Pt with synchronous bladder cancer
TCGA-G9-6499-11A 8c0d4ed2-f07e-4249-9294-85222d5f0936 09/03/2013 PRAD Pathology outside specification Normal tissue contains tumor
TCGA-GC-A3BM 7840aea9-40c4-473e-be33-8fa0b9f332c9 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-GC-A3RB a0bcf1b1-4dd4-4d7f-b63e-b49296671451 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-GC-A3WC db52c68a-ed44-4ec4-9381-d75f9bcbc29a 02/01/2013 BLCA Prior malignancy Patient had a prior breast cancer. No radiation or systemic chemotherapy.
TCGA-GC-A3YS 4d323b18-ce5a-4516-862d-7ed1fdf1f008 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-GI-A2C8 33fe5833-d7a0-43d7-a03d-56985ea448a6 06/16/2014 BRCA Neoadjuvant therapy systemic treatment
TCGA-GN-A261 47d64b2c-9da8-4f2d-ab12-752eef91693c 04/18/2013 SKCM Neoadjuvant therapy Patient received immunotherapy/vaccine for the TCGA tumor.
TCGA-GN-A262 e36c9411-773b-4a8e-9b43-895b3cb044c7 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-GN-A267 ab74d6ed-880e-4470-bfd5-2974a4c3a0d7 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-GN-A9SD ec4c4296-6ab4-420c-80a4-e7a34b9bf4a2 06/30/2014 SKCM Neoadjuvant therapy Patient had isolated limb profusion for the malignancy submitted to TCGA prior to tumor resection, treated with Actinomycin D and Melphalan.
TCGA-GU-A42P ff5b9238-38a7-42b4-9d44-3b8ec9913f6d 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-GV-A3QF 47990d5e-a0e1-4752-86f5-4f5b84e219df 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-GV-A3QG 79f23a0e-5aae-4618-8191-7dd7c0552408 02/01/2013 BLCA Prior malignancy Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-GV-A3QG 79f23a0e-5aae-4618-8191-7dd7c0552408 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-GV-A3QK 9ee8e704-c61d-413d-b69d-257ef829fdae 02/01/2013 BLCA Prior malignancy Patient had a prior colon cancer. No radiation or systemic chemotherapy.
TCGA-GV-A40E aa6142af-bad7-493c-98a0-fd070de39073 02/01/2013 BLCA Prior malignancy Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-GV-A40G 10422fe9-8d70-40a9-9875-3fe9fab68823 02/01/2013 BLCA Prior malignancy Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.
TCGA-H8-A6C1 3e09fd70-6464-42f6-96a6-b51d7c298fc5 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is atrophic pancreas
TCGA-H9-7969 (none) 06/16/2014 PRAD History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-HB-A43Z 9c9b53e5-cdbe-4510-a839-4a3b5039681b 04/18/2013 SARC Synchronous malignancy Patient had a synchronous cystic renal cell carcinoma.
TCGA-HC-7748 f6040682-4999-4d71-abc2-354b473c6980 10/31/2012 PRAD Prior malignancy Prior malignancy R kidney cancer. No systemic chemotherapy or radiation.
TCGA-HC-7821 929837f9-297a-47c0-ac9a-a142eef620d3 10/31/2012 PRAD Prior malignancy Prior malignancy SCC of the neck. No systemic chemotherapy or radiation.
TCGA-HC-8259 07ccb4e9-a2a9-4bfd-97bd-13873b01977a 06/19/2014 PRAD Item does not meet study protocol Upon second review, the frozen top slide used to qualify the case had no tumor.
TCGA-HD-7229 5c48e21f-1fe9-4007-9b0c-7ca766586fff 11/10/2012 HNSC Synchronous malignancy Pt with synchronous malignancy of the thyroid.
TCGA-HD-8634 22933e67-5c61-4c13-9772-5adb78785b34 10/31/2012 HNSC Prior malignancy Prior malignancy cervical cancer. No systemic chemotherapy or radiation.
TCGA-HD-8635 b843df7e-db06-4d29-b00d-6a93effd9191 10/31/2012 HNSC Prior malignancy Prior malignancy cancer of the vulva. No systemic chemotherapy or radiation.
TCGA-HF-7131 06fd3086-0801-4d74-bced-4916efc544d2 10/31/2012 STAD Prior malignancy Prior malignancy R breast cancer treated with Epirubicin Hydrochloride, Fluorouracil, Cyclophosphamide, Docetaxel, and Tamoxifen Citrate.
TCGA-HF-7131 06fd3086-0801-4d74-bced-4916efc544d2 11/10/2012 STAD History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy R breast cancer treated with Epirubicin Hydrochloride, Fluorouracil, Cyclophosphamide, Docetaxel, and Tamoxifen Citrate.
TCGA-HR-A2OG-01A (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A
TCGA-HR-A2OG-01A-02-TSB (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-02-TSB
TCGA-HR-A2OG-01A-11-A20N-20 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-11-A20N-20
TCGA-HR-A2OG-01A-21 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21
TCGA-HR-A2OG-01A-21D (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21D
TCGA-HR-A2OG-01A-21D-A18Y-02 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21D-A18Y-02
TCGA-HR-A2OG-01A-21D-A191-01 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21D-A191-01
TCGA-HR-A2OG-01A-21D-A197-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21D-A197-08
TCGA-HR-A2OG-01A-21D-A19C-05 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21D-A19C-05
TCGA-HR-A2OG-01A-21R (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21R
TCGA-HR-A2OG-01A-21R-A18U-07 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21R-A18U-07
TCGA-HR-A2OG-01A-21R-A18X-13 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21R-A18X-13
TCGA-HR-A2OG-01A-21W (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21W
TCGA-HR-A2OG-01A-21W-A20H-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OG-06A-21W-A20H-08
TCGA-HR-A2OH 6668acfe-1594-42c0-b839-8a592702675f 04/18/2013 SKCM Acceptable treatment for TCGA tumor Patient received interferon for the specimen submitted to TCGA.
TCGA-HR-A2OH-01A (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A
TCGA-HR-A2OH-01A-01-TSA (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-01-TSA
TCGA-HR-A2OH-01A-11 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11
TCGA-HR-A2OH-01A-11D (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11D
TCGA-HR-A2OH-01A-11D-A18Y-02 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11D-A18Y-02
TCGA-HR-A2OH-01A-11D-A191-01 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11D-A191-01
TCGA-HR-A2OH-01A-11D-A197-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11D-A197-08
TCGA-HR-A2OH-01A-11D-A19C-05 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11D-A19C-05
TCGA-HR-A2OH-01A-11R (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11R
TCGA-HR-A2OH-01A-11R-A18U-07 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11R-A18U-07
TCGA-HR-A2OH-01A-11R-A18X-13 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11R-A18X-13
TCGA-HR-A2OH-01A-11W (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11W
TCGA-HR-A2OH-01A-11W-A20H-08 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-11W-A20H-08
TCGA-HR-A2OH-01A-21-A20N-20 (none) 01/31/2014 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Correct barcode is TCGA-HR-A2OH-06A-21-A20N-20
TCGA-HS-A5N9 2948d657-e5dd-4d6e-91b5-88c54f73ac31 06/16/2014 SARC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-HT-7604 019c5de9-74fd-48b7-95a3-227532e16c5a 12/11/2014 LGG Case submitted is found to be a recurrence after submission patient had prior LGG malignancy (and complete resection) 5 years prior to TCGA malignancy. No treatment was given prior to procurement of TCGA specimen.
TCGA-HT-A619 c13bac88-c85b-4ee3-a51c-fd503cd7e726 12/19/2014 LGG History of unacceptable prior treatment related to a prior/other malignancy Patient had a prior LGG diagnosis, surgery and radiation to the head. TCGA tumor was resected 10 years later.
TCGA-HU-A4H6 416fd59b-a4f8-4610-9f8b-473cb5c04a4a 08/04/2015 STAD Neoadjuvant therapy Dates on Enrollment and Pharmaceutical forms are inconsistent. Neoadjuvant therapy prior to TCGA procurement can not be verified as TSS is non-responsive.
TCGA-HV-A70P (none) 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is a non-invasive IPMNs
TCGA-HW-7490 c3c41fd2-f0d7-4f46-9e18-cce4626538c2 01/24/2012 LGG Prior malignancy [intgen.org]: Prior malignancy of thyroid. No systemic treatment or radiation given.
TCGA-HZ-7918 620e0648-ec20-4a12-a6cb-5546fe829c77 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is an acinar cell carcinoma
TCGA-HZ-7920 1fe937f7-b4e5-4cf6-be9b-215a012533c6 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is atrophic pancreas
TCGA-HZ-7923 565ee830-5236-4414-aeaa-48ea7eb3b753 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is atrophic pancreas
TCGA-HZ-7924 ad220f0d-06b7-4dad-a87d-36dff31c8623 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is normal ampula of Vater
TCGA-IB-7654 65e5bf5f-f22a-4ec2-8839-aeda37212b98 06/16/2014 PAAD History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-IB-AAUV 6983fc34-9577-45e1-b246-40e18fab953f 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is normal pancreas with atrophy
TCGA-IB-AAUW 18960eb6-2d79-4d12-886a-4cd1e8fc1e21 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is normal pancreas with atrophy
TCGA-IC-A6RF 9dfddc49-1e66-4e26-9d71-40d748cca0a6 08/26/2014 ESCA History of unacceptable prior treatment related to a prior/other malignancy During Enrollment it was found that the patient had a prior right breast malignancy and recieved systemic pharma treatment (cytoxan and taxotere).
TCGA-IE-A4EH 32344f23-524b-4182-ae75-6ad6128eeba0 04/18/2013 SARC Synchronous malignancy Patient had a squamous cell carcinoma, NOS of the cervix. No radiation or systemic chemotherapy.
TCGA-IF-A3RQ 8488bb97-bf11-45cc-b1bd-52969598448d 04/18/2013 SARC Prior malignancy Patient had a prior tubular adenonoma of the colon. No radiation or systemic chemotherapy.
TCGA-IF-A4AJ-11A 9e81666b-55ce-4205-a4a1-c170ad59f63d 01/22/2015 SARC Item does not meet study protocol Normal sample should not have shipped for methylation, please use exome and SNP only.
TCGA-IF-A4AK 9393e4f1-6a1b-4181-b928-72b6f335bec2 04/18/2013 SARC History of unacceptable prior treatment related to a prior/other malignancy Patient had an invasive mammary carcinoma, NOS of the breast. Patient had localized radiation and systemic chemotherapy.
TCGA-IK-8125 a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f 10/31/2012 LGG Prior malignancy Prior malignancy basal cell carcinoma of the nose. No systemic chemotherapy or radiation.
TCGA-IQ-7630-01A-13-2074-20 5b028d32-519f-481f-8323-e071f1e98672 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-IQ-7631 d8a6383e-3320-4d2c-9017-31e8e1e8f120 10/31/2012 HNSC Item does not meet study protocol An amended pathology report was submitted after case qualified and was shipped with a diagnosis change from squamous cell carcinoma to mucoepidermoid carcinoma.
TCGA-IQ-7632-01A-13-2074-20 769b0868-51cd-438d-b152-cde4850287ee 12/17/2011 HNSC Item is noncanonical HNSC Proteomics MDA
TCGA-IS-A3K6 eaadfe2a-23fb-400b-86b3-4fba6d968aa3 04/18/2013 SARC Prior malignancy Patient had a prior basal cell carcinoma of the face. No radation or systemic chemotherapy.
TCGA-IS-A3K8 dcd4d76e-4e41-4a84-b87c-6c94586e73f4 04/18/2013 SARC Prior malignancy Patient had a prior melanoma of the arm and squamous cell carcinoma of the lip. No radiation or systemic chemotherapy.
TCGA-IW-A3M6 3ea1cbd8-f74a-4b14-aa49-23d5a47716ba 04/19/2013 SARC History of acceptable prior treatment related to a prior/other malignancy Patient had a prior DCIS in the breast. Patient received local radiation but no systemic therapy. Sarcoma is a uterine leiomyosarcoma.
TCGA-J1-A4AH 99daa971-31d0-4c37-9c12-b0dc42ddd19b 07/16/2013 LUSC Synchronous malignancy Patient was diagnosed with a thymoma at same time as this lung mallignancy.
TCGA-J2-8192 369f14c4-2191-4962-a309-3e23ddc4e5fc 10/31/2012 LUAD Prior malignancy Prior malignancy of breast, cervix, and uterus. No systemic chemotherapy or radiation.
TCGA-J2-8194 2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4 10/31/2012 LUAD Prior malignancy Prior malignancy breast cancer. No systemic chemotherapy or radiation.
TCGA-J4-A6G3 9b015929-99eb-4e74-8fbf-6b2e6d7f08e4 12/30/2014 PRAD Neoadjuvant therapy Case had prior neoadjuvant hormone therapy (leuprolide) prior to TCGA cancer procurement.
TCGA-J8-A3NZ 430ad51d-f68c-40b2-bfa2-9da68370b7fa 02/22/2013 THCA Prior malignancy Patient had a prior lobular carcinoma in situ of the breast. No radiation or systemic chemotherapy.
TCGA-J8-A4HW fd3315da-c870-4ad0-9d2a-50b1647d3e46 02/22/2013 THCA History of acceptable prior treatment related to a prior/other malignancy Patient had a prior adenocarcinoma of the breast treated with locoregional radiation. No systemic chemotherapy.
TCGA-JW-A5VL d1a5b028-ec79-456b-81a1-69838e2922df 06/16/2014 CESC Item does not meet study protocol non-invasive
TCGA-K1-A3PO-11A e6ea4d54-fb11-421d-8cf4-00f5874ca717 01/22/2015 SARC Item does not meet study protocol Normal sample should not have shipped for methylation, please use exome and SNP only.
TCGA-K1-A42X-11A db940aab-c3af-407a-801b-93217d48ab8f 01/22/2015 SARC Item does not meet study protocol Normal sample should not have shipped for methylation, please use exome and SNP only.
TCGA-K4-A3WS 68adacd1-a16e-4489-9e68-792a6bd8811c 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-K4-A3WU 9aa6522a-120a-4691-993e-3f8534f644b5 02/01/2013 BLCA Synchronous malignancy Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.
TCGA-K4-AAQO 383bf27a-9216-492e-b4bd-2b4eef8278de 11/07/2014 BLCA Neoadjuvant therapy Patient received neoadjuvant chemotherapy (gemcitabine and cisplatin).
TCGA-KC-A4BL 5089a8d2-a353-4150-8a6b-6478c5bb29bb 06/22/2015 PRAD Neoadjuvant therapy TSS confirm this patient had chemotherapy prior to cancer procurement.
TCGA-KF-A41W ca0f032b-a34c-4a92-a403-bc7dc6eca8e9 04/18/2013 SARC Prior malignancy Patient had an unknown prior tumor of the skin. No radiation or systemic chemotherapy.
TCGA-KF-A41W-11A eee23025-9048-4a92-a971-5f06bf2350ae 01/22/2015 SARC Item does not meet study protocol Normal sample should not have shipped for methylation, please use exome and SNP only.
TCGA-KJ-A3U4 1a36d5de-a097-4323-90e9-f1b924a8a5d8 05/16/2013 UCEC History of unacceptable prior treatment related to a prior/other malignancy Patient had a previous invasive ductal adenocarcinoma of the breast that was treated with locoregional radiation and systemic chemotherapy.
TCGA-KL-8328 452135f2-6de6-4593-a091-ddf6344ee431 11/10/2012 KICH History of acceptable prior treatment related to a prior/other malignancy Prior malignancy prostate cancer treated with locoregional radiation. Prior malignancy oncocytoma R kidney. No systemic chemotherapy or radiation.
TCGA-KL-8328 452135f2-6de6-4593-a091-ddf6344ee431 11/10/2012 KICH Prior malignancy Prior malignancy prostate cancer treated with locoregional radiation. Prior malignancy oncocytoma R kidney. No systemic chemotherapy or radiation.
TCGA-KL-8339 e0e38071-877f-4ebf-955f-483eb4865351 11/10/2012 KICH Prior malignancy Prior malignancy melanoma of the shoulder. No systemic chemotherapy or radiation.
TCGA-KM-8439 739deed4-d1dc-458f-bd0f-1e24d2bfd305 11/10/2012 KICH Synchronous malignancy Pt with synchronous bilateral kidney cancer.
TCGA-KM-8441 f31ba8ec-a3dd-4dd8-8d15-f6c5975ebe44 11/10/2012 KICH Prior malignancy Prior malignancy L kidney cancer. No systemic chemotherapy or radiation.
TCGA-KM-8442 40f79cfe-a51f-497b-b06e-7a4f9004f092 11/10/2012 KICH Synchronous malignancy Pt with synchronous L kidney cancer.
TCGA-KM-A7Q6 bce773e1-2a8d-4402-a662-88baf9f1b68b 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7Q7 62ac3498-2538-47d1-bce4-dd6cdfb3ffbf 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7Q8 8d30c7be-73b6-4c4c-80c5-31152b2f7cb0 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7Q9 84910fbb-e5fd-48e1-99ad-768fd66ea187 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QA 8fa3a7e1-249c-4958-af0d-5a30e1353ab7 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QB ec082842-b5e2-4673-b1d5-68ff36d3522b 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QC 0bde80b1-02bf-443e-b386-b44d9d5e3dc2 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QD e00f9035-679f-4465-990c-93a75497f6c0 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QE f828a188-7011-4483-b857-afe936d9ed9b 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QG 8a1a9872-6b3e-4ad7-8ebe-85cba80f7c58 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QH 879c40d9-d21f-4d6d-abc1-c8ed9e4c0acf 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QI d22a7911-a917-470a-b19b-1f4960da66e7 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QJ 2589e8b4-c76b-445f-80c4-60516c202c2d 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QK 07a3f9d8-b741-4f96-9e88-57030c3faabc 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KM-A7QL 1c43c45d-e767-4805-9c5b-fa21392145fb 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-KN-8430 9f8aa332-e625-46f7-b77b-1fcb3ca99ee2 11/10/2012 KICH History of unacceptable prior treatment related to a prior/other malignancy Prior malignancy epitheliod cancer R pleura treated with Alimta.
TCGA-KN-8430 9f8aa332-e625-46f7-b77b-1fcb3ca99ee2 11/10/2012 KICH Prior malignancy Prior malignancy epitheliod cancer R pleura treated with Alimta.
TCGA-KP-A3VZ 6b35a816-f9c4-44d4-9824-5dee4804b80d 05/16/2013 UCEC Prior malignancy Patient had a previous basaloid squamous cell carcinoma of the nose. No systemic radiation or chemotherapy.
TCGA-L5-A43M 29da08f4-c9e2-4e7a-9733-b4ec5b9c5f13 02/01/2013 ESCA Prior malignancy Patient had a prior colon cancer. No radiation or systemic chemotherapy.
TCGA-L5-A88T 6826bcdd-24a4-4dd1-9fab-201cf774e166 06/16/2014 ESCA History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-L6-A4ET e1ff7694-64e1-47ed-b0d8-34acfb4ffef1 02/22/2013 THCA Prior malignancy Patient had a prior small cell squamous cell carcinoma of the lung. No radiation or systemic chemotherapy.
TCGA-LL-A6FP 5c9d8163-a68e-43ce-9cba-effb7405761e 06/11/2014 BRCA Neoadjuvant therapy Patient recieved neoadjuvant therapy for the TCGA sample (Armidex).
TCGA-MO-A47P a34cfb9c-44dd-4617-bbd1-28edc8d527c4 06/16/2014 SARC Item does not meet study protocol This sarcoma case is a well-differentiated adenocarcinoma and the study requires the cases be de-differentiated.
TCGA-NK-A5D1 80aa8e99-41d5-422f-a1bb-69599aa8236f 06/16/2014 LUSC History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-NP-A5B3 9c7404d6-6e97-4be2-93f6-901153869bbc 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-NP-A5GY c7921a85-329b-4b23-ad87-5a695a88611e 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-NP-A5GZ c593c5c7-edcd-46fc-ae20-d32350a6adcf 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-NP-A5H1 c8890a69-cd2f-41d1-9280-769932228690 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-NP-A5H5 b947dcf8-c83a-4bb0-b517-6b5989421c61 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-NP-A5H6 8ee83284-3cdd-44d9-a3e2-2a567f10b605 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-NP-A5H7 3ba28f6a-28eb-4f32-993d-1fd1bb9f884e 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5JH 4f845fea-e823-47d6-89fb-36ee478a43b8 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5JU cac8eaba-9e40-4048-b8cc-87574f048d91 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5KB 09454ed6-64bc-4a35-af44-7c4344623d45 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5KP 653f1d34-73e9-4216-b40b-e25c1cfc7943 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5KQ a3383252-1161-4b65-8bac-125a6eda3d08 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5KS 11d8a9c2-14d8-4fc2-8388-386051e408b1 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5L1 3ed33021-8efd-420f-9a0b-e7420b586bcd 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5L2 a26b6f97-fd7e-4b96-bdf5-9df4f9233726 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5LF 7e61e3b8-c617-4a5f-afdf-689521c9a670 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-OR-A5LI ec9c3efe-af61-4deb-b047-dcf7ee735fd2 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-P5-A5EY 1f33aebc-edc1-42c5-baa9-e4b0a06fcb26 06/16/2014 LGG Neoadjuvant therapy systemic treatment
TCGA-P6-A5OG 0824b246-9fa2-4a8b-ad4c-1ffc7731bf7d 06/12/2014 ACC History of unacceptable prior treatment related to a prior/other malignancy Prior Osteosarcoma with Cisplatin, Methotrexate, and Adriamycin given to patient prior to TCGA specimen.
TCGA-P6-A5OH 92b67ca9-6c82-463e-9cc5-685a1d02ea3e 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-PC-A5DM a692aa06-e081-4b62-bc01-a5b0a296290d 06/16/2014 SARC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-PC-A5DP f0cbc2a4-c1f7-4b32-bce1-57eb59d351cc 06/16/2014 SARC History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-PK-A5HC 891b7a67-0a01-45f0-8a32-4a1b3e888f6c 07/16/2014 ACC Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-QQ-A8VB 4c323272-2e94-4910-a894-7836570852cd 07/31/2014 SARC Case submitted is found to be a recurrence after submission TSS confirmed this case is a recurrence and not a primary tumor
TCGA-R8-A6ML 5119aceb-ad95-4904-b6c0-a0a4b42c17d0 07/01/2015 LGG Neoadjuvant therapy During enrollment, the TSS discovered the patient had temozolomide chemotherapy prior to the TCGA cancer procurement.
TCGA-R8-A73M dc7ec60b-5ea5-48a4-8908-55caf9214272 06/16/2014 LGG History of unacceptable prior treatment related to a prior/other malignancy unknown treatment history
TCGA-RL-AAAS c53d66d9-ad9a-417e-a441-df5bcf1ae13f 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is normal pancreas with atrophy
TCGA-RP-A6K9 5359d381-e7f2-4155-a559-7da9cda42ed9 02/24/2015 SKCM Neoadjuvant therapy During Enrollment it was found that patient received chemotherapy and IFN prior to TCGA tumor procurement.
TCGA-T1-A6J8 59f163d2-6a7c-41b8-b4d6-f07174dafc6e 01/12/2015 LIHC History of unacceptable prior treatment related to a prior/other malignancy TSS confirmed the patient had a prior bladder and prostate cancer with an unknown treatment history which is unacceptable for TCGA cases.
TCGA-UD-AAC5 cb245767-f9d2-4cca-95f0-f3d247c05f01 10/03/2014 MESO Neoadjuvant therapy During Enrollment it was found that the patient received raditiaion treatment 2 months prior to TCGA tumor procurement.
TCGA-US-A77J 3a3a8fe1-e35c-45d0-aa0b-4fefa9ee9183 10/15/2014 PAAD Item does not meet study protocol Per the PAAD EPC, this tumor is normal pancreas with atrophy
TCGA-UW-A72H 3fe1ed4f-583d-4033-916e-3f4e8b5df2da 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72I 5b658942-2174-461d-8ef9-0cd08952aed0 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72J e1145eaa-6bea-4a82-af2a-7ad1dc8a262e 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72K b9356af2-c448-4809-ae29-e8b80f65fa73 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72L c7679861-f8a5-4dc1-853c-943b912253f6 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72M 14e2e718-40bd-411c-bffb-e0ba8e6f4a53 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72N 863c9086-e8ce-4e92-a0c7-a913cf01aacb 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72O 33ee63ed-6ff7-4145-bcb9-391b1d8867db 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72P 1860ba2a-76a9-4ec3-a19f-a05f3f28505a 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72Q e2ee1ddf-985e-491e-8e0c-39f9731fee7a 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72R 7c191769-f139-4dda-b9ab-4e4d81064a02 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72S 528a4d08-68ed-4622-b8ff-425bc3b8edc3 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A72T d3210869-e2f3-4429-ba46-ceeaa21de943 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GC f744cc77-1db1-4e3f-a9d6-fb8d38f2f9c5 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GG bfa595a1-7db5-4cf7-ba76-5c4dba8651a2 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GI 0cfbf4d0-3d17-4b6c-85a3-52a51ad5c32b 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GJ e2c4e773-ed5e-4274-aca6-1e7168d593de 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GK 8d002850-ddd4-442c-a5cd-81340cd4e88a 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GL f72cf636-3140-4d1a-bbe7-19a4bd9d51ae 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GN 99558a57-3692-439f-bd24-3f5b90411b60 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GP dfbe9b61-1f13-4bd1-8f87-364b186c69b5 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GR a86c2490-37da-46a3-88e2-0b0ce21d067f 06/16/2014 KICH Neoadjuvant therapy systemic treatment
TCGA-UW-A7GR a86c2490-37da-46a3-88e2-0b0ce21d067f 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GU f300efc6-a125-468a-bb2f-fbaac71fcca0 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GX d0a8cfdc-c025-4de9-94ad-f5160809ff8f 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-UW-A7GY e0901bb2-27ce-46a4-bd82-ee1a8ebbe48c 07/16/2014 KICH Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-V5-A7RE-11A 7c5a7626-d549-45c0-ae47-5dee771ac0b0 01/19/2015 ESCA Item does not meet study protocol The External pathology Committee determined this normal sample contained tumor per frozen slide review and it was verified by internal BCR pathologists and should not have shipped.
TCGA-V5-A7RE-11A 7c5a7626-d549-45c0-ae47-5dee771ac0b0 01/20/2015 ESCA Pathology outside specification The External pathology Committee determined this normal sample contained tumor per frozen slide review and it was verified by internal BCR pathologists and should not have shipped.
TCGA-W5-AA2J 3f7e0cbf-e48c-410a-9138-be9b373fef73 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-W5-AA2K 859ed2d9-668d-440c-86ab-dcd0d9742973 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-W5-AA2M bec2cf62-44a2-42e5-8e10-440aad69ed77 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-W5-AA36 f2d42e03-ca8d-4b57-ae39-0cc8f37b1b67 02/26/2015 CHOL Neoadjuvant therapy Patient received Gemcitabine + capecitabine prior to cancer procurement.
TCGA-W6-AA0T cb40327b-f3ac-4f0a-bb17-7db2a281e354 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-W7-A93N d64d8a1b-b31f-4cbb-a586-5ec7f058f0de 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-W7-A93O 15850852-5979-419d-ae38-76ffd0e9d7e8 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-W7-A93P ae8d1ed6-2ddf-47b0-8099-bbc9230b499e 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-WB-A820 766c325b-404a-48c3-ba6b-5e17daff83be 06/16/2014 PCPG History of unacceptable prior treatment related to a prior/other malignancy systemic treatment given to the prior/other malignancy
TCGA-XK-AAJ3 06c9eb11-6018-4015-9fbe-b46886b2c3e0 06/19/2014 PRAD History of unacceptable prior treatment related to a prior/other malignancy extent and type of chemotherapy unknown
TCGA-XK-AAK1 1bc21d56-299d-40bc-b9c8-c74db990611e 02/24/2015 PRAD History of unacceptable prior treatment related to a prior/other malignancy During Enrollment it was found that the patient had a prior skin malignancy where dates and txreatment information are unknown.
TCGA-XQ-A8TA b47791ba-85fd-41d0-ac1f-b6fa06f18e96 05/27/2015 PRAD Neoadjuvant therapy During Enrollment, TSS confirmed patient received pharmaceutical treatment prior to TCGA tumor procurement. No other information given.
TCGA-XR-A8TC 4db9de75-9297-46e5-acc5-9275f52a642a 07/17/2015 LIHC Case submitted is found to be a recurrence after submission During enrollment, the TSS found the patient had surgery 2 months prior to the TCGA cancer procurement.
TCGA-XT-AASU a48996be-7dae-451a-8129-9de8dfe7221a 05/01/2015 MESO Neoadjuvant therapy After adding pharmaceutical forms it was discovered that this patient received Cisplatin and Pemetrexed 2 months prior to the TCGA cancer procurement.
TCGA-XV-AB01-06A ab007526-e7e9-4382-9b67-0a69f9a7e7ca 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A. Correct barcode is TCGA-XV-AB01-06A
TCGA-XV-AB01-06A-01-TS1 6a2d1bb2-f0c1-4c1e-9fad-383866aa51bd 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-01-TS1. Correct barcode is TCGA-XV-AB01-06A-01-TS1
TCGA-XV-AB01-06A-12 92554f1d-bde9-4ae1-b229-a92ac7ab900e 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12. Correct barcode is TCGA-XV-AB01-06A-12
TCGA-XV-AB01-06A-12D a5129791-f2f3-4748-a456-fd174be5ea6a 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12D. Correct barcode is TCGA-XV-AB01-06A-12D
TCGA-XV-AB01-06A-12D-A400-01 c327cb94-cf26-4174-8261-d3a6ed1cafdb 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12D-A400-01. Correct barcode is TCGA-XV-AB01-06A-12D-A400-01
TCGA-XV-AB01-06A-12D-A401-08 056f24a0-0af8-44f3-83f0-496417ed8b0b 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12D-A401-08. Correct barcode is TCGA-XV-AB01-06A-12D-A401-08
TCGA-XV-AB01-06A-12D-A408-05 b6b3d948-d299-4bce-b74d-56deb4b8b61e 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12D-A408-05. Correct barcode is TCGA-XV-AB01-06A-12D-A408-05
TCGA-XV-AB01-06A-12R f927808d-77e2-4f50-8ed5-1c5834966ab2 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12R. Correct barcode is TCGA-XV-AB01-06A-12R
TCGA-XV-AB01-06A-12R-A404-13 c2472a32-f2c4-4c31-ba23-7b0f051bcdc8 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12R-A404. Correct barcode is TCGA-XV-AB01-06A-12R-A404
TCGA-XV-AB01-06A-12R-A40A-07 b6e6842a-3e5d-43ac-ac7f-e983b0614d76 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-12R-A40A. Correct barcode is TCGA-XV-AB01-06A-12R-A40A-07
TCGA-XV-AB01-06A-21-A444-20 a6077659-6c4f-4817-bd34-4ff94e8dbebd 05/04/2015 SKCM Barcode incorrect Originally identified as primary solid tumor, reclassified as metastatic. Data associated with this barcode will be transitioned to the correct barcode. Original barcode was TCGA-XV-AB01-01A-21-A444-20. Correct barcode is TCGA-XV-AB01-06A-21-A444-20
TCGA-ZH-A8Y3 1947a152-6339-4f66-b9a4-0229580f0287 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-ZH-A8Y7 37d60df9-2fa5-433b-9e54-dccb5ed5a638 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
TCGA-ZJ-A8QQ b12deb95-6aa1-49cb-a3c5-a711d42d6fb9 06/18/2014 CESC Duplicate item please notify: case matches EK-A2H0 This case was the first biopsy procured.
TCGA-ZK-AAYZ 91544f6b-90b6-45df-a501-3097fe0c74be 06/24/2015 CHOL Item is noncanonical Extension set. Only DNA from tumor and normal shipped.
Made with Nozzle